
<html lang="en"     class="pb-page"  data-request-id="8a2c9387-6150-4aad-8ce4-2cc5bf1be2d4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b00863;issue:issue:10.1021/jmcmar.2015.58.issue-15"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)" /></meta><meta name="dc.Creator" content="Gregory S.  Basarab" /></meta><meta name="dc.Creator" content="Peter  Doig" /></meta><meta name="dc.Creator" content="Vincent  Galullo" /></meta><meta name="dc.Creator" content="Gunther  Kern" /></meta><meta name="dc.Creator" content="Amy  Kimzey" /></meta><meta name="dc.Creator" content="Amy  Kutschke" /></meta><meta name="dc.Creator" content="Joseph P.  Newman" /></meta><meta name="dc.Creator" content="Marshall  Morningstar" /></meta><meta name="dc.Creator" content="John  Mueller" /></meta><meta name="dc.Creator" content="Linda  Otterson" /></meta><meta name="dc.Creator" content="Karthick  Vishwanathan" /></meta><meta name="dc.Creator" content="Fei  Zhou" /></meta><meta name="dc.Creator" content="Madhusudhan  Gowravaram" /></meta><meta name="dc.Description" content="A novel class of bacterial type-II topoisomerase inhibitor displaying a spiropyrimidinetrione architecture fused to a benzisoxazole scaffold shows potent activity against Gram-positive and fastidio..." /></meta><meta name="Description" content="A novel class of bacterial type-II topoisomerase inhibitor displaying a spiropyrimidinetrione architecture fused to a benzisoxazole scaffold shows potent activity against Gram-positive and fastidio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 24, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00863" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00863" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00863" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00863" /></link>
        
    
    

<title>Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00863" /></meta><meta property="og:title" content="Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0010.jpeg" /></meta><meta property="og:description" content="A novel class of bacterial type-II topoisomerase inhibitor displaying a spiropyrimidinetrione architecture fused to a benzisoxazole scaffold shows potent activity against Gram-positive and fastidious Gram-negative bacteria. Here, we describe a series of N-linked oxazolidinone substituents on the benzisoxazole that improve upon the antibacterial activity of initially described compounds of the class, show favorable PK properties, and demonstrate efficacy in an in vivo Staphylococcus aureus infection model. Inhibition of the topoisomerases DNA gyrase and topoisomerase IV from both Gram-positive and a Gram-negative organisms was demonstrated. Compounds showed a clean in vitro toxicity profile, including no genotoxicity and no bone marrow toxicity at the highest evaluated concentrations or other issues that have been problematic for some fluoroquinolones. Compound 1u was identified for advancement into human clinical trials for treatment of uncomplicated gonorrhea based on a variety of beneficial attributes including the potent activity and the favorable safety profile." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00863"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00863">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00863&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00863&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00863&amp;href=/doi/10.1021/acs.jmedchem.5b00863" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6264-6282</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00802" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00896" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Basarab">Gregory S. Basarab</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Doig">Peter Doig</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Galullo">Vincent Galullo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gunther++Kern">Gunther Kern</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Kimzey">Amy Kimzey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Kutschke">Amy Kutschke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Newman">Joseph P. Newman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marshall++Morningstar">Marshall Morningstar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Mueller">John Mueller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linda++Otterson">Linda Otterson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karthick++Vishwanathan">Karthick Vishwanathan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Zhou">Fei Zhou</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Madhusudhan++Gowravaram">Madhusudhan Gowravaram</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +27 (0)21 6505995. E-mail: <a href="/cdn-cgi/l/email-protection#e582978082cb87849684978487a5908691cb8486cb9f84"><span class="__cf_email__" data-cfemail="9ef9ecfbf9b0fcffedffecfffcdeebfdeab0fffdb0e4ff">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00863&amp;href=/doi/10.1021%2Facs.jmedchem.5b00863" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6264–6282</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 9, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 June 2015</li><li><span class="item_label"><b>Published</b> online</span>24 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00863" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00863</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6264%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGregory%2BS.%2BBasarab%252C%2BPeter%2BDoig%252C%2BVincent%2BGalullo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D15%26contentID%3Dacs.jmedchem.5b00863%26title%3DDiscovery%2Bof%2BNovel%2BDNA%2BGyrase%2BInhibiting%2BSpiropyrimidinetriones%253A%2BBenzisoxazole%2BFusion%2Bwith%2BN-Linked%2BOxazolidinone%2BSubstituents%2BLeading%2Bto%2Ba%2BClinical%2BCandidate%2B%2528ETX0914%2529%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6282%26publicationDate%3DAugust%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00863"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2124</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00863" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Basarab&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Doig&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Galullo&quot;},{&quot;first_name&quot;:&quot;Gunther&quot;,&quot;last_name&quot;:&quot;Kern&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Kimzey&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Kutschke&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Newman&quot;},{&quot;first_name&quot;:&quot;Marshall&quot;,&quot;last_name&quot;:&quot;Morningstar&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Mueller&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;Otterson&quot;},{&quot;first_name&quot;:&quot;Karthick&quot;,&quot;last_name&quot;:&quot;Vishwanathan&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Madhusudhan&quot;,&quot;last_name&quot;:&quot;Gowravaram&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6264-6282&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00863&quot;},&quot;abstract&quot;:&quot;A novel class of bacterial type-II topoisomerase inhibitor displaying a spiropyrimidinetrione architecture fused to a benzisoxazole scaffold shows potent activity against Gram-positive and fastidious Gram-negative bacteria. Here, we describe a series of N-linked oxazolidinone substituents on the benzisoxazole that improve upon the antibacterial activity of initially described compounds of the class, show favorable PK properties, and demonstrate efficacy in an in vivo Staphylococcus aureus infection model. Inhibition of the topoisomerases DNA gyrase and topoisomerase IV from both Gram-positive and a Gram-negative organisms was demonstrated. Compounds showed a clean in vitro toxicity profile, including no genotoxicity and no bone marrow toxicity at the highest evaluated concentrations or other issues that have been problematic for some fluoroquinolones. Compound 1u was identified for advancement into human clinical trials for treatment of uncomplicated gonorrhea based on a variety of beneficial attributes inclu&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00863&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00863" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00863&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00863" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00863&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00863" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00863&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00863&amp;href=/doi/10.1021/acs.jmedchem.5b00863" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00863" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00863" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00863%26sid%3Dliteratum%253Aachs%26pmid%3D26158756%26genre%3Darticle%26aulast%3DBasarab%26date%3D2015%26atitle%3DDiscovery%2Bof%2BNovel%2BDNA%2BGyrase%2BInhibiting%2BSpiropyrimidinetriones%253A%2BBenzisoxazole%2BFusion%2Bwith%2BN-Linked%2BOxazolidinone%2BSubstituents%2BLeading%2Bto%2Ba%2BClinical%2BCandidate%2B%2528ETX0914%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D15%26spage%3D6264%26epage%3D6282%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/jmcmar.2015.58.issue-15/20150813/jmcmar.2015.58.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel class of bacterial type-II topoisomerase inhibitor displaying a spiropyrimidinetrione architecture fused to a benzisoxazole scaffold shows potent activity against Gram-positive and fastidious Gram-negative bacteria. Here, we describe a series of <i>N</i>-linked oxazolidinone substituents on the benzisoxazole that improve upon the antibacterial activity of initially described compounds of the class, show favorable PK properties, and demonstrate efficacy in an in vivo <i>Staphylococcus aureus</i> infection model. Inhibition of the topoisomerases DNA gyrase and topoisomerase IV from both Gram-positive and a Gram-negative organisms was demonstrated. Compounds showed a clean in vitro toxicity profile, including no genotoxicity and no bone marrow toxicity at the highest evaluated concentrations or other issues that have been problematic for some fluoroquinolones. Compound <b>1u</b> was identified for advancement into human clinical trials for treatment of uncomplicated gonorrhea based on a variety of beneficial attributes including the potent activity and the favorable safety profile.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is a critical need to discover and develop antibacterial agents with a novel mode-of-action that address highly problematic resistance issues across the most widely used classes of antibacterials including, but not limited to, β-lactam and glycopeptide antibiotics that inhibit cell-wall biosynthesis, aminoglycoside and macrolide antibiotics that disrupt ribosome function, and fluoroquinolone topoisomerase inhibiting antibacterials that impede DNA replication.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Multidrug resistant <i>Staphylococcus aureus</i>, for example, represents one of a series of resistant pathogens encountered routinely in hospital settings where treatment options have become quite limited.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9">(5-9)</a> Recently, an alarming spread of drug resistant <i>Neisseria gonorrheae</i><a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> has caught the attention of the World Health Organization,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the Centers for Disease Control and Prevention,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and the European Centre for Disease Control and Reponse,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> which have implored the development of novel treatment options. To address such problems of resistance, we previously described a novel class of antibacterial agents with a benzisoxazole scaffold fused to a six-membered ring that displays a spirocyclic pyrimidinetrione pharmacophore (e.g., compound <b>1u</b>, ETX0914, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Compound <b>1u</b> showed activity against Gram-positive bacteria including <i>Streptococcus pneumoniae</i>, <i>Streptococcus pyogenes</i>, and methicillin-resistant fluoroquinolone-resistant (MRQR) <i>S. aureus</i> as well as against fastidious Gram-negative bacteria including <i>Haemophilus influenzae</i> and <i>N. gonorrheae</i>. Like fluoroquinolones (e.g., ciprofloxacin <b>2</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), <b>1u</b> and other spiropyrimidinetriones inhibit type II topoisomerases, DNA gyrase and topoisomerase IV (Topo IV), but through a different mode of inhibition as suggested by their potent activity against clinical bacterial strains resistant to the fluoroquinolones. Compound <b>1u</b> was also fully active against laboratory strains of <i>S. aureus</i> and <i>S. pneumoniae</i> resistant to novobiocin (<b>3</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which binds to the ATP site of DNA gyrase and Topo IV.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> It was also more active against <i>S. aureus</i> including MRSA (methicillin resistant <i>S. aureus</i>) than linezolid (<b>4</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a current standard of care for skin infections caused by the organism. Developing novel drugs that operate by a novel DNA gyrase and Topo IV inhibitory mechanism would ultimately expand the arsenal of drugs available to practicing physicians to treat bacterial infections. Preliminary structure–activity relationships around the benzisoxazole scaffold showed that the oxazolidinone substituent averted bone marrow toxicity and genotoxicity seen with other substituents, which led to the selection of <b>1u</b> for development through phase 1 clinical trials (Clinicaltrials.gov Identifier: NCT01929629).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The introduction of the oxazolidinone sp<sup>3</sup> centers enabled the incorporation of asymmetric centers that were not possible with a wide variety of aromatic substituents linked through a carbon or nitrogen atom to the benzisoxazole.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Clinical success has been correlated with increased fraction sp<sup>3</sup> (Fsp<sup>3</sup>) more generally in drug candidates attributed, in part, to the potential to increase solubility and decrease off-target activity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Herein, we describe a more in depth analysis of benzisoxazole spiropyrimidinetriones with N-linked oxazolidinone substituents that generated considerable import due to favorable antibacterial, physical property, and pharmacokinetic (PK) attributes. Presented are the associated structure–activity relationships, pharmacology, and toxicology properties that led to the selection of <b>1u</b> for human clinical trials.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antibacterial agents <b>1</b>–<b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Variation of Benzisoxazole Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>f</i><sub>u</sub>: fraction unbound.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last"><i>E. coli</i> FP-based DNA gyrase inhibition.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Spn: <i>S. pneumoniae</i>.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Spy: <i>S. pyogenes</i>.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Methicillin sensitive <i>S. aureus</i>.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Methicillin sensitive <i>S. aureus</i> + 50% human serum.</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">Methicillin resistant, quinolone resistant <i>S. aureus</i>.</p></div><div class="footnote" id="t1fn8"><sup>Table h</sup><p class="last"><i>H. influenzae</i>.</p></div><div class="footnote" id="t1fn9"><sup>Table i</sup><p class="last"><i>N. gonorrheoea</i>.</p></div><div class="footnote" id="t1fn10"><sup>Table j</sup><p class="last"><i>E. coli</i>.</p></div><div class="footnote" id="t1fn11"><sup>Table k</sup><p class="last">In vivo clearance.</p></div><div class="footnote" id="t1fn12"><sup>Table l</sup><p class="last">ND = not determined.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">The general synthesis of fluorobenzisoxazoles with oxazolidinone and imidazolidinone substituents (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) utilized either compound <b>5a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> or <b>5b</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), which can be made in multigram quantities in five steps from commercial starting materials. Chlorobenzisoxazole <b>5c</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) was made similarly to <b>5a</b> and was carried on in the reaction sequence of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Using the chiral trans (2<i>R</i>,4<i>R</i>)-dimethylmorpholine in <b>5a</b>, <b>5b</b>, and <b>5c</b> enabled the enantiospecific synthesis of final products. Treatment of the compounds with a variety of chiral oxazolidinones (X = O) and imidazolidinones (X = NH, NCH<sub>3</sub>) and sodium hydride afforded <b>6a</b>–<b>q</b>, the products of S<sub>N</sub>Ar displacement of the 3-position chloride. These were generally converted to spiropyrimidinetrione final products <b>1a</b>–<b>q</b> by heating with barbituric acid in acetic acid–water. For two compounds, <b>1d</b> and <b>1i</b> with pendant hydroxyl groups, the final conversion was better carried out in an ethanol–aqueous HCl cosolvent to avoid byproduct acylation seen with the acetic acid conditions. Overall, the sequence of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> enabled the efficient late stage introduction and survey of oxazolidinone/imidazolidinone substituents for SAR purposes. Compounds <b>1a</b>–<b>q</b> (as well as all final products herein) were purified predominately by chiral supercritical fluid chromatography (SFC) to remove <b>7a</b>–<b>q</b>, a minor diastereomer produced in each of the reactions. Although diastereomers and not enantiomers were being separated, purifications were best achieved via such chiral chromatography. The final reaction proceeded by an in situ ketal hydrolysis to the aldehyde, a Knövenagel condensation and a tertiary amino effect reaction (T-reaction).<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> The T-reaction in its current form was pioneered by Reinhoudt in the 1980s and involves an irreversible internal redox or [1,5]-hydride shift reaction to form a zwitterion intermediate.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> The morpholine methyl substituent next to the iminium species can epimerize, accounting for the configuration seen in compounds <b>1a</b>–<b>q</b>.<a onclick="showRef(event, 'ref16 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref16 ref26 ref27">(16, 26, 27)</a> The cyclization of the zwitterion iminium species under the reaction conditions can occur above and below the plane of either the <i>cis</i>- or <i>trans</i>-dimethylmorpholine rings in a reversible fashion to allow for four possible diastereomers. Only diastereomers <b>1</b> and <b>7</b> were seen in the crude reaction mixture, and their configurations represent the thermodynamically lowest energy of the four possible, with <b>1</b> being favored over <b>7</b> in a 9:1 ratio.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of N-Linked Oxazolidinones and Imidazolidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, 80 °C, 2–16 h, 12–47%; (b) AcOH, H<sub>2</sub>O or EtOH, 6 N HCl, 120 °C, 1 h, 15–72%.</p></p></figure><div class="NLM_p">In an alternative synthetic sequence utilized for the syntheses of <b>1r</b>–<b>u</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), the benzisoxazole and oxazolidinone were assembled before incorporation of the chiral morpholine unit, the latter introduced in the penultimate step. This proved advantageous for the scale-up of individual compounds for three reasons. First, the chiral morpholine accounted for much of the cost associated with the synthesis, which would be minimized by its late stage introduction. Second, the late stage introduction allowed for more facile diversification away from the dimethylmorpholine with alternate amines for the analogue program (work not included herein). Finally, overall yields of the reaction sequence were higher. The key intermediate <b>10</b> was prepared in four steps starting with protection of aldehyde <b>8</b> to set up a fluorine-directed <i>ortho</i>-lithiation<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> followed by DMF quench to form aldehyde <b>9</b>. The aldehyde was converted to oximoyl chloride <b>10</b> to be followed by chloride displacement with chiral aminoalcohols and cyclization to benzisoxazoles <b>11r</b>–<b>u</b> on treatment with strong base. The oxazolidinone was made by reaction with carbonyl diimidazole (CDI), and the acetal was hydrolyzed to the aldehyde with acid, affording <b>12r</b>–<b>u</b>. S<sub>N</sub>Ar dimethylmorpholine displacement of the fluoride adjacent to the aldehyde afforded <b>13r</b>–<b>u</b>, which was followed by Knövenagel condensation and T-reaction with barbituric acid. As before, a 9:1 ratio of diastereomers was obtained, with the major materials <b>1r</b>–<b>u</b> being separated from the minor diastereomers. In two cases, <b>1t</b> and <b>1u</b>, the minor diastereomers were isolated and fully characterized analytically and biologically. As described earlier for other spiropyrimidinetriones,<a onclick="showRef(event, 'ref16 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref16 ref26 ref27">(16, 26, 27)</a> the configurations of <b>1</b> and <b>7</b> were determined by NMR including detailed NOESY correlations around the morpholine ring (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for the NOESY spectra of <b>1u</b> and <b>7u</b>). The morpholine ring of both <b>1u</b> and <b>7u</b> exist primarily in a chair conformation in solution, with both methyl groups equatorial for the former and one methyl group axial, the other equatorial for the latter. A crystal structure of <b>1u</b> as a 1:1 methanol solvate confirmed the configuration, mirrored the solution conformation, and showed the attachment of the oxazolidinone ring to be nearly coplanar with the benzisoxazole scaffold with a 1° torsion (CCDC 1025296, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Finally, the enantiomers <i>ent</i>-<b>1t</b> and <i>ent</i>-<b>1u</b> of <b>1t</b> and <b>1u</b>, respectively, were synthesized in an independent synthetic sequence using meso <i>cis</i>-dimethylmorpholine and chiral oxazolidinones. The sequence therefore required the separation of (2<i>R</i>,4<i>S</i>,4a<i>S</i>)- and (2<i>S</i>,4<i>R</i>,4a<i>R</i>)-morpholine diastereomers in the final products (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Alternative Synthetic Scheme to N-Linked Oxazolidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethylene glycol, <i>p</i>-TsOH, refluxing toluene, 78% yield; (b) <i>n</i>-BuLi, −70 °C, THF, DMF quench, 93% yield; (c) NH<sub>2</sub>OH, EtOH, rt, 24 h, 80% yield; (d) NCS, DMF, rt, 4 h, 76% yield; (e) excess amine, DMF, rt, 1–3 h; (f) NaO<i>t</i>-Bu or Cs<sub>2</sub>CO<sub>3</sub>, rt, 2 steps, 59–93%; (g) CDI, DIEA, DMF, 70 °C, 2–3 h; (h) HCl, dioxane or THF, water, 70 °C, 2 steps: 75–99%; (i) K<sub>2</sub>CO<sub>3</sub> or DIEA, CH<sub>3</sub>CN, water, 80 °C, 4–5 h, 73–98%; (j) AcOH, water 120 °C, 1h, 26–81%.</p></p></figure><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>1u</b> (data in the Cambridge Crystallographic Data Centre: CCDC 1025296). Left: Ortep representation with MeOH solvate removed. Right: side view (with hydrogen atoms also removed) showing morpholine chair conformation and perpendicular orientation of oxazolidinone methyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Activity Relationships</h3><div class="NLM_p">Compounds were evaluated for inhibition of DNA gyrase activity using the <i>Escherichia coli</i> isozyme amenable (versus other isozymes) to a robust fluorescence polarization (FP) anisotropy-based DNA supercoiling assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) that is considerably higher through-put than typically used gel-based assays.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Antibacterial activity, determined as the MIC (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), did not correlate well with inhibitory potency for <i>E. coli</i> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) as ascertained by the <i>R</i><sup>2</sup> factor from regression analysis being only 0.16. Deviations from linearity were likely due to variable membrane permeability and the capability of the compounds to also inhibit Topo IV (see below). However, as the log <i>D</i> range narrows further to reflect compounds that might have similar permeability, the <i>R</i><sup>2</sup> continued to increase: for example, a narrow log <i>D</i> range of 1.5–1.9 led to an <i>R</i><sup>2</sup> of 0.91 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). It was within this narrow range that the aggregate of multivariate compound properties proved best toward identifying a candidate drug. Among such properties are solubility, protein binding, and in vivo clearance in addition to antibacterial activity. Four compounds (<b>1h</b>, <b>1o</b>, <b>1t</b>, and <b>1u</b>) showed MIC values <10 μM versus <i>E. coli</i>, although the values were not sufficiently low to anticipate efficacy against the pathogen at reasonable doses in an in vivo situation. Nonetheless, the robust spread of MIC data seen for <i>E. coli</i> offered a measure of differentiation among the compounds and a tool for understanding parameters that account for activity. Compounds with higher antibacterial activity against <i>E. coli</i> generally showed higher activity against the other bacteria in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, demonstrating the utility of the FP assay for understanding the SAR. In contrast to <i>E. coli</i>, the other bacteria did show sufficient susceptibility to anticipate demonstration of in vivo efficacy. These include the fastidious Gram-negative pathogens <i>H. influenzae</i> and <i>N. gonorrheae</i> and four Gram-positive pathogens, namely <i>S. pneumoniae</i>, <i>Streptococcus pyogenes</i>, and two strains of <i>S. aureus</i>, a drug susceptible strain (MSSA) and a methicillin and fluoroquinolone resistant strain (MRQR). Two comparators, ciprofloxacin and linezolid, are included in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>; ciprofloxacin provides a frame of reference as a fluoroquinolone DNA gyrase inhibitor, and linezolid serves as a standard of care for Gram-positive skin infections. Resistance to fluoroquinolones in the MRQR strain is due to two topoisomerase mutations, S85P in GyrA and S80Y in ParC. As a result, the MIC for ciprofloxacin against the MSSA strain was 0.78 and >50 μM versus the MRQR strain. In contrast, the MIC values for the spiropyrimidinetriones of <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> versus the MSSA and MRQR strains were similar with variations only 1–4-fold. This supports the differential mode-of-inhibition for spiropyrimidinetriones relative to fluoroquinolones. A balanced set of MIC values for the compounds of <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were also obtained across the <i>Staphylococcus</i> and <i>Streptococcus</i> species. Compound <b>1t</b>, for example, showed MIC values of 0.2–0.4 μM across <i>S. pneumoniae</i>, <i>S. pyogenes</i>, and MSSA in contrast to initial benzisoxazole spiropyrimidinetriones that showed notably higher antibacterial activity against Staphylococci relative to Streptococci.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Overall, the compounds with more favorable physical and PK properties critical for advancing a drug candidate also showed sufficient antibacterial potency against <i>S. aureus</i> and <i>S. pyogenes</i> to address skin infections, against <i>S. aureus</i>, <i>S. pneumoniae</i>, and <i>H. influenzae</i> to address respiratory tract infections, and against <i>N. gonorrheae</i> to address uncomplicated gonorrhea.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Correlation between <i>E. coli</i> DNA gyrase inhibitory potency and antibacterial activity: (A) compounds within <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>; (B) select compounds with a narrow log <i>D</i> range (1.5–1.9).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As comparators, the opposite enantiomers (<i>ent</i>-<b>1t</b> and <i>ent</i>-<b>1u</b>) of two compounds, <b>1t</b> and <b>1u</b>, were made, and the corresponding minor diastereomers <b>7t</b> and <b>7u</b> were separated for biological and physical property profiling (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). As shown in previous publications describing spiropyrimidinetriones,<a onclick="showRef(event, 'ref16 ref26'); return false;" href="javascript:void(0);" class="ref ref16 ref26">(16, 26)</a> stereochemistry around the morpholine ring had a profound impact on inhibitory potency and thereby antibacterial activity, and compounds with the (<i>R</i>,<i>S</i>,<i>S</i>)-morpholine configuration as diagrammed for <b>1</b> displayed much higher activity than the enantiomeric antipodes (<i>ent</i>-<b>1t</b> and <i>ent</i>-<b>1u</b>) and minor diastereomers (<b>7t</b> and <b>7u</b>). Importantly, there was also a recognition element for human plasma protein binding (PPB) as the more active diastereomers <b>1t</b> and <b>1u</b> showed a 6–9-fold higher free fraction (or fraction unbound, <i>f</i><sub>u</sub>) than those of the respective enantiomers or the respective minor diastereomers. A higher <i>f</i><sub>u</sub> would be expected to afford higher activity in an in vivo situation as unbound drug is thought to be necessary for interaction with the target and the pathogen. As an in vitro indication of this, MIC values were determined for MSSA in the presence of 50% human serum (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> For the most part, the shift to a higher MIC was around 2-fold. However, more highly protein bound compounds such as <b>1m</b> with <i>f</i><sub>u</sub> = 0.01 displayed a notably larger 16-fold MIC increase. On the other hand, PPB can increase compound exposure in vivo due to its role in protecting a compound from clearance mechanisms; compounds with both a high <i>f</i><sub>u</sub> and a low clearance would be thus best suited as drug candidates.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> Realizing maximal drug exposure and efficacy in a disease model thus relates to the free AUC with the preference being for compounds with a higher <i>f</i><sub>u</sub> and AUC (lower clearance) and a lower MIC.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Influence of Stereochemistry on DNA Gyrase Inhibitory Potency, MIC Values, and PPB</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0009.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>E. coli</i> FP-based DNA gyrase inhibition.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last"><i>f</i><sub>u</sub>: fraction unbound.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Spn: <i>S. pneumoniae</i>.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Spy: <i>S. pyogenes</i>.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Methicillin sensitive <i>S. aureus</i>.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Methicillin resistant, quinolone resistant <i>S. aureus</i>.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last"><i>H. influenzae</i>.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last"><i>E. coli</i>.</p></div></div><div></div></div><div class="NLM_p">Structure insights of DNA gyrase or Topo IV could not be used for optimization of spiropyrimidinetrione analogues as their binding environment has not been determined to date by X-ray diffraction or NMR as has been done for fluoroquinolones,<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> aminopiperidine topoisomerase inhibitors termed NBTIs (novel bacterial topoisomerase inhibitors),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> aminocoumarins,<a onclick="showRef(event, 'ref17 ref18 ref38'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref38">(17, 18, 38)</a> and other ATP competitive inhibitors.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Hence, the latitude for substitution on the oxazolidinone and imidazolidinone ring as seen in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> was determined through SAR correlations and was shown to be quite broad. Both saturated carbon positions of the oxazolidinone (4- and 5-positions, see <b>1a</b> of <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> for numbering) tolerated substitutions in either possible configuration. However, in every matched pair, substituents below the plane of the oxazolidinone ring as drawn in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were preferred over those above. This includes the matched pairs <b>1t</b> and <b>1u</b> that showed higher inhibitory potency and antibacterial activity than <b>1b</b> and <b>1g</b>, respectively. Substituents at each of the oxazolidinone 4- and 5-positions showed similar activity; hence, <b>1b</b>–<b>f</b> and <b>1t</b> with 5-position substituents showed similar activity to <b>1g</b>–<b>k</b> and <b>1u</b> that have respectively identical 4-position substituents. Substitution at both the 4- and 5-positions with methyl groups followed the trend that overall highest potency was seen with the orientation of both methyl groups below the plane of the oxazolidinone ring as seen by comparing <b>1o</b> with <b>1n</b>. More polar substituents, as incorporated in <b>1d</b>, <b>1l</b>, <b>1p</b>, <b>1q</b>, and <b>1r</b>, diminished antibacterial activity presumably due to decreased target potency and/or bacterial membrane permeability. Importantly, addition of the substituents onto the oxazolidinone generally increased solubility (compare with <b>1a</b><a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), presumably due to reorganization of crystal packing arrangements. The X-ray structure of <b>1u</b> showed the oxazolidinone methyl group to be nearly perpendicular (81°) to the plane encompassing the benzisoxazole and oxazolidinone (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) without π–π stacking within the crystal lattice. Fluorine and chlorine substituents on the benzisoxazole ring were about equipotent; the increased lipophilicity of chlorine decreased <i>f</i><sub>u</sub> and solubility. Finally, replacement of the oxazolidinone ring oxygen atom with nitrogen (<b>1p</b> and <b>1q</b>) decreased but did not eliminate activity.</div><div class="NLM_p">IV pharmacokinetic (PK) parameters were determined in the rat for select compounds with higher antibacterial activity, solubility, and <i>f</i><sub>u</sub> (clearances shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Low clearance (Cl) was generally seen with methyl substituents on the oxazolidinone ring. Methoxymethyl substituents generally afforded higher Cl as seen with <b>1e</b>, <b>1j</b>, and <b>1k</b>. Replacement of the fluorine atom with chlorine usually lowered Cl, as in the instances of <b>1c</b>, <b>1f</b>, and <b>1h</b> relative to <b>1t</b>, <b>1e</b>, and <b>1u</b>, respectively, correlating with the lower <i>f</i><sub>u</sub>. Distilling <i>f</i><sub>u</sub>, antibacterial activity, and rat Cl (normalizing AUC to a 1 mg dose) into a single number fAUC/MIC (<i>f</i><sub>u</sub>·AUC/dose·MIC)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> showed favorable values for three compounds, <b>1o</b>, <b>1t</b>, and <b>1u</b>, relative to other compounds of <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. These three compounds were evaluated in rat and dog for both IV and oral PK (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The Cl, associated fAUC/MIC, and bioavailability for the three compounds in both species were sufficiently high that, taking cross-species hepatocyte stability into account, the expected human exposure would be favorable.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro and in Vivo PK Properties of Select Compound in Rat, Dog, and Human</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">PPB (%<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">hepatocyte Cl<sub>int</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (μL/min/mg)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">in vivo Cl<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (mL/min/kg)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">bioavailability <i>F</i> (%)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">fAUC/MIC<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1o</b></td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1u</b></td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last"><i>f</i><sub>u</sub>: fraction unbound.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Intrinsic clearance.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Clearance.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Free area under the curve/MIC.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Genotoxicity Attributes</h3><div class="NLM_p">A link has been made between the inhibition of mammalian topoisomerase IIα (Topo IIα) and genotoxicity as manifested in a mouse micronucleus chromosome aberration assay (MMA) and a mouse lymphoma assay (MLA).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Indeed, the use of the fluoroquinolone gemifloxacin, a 20 μM inhibitor of Topo IIα (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), has been limited due to clastogenicity in the MLA, an in vitro human lymphocyte chromosome aberration assay and an in vivo rat micronucleus chromosome aberration assay.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Compounds <b>1t</b> and <b>1u</b> were profiled for inhibition of human Topo IIα,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> more broadly for human topoisomerase IIβ (Topo IIβ)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and for mammalian in vitro genotoxicity in the MMA and MLA (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Gemifloxacin was included as a genotoxic agent and ciprofloxacin as a fluoroquinolone with a clinically acceptable genotoxicity profile. Neither <b>1t</b> nor <b>1u</b> showed evidence of genotoxicity at the highest concentrations tested in both assays and a more favorable profile than both ciprofloxacin and gemifloxacin. The data in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> reflects experiments done in the absence of metabolizing S9 liver fractions. Compounds <b>1t</b> and <b>1u</b> were also shown to be negative for genotoxicity in the presence of S9 liver fractions (data not shown). Moreover, <b>1t</b> and <b>1u</b> were less active against the human Topo IIα and Topo IIβ with multiples ranging from 210- to 2350-fold relative to inhibition of <i>E. coli</i> DNA gyrase. Overall, the data of <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> indicate a correlation between potent Topo IIα inhibition and mammalian in vitro genotoxicity as measured by the MMA and MLA. Both <b>1t</b> and <b>1u</b> were tested at sublethal concentrations for Ames mutagenicity against a standard five strain <i>Salmonella typhimurium</i> LT2 panel (TA1535, TA1537, TA100, TA98, TA102) with and without added S9. Similar to fluoroquinolones, the compounds were positive in only the DNA repair proficient TA102 strain as would be expected with the topoisomerase mode-of-action. Consistent with these in vitro results, compound <b>1u</b> was negative in an in vivo rat micronucleus assay at the maximum tolerated oral dose of 500 mg/kg/day for 2 days.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Human Topoisomerase Inhibition and Genotoxicity</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM) topoisomerase</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">mouse micronucleus</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MLA<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (3 h incubation)</th><th class="rowsep1 colsep0" colspan="2" align="center">MLA (24 h incubation)</th><th class="colsep0 rowsep0" align="center" char="±"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human Topo IIα</th><th class="colsep0 rowsep0" align="center" char=".">human Topo IIβ</th><th class="colsep0 rowsep0" align="center" char=".">NOEL<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">LOEL<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">NOEL (μM)</th><th class="colsep0 rowsep0" align="center">LOEL (μM)</th><th class="colsep0 rowsep0" align="center">NOEL (μM)</th><th class="colsep0 rowsep0" align="center">LOEL (μM)</th><th class="colsep0 rowsep0" align="center" char="±">Ames (+)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">>400</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">>510</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="±">TA102 (± S9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1u</b></td><td class="colsep0 rowsep0" align="char" char=".">>400</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">>400</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">>510</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="±">TA102 (± S9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b> (Cip)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">300</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="char" char="±">TA102 (± S9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gemi<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="±">TA102 (± S9)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Mouse lymphoma assay.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">No observable effect level.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Lowest observable effect level.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Not determined.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Ciprofloxacin.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Gemifloxacin.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Mammalian Cellular Toxicity</h3><div class="NLM_p">Given the low, but measurable inhibitory activity of <b>1t</b> and <b>1u</b> against the human topoisomerases, toxicity to mammalian cell lines was also investigated. Cross screening against mammalian cell cultures, oftentimes immortalized, offers an avenue to mitigate toxicity. Neither <b>1t</b> nor <b>1u</b> registered high antiproliferative activity against the human A459 cell line, a human THLE liver cell line, or a THP-1 monocyte white blood cell line. Assessing the THLE cell line was particularly important as hepatic toxicity is a major factor leading to the termination of new drug development.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a> Furthermore, neither <b>1t</b> nor <b>1u</b> lysed sheep red blood cells at the highest concentrations tested. The safety indicated from these assays is not unlike other on the market antibacterials including linezolid, levofloxacin, and gemifloxacin as seen in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. However, it should be noted that longer term dosing of linezolid and gemifloxacin in the clinic has been limited due to bone marrow suppression characterized by thrombocytopenia, which would not be foreseen by monitoring cytotoxicity against mature mammalian cell lines.<a onclick="showRef(event, 'ref41 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref41 ref47 ref48">(41, 47, 48)</a> Hence, the toxicity against immature bone-marrow myeloid and erythroid cell lines was evaluated (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The bone marrow suppression seen in the clinic with linezolid and gemifloxacin would be predictable based on the IC<sub>50</sub> measurements against myeloids and erythroids, while <b>1u</b> notably showed no activity against either cell line at the highest 100 μM concentration tested. This is similar to the profile seen for levofloxacin, which does not suffer from issues of thrombocytopenia in clinical use. In our opinion, the inhibition of bone marrow cell growth should be assessed more routinely as a more sensitive gauge of potential toxicity issues associated with longer term use of antibacterial agents targeting enzymes or receptors with human homologues similar to what is routinely done for oncology cytotoxic drugs.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cytoxicity</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">blood cells</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">somatic cells</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">bone marrow cells</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">RBC lysis IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">THP1 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">A549 MIC (μM)</th><th class="colsep0 rowsep0" align="center" char=".">THLE MIC (μM)</th><th class="colsep0 rowsep0" align="center" char=".">myeloid IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">erythroid IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="char" char=".">>120</td><td class="colsep0 rowsep0" align="char" char=".">>200</td><td class="colsep0 rowsep0" align="char" char=".">185</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1u</b></td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="char" char=".">>120</td><td class="colsep0 rowsep0" align="char" char=".">>200</td><td class="colsep0 rowsep0" align="char" char=".">>300</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lin<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="char" char=".">>120</td><td class="colsep0 rowsep0" align="char" char=".">>130</td><td class="colsep0 rowsep0" align="char" char=".">>300</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Levo<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">>200</td><td class="colsep0 rowsep0" align="char" char=".">>120</td><td class="colsep0 rowsep0" align="char" char=".">>180</td><td class="colsep0 rowsep0" align="char" char=".">>300</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gemi<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Linezolid.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Levofloxacin.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Gemifloxacin.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Efficacy</h3><div class="NLM_p">Compounds <b>1t</b> and <b>1u</b> were evaluated for efficacy in a <i>S. aureus</i> neutropenic thigh infection model in mice (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) using the MSSA strain of <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (<i>S. aureus</i> ARC516).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> A higher Cl of 57 mL/min/kg was measured for <b>1u</b> in the mouse despite it having a lower mouse hepatic Cl<sub>int</sub> (6.9 μL/min/mg). By comparison, the mouse hepatic Cl<sub>int</sub> (15 μL/min/mg) for <b>1t</b> was higher than that for <b>1u</b> while the in vivo mouse Cl (20 mL/min/kg) was lower. The mechanism of clearance for the two compounds in the mouse has not been fully elucidated. However, coadministration of the P450 inhibitor 1-aminobenzotriazole (ABT)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with <b>1u</b> in mice lowered Cl to 15 mL/min/kg, suggesting a susceptibility to oxidative metabolism. Hence, ABT was coadministered for an efficacy study with <b>1u</b> and was not used for <b>1t</b>. The untreated control typically showed about a 3.0 log (1000-fold) growth in CFU relative to the level of 5 × 10<sup>5</sup> CFU inoculum achieved at the time zero. Gratifyingly, both compounds demonstrated efficacy in the models. Compound <b>1u</b> showed a static response at about 10 mg/kg/day and <b>1t</b> between 10 and 25 mg/kg/day. Maximal responses of nearly a 2-log reduction in CFU were seen at 25 and 50 mg/kg/day for <b>1t</b> and <b>1u</b>, respectively, and higher doses did not improve efficacy. Overall, <b>1t</b> and <b>1u</b> could not be differentiated from one another based on the pharmacology, and extensive side-by-side rat and dog tolerability studies (data not shown) along with the aforementioned somewhat better cytotoxicity profile (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) led to <b>1u</b> being selected for preclinical development.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response of <b>1t</b> (left) and <b>1u</b> (right) in a mouse neutropenic <i>S. aureus</i> thigh infection model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro Mode-of-Inhibition</h3><div class="NLM_p">The selection of <b>1u</b> for preclinical development instigated studies to validate the mode-of-action in line with what was observed for previous spiropyrimidinetriones.<a onclick="showRef(event, 'ref16 ref53'); return false;" href="javascript:void(0);" class="ref ref16 ref53">(16, 53)</a> DNA gyrase is a large tetrameric complex of two GyrA and two GyrB subunits operating as a molecular machine to alter the topological state of DNA necessary for replication. Topo IV is highly homologous to DNA gyrase containing two analogous ParC and ParE (to GyrA and GyrB, respectively) subunits. The primary function of DNA gyrase is to introduce negative supercoils ahead of the DNA replication fork, while the primary role of Topo IV is to decatenate DNA strands. As with other type II topoisomerases, DNA gyrase and Topo IV cleave both strands of duplex DNA to engineer the change in topological state. Agarose gel assays from <i>E. coli</i> and <i>S. aureus</i> (Gram-negative and Gram-positive isozymes) were set up to track the conversion of relaxed to supercoiled plasmid DNA mediated by DNA gyrase and of catenated to decantanated DNA mediated by Topo IV (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Compound <b>1u</b> and the comparator ciprofloxacin inhibited <i>E. coli</i> and <i>S. aureus</i> DNA gyrase supercoiling and Topo IV decatenation activity, causing double-stranded cleaved DNA to accumulate. This is in contrast to the NBTI class, for which mostly single-stranded DNA cleavage was observed,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and to novobiocin, which does not induce DNA strand cleavage.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In the gel-based DNA gyrase assay, only fully supercoiled DNA is quantitatively assessed, and therefore a high amount of supercoiling needs to be introduced into the test DNA. In the FP assay, a DNA oligomer’s ability to form triplexes with double-stranded DNA is measured, and the amount of supercoiled DNA that abrogates triplex formation has not been determined. Hence, although the IC<sub>50</sub> values between the two assays will differ, they both serve to rank order relative inhibitor potency. The gel-based assays showed that, like fluoroquinolones, <b>1u</b> has the potential for dual-target inhibition in both Gram-negative and Gram-positive bacteria. Ultimately, analysis of mutations in the targets and their capability to confer resistance in cell growth assays is required to dissect the relative importance of the two enzyme targets to inhibition by <b>1u</b>. Indeed, spontaneous mutants to <b>1u</b> in <i>S. aureus</i> and <i>N. gonorrheae</i> shown to have GyrB modifications in the DNA cleavage domain are not cross-resistant to fluoroquinolone antibacterials. The data supported DNA gyrase over Topo IV being the primary target of inhibition for <b>1u</b> for the two organisms.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Gel-Based Inhibition of <i>S. aureus</i> and <i>E. coli</i> Topoisomerases</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>S. aureus</i> IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>E. coli</i> IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">DNA gyrase</th><th class="colsep0 rowsep0" align="center" char="±">Topo IV</th><th class="colsep0 rowsep0" align="center" char="±">DNA gyrase</th><th class="colsep0 rowsep0" align="center" char="±">Topo IV</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1u</b></td><td class="colsep0 rowsep0" align="char" char="±">5.8 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">22 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b> (ciprofloxacin)</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 5.4</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 1</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compound <b>1u</b><a onclick="showRef(event, 'ref15 ref58'); return false;" href="javascript:void(0);" class="ref ref15 ref58">(15, 58)</a> was given the designation ETX0914 as it progressed through extensive preclinical investigations including toxicology, formulations development, and microbiological characterization toward entering human clinical trials. The activity and pharmacokinetics of the compound support utility against skin and skin structure infections caused by Gram-positive bacteria, <i>S. aureus</i> and <i>S. pyogenes</i> in particular. The spectrum of activity suggests coverage against respiratory tract infections caused by <i>S. aureus</i>, <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>Moraxella catarrhalis</i>, and various atypical bacterial pathogens. The high activity against <i>N. gonorrheae</i>, including resistant isolates, supports treatment of sexually transmitted uncomplicated gonorrhea.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> To identify better analogues, optimization work closely monitored antibacterial activity, solubility, PPB, and PK attributes in a multivariate fashion. In parallel, a variety of in vitro toxicology parameters were monitored to mitigate safety issues that might occur in clinical use. Among these were ion channel inhibition including hERG, bone marrow toxicity, and mammalian genotoxicity. Genotoxicity in particular became of paramount concern as early spiropyrimidinetrione analogues showed positive in vitro activity; hence, the clean genotoxicity profile for <b>1u</b> and, in fact, for the other oxazolidinone analogues herein that were evaluated, bodes well for progression of the drug candidate. Ultimately, gonorrhea was chosen as a gateway indication to evaluate <b>1u</b> in clinical trials to address a pressing medical need and to enable a relatively rapid route to evaluate human tolerability and clinical efficacy, both particularly important for a novel drug class without precedence in medicine.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Considerations</h3><div class="NLM_p">All of the solvents and reagents used were obtained commercially and used as such unless noted otherwise. <sup>1</sup>H NMR spectra were recorded in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> solutions at 300 K using a Bruker Ultrashield 300 MHz instrument or a Bruker Ultrashield 400 MHz instrument. <sup>13</sup>C NMR spectra were recorded in DMSO-<i>d</i><sub>6</sub> solutions at 300 K and 126 MHz using a Bruker DRX-500 500 MHz instrument with a QNP cryoprobe or at 101 MHz using a Bruker Ultrashield 400 MHz instrument or at 75.5 MHz using a Bruker Ultrashield 300 MHz instrument. <sup>19</sup>F NMR spectra were recorded at 282 MHz in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> solutions at 300 K using a Bruker Ultrashield 300 MHz instrument. Chemical shifts are reported as parts per million relative to TMS (0.00) for <sup>1</sup>H and <sup>13</sup>C NMR and CFCl<sub>3</sub> for <sup>19</sup>F NMR. High-resolution mass spectra (HRMS) were obtained using a hybrid quadrupole time-of-flight mass spectrometer (microTOFq II, Bruker Daltonics) in ESI<sup>+</sup> mode. Silica gel chromatographies were performed on an ISCO Combiflash Companion Instruments using ISCO RediSep Flash Cartridges (particle size: 35–70 μm) or Silicycle SiliaSep Flash Cartridges (particle size: 40–63 μm). Preparative reverse phase HPLC was carried out using YMC Pack ODS-AQ (100 mm × 20 mm ID, S-5 μ particle size, 12 nm pore size) on Agilent instruments. When not indicated, compound intermediates and reagents were purchased from chemical supply houses. All final compounds (compounds <b>7a</b>–<b>u</b>) were determined to be greater than 95% pure via analysis by reversed phase UPLC-MS (retention times, RT, in minutes) with a Waters Acquity UPLC instrument with DAD and ELSD and a UPLC HSS T3, 2.1 mm × 30 mm, 1.8 μm column and a gradient of 2–98% acetonitrile in water with 0.1% formic acid over 2.0 min at 1 mL/min. Injection volume was 1 μL, and the column temperature was 30 °C. Detection was based on electrospray ionization (ESI) in positive and negative polarity using Waters ZQ mass spectrometer (Milford, MA, USA), diode-array UV detector from 210 to 400 nm, and evaporative light scattering detector (Sedex 75, Sedere, Alfortville Cedex, France).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-(5-(Dimethoxymethyl)-6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)oxazolidin-2-one (<b>6a</b>)</h4><div class="NLM_p last">A solution of 2-oxazolidinone (728 mg, 8.36 mmol) in 1 mL of DMF was added slowly to a stirred suspension of NaH (60% oil dispersion, 290 mg, 7.25 mmol) in 1 mL DMF at 0 °C. The mixture was stirred at rt for 10 min, and a solution of <b>5b</b> (0.25 g, 0.7 mmol, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in 3 mL of DMF was added. This mixture was heated at 80 °C for 5 h, poured into ice-cooled aqueous NH<sub>4</sub>Cl, and extracted twice with EtOAc. The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The residue was chromatographed on silica gel (20–50% EtOAc gradient in CHCl<sub>3</sub>) to afford 500 mg starting material <b>5b</b> and 800 mg (35%) of the title compound. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (s, 1H), 5.74 (s, 1H), 4.45–4.73 (m, 2H), 3.93–4.25 (m, 4H), 2.71–2.93 (m, 2H), 3.06–3.35 (m, 8H), 1.23 (br s, 6H). MS (ES) MH<sup>+</sup>: 410.4 for C<sub>19</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>6</sub>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (5<i>S</i>)-3-{6-[(2<i>R</i>,6<i>S</i>)-2,6-Dimethylmorpholin-4-yl]-5-(1,3-dioxolan-2-yl)-7-fluoro-1,2-benzoxazol-3-yl}-5-methyl-1,3-oxazolidin-2-one (<b>6b</b>)</h4><div class="NLM_p last">NaH (60% dispersion) (0.157 g, 3.92 mmol) was added to a solution of (<i>S</i>)-5-methyloxazolidin-2-one<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (0.397 g, 3.92 mmol) in 6 mL of DMF at rt. After stirring for 30 min, <b>5a</b> (0.7 g, 1.96 mmol) was added, and the mixture was heated at 90 °C for 4 h. The mixture was quenched with aqueous NH<sub>4</sub>Cl, and solvent was removed. The residue was taken up in Et<sub>2</sub>O, which was washed three times with water and once with brine. The combined aqueous layers were extracted with Et<sub>2</sub>O, which was washed twice more with water and once with brine. The combined Et<sub>2</sub>O layers were dried (MgSO<sub>4</sub>) and concentrated to give an oil that was chromatographed on silica gel (0–30% gradient of EtOAc in CH<sub>2</sub>Cl<sub>2</sub>) to afford 230 mg of starting material <b>5b</b> and 250 mg (30%) of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.52 (d, <i>J</i> = 1.0 Hz, 1H), 6.35 (s, 1H), 4.79–5.13 (m, 1H), 4.33 (dd, <i>J</i> = 8.0, 9.8 Hz, 1H), 4.12–4.26 (m, 4H), 3.97–4.12 (m, 2H), 3.84 (dd, <i>J</i> = 7.0, 10.0 Hz, 1H), 3.00 (dd, <i>J</i> = 5.5, 11.0 Hz, 2H), 1.62 (d, <i>J</i> = 6.3 Hz, 3H), 1.35 (br s, 6H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −144.46. MS (ES) MH<sup>+</sup>: 422.1 for C<sub>20</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>6</sub>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-3-(7-Chloro-6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-5-(1,3-dioxolan-2-yl)benzo[<i>d</i>]isoxazol-3-yl)-5-methyloxazolidin-2-one (<b>6c</b>)</h4><div class="NLM_p last">A solution of (<i>R</i>)-5-methyloxazolidin-2-one<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> (271 mg, 2.68 mmol) in 4 mL of DMF was added slowly to a stirred suspension of NaH (60% oil dispersion, 107 mg, 2.68 mmol) in 3 mL of DMF at 0 °C. The mixture was stirred at rt for 10 min, and a solution of <b>5c</b> (1.0 g, 2.68 mmol, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in 5 mL of DMF was added. The resulting mixture was heated at 85 °C for 2 h, poured into ice-cooled aqueous NH<sub>4</sub>Cl, and extracted twice with EtOAc. The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The residue was chromatographed on silica gel (25% EtOAc gradient in hexanes) to afford 500 mg of starting material <b>5c</b> and 800 mg (35%) of the title compound. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (s, 1H), 6.22 (s, 1H), 4.87–5.17 (m, 1H), 3.48–4.34 (m, 9H), 2.67–3.20 (m, 3H), 1.49 (d, <i>J</i> = 6.4 Hz, 3H), 1.32 (br s, 3H), 1.13 (br s, 3H). MS (ES) MH<sup>+</sup>: 438 for C<sub>20</sub>H<sub>25</sub>ClN<sub>3</sub>O<sub>6</sub>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i>)-5-((<i>tert</i>-Butyldiphenylsilyloxy)methyl)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)oxazolidin-2-one</h4><div class="NLM_p last">A solution of (<i>S</i>)-5-((<i>tert</i>-butyldiphenylsilyloxy)methyl)oxazolidin-2-one (3.0 g, 8.4 mmol, described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in 10 mL of DMF was added slowly to a stirred suspension of NaH (60% dispersion, 0.37 g, 8.4 mmol) in 10 mL of DMF at 0 °C over 10 min. The mixture was stirred at rt for 30 min, and a solution of <b>5a</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (3.0 g, 8.4 mmol) in 10 mL of DMF was added. This mixture was heated at 80 °C for 2 h and poured into ice-cooled aqueous NH<sub>4</sub>Cl before being extracted twice with EtOAc. The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a residue that was chromatographed over silica gel (40–50% EtOAc gradient in petroleum ether) to afford the title compound. Yield 2.13 g (37%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (s, 1H), 7.30–7.70 (m, 10H), 6.19 (s, 1 H), 4.95–5.11 (m, 1H), 4.30 (t, <i>J</i> = 9.3 Hz, 1H), 3.83–4.14 (m, 9H), 3.17–3.27 (m, 2H), 2.90 (dd, <i>J</i> = 10.83, 5.4 Hz, 2H), 1.23 (d, <i>J</i> = 5.4 Hz, 6H), 0.89 (s, 9H). MS (ES) MH<sup>+</sup>: 676 for C<sub>36</sub>H<sub>43</sub>FN<sub>3</sub>O<sub>7</sub>Si.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)-5-(hydroxymethyl)oxazolidin-2-one (<b>6d</b>)</h4><div class="NLM_p last">Acetic acid (0.89 mL, 15.5 mmol) and a solution of 1 M TBAF (3.1 mL, 3.1 mmol) in THF were added sequentially to a solution of the preceding compound (2.1 g, 3.11 mmol) in 15 mL of THF. The mixture was stirred at rt for 18 h before being diluted with water and extracted with EtOAc. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to afford material that was purified on a silica gel column (50–70% EtOAc gradient in hexanes) to give the title compound (1.33 g, 98% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.4 (s, 1H), 6.2 (s, 1H), 4.7–5.05 (m, 1H), 3.9–4.3 (m, 8H), 3.5–3.8 (m, 2H), 2.8–3.3 (m, 4H), 1.2 (d, <i>J</i> = 5.8 Hz, 6H). MS (ES) MH<sup>+</sup>: 438.1 for C<sub>20</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>7</sub>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one (<b>6e</b>)</h4><div class="NLM_p last">Prepared as described for <b>6c</b> with (<i>S</i>)-5-(methoxymethyl)oxazolidin-2-one (294 mg, 2,24 mmol), NaH (60% dispersion, 90 mg, 2.24 mmol), and <b>5a</b> (800 mg, 2.24 mmol) to afford 480 mg (47% yield) of the title compound. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (s, 1H), 6.18 (s, 1H), 4.91–5.19 (m, 1H), 4.22 (t, <i>J</i> = 8 Hz, 1H), 2 3.6–4.3 (m, 9H), 3.34 (s, 3H), 3.16–3.28 (m, 2H), 2.7–2.90 (m, 2H), 1.23 (d, <i>J</i> = 6.2 Hz, 6H). MS (ES) MH<sup>+</sup>: 452 for C<sub>21</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>7</sub>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-chlorobenzo[<i>d</i>]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one (<b>6f</b>)</h4><div class="NLM_p last">Prepared as described for <b>6h</b> with 1.05 g (8.04 mmol) of (<i>S</i>)-5-(methoxymethyl)oxazolidin-2-one, NaH (60% dispersion, 322 mg, 8.04 mmol), and <b>5c</b> (1.0 g, 2.68 mmol) (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) to afford 600 mg (48%) of the title compound. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.68 (s, 1H), 6.35 (s, 1 H), 4.9 (m, 1H), 4.1–4.35 (m, 6H), 3.9–4.1 (m, 2H), 3.70 (dd, <i>J</i> = 10.7, 4.0 Hz, 1H), 3.67 (dd, <i>J</i> = 10.7, 4.0 Hz, 1H), 3.45 (s and m, 4H), 3.25 (m, 1H), 3.05 (m, 1H), 2.7–2.85 (m, 1H), 1.45 (br s, 3H), 1.15 (br s, 3H). MS (ES) MH<sup>+</sup>: 468.2 for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>7</sub>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (4<i>R</i>)-3-{6-[(2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholin-4-yl]-5-(1,3-dioxolan-2-yl)-7-fluoro-1,2-benzoxazol-3-yl}-4-methyl-1,3-oxazolidin-2-one (<b>6g</b>)</h4><div class="NLM_p last">A solution of (4<i>R</i>)-4-methyl-1,3-oxazolidin-2-one<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (1.0 g, 9.9 mmol) in 10 mL of DMF was added slowly to a stirred suspension of NaH (60% dispersion, 0.24 g, 9.9 mmol) in 10 mL of DMF at 0 °C over 10 min. The mixture was stirred at rt for 30 min, and a solution of <b>5a</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (1.1 g, 3.1 mmol) in 3 mL of DMF was added. This mixture was heated at 80 °C for 12 h and poured into ice-cooled water before being extracted twice with EtOAc. The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a residue that was chromatographed over silica gel (EtOAc gradient in petroleum ether) to afford the title compound. Yield: 0.15 g (12%). MS (ES) MH<sup>+</sup>: 422.4 for C<sub>20</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>6</sub>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-3-(7-Chloro-6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-5-(1,3-dioxolan-2-yl)benzo[<i>d</i>]isoxazol-3-yl)-4-methyloxazolidin-2-one (<b>6h</b>)</h4><div class="NLM_p last">NaH (60% dispersion, 322 mg, 8.04 mmol) was added to a solution of (<i>S</i>)-4-methyloxazolidin-2-one<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (1.05 g, 8.04 mmol) in 10 mL of DMF. After 10 min stirring, a solution of <b>5c</b> (1.0 g, 2.68 mmol, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in 5 mL of DMF was added, and the mixture was heated at 100 °C for 1 h. After quenching with saturated aqueous NH<sub>4</sub>Cl, the mixture was extracted with EtOAc, which was washed with brine. Drying (Na<sub>2</sub>SO<sub>4</sub>) and removal of solvent gave a residue that was chromatographed on silica gel (20% acetone in hexanes) to afford 0.6 g (48%) of the title compound as an oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 6.36 (s, 1H), 4.94 (m, 1H), 4.00–4.33 (m, 10H), 3.80–3.91 (m, 1H), 3.71–3.79 (m, 1H), 3.63–3.70 (m, 1H), 3.18–3.35 (m, 1H), 3.06 (d, <i>J</i> = 10.0 Hz, 1H), 2.79 (d, <i>J</i> = 10.7 Hz, 1H), 1.45 (d, <i>J</i> = 5.1 Hz, 3H), 1.19–1.26 (m, 3H). MS (ES) MH<sup>+</sup>: 468.2 for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>7</sub>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>)-4-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)oxazolidin-2-one (<b>6i</b>)</h4><div class="NLM_p last">NaH (60% dispersion) (0.056 g, 1.40 mmol) was added to a solution of (<i>R</i>)-4-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)oxazolidin-2-one<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> (0.324 g, 1.40 mmol) in DMF (5 mL) at rt. After stirring for 30 min, <b>5a</b> (0.5 g, 1.40 mmol) was added, and the mixture was heated at 80 °C for 6 h. The mixture was quenched with aqueous NH<sub>4</sub>Cl, and solvent was removed. The residue was taken up in Et<sub>2</sub>O, which was washed three times with water and once with brine. The combined aqueous layers were extracted with Et<sub>2</sub>O, which was washed twice more with water and once with brine. The combined Et<sub>2</sub>O layers were dried (MgSO<sub>4</sub>) and concentrated to give an oil that was chromatographed on silica gel (0–30% gradient of EtOAc in CH<sub>2</sub>Cl<sub>2</sub>) to isolate two materials. The first eluting material was consistent with starting material <b>5a</b>, and the second eluting material with the title compound as a white solid. Yield 233 mg (30%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34 (s, 1H), 6.23 (s, 1H), 4.74 (d, <i>J</i> = 3.8 Hz, 2H), 4.43–4.54 (m, 1H), 3.96–4.26 (m, 7H), 3.80 (d, <i>J</i> = 10.9 Hz, 1H), 3.31 (s, 2H), 3.27 (d, <i>J</i> = 10.9 Hz, 2H), 2.95 (dd, <i>J</i> = 5.65, 10.7 Hz, 2H), 1.27 (d, <i>J</i> = 6.2 Hz, 6H), 0.81 (s, 9H), 0.00 (s, 3H), −0.15 (s, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −145.55. MS (ES) MH<sup>+</sup>: 552.0 for C<sub>26</sub>H<sub>39</sub>FN<sub>3</sub>O<sub>7</sub>Si.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (4<i>S</i>)-3-{6-[(2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholin-4-yl]-5-(1,3-dioxolan-2-yl)-7-fluoro-1,2-benzoxazol-3-yl}-4-(methoxymethyl)-1,3-oxazolidin-2-one (<b>6j</b>)</h4><div class="NLM_p last">NaH (60% dispersion, 0.102 g, 2.55 mmol) was added to a solution of (<i>S</i>)-4-(methoxymethyl)oxazolidin-2-one in 5 mL of DMF at rt. After stirring for 30 min, <b>5a</b> (0.7 g, 1.96 mmol) was added and the mixture was heated at 80 °C for 6 h. The mixture was quenched with aqueous NH<sub>4</sub>Cl, and solvent was removed. The residue was taken up in Et<sub>2</sub>O, which was washed three times with water and once with brine. The combined aqueous layers were extracted with Et<sub>2</sub>O, which was washed twice more with water and once with brine. The combined Et<sub>2</sub>O layers were dried (MgSO<sub>4</sub>) and concentrated to give an oil that was chromatographed on silica gel (0–30% gradient of EtOAc in CH<sub>2</sub>Cl<sub>2</sub>). Two materials were isolated. The first eluting material was consistent with starting material (221 mg) and the second eluting material with the title compound (243 mg, 27%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.45 (d, <i>J</i> = 1.0 Hz, 1H), 6.35 (s, 1H), 4.72–4.82 (m, 1H), 4.63–4.69 (m, 1H), 4.57–4.63 (m, 1H), 4.14–4.24 (m, 4H), 4.00–4.10 (m, 2H), 3.91 (dd, <i>J</i> = 5.0, 10.3 Hz, 1H), 3.70 (dd, <i>J</i> = 2.6, 10.2 Hz, 1H), 3.37 (s, 3H), 3.25–3.37 (m, 2H), 3.00 (dd, <i>J</i> = 5.5, 10.8 Hz, 2H), 1.34 (br s, 6H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −145.51. MS (ES) MH<sup>+</sup>: 452.3 for C<sub>21</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>7</sub>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-3-(7-Chloro-6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-5-(1,3-dioxolan-2-yl)benzo[<i>d</i>]isoxazol-3-yl)-4-(methoxymethyl)oxazolidin-2-one (<b>6k</b>)</h4><div class="NLM_p last">Prepared as described for <b>7c</b> with 703 mg (5.36 mmol) of (<i>S</i>)-5-(methoxymethyl)oxazolidin-2-one, 214 mg (60% dispersion, 5.35 mmol) of NaH, and 2.0 g (5.36 mmol) of <b>5c</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) to afford 421 mg (17%) of the title compound. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (s, 1H), 6.21 (s, 1H), 4.72–4.79 (m, 1H), 4.46 (dd, <i>J</i> = 3.5, 7.6 Hz, 1H), 3.93–4.15 (m, 8H), 3.87 (dd, <i>J</i> = 3.5, 10.5 Hz, 1H), 3.57 (dd, <i>J</i> = 2.0, 10.5 Hz, 1H), 3.25 (s, 3H), 3.06 (br s, 2H), 2.67–2.87 (m, 1H), 1.32 (br s, 3H), 1.13 (br s, 3H). MS (ES) MH<sup>+</sup>: 468.2 for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>7</sub>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (4<i>S</i>)-4-[(Dimethylamino)methyl]-3-{6-[(2<i>R</i>,6<i>S</i>)-2,6-dimethylmorpholin-4-yl]-5-(1,3-dioxolan-2-yl)-7-fluoro-1,2-benzoxazol-3-yl}-1,3-oxazolidin-2-one (<b>6l</b>)</h4><div class="NLM_p last">Prepared from <b>5a</b> (335 mg, 0.94 mmol), NaH (60% dispersion, 38 mg, 0.94 mmol), and (135 mg, 0.94 mmol) (4<i>S</i>)-4-[(dimethylamino)methyl]-1,3-oxazolidin-2-one (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) using the method described for <b>6c</b> to afford 102 mg (34%) of the title compound. <sup>1</sup>H NMR (400 MHz, DMSO- <i>d</i><sub>6</sub>) δ 8.25 (s, 1H), 6.1 (s, 1H), 4.7 (d, 2H), 4.45 (d, 1H), 4.1 (m, 2H), 3.75 (m, 2H), 4.0 (m, 2H), 3.1 (d, 2H), 2.85 (t, 2H), 2.5 (m, 2H), 2.2 (s, 6H), 1.1 (d, 6H). MS (ES) MH<sup>+</sup>: 465.5 for C<sub>22</sub>H<sub>30</sub>FN<sub>4</sub>O<sub>6</sub>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)-4-phenyloxazolidin-2-one (<b>6m</b>)</h4><div class="NLM_p last">NaH (60% dispersion, 56 mg, 1.40 mmol) was added to a solution of (<i>S</i>)-4-phenyloxazolidin-2-one (0.229 g, 1.40 mmol) in DMF (20 mL) at rt. After stirring for 30 min, <b>5a</b> (0.5 g, 1.40 mmol) was added and the mixture was heated at 80 °C for 24 h. The mixture was quenched with aqueous NH<sub>4</sub>Cl, and solvent was removed. The residue was taken up in Et<sub>2</sub>O, which was washed three times with water and once with brine. The combined aqueous layers were extracted with Et<sub>2</sub>O, which was washed twice more with water and once with brine. The combined Et<sub>2</sub>O layers were dried (MgSO<sub>4</sub>) and concentrated to give an oil that was chromatographed on silica gel (0–30% gradient of EtOAc in CH<sub>2</sub>Cl<sub>2</sub>) to afford two components. The first eluting component was consistent with recovered starting material <b>5a</b> (225 mg). The second eluting component was identified as the title compound and was isolated as a white solid (96 mg, 14%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41 (d, <i>J</i> = 1.0 Hz, 1H), 7.31–7.47 (m, 5H), 6.34 (s, 1H), 5.70 (dd, <i>J</i> = 6.3, 8.8 Hz, 1H), 4.96 (t, <i>J</i> = 8.8 Hz, 1H), 4.47 (dd, <i>J</i> = 6.3, 8.8 Hz, 1H), 3.99–4.27 (m, 7H), 2.97 (dd, <i>J</i> = 5.65, 11.2 Hz, 2H), 1.29–1.45 (br s, 6H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −145.2. MS (ES) MH<sup>+</sup>: 484.1 for C<sub>25</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>6</sub>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (4<i>S</i>,5<i>R</i>)-3-[6-[(2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholin-4-yl]-5-(1,3-dioxolan-2-yl)-7-fluoro-1,2-benzoxazol-3-yl]-4,5-dimethyl-oxazolidin-2-one (<b>6o</b>) and (4<i>R</i>,5<i>S</i>)-3-[6-[(2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholin-4-yl]-5-(1,3-dioxolan-2-yl)-7-fluoro-1,2-benzoxazol-3-yl]-4,5-dimethyl-oxazolidin-2-one (<b>6n</b>)</h4><div class="NLM_p last">A solution of <i>rel</i>-(<i>R</i>,<i>R</i>)-4,5-dimethyloxazolidin-2-one<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (2.7 g, 18.8 mmol) in 50 mL of DMF was added slowly to a suspension of NaH (60% dispersion, 752 mg, 18.8 mmol) in 10 mL of DMF at rt. After 10 min stirring, <b>5a</b> (6.7 g, 18.8 mmol) was added and the mixture was heated in the microwave at 100 °C for 1 h. The resulting mixture was cooled and poured into ice-cold aqueous NH<sub>4</sub>Cl and extracted with EtOAc. The organic layer was washed with water and brine and dried (Na<sub>2</sub>SO<sub>4</sub>). After concentration, the residue was purified on a silica gel column (elution with 0–5% methanol in CHCl<sub>3</sub>) to give a solid as a mixture of diastereomers. The diastereomers were separated by chiral HPLC using Chiralpak IC (250 mm × 4.6 mm) column (hexane:methanol:ethanol (70:15:15) 1.0 mL/min) to afford two components. The first eluting component was identified as <b>6o</b> (840 mg, 10% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (s, 1H), 6.18 (s, 1H), 4.91–5.23 (m, 1H), 4.57–4.77 (m, 1H), 4.03–4.13 (m, 5H), 3.99 (dd, <i>J</i> = 5.0, 8.0 Hz, 2H), 3.24 (m, 1H), 3.20 (m, 1H), 2.91 (d, <i>J</i> = 4.90 Hz, 1H), 2.88 (d, <i>J</i> = 4.7 Hz, 1H), 1.39 (d, <i>J</i> = 6.6 Hz, 3H), 1.33 (d, <i>J</i> = 6.4 Hz, 3H), 1.23 (d, <i>J</i> = 6.0 Hz, 6H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −145.46. MS (ES) MH<sup>+</sup>: 436.2 for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>6</sub>. The material matched that made from (<i>R</i>,<i>R</i>)-4,5-dimethyloxazolidin-2-one.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The second eluting component was identified as <b>6n</b> (920 mg, 11% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (s, 1H), 6.18 (s, 1H), 4.90–5.21 (m, 1H), 4.56–4.80 (m, 1H), 3.91–4.15 (m, 7H), 3.28 (m, 1H), 3.24 (m, 1H), 3.20 (m, 1H), 2.91 (d, <i>J</i> = 6.4 Hz, 1H), 2.88 (d, <i>J</i> = 5.5 Hz, 1H), 1.39 (d, <i>J</i> = 6.6 Hz, 3H), 1.33 (d, <i>J</i> = 6.6 Hz, 3H), 1.23 (d, <i>J</i> = 5.8 Hz, 6H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −145.47. MS (ES) MH<sup>+</sup>: 436.2 for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>6</sub>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)imidazolidin-2-one (<b>6p</b>)</h4><div class="NLM_p last">Prepared from <b>5a</b> (200 mg, 0.56 mmol), NaH (60% dispersion, 33.6 mg, 0.84 mmol), and imidazolidin-2-one (72.4 mg, 0.84 mmol) using the method described for <b>3b</b> to afford 30 mg (13%) of the title compound. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.56 (d, <i>J</i> = 1.1 Hz, 1H), 6.33 (s, 1H), 5.15 (br s, 1H), 4.2–4.3 (m, 6H), 4.0–4.1 (m, 2H), 3.7–3.8 (m, 2H), 3.25–3.4 (br s, 2H), 2.9–3.0 (dd, <i>J</i> = 11.0, 5.6 Hz, 2H), 1.32 (d, <i>J</i> = 6.2 Hz, 6H). MS (ES) MH<sup>+</sup>: 407.1 for C<sub>19</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>5</sub>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-5-(1,3-dioxolan-2-yl)-7-fluorobenzo[<i>d</i>]isoxazol-3-yl)-3-methylimidazolidin-2-one (<b>6q</b>)</h4><div class="NLM_p last">NaH (60% dispersion, 0.056 g, 1.40 mmol) was added to a solution of 1-methylimidazolidin-2-one (0.140 g, 1.40 mmol) in DMF (5 mL) at rt. After stirring for 30 min, <b>5a</b> (0.5 g, 1.40 mmol) was added and the mixture was heated at 80 °C for 6 h. The mixture was quenched with aqueous NH<sub>4</sub>Cl, and solvent was removed. The residue was taken up in Et<sub>2</sub>O, which was washed three times with water and once with brine. The combined aqueous layers were extracted with Et<sub>2</sub>O, which was washed twice more with water and once with brine. The combined Et<sub>2</sub>O layers were dried (MgSO<sub>4</sub>) and concentrated to give an oil that was chromatographed on silica gel (0–30% gradient of EtOAc in CH<sub>2</sub>Cl<sub>2</sub>) to afford 216 mg (37%) of the title compound as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.65 (s, 1H), 6.35 (s, 1H), 4.11–4.29 (m, 5H), 3.97–4.08 (m, 5H), 3.64 (t, <i>J</i> = 7.9 Hz, 2H), 3.00 (m, 5H), 1.34 (br s, 6H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −145.0. MS (ES) MH<sup>+</sup>: 421.9 for C<sub>20</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>5</sub>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-2-(5-(1,3-Dioxolan-2-yl)-2,3,4-trifluoro-<i>N</i>′-hydroxybenzimidamido)-3-hydroxy-<i>N</i>,<i>N</i>-dimethylpropanamide</h4><div class="NLM_p last">Et<sub>3</sub>N (1.5 mL, 10.7 mmol) and <b>10</b> (2.5 g, 8.9 mmol, described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) were added to a solution of (<i>R</i>)-2-amino-3-hydroxy-<i>N</i>,<i>N</i>-dimethylpropanamide (1.4 g, 10.7 mmol, described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) in 30 mL of DMF, and the mixture was stirred at rt for 16 h. The mixture was poured into water (75 mL) and extracted three times with EtOAc. The combined organic layers were washed twice with water and once with brine before being dried (Na<sub>2</sub>SO<sub>4</sub>). Removal of solvent was followed by chromatography on silica gel (3% MeOH in CHCl<sub>3</sub>) to afford the title compound as a pale-yellow oil. Yield: 3.0 g (90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.72 (s, 3H), 2.79 (s, 3H), 3.40–3.43 (m, 1H), 3.97–4.07 (m, 6H), 4.92 (t, 1H), 5.92 (d, 1H), 6.03 (s, 1H), 7.28 (t, 1H), 10.16 (s, 1H). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ −134.4 (m), −138.2 (m), −159.48 (m). MS (ES) MH<sup>+</sup>: 378.3 for C<sub>15</sub>H<sub>19</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-2-((5-(1,3-Dioxolan-2-yl)-6,7-difluorobenzo[<i>d</i>]isoxazol-3-yl)amino)-3-hydroxy-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>11r</b>)</h4><div class="NLM_p last">A solution of the preceding compound (3.0 g, 7.95 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (5.7 g, 17.5 mmol) in 10 mL of DMF was stirred at rt for 16 h. The mixture was poured into water (75 mL) and extracted three times with EtOAc. The combined organic layers were washed with twice with water and once with brine before being dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The residue was chromatographed on silica gel (1% MeOH in CHCl<sub>3</sub>) to afford the title compound as a pale-yellow solid. Yield: 2.0 g (70%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.85 (s, 3H), 3.14 (s, 3H), 3.63–3.71 (m, 2H), 4.00–4.09 (m, 4H), 4.64–4.69 (m, 1H), 5.03 (t, 1H), 6.09 (s, 1H), 7.61 (d, 1H), 8.11 (d, 1H). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ −143.2 (d), −161.8 (d). MS (ES) MH<sup>+</sup>: 358.3 for C<sub>15</sub>H<sub>18</sub>F<sub>2</sub>N<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-3-(5-(1,3-Dioxolan-2-yl)-6,7-difluorobenzo[<i>d</i>]isoxazol-3-yl)-<i>N</i>,<i>N</i>-dimethyl-2-oxooxazolidine-4-carboxamide</h4><div class="NLM_p last">A solution of <b>11r</b> (2.0 g, 5.59 mmol) in 10 mL of THF was added to a stirring mixture of NaH (60% dispersion, 223 mg, 5.59 mmol) in 10 mL of THF at −10 °C, and stirring was continued for 10 min. A solution of CDI (1.8 g, 11.2 mmol) in 10 mL of THF was added, and after stirring for another 10 min, the reaction mixture was then poured into ice water. The mixture was extracted twice with EtOAc, and the combined organic layers were washed with water and brine. Drying (Na<sub>2</sub>SO<sub>4</sub>) and removal of solvent was followed by chromatography on silica gel (CHCl<sub>3</sub>) to afford the title compound as a pale-yellow solid. Yield: 2.0 g (93%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.86 (s, 3H), 3.07 (s, 3H), 3.98–4.07 (m, 4H), 4.53 (dd, 1H), 4.82 (t, 1H), 5.63 (dd, 1H), 6.10 (s, 1H), 8.39 (dd, 1H). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ −140.2 (d, <i>J</i> = 18.8 Hz), −160.9 (d, <i>J</i> = 18.8 Hz). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −140.2 (d), −160.9 (d). MS (ES) MH<sup>+</sup>: 384.3 for C<sub>16</sub>H<sub>16</sub>F<sub>2</sub>N<sub>3</sub>O<sub>6</sub></div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-3-(6,7-Difluoro-5-formylbenzo[<i>d</i>]isoxazol-3-yl)-<i>N</i>,<i>N</i>-dimethyl-2-oxooxazolidine-4-carboxamide (<b>12r</b>)</h4><div class="NLM_p last">A stirred solution of the preceding compound (1.9 g, 4.96 mmol) in 15 mL of 1,4-dioxane and 7.5 mL of 6 N HCl (4.5 mL) was stirred at rt for 8 h. The mixture was poured into ice-cooled water and extracted with twice with EtOAc. The combined organic layers were washed with water and brine. Drying (Na<sub>2</sub>SO<sub>4</sub>) and removal of solvent afforded the title product as a solid. Yield: 1.65 g (98%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.86 (s, 3H), 3.08 (s, 3H), 4.57 (dd, 1H), 4.85 (t, 1H), 5.64 (dd, 1H), 8.79 (dd, 1H), 10.19 (s, 1H). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ −142.9 (d, <i>J</i> = 22.6 Hz), −160.2 (d, <i>J</i> = 22.6 Hz). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −140.9 (d), −160.2 (d). MS (ES) MH<sup>+</sup>: 340.3 for C<sub>14</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-3-(6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-7-fluoro-5-formylbenzo[<i>d</i>]isoxazol-3-yl)-<i>N</i>,<i>N</i>-dimethyl-2-oxooxazolidine-4-carboxamide (<b>13r</b>)</h4><div class="NLM_p last">A solution of <b>12r</b> (1.65 g, 4.80 mmol), DIEA (1.7 mL, 9.6 mmol), and (2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholine (0.68 g, 5.8 mmol) in 20 mL of CH<sub>3</sub>CN was heated at 80 °C for 16 h. After cooling to rt, volatiles were removed and the residue was chromatographed on silica gel (EtOAc gradient in CHCl<sub>3</sub>) to give title compound as pale-yellow solid. Yield: 1.95 g (92%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (s, 1H), 8.65 (s, 1H), 5.64 (dd, <i>J</i> = 3.2, 8.7 Hz, 1H), 4.84 (t, <i>J</i> = 8.8 Hz, 1H), 4.55 (dd, <i>J</i> = 3.2, 8.8 Hz, 1H), 4.11–4.15 (m, 2H), 3.38–3.41 (m, 2H), 3.08 (s, 3H), 2.99–3.03 (m, 2H), 2.87 (s, 3H), 1.20 (d, <i>J</i> = 6.3 Hz, 6H). <sup>19</sup>F NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −146.81. ES MH<sup>+</sup>: 435.4 for C<sub>20</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>6</sub>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (2<i>R</i>)-1-[[5-(1,3-Dioxolan-2-yl)-6,7-difluoro-1,2-benzoxazol-3-yl]amino]propan-2-ol (<b>11t</b>)</h4><div class="NLM_p last">(<i>R</i>)-1-Aminopropan-2-ol (1.3 mL, 16.6 mmol) was added to a solution of <b>10</b> (2.22 g, 7.88 mmol, described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and 30 mL of DMF at rt wherein there was a slow exotherm. After stirring for 40 min, potassium <i>tert</i>-butoxide (1.77 g, 15.8 mmol) was added all at once. After stirring for 1 h, the reaction was incomplete by LC-MS analysis and additional potassium <i>tert</i>-butoxide was added (400 mg, 3.6 mmol). The resulting mixture was stirred at rt for 1 h before being quenched with aqueous NH<sub>4</sub>Cl. Solvent was removed, and the solid residue was taken up in water while breaking up the solid mass with a spatula, and the mixture was stirred at rt overnight. The solids were filtered and rinsed through with water before being dried in vacuo to give the title compound. Yield 2.24 g (95%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30–8.55 (m, 1H), 6.10 (s, 1H), 4.87–5.21 (m, 1H), 4.27 (t, <i>J</i> = 8.9 Hz, 1H), 4.04 (m, 4H), 3.78 (dd, <i>J</i> = 7.2, 9.4 Hz, 1H), 1.49 (d, <i>J</i> = 6.2 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −140.64 (d, <i>J</i> = 21.5 Hz), −161.34 (d, <i>J</i> = 21.5 Hz). ES MH<sup>+</sup>: 301 for C<sub>13</sub>H<sub>14</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>R</i>)-3-(5-(1,3-Dioxolan-2-yl)-6,7-difluorobenzo[<i>d</i>]isoxazol-3-yl)-5-methyloxazolidin-2-one</h4><div class="NLM_p last">A mixture of <b>11t</b> (500 mg, 1.67 mmol), CDI (405 mg, 2.50 mmol), and DMAP (102 mg, 0.83 mmol) in 10 mL of THF was heated at reflux overnight (21 h). The solvent was removed, and the residue was taken up in 1 N HCl with stirring at rt for 90 min, affording solids. The solids were filtered and rinsed well with water, breaking them up with a spatula before drying in vacuo. The material is consistent with the title compound with about 5% impurity due to hydrolysis of the ketal to corresponding aldehyde. Yield 407 mg (75%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33–8.55 (m, 1H), 6.10 (s, 1H), 4.86–5.17 (m, 1H), 4.27 (t, <i>J</i> = 8.9 Hz, 1H), 4.04 (d, <i>J</i> = 4.3 Hz, 5H), 3.78 (dd, <i>J</i> = 7.2, 9.4 Hz, 1H), 1.49 (d, <i>J</i> = 6.2 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −140.64 (d, <i>J</i> = 21.5 Hz), −161.34 (d, <i>J</i> = 21.5 Hz). MS (ES) MH<sup>+</sup>: 327 for C<sub>14</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>R</i>)-6,7-Difluoro-3-(5-methyl-2-oxooxazolidin-3-yl)benzo[<i>d</i>]isoxazole-5-carbaldehyde (<b>12t</b>)</h4><div class="NLM_p last">A solution of the preceding intermediate (404 mg, 1.24 mmol) in HCl (1.0 M in water) (10 mL, 10.0 mmol) and 10 mL of THF was stirred at rt for 3 d. The reaction mixture was diluted with water and extracted twice with EtOAc, and each extract was washed with brine. The organic layers were combined and dried (MgSO<sub>4</sub>) and concentrated to afford material as an off-white solid consistent to give the title compound. Yield 350 mg (100%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.29 (s, 1H), 8.95 (dd, <i>J</i> = 1.9, 5.8 Hz, 1H), 5.02 (m, 1H), 4.33 (dd, <i>J</i> = 8.1, 10.0 Hz, 1H), 3.85 (dd, <i>J</i> = 7.2, 10.0 Hz, 1H), 1.64 (d, <i>J</i> = 6.4 Hz, 3H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −142.71 (d, <i>J</i> = 19.4 Hz), −158.95 (d, <i>J</i> = 19.4 Hz).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-7-fluoro-3-((<i>R</i>)-5-methyl-2-oxooxazolidin-3-yl)benzo[<i>d</i>]isoxazole-5-carbaldehyde (<b>13t</b>)</h4><div class="NLM_p last">A mixture of <b>12t</b> (250 mg, 0.89 mmol), (2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholine (122 mg, 1.06 mmol), and K<sub>2</sub>CO<sub>3</sub> (122 mg, 0.89 mmol) in 4.5 mL of CH<sub>3</sub>CN and 0.5 mL of water was heated at 100 °C in a microwave reactor vessel for 2 h. The solvent was removed, and the residue diluted with water and extracted two times with EtOAc with each extract being washed with brine. The organic layers were combined, dried (MgSO<sub>4</sub>), and concentrated to afford material that was chromatographed on silica gel (0–30% EtOAc gradient in CH<sub>2</sub>CH<sub>2</sub>) to afford a white solid consistent with the title compound. Yield 245 mg (73%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.40 (s, 1H), 8.67 (d, <i>J</i> = 1.1 Hz, 1H), 4.53–4.95 (m, 2H), 4.03–4.41 (m, 3H), 3.44 (d, <i>J</i> = 12.1 Hz, 2H), 3.05 (dd, <i>J</i> = 5.65, 11.5 Hz, 2H), 1.57–1.63 (m, 3H), 1.34 (d, <i>J</i> = 6.6 Hz, 6H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −146.0. MS (ES) MH<sup>+</sup>: 378.0 for C<sub>18</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-5-(1,3-Dioxolan-2-yl)-2,3,4-trifluoro-<i>N</i>′-hydroxy-<i>N</i>-(1-hydroxypropan-2-yl)benzimidamide</h4><div class="NLM_p last">(<i>S</i>)-2-Aminopropan-1-ol (2.35 g, 31.2 mmol) was added to a solution of <b>10</b> (4.0 g, 142 mmol) in 10 mL of DMF cooled in an ice–water bath. After warming to rt 30 min, the mixture was diluted with water and extracted with twice with EtOAc. The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated to give the title compound (3.9 g, 86%) as a solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.93 (s, 1H), 7.34 (td, <i>J</i> = 7.3, 2.4 Hz, 1H), 6.03 (s, 1H), 5.72 (d, <i>J</i> = 10.4 Hz, 1H), 4.66 (t, <i>J</i> = 5.5 Hz, 1H), 3.93–4.11 (m, 4H), 3.24 (t, <i>J</i> = 5.5 Hz, 2H), 2.86–3.05 (m, 1H), 0.98 (d, <i>J</i> = 6.4 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −134.55 (dd, <i>J</i> = 9.3, 21.6 Hz), −138.45 (dd, <i>J</i> = 9.3, 21.6 Hz), −159.78 (t, <i>J</i> = 21.6 Hz). MS (ES) MH<sup>+</sup>: 321 for C<sub>13</sub>H<sub>16</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>S</i>)-3-(5-(1,3-Dioxolan-2-yl)-6,7-difluorobenzo[<i>d</i>]isoxazol-3-yl)-4-methyloxazolidin-2-one (<b>11u</b>)</h4><div class="NLM_p last">A mixture of the preceding compound (3.82 mg, 11.9 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (15.5 g, 47.7 mmol) in 25 mL of DMF was stirred at rt for 3 h. CDI (1.93 g, 11.9 mmol) in 6 mL of DMF was added with subsequent stirring for 1 h. The mixture was diluted with EtOAc and water. The organic layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated to give material that was chromatographed on silica gel (40–50% EtOAc gradient in hexanes) to give the title compound (2.06 g, 53%) as a solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.37 (dd, <i>J</i> = 1.8, 5.9 Hz, 1H), 6.16 (s, 1H), 4.69–4.85 (m, 2H), 4.17–4.25 (m, 3H), 4.07–4.12 (m, 2H), 1.59 (d, <i>J</i> = 6.0 Hz, 3H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −139.87 (d, <i>J</i> = 19.5 Hz), −160.39 (d, <i>J</i> = 19.5 Hz). ES MH<sup>+</sup>: 327 for C<sub>14</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>S</i>)-6,7-Difluoro-3-(4-methyl-2-oxooxazolidin-3-yl)benzo[<i>d</i>]isoxazole-5-carbaldehyde (<b>12u</b>)</h4><div class="NLM_p last">A solution the <b>11u</b> (456 mg, 1.3 mmol) in 1 M aqueous HCl (10 mL, 10.0 mmol) and 10 mL of THF was stirred at rt for 2 d. The reaction mixture was diluted with water and extracted two times with EtOAc. The combined organic layers were washed with water and brine before being dried (MgSO<sub>4</sub>) and concentrated to give 390 mg (99%) of the title compound as a solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.2 (s, 1H), 8.69 (dd, <i>J</i> = 6.0, 1.7 Hz, 1H), 4.64–4.84 (m, 2H), 4.18–4.34 (m, 1H) 1.46 (d, <i>J</i> = 6.0 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −143.25 (d, <i>J</i> = 21.6 Hz), −160.42 (d, <i>J</i> = 20.5 Hz).</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-7-fluoro-3-((<i>R</i>)-5-methyl-2-oxooxazolidin-3-yl)benzo[<i>d</i>]isoxazole-5-carbaldehyde (<b>13u</b>)</h4><div class="NLM_p last">A mixture of the preceding intermediate (250 mg, 0.90 mmol), (2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholine (124 mg, 1.07 mmol), and K<sub>2</sub>CO<sub>3</sub> (124 mg, 0.90 mmol) in butyronitrile (3 mL) and water (0.5 mL) was heated at 100 °C in a microwave reactor vessel for 1 h. The solvent was removed, and the residue diluted with water and extracted two times with EtOAc, with each extract being washed with brine. The organic layers were combined, dried (MgSO<sub>4</sub>), and concentrated to afford material that was chromatographed on silica gel (0–30% EtOAc gradient in CH<sub>2</sub>CH<sub>2</sub>) to afford a yellow solid consistent with the title compound. Yield 245 mg (73%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.25 (s, 1H), 6.19 (s, 1H), 4.63–4.81 (m, 2H), 4.20–4.28 (m, 1H), 3.23 (d, <i>J</i> = 11.3 Hz, 2H), 2.91 (dd, <i>J</i> = 10.7, 5.3 Hz, 2H), 1.44 (d, <i>J</i> = 6.03 Hz, 3H), 1.23 (d, <i>J</i> = 5.84 Hz, 6H). <sup>19</sup>F NMR (282 MHz, CDCl<sub>3</sub>) δ −142.0. MS (ES) MH<sup>+</sup>: 378.0 for C<sub>18</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>)-<i>N</i>-(1-Cyclopropyl-2-hydroxyethyl)-5-(1,3-dioxolan-2-yl)-2,3,4-trifluoro-<i>N</i>′-hydroxybenzimidamide</h4><div class="NLM_p last">A solution of (<i>S</i>)-2-amino-2-cyclopropylethanol (1.38 g, 13.3 mmol), Et<sub>3</sub>N (1.85 mL, 13.3 mmol), and <b>10</b> (2.50 g, 8.89 mmol) in 20 mL of DMF was stirred at rt for 16 h. The mixture was poured into water and extracted with three times with EtOAc. The combined organic layers were washed with twice with water and once with brine. Drying (Na<sub>2</sub>SO<sub>4</sub>) and removal of solvent gave a residue that was chromatographed on silica gel (3% MeOH in CHCl<sub>3</sub>) to afford the title compound as a pale-yellow solid. Yield: 2.2 g (72%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.0 (s, 1H), 7.04 (t, <i>J</i> = 7.3 Hz, 1H), 6.04 (s, 1H), 5.83 (d, <i>J</i> = 10.6 Hz, 1H), 4.73 (t, <i>J</i> = 5.4 Hz, 1H), 3.96–4.08 (m, 4H), 3.41 (t, <i>J</i> = 5.1 Hz, 2H), 2.17–2.32 (m, 1H), 0.90–0.92 (m, 1H), 0.33 (m, 2H), −0.90–0.12 (m, 1H), −0.77–0.87 (m, 1H).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-2-((5-(1,3-Dioxolan-2-yl)-6,7-difluorobenzo[<i>d</i>]isoxazol-3-yl)amino)-2-cyclopropylethanol (<b>11s</b>)</h4><div class="NLM_p last">A stirred solution of the preceding compound (2.2 g, 6.4 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (4.6 g, 14.1 mmol) in 20 mL of DMF was stirred at rt for 16 h. The mixture was poured into water and extracted three times with EtOAc. The combined organic layers were washed with twice with water and once with brine. Drying (Na<sub>2</sub>SO<sub>4</sub>) and removal of solvent gave a residue that chromatographed on silica gel (1% MeOH in CHCl<sub>3</sub>) to afford the title compound as a pale-yellow solid. Yield: 1.80 g (87%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05 (dd, <i>J</i> = 1.2, 5.8 Hz, 1H), 7.16 (d, <i>J</i> = 8.1 Hz, 1H), 6.08 (s, 1H), 4.75 (t, <i>J</i> = 5.6 Hz, 1H), 4.03–4.10 (m, 4H), 3.64–3.65 (m, 1H), 3.53–3.56 (m, 1H), 3.03–3.05 (m, 1H), 1.01–1.12 (m, 1H), 0.37–0.45 (m, 3H), 0.23–0.25 (m, 1H). MS (ES) MH<sup>+</sup>: 327.3 for C<sub>15</sub>H<sub>17</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-3-(5-(1,3-Dioxolan-2-yl)-6,7-difluorobenzo[<i>d</i>]isoxazol-3-yl)-4-cyclopropyloxazolidin-2-one</h4><div class="NLM_p last">The title compound was synthesized following the procedure described for the preparation of <b>12r</b> using <b>11s</b> (1.20 g, 3.67 mmol), Cs<sub>2</sub>CO<sub>3</sub> (4.77 g, 14.7 mmol), and CDI (602 mg, 3.67 mmol). Yield: 1.10 g (85%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (dd, <i>J</i> = 1.4, 5.9 Hz, 1H), 6.10 (s, 1H), 4.70 (t, <i>J</i> = 8.4 Hz, 1H), 4.30–4.33 (m, 1H), 4.21–4.25 (m, 1H), 4.01–4.08 (m, 4H), 1.21–1.23 (m, 1H), 0.53–0.56 (m, 2H), 0.42–0.44 (m, 1H), 0.28–0.31 (m, 1H). MS (ES) MH<sup>+</sup>: 353.3 for C<sub>16</sub>H<sub>15</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>S</i>)-3-(4-Cyclopropyl-2-oxooxazolidin-3-yl)-6,7-difluorobenzo[<i>d</i>]isoxazole-5-carbaldehyde (<b>12s</b>)</h4><div class="NLM_p last">The title compound was synthesized following the procedure described for the preparation of <b>12r</b> using the preceding intermediate (1.10 g, 3.12 mmol). Yield: 0.91 g (95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.20 (s, 1H), 8.64 (dd, <i>J</i> = 1.6, 5.9 Hz, 1H), 4.72 (t, <i>J</i> = 8.4 Hz, 1H), 4.32–4.36 (m, 1H), 4.24–4.28 (m, 1H), 1.21–1.25 (m, 1H), 0.56–0.62 (m, 2H), 0.44–0.49 (m, 1H), 0.30–0.34 (m, 1H). MS (ES) MH<sup>+</sup>: 309.3 for C<sub>14</sub>H<sub>11</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-((<i>S</i>)-4-Cyclopropyl-2-oxooxazolidin-3-yl)-6-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)-7-fluorobenzo[<i>d</i>]isoxazole-5-carbaldehyde (<b>13s</b>)</h4><div class="NLM_p last">The title compound was synthesized following the procedure described for the preparation of <b>13r</b> using <b>12s</b> (0.90 g, 2.92 mmol), (2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholine (402 mg, 3.5 mmol), and K<sub>2</sub>CO<sub>3</sub> (403 mg, 2.92 mmol). Yield: 1.0 g (86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (s, 1H), 8.47 (s, 1H), 8.30 (s, 1H), 4.69 (t, <i>J</i> = 8.0 Hz, 1H), 4.19–4.33 (m, 2H), 4.10–4.15 (m, 2H), 3.31–3.39 (m, 2H), 2.99–3.03 (m, 2H), 1.20 (d, <i>J</i> = 6.4 Hz, 6H), 0.57–0.60 (m, 2H), 0.44–0.49 (m, 1H), 0.30–0.34 (m, 1H). MS (ES) MH<sup>+</sup>: 404.4 for C<sub>20</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-(2-oxo-1,3-oxazolidin-3-yl)-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1a</b>)</h4><div class="NLM_p last">A mixture of <b>6a</b> (800 mg, 1.95 mmol) and barbituric acid (250 mg, 1.95 mmol) in 8 mL of acetic acid and 2 mL of water was heated at 110 °C for 3.5 h. The solvents were removed, and the reaction mixture was purified using SFC (Chiralpak IA column with 40% 2-propanol and 60% CO<sub>2</sub> mobile phase) to afford 571 mg (62%) of the title compound as the major eluting component. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 11.45 (s, 1H), 7.75 (s, 1H), 4.58 (t, <i>J</i> = 8.0 Hz, 2H), 4.04–4.21 (m, 3H), 3.94 (d, <i>J</i> = 8.8 Hz, 1H), 3.74–3.87 (m, 1H), 3.59–3.73 (m, 2H), 3.01–3.20 (m, 1H), 2.91 (d, <i>J</i> = 14.2 Hz, 1H), 1.15 (d, <i>J</i> = 6.3 Hz, 3H), 0.89 (d, <i>J</i> = 6.3 Hz, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.17 (s, 1F). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.7, 154.2, 153.7 (d, <i>J</i> = 12.8 Hz), 152.8 (d, <i>J</i> = 1.8 Hz), 149.5, 134.7, 133.3 (d, <i>J</i> = 238.3 Hz), 122.2, 118.5 (d, <i>J</i> = 1.8 Hz), 106.1, 72.1, 71.6, 64.4, 63.9, 56.2 (d, <i>J</i> = 10.1 Hz), 52.9, 44.8, 38.5, 18.2, 18.1. MS RT = 2.20 min, (ES) MH<sup>+</sup>: 474.1 for C<sub>21</sub>H<sub>21</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>21</sub>H<sub>21</sub>FN<sub>5</sub>O<sub>7</sub> 474.1420, found 474.1439. [α]<sub>D</sub><sup>20</sup> = −177 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-[(5<i>S</i>)-5-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1b</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6b</b> (243 mg, 0.58 mmol) and barbituric acid (74 mg, 0.58 mmol) to afford 148 mg (53%) of the title compound as the major eluting component from SFC ((<i>S</i>,<i>S</i>) Whelk-O1, 60% CO<sub>2</sub>, 40% EtOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.81 (s, 1H), 11.43 (s, 1H), 7.74 (s, 1H), 4.89–5.07 (m, 1H), 4.21 (dd, <i>J</i> = 8.0, 9.5 Hz, 1H), 4.10 (d, <i>J</i> = 12.6 Hz, 1H), 3.97–4.04 (m, 1H), 3.94 (d, <i>J</i> = 9.0 Hz, 1H), 3.63–3.82 (m, 4H), 3.11 (t, <i>J</i> = 12.8 Hz, 1H), 2.92 (d, <i>J</i> = 14.0 Hz, 1H), 1.46 (d, <i>J</i> = 6.3 Hz, 3H), 1.15 (d, <i>J</i> = 6.3 Hz, 3H), 0.89 (d, <i>J</i> = 6.5 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.14. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 153.6, 153.6 (d, <i>J</i> = 13.2 Hz), 152.9 (d, <i>J</i> = 2.2 Hz), 149.4, 134.7, 133.3 (d, <i>J</i> = 238.6 Hz), 122.2, 118.5, 106.2, 72.5, 72.1, 71.6, 64.4, 56.2 (d, <i>J</i> = 9.5 Hz), 52.9, 51.1, 38.6, 19.7, 18.14, 18.12. UPLC RT = 0.98 min, MS (ES) MH<sup>+</sup>: 488.3 for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>7</sub> 488.1576, found 488.1579. [α]<sub>D</sub><sup>20</sup> = −130 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> ((2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Chloro-2,4-dimethyl-8-((<i>R</i>)-5-methyl-2-oxooxazolidin-3-yl)-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1c</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6c</b> (420 mg, 0.96 mmol) and barbituric acid (123 mg, 0.96 mmol) to afford 328 mg (68%) of the title compound as the major eluting component from SFC (Chiralpak IA column, 60% CO<sub>2</sub>, 40% MeOH). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.57 (br s, 2H), 7.84 (s, 1H), 4.90–5.02 (m, 1H), 4.43–4.56 (m, 1H), 4.23 (dd, <i>J</i> = 8.3, 9.4 Hz, 1H), 3.90–4.04 (m, 2H), 3.55–3.77 (m, 3H), 2.90–3.19 (m, 2H), 1.40–1.51 (m, 3H), 1.09–1.25 (m, 3H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 167.6, 162.3, 153.6, 153.0, 149.5, 144.4, 122.2, 121.5, 105.3, 97.1, 72.5, 72.4, 65.9, 56.2, 52.7, 50.9, 19.9, 18.1. UPLC RT = 0.96 min. (ES) MH<sup>+</sup>: 504.2 for C<sub>22</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>7</sub> 504.1281, found 504.1303. [α]<sub>D</sub><sup>20</sup> = −249 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-8-[(5<i>S</i>)-4-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-2,4-dimethyl-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1d</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6d</b> (100 mg, 0.23 mmol) and barbituric acid (29.3 mg, 0.23 mmol) in 3:1 EtOH–aqueous 6 N HCl as solvent to afford 60 mg (52%) of the title compound as the major eluting component from SFC (Chiralpak 1B column with 30% MeOH and 75% CO<sub>2</sub> mobile phase). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.75 (br s, 1 H), 11.42 (br s, 1 H), 7.76 (s, 1 H), 5.23 (t, <i>J</i> = 5.65 Hz, 1 H), 4.75–4.94 (m, 1H), 4.04–4.22 (m, 2H), 3.85–3.99 (m, 2H), 3.53–3.84 (m, 5H), 3.03–3.20 (m, 1H), 2.91 (d, <i>J</i> = 14.3 Hz, 1H), 1.14 (d, <i>J</i> = 6.2 Hz, 3H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.18. UPLC RT = 0.81 min. (ES) MH<sup>+</sup>: 504.2 for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>8</sub> 504.1525, found 504.1533. [α]<sub>D</sub><sup>20</sup> = −165 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-8-[(5<i>S</i>)-4-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-2,4-dimethyl-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1e</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6e</b> (445 mg, 0.99 mmol) and barbituric acid (126 mg, 0.99 mmol) to afford 368 mg (72%) of the title compound as the major eluting component from SFC ((<i>S</i>,<i>S</i>) Whelk-O1 column with 25% of 85:15 acetonitrile–methanol and 75% CO<sub>2</sub> mobile phase). Yield 368 mg (72%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 1.44 (s, 1H), 7.77 (s, 1H), 4.89–5.09 (m, 1H), 3.54–4.27 (m), 2.84–3.20 (m, 2H), 1.15 (d, <i>J</i> = 6.0 Hz, 3H), 0.89 (d, <i>J</i> = 6.2 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.18. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 153.8, 153.6, 152.7, 149.4, 134.8, 133.3 (d, <i>J</i> = 238.8 Hz), 122.3, 118.5, 106.0, 74.1, 72.2, 72.1, 71.6, 64.4, 58.7, 56.2 (d, <i>J</i> = 9.4 Hz), 52.9, 46.2, 38.6, 18.1, 18.1. MS (ES) RT = 2.26 min. MH<sup>+</sup>: 518.2 for C<sub>23</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>8</sub> 518.1682, found 518.1706. [α]<sub>D</sub><sup>20</sup> = −174 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Chloro-8-[(5<i>S</i>)-4-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-2,4-dimethyl-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1f</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6f</b> (600 mg, 1.28 mmol) and barbituric acid (164 mg, 1.28 mol) to afford 360 mg (53%) of the title compound as the major eluting component from reverse phase HPLC (20–50% acetonitrile/water gradient with 0.1% TFA) purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (br s) 11.4 (br s) 7.9 (s) 4.9–5.1 (m) 4.5 (dd, <i>J</i> = 13.9, 1.8 Hz) 4.2 (t, <i>J</i> = 9.3 Hz) 4.0 (d, <i>J</i> = 8.7 Hz) 3.9–4.0 (m) 3.8 (dd, <i>J</i> = 9.6, 6.0 Hz) 3.6–3.7 (m) 3.3 (s) 3.0 (dd, <i>J</i> = 14.0, 10.0 Hz) 3.0 (dd, <i>J</i> = 14.4, 1.1 Hz) 1.2 (d, <i>J</i> = 6.2 Hz) 0.9 (d, <i>J</i> = 6.4 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 167.6, 162.3, 153.6, 152.8, 149.5, 144.4, 122.2, 121.4, 105.2, 97.1, 74.1, 72.5, 72.2, 65.8, 58.7, 56.2, 52.7, 46.1, 39.1, 18.1. MS RT = 2.81 min, UPLC RT = 0.93 min. (ES) MH<sup>+</sup>: 534.2 for C<sub>23</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>8</sub> 534.1386, found 534.1412. [α]<sub>D</sub><sup>20</sup> = −243 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-[(4<i>R</i>)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1g</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6g</b> (100 mg, 0.24 mmol) and barbituric acid (31 mg, 0.24 mmol) to afford 34 mg (29%) of the title compound as the major eluting component from reverse phase HPLC (20–50% acetonitrile/water gradient with 0.1% TFA) purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (s, 1 H) 11.46 (s, 1 H) 7.59 (s, 1 H) 4.65 (m, 2 H) 4.19 (dd, <i>J</i> = 7.6, 4.2 Hz, 1 H) 4.10 (d, <i>J</i> = 12.5 Hz, 1 H) 3.93 (d, <i>J</i> = 8.7 Hz, 1 H) 3.69 (m, 3 H) 3.10 (t, <i>J</i> = 12.7 Hz, 1 H) 2.91 (d, <i>J</i> = 14.0 Hz, 1 H) 1.41 (d, <i>J</i> = 5.9 Hz, 3 H) 1.14 (d, <i>J</i> = 6.2 Hz, 3 H) 0.89 (d, <i>J</i> = 6.2 Hz, 3 H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −73.78 (s, 1F), −158.09 (s, 1F). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 154.0, 153.4 (d, <i>J</i> = 13.2 Hz), 152.2 (d, <i>J</i> = 2.2 Hz), 149.4, 134.7, 133.2 (d, <i>J</i> = 238.8 Hz), 122.4, 118.1, 107.0, 72.1, 71.6, 70.3, 64.4, 56.3 (d, <i>J</i> = 9.9 Hz), 52.8, 38.6, 18.1, 18.1, 17.5. UPLC RT = 0.99 min. (ES) MH<sup>+</sup>: 488.0 for C<sub>22</sub>H<sub>22</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub> 488.1576, found 488.1577. [α]<sub>D</sub><sup>20</sup> = −239 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Chloro-2,4-dimethyl-8-((<i>S</i>)-4-methyl-2-oxooxazolidin-3-yl)-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′H)-trione (<b>1h</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6h</b> (262 mg, 0.60 mmol) and barbituric acid (77 mg, 60 mmol) to afford 102 mg (34%) of the title compound as the major eluting component from SFC (Chiralpak IA column, 60% CO<sub>2</sub>, 40% MeOH). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.78 (s, 1H), 11.40 (s, 1H), 7.68 (s, 1H), 4.59–4.78 (m, 2H), 4.49 (d, <i>J</i> = 12.5 Hz, 1H), 4.09–4.27 (m, 1H), 3.89–4.07 (m, 2H), 3.50–3.75 (m, 2H), 2.92–3.12 (m, 2H), 1.41 (d, <i>J</i> = 5.9 Hz, 3H), 1.08–1.26 (m, 3H), 0.90 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 167.6, 162.1, 154.1, 152.3, 149.4, 144.5, 122.3, 121.0, 106.0, 97.2, 72.5, 70.2, 65.8, 65.6, 58.9, 56.2, 52.7, 52.4, 20.7, 18.1, 17.3. UPLC RT = 0.95 min. (ES) MH<sup>+</sup>: 504.3 for C<sub>22</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>7</sub> 504.1281, found 504.1290. [α]<sub>D</sub><sup>20</sup> = −176 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-8-((<i>S</i>)-4-(hydroxymethyl)-2-oxooxazolidin-3-yl)-2,4-dimethyl-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1i</b>)</h4><div class="NLM_p last">A mixture of <b>6i</b> (231 mg, 0.42 mmol), 1 mL of 6 N HCl, and barbituric acid (53.6 mg, 0.42 mmol) in 3 mL of ethanol was heated at 120 °C for 1 h in a microwave reactor. The solvents were removed, and the reaction mixture was purified using SFC (Chiralpak IC column with 35% ethanol and 65% CO<sub>2</sub> mobile phase) to give the title compound (62 mg, 29% yield) as a solid as the major eluting component. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.81 (s, 1H), 11.43 (s, 1H), 7.72 (s, 1H), 5.21 (br s, 1H), 4.54–4.68 (m, 2H), 4.46 (dd, <i>J</i> = 3.0, 7.0 Hz, 1H), 4.10 (d, <i>J</i> = 13.0 Hz, 1H), 3.94 (d, <i>J</i> = 9.0 Hz, 2H), 3.74–3.85 (m, 1H), 3.63–3.71 (m, 2H), 3.54 (d, <i>J</i> = 11.8 Hz, 1H), 3.11 (t, <i>J</i> = 12.0 Hz, 1H), 2.93 (d, <i>J</i> = 14.3 Hz, 1H), 1.15 (d, <i>J</i> = 6.0 Hz, 3H), 0.89 (d, <i>J</i> = 6.3 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) −158.3. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.7, 154.4, 153.5 (d, <i>J</i> = 13.2 Hz), 152.2, 149.4, 134.7, 133.3 (d, <i>J</i> = 238.6 Hz), 122.1, 118.6, 106.7, 72.1, 71.6, 66.2, 64.4, 57.8, 57.4, 56.3 (d, <i>J</i> = 9.5 Hz), 52.9, 38.6, 18.14, 18.11. UPLC RT = 0.85 min. (ES) MH<sup>+</sup>: 504.1 for C<sub>22</sub>H<sub>23</sub>fN<sub>5</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>8</sub> 504.1525, found 504.1506. [α]<sub>D</sub><sup>20</sup> = −104.7 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-8-[(4<i>S</i>)-4-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-2,4-dimethyl-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1j</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6j</b> (0.67 g, 1.5 mmol) and barbituric acid (0.21 g, 1.6 mmol) to afford 561 mg (72%) of the title compound as the major eluting component from SFC (Chiralpak IA column with 20% methanol and 80% CO<sub>2</sub> mobile phase). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.76 (br s, 1H), 11.43 (br s, 1H), 7.66 (s, 1H), 4.69–4.76 (m, 1H), 4.60–4.68 (m, 1H), 4.43 (dd, <i>J</i> = 3.95, 8.1 Hz, 1H), 4.11 (d, <i>J</i> = 12.8 Hz, 1H), 3.95 (d, <i>J</i> = 9.0 Hz, 1H), 3.85 (dd, <i>J</i> = 3.6, 10.4 Hz, 1H), 3.75–3.82 (m, 1H), 3.61–3.72 (m, 2H), 3.54 (dd, <i>J</i> = 2.1, 10.4 Hz, 1H), 3.26 (s, 3H), 3.08–3.15 (m, 1H), 2.92 (d, <i>J</i> = 14.3 Hz, 1H), 1.15 (d, <i>J</i> = 6.0 Hz, 3H), 0.90 (d, <i>J</i> = 6.4 Hz, 3H). <sup>19</sup>F NMR (564 MHz, DMSO-<i>d</i><sub>6</sub>) δ −161.8. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.7, 154.2, 153.5 (d, <i>J</i> = 13.2 Hz), 152.1 (d, <i>J</i> = 2.9 Hz), 149.4, 134.8, 133.3 (d, <i>J</i> = 239.3 Hz), 122.4, 118.3, 106.6, 72.1, 71.7, 69.1, 66.6, 64.4, 58.8, 56.2 (d, <i>J</i> = 8.8 Hz), 55.9, 52.9, 38.5, 18.13, 18.09. UPLC RT = 0.96 min. (ES) MH<sup>+</sup>: 518.4 for C<sub>23</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>8</sub> 518.1682, found 518.1694. [α]<sub>D</sub><sup>20</sup> = −128 (<i>c</i> = 1.14; MeOH).</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Chloro-8-((<i>S</i>)-4-(methoxymethyl)-2-oxooxazolidin-3-yl)-2,4-dimethyl-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1k</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6k</b> (350 mg, 0.75 mmol) and barbituric acid (96 mg, 0.75 mmol) to afford 218 mg (55%) of the title compound as the major eluting component from reverse phase HPLC (20–50% acetonitrile/water gradient with 0.1% TFA) purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.26–11.96 (m, 2H), 7.76 (s, 1H), 4.60–4.76 (m, 2H), 4.45–4.55 (m, 1H), 4.42 (dd, <i>J</i> = 3.7, 7.7 Hz, 1H), 3.91–4.04 (m, 2H), 3.84 (dd, <i>J</i> = 3.3, 10.3 Hz, 1H), 3.58–3.72 (m, 2H), 3.52 (dd, <i>J</i> = 1.8, 10.3 Hz, 1H), 3.25 (s, 3H), 2.97 (d, <i>J</i> = 13.2 Hz, 1H), 2.51–2.54 (m, 1H), 1.17 (d, <i>J</i> = 6.2 Hz, 3H), 0.90 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 167.6, 162.2, 154.2, 152.3, 149.4, 144.5, 122.3, 121.3, 105.7, 97.2, 72.5, 69.0, 66.6, 65.8, 58.8, 56.2, 55.7, 52.7, 39.1, 18.1, 18.1. UPLC RT = 0.96 min. (ES) MH<sup>+</sup>: 534.2 for C<sub>23</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>8</sub> 534.1386, found 534.1406. [α]<sub>D</sub><sup>20</sup> = −195 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-8-{(4<i>S</i>)-4-[(Dimethylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-11-fluoro-2,4-dimethyl-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione, TFA Salt (<b>1l</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6l</b> (92 mg, 0.21 mmol) and barbituric acid (27 mg, 0.21 mmol) to afford 41 mg (37%) of the title compound as the major eluting component reverse phase HPLC (20–50% acetonitrile/water gradient with 0.1% TFA) purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.84 (s, 1H), 11.43 (s, 1H), 9.62 (br s, 1H), 7.69 (s, 1H), 4.99 (br s, 1H), 4.74 (t, <i>J</i> = 8.5 Hz, 1H), 4.55 (dd, <i>J</i> = 3.6, 9.0 Hz, 1H), 4.10 (d, <i>J</i> = 12.6 Hz, 1H), 3.94 (d, <i>J</i> = 8.8 Hz, 1H), 3.72–3.84 (m, 1H), 3.50–3.71 (m, 4H), 3.06–3.19 (m, 1H), 2.78–3.00 (m, 7H), 1.14 (d, <i>J</i> = 6.0 Hz, 3H), 0.89 (d, <i>J</i> = 6.3 Hz, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −73.6, −158.4. <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 157.8, 153.8 (d, <i>J</i> = 12.8 Hz), 153.5, 152.1, 149.5, 135.0, 133.3 (d, <i>J</i> = 238.3 Hz), 122.6, 118.4, 106.2, 72.1, 71.7, 68.1, 64.4, 57.5, 56.2 (d, <i>J</i> = 9.2 Hz), 52.8, 51.8, 43.3, 38.5, 18.1, 18.1. UPLC RT = 0.65 min. (ES) MH<sup>+</sup>: 531.1 for C<sub>24</sub>H<sub>27</sub>FN<sub>6</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>24</sub>H<sub>28</sub>FN<sub>6</sub>O<sub>7</sub>, 531.1998 found 531.2021. [α]<sub>D</sub><sup>20</sup> = −99 (<i>c</i> = 0.1; MeOH).</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-[(4<i>S</i>)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1m</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6m</b> (93 mg, 0.19 mmol) and barbituric acid (24.6 mg, 0.10 mmol) to afford 52 mg (49%) of the title compound as the major eluting component from reverse phase HPLC (20–50% CH<sub>3</sub>CN/water gradient with 0.1% TFA) purification. Yield 52 mg (49%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.84 (s, 1H), 11.49 (s, 1H), 7.66 (s, 1H), 7.29–7.46 (m, 5H), 5.68 (dd, <i>J</i> = 6.2, 8.7 Hz, 1H), 4.98 (t, <i>J</i> = 8.8 Hz, 1H), 4.35 (dd, <i>J</i> = 6.0, 8.51 Hz, 1H), 4.07 (d, <i>J</i> = 13.2 Hz, 1H), 3.93 (d, <i>J</i> = 8.8 Hz, 1H), 3.70–3.79 (m, 1H), 3.60–3.70 (m, 2H), 3.22 (s, 1H), 3.10 (t, <i>J</i> = 12.1 Hz, 1H), 2.95 (d, <i>J</i> = 14.2 Hz, 1H), 1.13 (d, <i>J</i> = 6.3 Hz, 3H), 0.89 (d, <i>J</i> = 6.3 Hz, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.03. <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.7, 154.3, 153.3 (d, <i>J</i> =12.8 Hz), 151.9, 151.9, 149.4, 138.0, 134.8, 133.2 (d, <i>J</i> =239.2 Hz), 128.9, 128.4, 126.5, 122.5, 117.9, 106.7, 72.1, 71.7, 71.4, 64.4, 59.5, 56.2 (d, <i>J</i> =9.2 Hz), 52.8, 38.5, 18.1, 18.1. UPLC RT = 1.06 min. (ES) MH<sup>+</sup>: 550.1 for C<sub>27</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>27</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>7</sub> 550.1733, found 550.1743. [α]<sub>D</sub><sup>20</sup> = −228 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-8-((4<i>R</i>,5<i>S</i>)-4,5-Dimethyl-2-oxooxazolidin-3-yl)-11-fluoro-2,4-dimethyl-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1n</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6n</b> (920 mg, 2.11 mmol) and barbituric acid (270 mg, 2.11 mmol) to afford 740 mg (70%) of the title compound as the major eluting component from reverse phase HPLC (20–50% acetonitrile/water gradient with 0.1% TFA) purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br s, 2H), 7.62 (s, 1H), 5.02 (quin, <i>J</i> = 6.7 Hz, 1H), 4.59 (quin, <i>J</i> = 6.7 Hz, 1H), 4.09 (d, <i>J</i> = 12.7 Hz, 1H), 3.93 (d, <i>J</i> = 8.7 Hz, 1H), 3.57–3.84 (m, 3H), 3.10 (t, <i>J</i> = 12.5 Hz, 1H), 2.91 (d, <i>J</i> = 14.2 Hz, 1H), 1.26–1.41 (m, 6H), 1.14 (d, <i>J</i> = 6.2 Hz, 3H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.15. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 153.4 (d, <i>J</i> = 13.2 Hz), 153.2, 152.2 (d, <i>J</i> = 2.8 Hz), 149.5, 134.7, 133.3 (d, <i>J</i> = 238.8 Hz), 122.3 (d, <i>J</i> = 2.2 Hz), 118.2, 106.8, 75.6, 72.1, 71.6, 64.4, 56.2 (d, <i>J</i> = 9.4 Hz), 56.1, 52.9, 38.6, 18.1, 18.1, 14.1, 12.0. UPLC RT = 1.02 min, (ES) MH<sup>+</sup>: 502 for C<sub>23</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>7</sub> 502.1733, found 502.1729. [α]<sub>D</sub><sup>20</sup> = −117 (<i>c</i> = 0.1; MeOH).</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-8-((4<i>S</i>,5<i>R</i>)-4,5-Dimethyl-2-oxooxazolidin-3-yl)-11-fluoro-2,4-dimethyl-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1o</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6o</b> (840 mg, 1.93 mmol) and barbituric acid (247 mg, 1.93 mmol) to afford 690 mg (71%) of the title compound as the major eluting component from reverse phase HPLC (20–50% acetonitrile/water gradient with 0.1% TFA) purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (s, 1 H) 11.4 (s, 1 H) 7.6 (s, 1 H) 5.0 (q, <i>J</i> = 6.7 Hz, 1 H) 4.6 (q, <i>J</i> = 6.7 Hz, 1 H) 4.1 (d, <i>J</i> = 12.7 Hz, 1 H) 3.9 (d, <i>J</i> = 8.7 Hz, 1 H) 3.7–3.9 (m, 1 H) 3.6–3.7 (m, 2 H) 3.0–3.2 (m, 1 H) 2.9 (d, <i>J</i> = 14.0 Hz, 1 H) 1.4 (d, <i>J</i> = 6.6 Hz, 3 H) 1.3 (d, <i>J</i> = 6.4 Hz, 3 H) 1.1 (d, <i>J</i> = 6.0 Hz, 3 H) 0.9 (d, <i>J</i> = 6.4 Hz, 3 H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.2. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.7, 153.4 (d, <i>J</i> = 13.2 Hz), 153.3, 152.2 (d, <i>J</i> = 2.2 Hz), 149.4, 134.7, 133.3 (d, <i>J</i> = 238.6 Hz), 122.3, 118.2, 106.8, 75.5, 72.1, 71.6, 64.4, 56.2 (d, <i>J</i> = 9.5 Hz), 55.7, 52.9, 38.6, 18.1, 18.1, 14.2, 12.0. UPLC RT = 0.98 min. (ES) MH<sup>+</sup>: 502.3 for C<sub>23</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>7</sub> 502.1733, found 502.1753. [α]<sub>D</sub><sup>20</sup> = −221 (<i>c</i> = 0.1; MeOH).</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-(2-oxoimidazolidin-1-yl)-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1p</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6p</b> (30 mg, 0.07 mmol) and barbituric acid (10.4 mg, 0.08 mmol) to afford 9.8 mg (26%) of the title compound as the major eluting component from reverse phase HPLC purification (25–40% CH<sub>3</sub>CN gradient in water with 0.1% HCO<sub>2</sub>H). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.5 (br s, 2H), 7.77 (s, 1H), 7.43 (s, 1H), 6.55 (br s, 1H), 4.02 (d, <i>J</i> = 13.6 Hz, 1H), 3.85 (m, 2H), 3.70 (m, 1H), 3.60 (m, 1H), 3.45 (t, <i>J</i> = 8.0 Hz, 2H), 3.02 (m, 1H), 2.84 (d, <i>J</i> = 13.9 Hz, 1H), 1.07 (d, <i>J</i> = 6.2 Hz, 3H), 0.81 (d, <i>J</i> = 6.2 Hz, 3H). MS RT = 2.04 min. (ES) MH<sup>+</sup>: 473.3 for C<sub>21</sub>H<sub>21</sub>FN<sub>6</sub>O<sub>6</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>FN<sub>6</sub>O<sub>6</sub> 473.1579, found 473.1594. [α]<sub>D</sub><sup>20</sup> = −114 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-(3-methyl-2-oxoimidazolidin-1-yl)-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1q</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>6q</b> (213 mg, 0.51 mmol) and barbituric acid (64.9 mg, 0.51 mmol) to afford 130 mg (53%) of the title compound as the major eluting component from SFC (Chiralpak IC column with 50% methanol and 60% CO<sub>2</sub> mobile phase). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.71 (br s, 1H), 11.35 (br s, 1H), 7.83 (s, 1H), 4.02 (d, <i>J</i> = 12.5 Hz, 1H), 3.85 (d, <i>J</i> = 8.8 Hz, 1H), 3.75–3.82 (m, 2H), 3.65–3.74 (m, 1H), 3.46–3.64 (m, 4H), 3.18–3.23 (m, 1H), 2.98–3.09 (m, 1H), 2.84 (d, <i>J</i> = 14.0 Hz, 1H), 1.07 (d, <i>J</i> = 6.0 Hz, 3H), 0.81 (d, <i>J</i> = 6.3 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.42. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 155.7, 154.2, 153.4 (d, <i>J</i> = 12.4 Hz), 149.4, 134.4, 133.4 (d, <i>J</i> = 237.8 Hz), 121.4, 119.5, 106.9, 72.1, 71.6, 64.3, 56.2 (d, <i>J</i> = 8.8 Hz), 53.1, 44.4, 41.8, 38.8, 30.5, 18.2, 18.1. UPLC RT = 0.90 min (ES) MH<sup>+</sup>: 487.1 for C<sub>22</sub>H<sub>24</sub>FN<sub>6</sub>O<sub>6</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>6</sub>O<sub>6</sub> 487.1736, found 487.1718. [α]<sub>D</sub><sup>20</sup> = −115.6 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>R</i>)-3-((2<i>R</i>,4<i>S</i>,4aS)-11-Fluoro-2,4-dimethyl-2′,4′,6′-trioxo-2,2′,3′,4,4a,4′,6,6′-octahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidin]-8-yl)-<i>N</i>,<i>N</i>-dimethyl-2-oxooxazolidine-4-carboxamide (<b>1r</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>13r</b> (1.95 g, 4.48 mmol) and barbituric acid (573 mg, 4.48 mmol) to afford 1.68 g (69%) of the title compound as the major eluting component from reverse phase HPLC (25–40% CH<sub>3</sub>CN/water gradient with 0.1% HCO<sub>2</sub>H). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (s, 1H), 11.45 (s, 1H), 7.76 (s, 1H), 5.59 (dd, <i>J</i> = 3.6, 8.9 Hz, 1H), 4.79 (t, <i>J</i> = 8.9 Hz, 1H), 4.44 (dd, <i>J</i> = 3.7, 8.8 Hz, 1H), 4.09 (d, <i>J</i> = 12.8 Hz, 1H), 3.94 (d, <i>J</i> = 8.9 Hz, 1H), 3.60–3.84 (m, 3H), 3.12 (m, 1H), 3.09 (s, 3H), 2.88–2.95 (m, 1H), 2.87 (s, 3H), 1.14 (d, <i>J</i> = 6.2 Hz, 3H), 0.89 (d, <i>J</i> = 6.2 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.28. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 167.7, 167.2, 154.0, 153.7 (d, <i>J</i> = 12.4 Hz), 152.2 (d, <i>J</i> = 2.9 Hz), 149.4, 134.3, 133.3 (d, <i>J</i> = 238.6 Hz), 122.5, 118.3, 106.1, 72.1, 71.7, 66.7, 64.4, 56.2 (d, <i>J</i> = 8.8 Hz), 55.1, 53.0, 38.6, 36.2, 35.5, 18.1, 18.1. UPLC RT = 0.85 min. MS (ES) MH<sup>+</sup>: 545.1 for C<sub>24</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>8</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>24</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>8</sub> 545.1791, found 545.1807. [α]<sub>D</sub><sup>20</sup> = −171 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-8-((<i>S</i>)-4-Cyclopropyl-2-oxooxazolidin-3-yl)-11-fluoro-2,4-dimethyl-2,4,4a,6-tetrahydro-1<i>H</i>,1′<i>H</i>-spiro[isoxazolo[4,5-<i>g</i>][1,4]oxazino[4,3-<i>a</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(3′<i>H</i>)-trione (<b>1s</b>)</h4><div class="NLM_p last">A mixture of <b>13s</b> (1.0 g, 2.48 mmol) and barbituric acid (317 mg, 2.48 mmol) in 2 mL of <i>i</i>-PrOH was heated at 130 °C for 2 h. After removal of solvent, the residue was stirred in a mixture of 2 mL of MeOH and 5 mL of water. Solid material was filtered and dried in vacuo. Yield 1.0 g (79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 11.46 (s, 1H), 7.53 (s, 1H), 4.63–4.69 (m, 1H), 4.17–4.29 (m, 3H), 4.11 (d, <i>J</i> = 12.8 Hz, 1H), 3.95 (d, <i>J</i> = 8.8 Hz, 1H), 3.72–3.86 (m, 1H), 3.57–3.72 (m, 2H), 3.05–3.21 (m, 1H), 2.95 (d, <i>J</i> = 14.0 Hz, 1H), 1.15 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.3 Hz, 3H), 0.51–0.59 (m, 2H), 0.39–0.48 (m, 1H), 0.24–0.32 (m, 1H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.01. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 167.7, 154.3, 153.4 (d, <i>J</i> = 12.4 Hz), 152.5 (d, <i>J</i> = 2.2 Hz), 149.4, 134.8, 133.4 (d, <i>J</i> = 239.3 Hz), 122.5, 117.7, 107.4, 72.1, 71.7, 68.1, 64.4, 59.9, 56.3 (d, <i>J</i> = 8.8 Hz), 52.9, 38.5, 18.1, 18.1, 12.8, 4.5, 0.1. UPLC RT = 1.02 min. (ES) MH<sup>+</sup>: 514.1 for C<sub>24</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>24</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>7</sub> 514.1733, found 514.1722. [α]<sub>D</sub><sup>20</sup> = −84.4 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-[(5<i>R</i>)-5-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1t</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>7a</b> using <b>13t</b> (1.67 g, 3.96 mmol) and barbituric acid (508 mg, 3.96 mmol) to afford 1.56 g (81%) of the title compound as the major eluting component from SFC (Chiralpak IC column with 30% methanol and 70% CO<sub>2</sub> mobile phase) <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (br s, 1 H), 11.35 (br s, 1H), 7.8 (s, 1H), 4.9–5.1 (m, 1H), 4.3 (s, 1H), 4.1–4.2 (m, 1H), 4.0 (d, <i>J</i> = 8.9 Hz, 1H), 3.7 (d, <i>J</i> = 6.4 Hz, 4H), 3.1–3.3 (m, 1H), 2.9–3.1 (m, 1H), 1.5 (d, <i>J</i> = 6.2 Hz, 3H), 1.2 (d, <i>J</i> = 6.2 Hz, 3H), 0.9 (d, <i>J</i> = 6.4 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.16. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.6, 153.6 (d, <i>J</i> = 12.7 Hz), 153.6, 152.8 (d, <i>J</i> = 2.2 Hz), 149.4, 134.7 (d, <i>J</i> = 1.7 Hz), 133.2 (d, <i>J</i> = 238.8 Hz), 122.2 (d, <i>J</i> = 2.2 Hz), 118.5, 106.2, 72.4, 72.1, 71.6, 64.4, 56.2 (d, <i>J</i> = 9.9 Hz), 52.9, 51.0, 38.6, 19.9, 18.1, 18.1. UPLC RT = 0.93 min. (ES) MH<sup>+</sup>: 488.2 for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub> 488.1576 found 488.1580. [α]<sub>D</sub><sup>20</sup> = −188 (<i>c</i> = 1; MeOH). Also isolated as the second component eluting from the SFC purification was (2<i>R</i>,4<i>R</i>,4a<i>R</i>)-11-fluoro-2,4-dimethyl-8-[(5<i>R</i>)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>7t</b>).</div></div><div id="sec4_1_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (2<i>R</i>,4<i>R</i>,4a<i>R</i>)-11-fluoro-2,4-dimethyl-8-[(5<i>R</i>)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>7t</b>)</h4><div class="NLM_p last">Yield: 122 mg (6.3%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.76 (s, 1H), 11.46 (s, 1H), 7.74 (s, 1H), 4.89–5.09 (m, 1H), 4.22 (dd, <i>J</i> = 8.3, 9.5 Hz, 1H), 4.03–4.14 (m, 1H), 3.91–4.01 (m, 1H), 3.87 (dd, <i>J</i> = 2.9, 13.2 Hz, 1H), 3.71–3.79 (m, 2H), 3.54–3.66 (m, 2H), 3.07 (d, <i>J</i> = 14.8 Hz, 1H), 1.47 (d, <i>J</i> = 6.3 Hz, 3H), 1.29–1.32 (d, <i>J</i> = 6.3 Hz, 3H), 0.95 (d, <i>J</i> = 6.3 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.16. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.0, 168.5, 153.6, 153.2 (d, <i>J</i> = 13.2 Hz), 152.8, 149.6, 135.5, 133.6 (d, <i>J</i> = 240.0 Hz), 121.8, 118.6, 106.6, 72.5, 66.8, 65.0, 64.8, 53.2 (d, <i>J</i> = 9.5 Hz), 51.1, 51.0, 37.8, 19.8, 18.6, 16.5. UPLC RT = 0.91 min. (ES) MH<sup>+</sup>: 488.2 for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub> 488.1576, found 488.1576. [α]<sub>D</sub><sup>20</sup> = 93 (<i>c</i> = 1; MeOH).</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (2<i>R</i>,4<i>S</i>,4a<i>S</i>)-11-Fluoro-2,4-dimethyl-8-[(4<i>S</i>)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>1u</b>)</h4><div class="NLM_p last">Prepared following the procedure described for the preparation of <b>1a</b> using <b>13u</b> (585 mg, 1.39 mmol) and barbituric acid (178 mg, 1.39 mmol) to afford 480 mg (71%) of the title compound as the major eluting component from SFC (Chiralpak IC column with 30% methanol and 70% CO<sub>2</sub> mobile phase). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 11.43 (s, 1H), 7.59 (s, 1H), 4.55–4.79 (m, 2H), 4.15–4.23 (m, 1H), 4.10 (d, <i>J</i> = 12.8 Hz, 1H), 3.94 (d, <i>J</i> = 8.8 Hz, 1H), 3.78 (br s, 1H), 3.55–3.72 (m, 2H), 3.13 (d, <i>J</i> = 12.8 Hz, 1H), 2.94 (d, <i>J</i> = 13.9 Hz, 1H), 1.42 (d, <i>J</i> = 5.8 Hz, 3H), 1.15 (d, <i>J</i> = 6.2 Hz, 3H), 0.89 (d, <i>J</i> = 6.2 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −158.12. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 167.7, 154.0, 153.4 (d, <i>J</i> = 13.2 Hz), 152.1 (d, <i>J</i> = 2.8 Hz), 149.4, 134.8 (d, <i>J</i> = 1.7 Hz), 133.3 (d, <i>J</i> = 238.8 Hz), 122.4 (d, <i>J</i> = 2.2 Hz), 118.1 (d, <i>J</i> = 2.8 Hz), 106.9, 72.1, 71.7, 70.2, 64.4, 56.3 (d, <i>J</i> = 9.4 Hz), 52.9, 52.5, 38.6, 18.1, 18.1, 17.3. UPLC RT = 0.92 min. (ES) MH<sup>+</sup>: 488.1 for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub> 488.1576 found 488.1597. [α]<sub>D</sub><sup>20</sup> = −92 (<i>c</i> = 1; MeOH). Also isolated as the second component eluting from the SFC purification was (2<i>R</i>,4<i>R</i>,4a<i>R</i>)-11-fluoro-2,4-dimethyl-8-[(4<i>S</i>)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>7u</b>).</div></div><div id="sec4_1_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (2<i>R</i>,4<i>R</i>,4a<i>R</i>)-11-Fluoro-2,4-dimethyl-8-[(4<i>S</i>)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-1,2,4,4a-tetrahydro-2′<i>H</i>,6<i>H</i>-spiro[1,4-oxazino[4,3-<i>a</i>][1,2]oxazolo[4,5-<i>g</i>]quinoline-5,5′-pyrimidine]-2′,4′,6′(1′<i>H</i>,3′<i>H</i>)-trione (<b>7u</b>)</h4><div class="NLM_p last">Yield: 35 mg (5.2%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.73 (br s, 1 H), 11.47 (br s, 1H), 7.58 (s, 1H), 4.55–4.74 (m, 2H), 3.71–4.22 (m, 5H), 3.51–3.65 (m, 2H), 3.06 (d, <i>J</i> = 15.3 Hz, 1H), 1.40 (d, <i>J</i> = 5.6 Hz, 3H), 1.29 (d, <i>J</i> = 5.3 Hz, 3H), 0.95 (d, <i>J</i> = 6.2 Hz, 3H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −155.17. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.2, 168.7, 154.1, 152.9 (d, <i>J</i> = 12.6 Hz), 152.1, 149.8, 135.5, 133.6 (d, <i>J</i> = 241.0 Hz), 122.2, 118.1, 107.4, 70.3, 66.7, 65.0, 64.8, 53.3, 52.8, 51.0, 37.8, 18.6, 17.4, 16.5. UPLC RT = 0.94 min. (ES) MH<sup>+</sup>: 488.2 for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub>. HRMS (ES) MH<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>5</sub>O<sub>7</sub> 488.1576 found 488.1596. [α]<sub>D</sub><sup>20</sup> = 151 (<i>c</i> = 1; MeOH).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Animals</h3><div class="NLM_p last">Compounds for PO, IV, and IP dosing in mice, rats, and dogs were formulated in 0.2 M meglumine/20% hydroxypropyl-β-cyclodextrin in rats and dogs and DMA:TEG:saline 40/40/20% in mice. Wistar Han rats for pharmacokinetic and pharmacology studies were obtained from Charles River Laboratories (Raleigh, NC). CD-1 mice were obtained from Charles River Laboratories (Kingston, NY). All animals were housed and acclimated in the animal facility on site before each study. All experimental procedures were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>S. aureus</i> Neutropenic Thigh Infection Model</h3><div class="NLM_p last">Compounds <b>1t</b> and <b>1u</b> were studied in a neutropenic mouse thigh infection model as described previously.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Briefly, mice were rendered neutropenic by injecting cyclophosphamide (Sigma-Aldrich, St. Louis MO) intraperitoneally 4 days (150 mg/kg of body weight) and 1 day (100 mg/kg) before experimental infection. For <b>7u</b>, 2 h prior to infection, mice received an administration of 50 mg/kg ABT orally to inhibit cytochrome P450 activity, and mice received a second 50 mg/kg administration 12 h later.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> No ABT was administered for similar experiments with <b>7t</b>. Mice were infected with <i>S. aureus</i> ARC516 to achieve a target inoculum of 5 × 10<sup>5</sup> CFU. Groups of five animals each received intraperitoneal injections of either <b>1t</b> or <b>1u</b> on a bid, q12h regimen prepared in 2 M meglumine/30% HPbCD starting 2 h after infection. An additional group of five mice received vehicle alone. Efficacy was determined 24 h after the start of treatment. Thighs were removed, weighed, homogenized, and aliquots plated onto tryptic soy agar plates and incubated at 37 °C overnight for CFU determination.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Minimum Inhibitory Concentration (MIC)</h3><div class="NLM_p last">The bacterial strains included in these studies are maintained in the AstraZeneca Research Collection (ARC). The minimum inhibitory concentration (MIC) against each isolate was determined following the guidelines of the Clinical Laboratory Standards Institute (CLSI).<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> Susceptibility testing against all species was performed using the broth microdilution method with the exception of <i>N. gonorrheae</i> isolates, where the standard agar dilution method was used. The quality control isolates obtained from the American Type Culture Collection and used during testing were <i>N. gonorrheae</i> ATCC49226, <i>S. aureus</i> ATCC29213, and <i>S. pneumoniae</i> ATCC49619. Reference antimicrobials were obtained from the US Pharmacopeial Convention (Rockville, MD; novobiocin) and MP Biomedicals (Santa Ana, CA; ciprofloxacin) and were tested in accordance with CLSI recommendations. For more potent compounds with MIC values <6 μM, the reported data represents the averages of three or more replications.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Cytotoxicity Assays</h3><div class="NLM_p">Experiments for assessing THLE cytotoxicity,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> myeloid cytotoxicity,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and erythroid cytotoxicity<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> were performed as described previously. A resazurin-based cyctotoxicity assay was used with THP1 human monocyte cells.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Modification of literature procedures<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> was used to assess A549 proliferation. Briefly, an A549 cell line was trypsinized, resuspended, and counted. Then 100 μL of cells were deposited into 96-well flat bottomed plates at a cell density of 1000 cells/well and incubated for 24 h in a CO<sub>2</sub> atmosphere. Compounds were added to test plates in 50 μL of culture medium (RPMI w/o PR) with 10 doubling dilutions from 200 to 0.2 μM and incubated for 72 h in a CO<sub>2</sub> atmosphere. Then 20 μL of an MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium, inner salt] solution (Promega, product no. G3582) was added. The test plates which were incubated for 2 h and read in a plate reader at 650 and 490 nm (the reading at A650 nm is subtracted from the reading at A490 nM). The MIC is recorded as the highest compound concentration that does not give a positive value.</div><div class="NLM_p last">To assess sheep red blood cell lysis, compounds were added to test plates with 10 doubling dilutions in 2 μL of DMSO. A sheep red blood cell suspension (10<sup>7</sup> cells/ml) diluted in 0.2% PBS buffer was added (final volume 100 μL). The plates were incubated for 2 h at rt and read by eye. MIC is the minimum concentration of compound at which the test well looks completely clear.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> In Vitro Micronucleus Assay, in Vitro MLA, and Ames Mutagenicity</h3><div class="NLM_p last">Experiments for assessing micronuclei in mouse lymphoma cells, the mouse lymphoma assay, and the Ames assay were performed as described previously.<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69-71)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Pharmacokinetic Studies</h3><div class="NLM_p last">Pharmacokinetic properties of selected compounds were studied in male rats and dogs and mice of either gender. Plasma pharmacokinetics were determined from 0 to 24 h following 15 min IV infusions at 3 mg/kg or PO administration at 10 mg/kg. Serial 200 μL samples of whole blood were taken from the jugular vein of each animal at time intervals. Concentration of compound in plasma was determined by LC-MS/MS, and pharmacokinetic parameters were estimated using a noncompartmental model in WinNonLin (Pharsight). Mean results were determined for each experiment with three mice or three rats.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> log <i>D</i> Determination</h3><div class="NLM_p last">The partition coefficient (log <i>D</i>) was measured by shake flask method, using 10 mM phosphate buffer at pH 7.4 and <i>n</i>-octanol. The samples were allowed to reach equilibrium by shaking for 1 h at 1200 rpm, and sample analysis was done by LC/UV, with MS for mass confirmation.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> FP-Based Inhibition of DNA Topoisomerase Activity</h3><div class="NLM_p last">IC<sub>50</sub> values against <i>E. coli</i> DNA gyrase, human topoisomerase IIα, and human topoisomerase IIβ were determined using literature procedures.<a onclick="showRef(event, 'ref30 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref30 ref42 ref43">(30, 42, 43)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Inhibition of DNA Topoisomerase Activity</h3><div class="NLM_p last">Two-fold decreasing concentrations of <b>1u</b> or ciprofloxacin were prepared in DMSO and diluted 10-fold in water. A total of 3 μL of serial dilutions in 10% DMSO were transferred a 96-well polypropylene plate. DMSO served as a control for the uninhibited reaction. Next, 24 μL assay buffer containing DNA substrate and ATP were added to compound and control wells (no compound) and reactions were initiated by addition of enzyme prepared in enzyme dilution buffer. Supercoiling reactions were conducted for 1 h at 20 °C and contained 1.8 mM spermidine, 8 mM MgCl<sub>2</sub>, 24 mM KCl, 6.5% (w/v) glycerol, 0.005% Brij-35, and 2 mM dithiolthreitol. Relaxed DNA plasmid was present at 0.0013 μg/mL and DNA gyrase tetramer at 3 nM (<i>S. aureus</i>) or 2 nM (<i>E. coli</i>). Decatenation reactions for <i>E. coli</i> were 30 min at 20 °C and for <i>S. aureus</i> 60 min at 37 °C and contained 20 mM Tris, pH 8.0, 50 mM ammonium acetate, 5 mM dithiothreitol, 8 mM MgCl<sub>2</sub>, 0.5 mM EDTA, 5% w/v glycerol, 0.005% w/v Brij-35, 200 ng kinetoplast DNA, and 1 mM ATP and 2 nM <i>E. coli</i> or 20 nM <i>S. aureus</i> Topo IV tetramer. Controls were initiated with either 3 μL of enzyme solution (100% reaction) or dilution buffer (no enzyme). Final DMSO concentration was 1%. Reactions were stopped by addition of 6 μL of 0.5 M EDTA and subsequent addition of 4 μL of STOP DYE. Gel electrophoresis was performed using 1% agarose buffered with 40 mM Tris, 20 mM acetic acid, and 1 mM EDTA and run 18– 20 h at 30 V and stained using 1 μg/mL ethidium bromide solution. Gels images were captured using AlphaEase software. For supercoiling reactions, the amount of supercoiled products present in the control reactions (no compound, with and without gyrase) were quantified using AlphaEase software and were used to define conditions of no inhibition (no compound, with gyrase) and full inhibition (no compound, no gyrase). The supercoiled DNA products in reactions containing DNA gyrase and <b>7u</b> or ciprofloxacin were quantified using AlphaEase software, and % inhibition relative to the control reactions were calculated. This data was fit using the following equation (fit = (<i>A </i>+ ((<i>B</i> × <i>x</i>)/((<i>C</i>(<i>D</i> + 1)) + <i>x</i>))) to calculate IC<sub>50</sub> values. For decatenation reactions, the amount of decatenated products present in the control reactions (no compound, with and without Topo IV) were quantified using AlphaEase software and were used to define conditions of no inhibition (no compound, with Topo IV) and full inhibition (no compound, no Topo IV). The decatenated DNA products in reactions containing Topo IV and <b>7u</b> or ciprofloxacin were quantified using AlphaEase software, and % inhibition relative to the control reactions were calculated. This data was fit using the following equation (fit = (<i>A</i> + ((<i>B</i> × <i>x</i>)/((<i>C</i>(<i>D</i> + 1)) + <i>x</i>))) to calculate IC<sub>50</sub> values.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Plasma Protein Binding Determination</h3><div class="NLM_p last">Human, rat, and dog plasma protein binding was determined from a 10 μM compound solution in a Dianorm plasma well incubating at 37 °C for 16 h. Free fractions were calculated from ratios of drug concentration in buffer and plasma wells determined by LC-MS/MS.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> X-ray Crystallography</h3><div class="NLM_p last">Colorless crystals of <b>1u</b> (MeOH solvate form) were obtained by slow evaporation from MeOH/<i>i</i>-PrOAc solution. The diffraction data were collected at 23 °C on the Bruker Apex diffractometer (Mo source) at the University of Georgia. The crystal structure was solved and refined with the SHELXTL package. Hydrogen atoms attached on nitrogen and oxygen atoms were located in the electronic density map, and all the positions of other hydrogen atoms were calculated. Experimental details were included in the cif file (CCDC 1025296).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00863">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Syntheses of intermediates <b>2b</b>, <b>2c</b>, and <b>8</b> and of <i>ent</i>-<b>7t</b> and <i>ent</i>-<b>7u</b> (PDF). The SMILES formula, DNA gyrase inhibitory potency and select MIC values for compounds are provided (CSV). The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00863" class="ext-link">10.1021/acs.jmedchem.5b00863</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00863/suppl_file/jm5b00863_si_001.pdf">jm5b00863_si_001.pdf (481.15 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00863/suppl_file/jm5b00863_si_002.csv">jm5b00863_si_002.csv (2.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00863" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Basarab</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe998c9b99d09c9f8d9f8c9f9cbe8b9d8ad09f9dd0849f"><span class="__cf_email__" data-cfemail="6d0a1f080a430f0c1e0c1f0c0f2d180e19430c0e43170c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Doig</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Galullo</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gunther Kern</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Kimzey</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Kutschke</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Newman</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marshall Morningstar</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Mueller</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda Otterson</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karthick Vishwanathan</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Zhou</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Madhusudhan Gowravaram</span> - <span class="hlFld-Affiliation affiliation">Infection
Innovative Medicines, AstraZeneca R&D
Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All the authors were employed by AstraZeneca Pharmaceuticals.<br /></br></div></li></ul></div><div class="ack" id="ACK-d761e8673-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following individuals from AstraZeneca for their analytical services and helpful advice: Natascha Bezdenejnih, Nancy DeGrace, Dr. Camil Joubran, and Sharon Tentarelli. Dr. Richard Alm, Michael Huband, and Dr. Sushmita Lahiri contributed to in vitro microbiological characterizations and annotations of resistant mutants. Beth Andrews contributed to the DNA gyrase and Topo IV inhibition assays. Marie-Eve Beaudoin, Dr. Eric Gangl, Erica Manyak, Debora Roaquim, Crystal Brown, and Eric Miele are acknowledged for DMPK work and Lena Grosser and Georg Neckermann for contributing to the in vivo efficacy studies. Dr. Mick Fellows contributed to the genotoxicity studies. Dr. Dedong Wu coordinated the small molecule X-ray crystallography work. We also appreciate contributions for the synthesis of compounds and intermediates by scientists at Biocon, Inc.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> Abbreviations Used</h2><tr><td class="NLM_term">ABT</td><td class="NLM_def"><p class="first last">aminobenzotriazole</p></td></tr><tr><td class="NLM_term">ARC</td><td class="NLM_def"><p class="first last">AstraZeneca Research Collection</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl dimidazole</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming unit</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">Fsp<sup>3</sup></td><td class="NLM_def"><p class="first last">fraction sp<sup>3</sup></p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylaminoethylamine</p></td></tr><tr><td class="NLM_term">GyrA</td><td class="NLM_def"><p class="first last">the A-subunit of DNA gyrase</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">GyrB</td><td class="NLM_def"><p class="first last">the B-subunit of DNA gyrase</p></td></tr><tr><td class="NLM_term">LOEL</td><td class="NLM_def"><p class="first last">lowest observable effect level</p></td></tr><tr><td class="NLM_term">MLA</td><td class="NLM_def"><p class="first last">mouse lymphoma assay</p></td></tr><tr><td class="NLM_term">MMA</td><td class="NLM_def"><p class="first last">mouse micronucleus chromosome aberration assay</p></td></tr><tr><td class="NLM_term">MRQR MRQR</td><td class="NLM_def"><p class="first last">methicillin resistant, quinolone resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">MSSA</td><td class="NLM_def"><p class="first last">methicillin sensitive <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">NBTI</td><td class="NLM_def"><p class="first last">novel bacterial topoisomerase inhibitor</p></td></tr><tr><td class="NLM_term">NOEL</td><td class="NLM_def"><p class="first last">no observable effect level</p></td></tr><tr><td class="NLM_term">ParC</td><td class="NLM_def"><p class="first last">C-subunit of topoisomerase IV</p></td></tr><tr><td class="NLM_term">ParE</td><td class="NLM_def"><p class="first last">E-subunit of topoisomerase IV</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">TBDPS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylphenylsilyl</p></td></tr><tr><td class="NLM_term">T-reaction</td><td class="NLM_def"><p class="first last">tertiary amino effect reaction</p></td></tr><tr><td class="NLM_term">Topo IV</td><td class="NLM_def"><p class="first last">topoisomerase IV</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Livermore, D. M.</span><span> </span><span class="NLM_article-title">Discovery research: the scientific challenge of finding new antibiotics</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1941</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span><span class="refDoi"> DOI: 10.1093/jac/dkr262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkr262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=21700626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1941-1944&author=D.+M.+Livermore&title=Discovery+research%3A+the+scientific+challenge+of+finding+new+antibiotics&doi=10.1093%2Fjac%2Fdkr262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery research: the scientific challenge of finding new antibiotics</span></div><div class="casAuthors">Livermore, David M.; Blaser, Martin; Carrs, Otto; Cassell, Gail; Fishman, Neil; Guidos, Robert; Levy, Stuart; Powers, John; Norrby, Ragnar; Tillotson, Glenn; Davies, Rick; Projan, Steven; Dawson, Mike; Monnet, Dominique; Keogh-Brown, Marcus; Hand, Kieran; Garner, Sarah; Findlay, David; Morel, Chantal; Wise, Richard; Bax, Richard; Burke, Frances; Chopra, Ian; Czaplewski, Lloyd; Finch, Roger; Livermore, David; Piddock, Laura J. V.; White, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1941-1944</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The dwindling supply of new antibiotics largely reflects regulatory and com. challenges, but also a failure of discovery.  In the 1990s the pharmaceutical industry abandoned its classical ways of seeking antibiotics and instead adopted a strategy that combined genomics with high-throughput screening of existing compd. libraries.  Too much emphasis was placed on identifying targets and mols. that bound to them, and too little emphasis was placed on the ability of these mols. to permeate bacteria, evade efflux and avoid mutational resistance; moreover, the compd. libraries were systematically biased against antibiotics.  The sorry result is that no antibiotic found by this strategy has yet entered clin. use and many major pharmaceutical companies have abandoned antibiotic discovery.  Although a raft of start-up companies-variously financed by venture capital, charity or public money-are now finding new antibiotic compds. (some of them very promising in vitro or in early trials), their development through Phase III depends on financial commitments from large pharmaceutical companies, where the discouraging regulatory environment and the poor likely return on investment remain paramount issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwO4njZRli1rVg90H21EOLACvtfcHk0li_tWgpBaphNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLjL&md5=cf9e5b409fdb2d7a98f3e3b4c976ef05</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr262%26sid%3Dliteratum%253Aachs%26aulast%3DLivermore%26aufirst%3DD.%2BM.%26atitle%3DDiscovery%2520research%253A%2520the%2520scientific%2520challenge%2520of%2520finding%2520new%2520antibiotics%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1941%26epage%3D1944%26doi%3D10.1093%2Fjac%2Fdkr262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrs, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norrby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillotson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Projan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keogh-Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piddock, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T.</span><span> </span><span class="NLM_article-title">The urgent need for new antibacterial agents</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1939</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span><span class="refDoi"> DOI: 10.1093/jac/dkr261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkr261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=21700627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1939-1940&author=R.+Wiseauthor=M.+Blaserauthor=O.+Carrsauthor=G.+Cassellauthor=N.+Fishmanauthor=R.+Guidosauthor=S.+Levyauthor=J.+Powersauthor=R.+Norrbyauthor=G.+Tillotsonauthor=R.+Daviesauthor=S.+Projanauthor=M.+Dawsonauthor=D.+Monnetauthor=M.+Keogh-Brownauthor=K.+Handauthor=S.+Garnerauthor=D.+Findlayauthor=C.+Morelauthor=R.+Wiseauthor=R.+Baxauthor=F.+Burkeauthor=I.+Chopraauthor=L.+Czaplewskiauthor=R.+Finchauthor=D.+Livermoreauthor=L.+J.+V.+Piddockauthor=T.+White&title=The+urgent+need+for+new+antibacterial+agents&doi=10.1093%2Fjac%2Fdkr261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The urgent need for new antibacterial agents</span></div><div class="casAuthors">Wise, Richard; Blaser, Martin; Carrs, Otto; Cassell, Gail; Fishman, Neil; Guidos, Robert; Levy, Stuart; Powers, John; Norrby, Ragnar; Tillotson, Glenn; Davies, Rick; Projan, Steven; Dawson, Mike; Monnet, Dominique; Keogh-Brown, Marcus; Hand, Kieran; Garner, Sarah; Findlay, David; Morel, Chantal; Wise, Richard; Bax, Richard; Burke, Frances; Chopra, Ian; Czaplewski, Lloyd; Finch, Roger; Livermore, David; Piddock, Laura J. V.; White, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1939-1940</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfUVMX8PqCsrVg90H21EOLACvtfcHk0lgTuDlA54fcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLfM&md5=22fd52867f58bbeb905b807f36084d24</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr261%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DR.%26aulast%3DBlaser%26aufirst%3DM.%26aulast%3DCarrs%26aufirst%3DO.%26aulast%3DCassell%26aufirst%3DG.%26aulast%3DFishman%26aufirst%3DN.%26aulast%3DGuidos%26aufirst%3DR.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DNorrby%26aufirst%3DR.%26aulast%3DTillotson%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DProjan%26aufirst%3DS.%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DMonnet%26aufirst%3DD.%26aulast%3DKeogh-Brown%26aufirst%3DM.%26aulast%3DHand%26aufirst%3DK.%26aulast%3DGarner%26aufirst%3DS.%26aulast%3DFindlay%26aufirst%3DD.%26aulast%3DMorel%26aufirst%3DC.%26aulast%3DWise%26aufirst%3DR.%26aulast%3DBax%26aufirst%3DR.%26aulast%3DBurke%26aufirst%3DF.%26aulast%3DChopra%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%26aulast%3DFinch%26aufirst%3DR.%26aulast%3DLivermore%26aufirst%3DD.%26aulast%3DPiddock%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DWhite%26aufirst%3DT.%26atitle%3DThe%2520urgent%2520need%2520for%2520new%2520antibacterial%2520agents%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1939%26epage%3D1940%26doi%3D10.1093%2Fjac%2Fdkr261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Walsh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wencewicz, T. A.</span><span> </span><span class="NLM_article-title">Prospects for new antibiotics: a molecule-centered perspective</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1038/ja.2013.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fja.2013.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=23756684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1yitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=7-22&author=C.+T.+Walshauthor=T.+A.+Wencewicz&title=Prospects+for+new+antibiotics%3A+a+molecule-centered+perspective&doi=10.1038%2Fja.2013.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for new antibiotics: a molecule-centered perspective</span></div><div class="casAuthors">Walsh, Christopher T.; Wencewicz, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-22</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a continuous need for iterative cycles of antibiotic discovery and development to deal with the selection of resistant pathogens that emerge as therapeutic application of an antibiotic becomes widespread.  A short golden age of antibiotic discovery from nature followed by a subsequent golden half century of medicinal chem. optimization of existing mol. scaffolds emphasizes the need for new antibiotic mol. frameworks.  The authors bring a mol.-centered perspective to the questions of where will new scaffolds come from, when will chemogenetic approaches yield useful new antibiotics and what existing bacterial targets merit contemporary re-examn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8hr8BTzzMG7Vg90H21EOLACvtfcHk0lgTuDlA54fcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1yitrc%253D&md5=fb100c0954679a78210c497daa4fab1d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fja.2013.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2013.49%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DWencewicz%26aufirst%3DT.%2BA.%26atitle%3DProspects%2520for%2520new%2520antibiotics%253A%2520a%2520molecule-centered%2520perspective%26jtitle%3DJ.%2520Antibiot.%26date%3D2014%26volume%3D67%26spage%3D7%26epage%3D22%26doi%3D10.1038%2Fja.2013.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Georgopapadakou, N. H.</span><span> </span><span class="NLM_article-title">Prospects for new antibacterials: can we do better?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1517/13543784.2014.847087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1517%2F13543784.2014.847087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=145-148&author=N.+H.+Georgopapadakou&title=Prospects+for+new+antibacterials%3A+can+we+do+better%3F&doi=10.1517%2F13543784.2014.847087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.847087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.847087%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgopapadakou%26aufirst%3DN.%2BH.%26atitle%3DProspects%2520for%2520new%2520antibacterials%253A%2520can%2520we%2520do%2520better%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D145%26epage%3D148%26doi%3D10.1517%2F13543784.2014.847087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Rice, L. B.</span><span> </span><span class="NLM_article-title">Progress and challenges in implementing the research on ESKAPE pathogens</span> <span class="citation_source-journal">Infect. Cont. Hosp. Ep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span><span class="NLM_x">–</span> <span class="NLM_lpage">S10</span><span class="refDoi"> DOI: 10.1086/655995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1086%2F655995" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=S7-S10&author=L.+B.+Rice&title=Progress+and+challenges+in+implementing+the+research+on+ESKAPE+pathogens&doi=10.1086%2F655995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1086%2F655995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F655995%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DL.%2BB.%26atitle%3DProgress%2520and%2520challenges%2520in%2520implementing%2520the%2520research%2520on%2520ESKAPE%2520pathogens%26jtitle%3DInfect.%2520Cont.%2520Hosp.%2520Ep.%26date%3D2010%26volume%3D31%26spage%3DS7%26epage%3DS10%26doi%3D10.1086%2F655995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Boucher, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, J.</span><span> </span><span class="NLM_article-title">Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1086/595011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1086%2F595011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=19035777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Krsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1-12&author=H.+W.+Boucherauthor=G.+H.+Talbotauthor=J.+S.+Bradleyauthor=J.+E.+Edwardsauthor=D.+Gilbertauthor=L.+B.+Riceauthor=M.+Scheldauthor=B.+Spellbergauthor=J.+Bartlett&title=Bad+bugs%2C+no+drugs%3A+no+ESKAPE%21+An+update+from+the+Infectious+Diseases+Society+of+America&doi=10.1086%2F595011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America</span></div><div class="casAuthors">Boucher Helen W; Talbot George H; Bradley John S; Edwards John E; Gilbert David; Rice Louis B; Scheld Michael; Spellberg Brad; Bartlett John</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Infectious Diseases Society of America (IDSA) continues to view with concern the lean pipeline for novel therapeutics to treat drug-resistant infections, especially those caused by gram-negative pathogens.  Infections now occur that are resistant to all current antibacterial options.  Although the IDSA is encouraged by the prospect of success for some agents currently in preclinical development, there is an urgent, immediate need for new agents with activity against these panresistant organisms.  There is no evidence that this need will be met in the foreseeable future.  Furthermore, we remain concerned that the infrastructure for discovering and developing new antibacterials continues to stagnate, thereby risking the future pipeline of antibacterial drugs.  The IDSA proposed solutions in its 2004 policy report, "Bad Bugs, No Drugs: As Antibiotic R&D Stagnates, a Public Health Crisis Brews," and recently issued a "Call to Action" to provide an update on the scope of the problem and the proposed solutions.  A primary objective of these periodic reports is to encourage a community and legislative response to establish greater financial parity between the antimicrobial development and the development of other drugs.  Although recent actions of the Food and Drug Administration and the 110th US Congress present a glimmer of hope, significant uncertainly remains.  Now, more than ever, it is essential to create a robust and sustainable antibacterial research and development infrastructure--one that can respond to current antibacterial resistance now and anticipate evolving resistance.  This challenge requires that industry, academia, the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control and Prevention, the US Department of Defense, and the new Biomedical Advanced Research and Development Authority at the Department of Health and Human Services work productively together.  This report provides an update on potentially effective antibacterial drugs in the late-stage development pipeline, in the hope of encouraging such collaborative action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKtuWEUmAWleWhZTslLrfffW6udTcc2eb80VMWEhmUm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Krsg%253D%253D&md5=a3f71406b891f90f4f0f77b5f1ebc4f8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1086%2F595011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F595011%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DH.%2BW.%26aulast%3DTalbot%26aufirst%3DG.%2BH.%26aulast%3DBradley%26aufirst%3DJ.%2BS.%26aulast%3DEdwards%26aufirst%3DJ.%2BE.%26aulast%3DGilbert%26aufirst%3DD.%26aulast%3DRice%26aufirst%3DL.%2BB.%26aulast%3DScheld%26aufirst%3DM.%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DBartlett%26aufirst%3DJ.%26atitle%3DBad%2520bugs%252C%2520no%2520drugs%253A%2520no%2520ESKAPE%2521%2520An%2520update%2520from%2520the%2520Infectious%2520Diseases%2520Society%2520of%2520America%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D48%26spage%3D1%26epage%3D12%26doi%3D10.1086%2F595011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Stryjewski, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, G. R.</span><span> </span><span class="NLM_article-title">Methicillin-resistant <i>Staphylococcus aureus</i>: an evolving pathogen</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">S10</span><span class="NLM_x">–</span> <span class="NLM_lpage">S19</span><span class="refDoi"> DOI: 10.1093/cid/cit613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fcid%2Fcit613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=24343827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCjs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=S10-S19&author=M.+E.+Stryjewskiauthor=G.+R.+Corey&title=Methicillin-resistant+Staphylococcus+aureus%3A+an+evolving+pathogen&doi=10.1093%2Fcid%2Fcit613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen</span></div><div class="casAuthors">Stryjewski, Martin E.; Corey, G. Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">suppl. 1</span>),
    <span class="NLM_cas:pages">S10-S19</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The horizontal transmission of methicillin resistance to Staphylococcus aureus (MRSA) in hospital and community settings, and growing prevalence of these strains, presents a significant clin. challenge to the management of serious infections worldwide.  While infection control initiatives have stemmed the rising prevalence, MRSA remains a significant pathogen.  More recently, evidence that MRSA is becoming resistant to glycopeptides and newer therapies raises concern about the use of these therapies in clin. practice.  Vancomycin resistance has become evident in select clin. settings through rising MICs, growing awareness of heteroresistance, and emergence of intermediate-resistant and fully resistant strains.  While resistance to linezolid and daptomycin remains low overall, point mutations leading to resistance have been described for linezolid, and horizontal transmission of cfr-mediated resistance to linezolid has been reported in clin. isolates.  These resistance trends for newer therapies highlight the ongoing need for new and more potent antimicrobial therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Ok0jZWhNbLVg90H21EOLACvtfcHk0lhEroh7dEcmOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCjs73K&md5=fcf0e4157684d88420eee2d4eed09501</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcit613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcit613%26sid%3Dliteratum%253Aachs%26aulast%3DStryjewski%26aufirst%3DM.%2BE.%26aulast%3DCorey%26aufirst%3DG.%2BR.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%253A%2520an%2520evolving%2520pathogen%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D58%26spage%3DS10%26epage%3DS19%26doi%3D10.1093%2Fcid%2Fcit613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Rodvold, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConeghy, K. W.</span><span> </span><span class="NLM_article-title">Methicillin-resistant <i>Staphylococcus aureus</i> therapy: past, present and future</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S20</span><span class="NLM_x">–</span> <span class="NLM_lpage">S27</span><span class="refDoi"> DOI: 10.1093/cid/cit614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fcid%2Fcit614" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=S20-S27&issue=S1&author=K.+A.+Rodvoldauthor=K.+W.+McConeghy&title=Methicillin-resistant+Staphylococcus+aureus+therapy%3A+past%2C+present+and+future&doi=10.1093%2Fcid%2Fcit614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcit614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcit614%26sid%3Dliteratum%253Aachs%26aulast%3DRodvold%26aufirst%3DK.%2BA.%26aulast%3DMcConeghy%26aufirst%3DK.%2BW.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%2520therapy%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D58%26issue%3DS1%26spage%3DS20%26epage%3DS27%26doi%3D10.1093%2Fcid%2Fcit614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Moellering, R. C.</span><span> </span><span class="NLM_article-title">MRSA: the first half century</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1093/jac/dkr437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkr437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=22010206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1CqtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=4-11&author=R.+C.+Moellering&title=MRSA%3A+the+first+half+century&doi=10.1093%2Fjac%2Fdkr437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MRSA: the first half century</span></div><div class="casAuthors">Moellering, Robert C., Jr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-11</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Fifty years ago methicillin-resistant Staphylococcus aureus (MRSA) first revealed themselves to the medical community, having been described in a landmark article published in the British Medical Journal.  Among other things, their discovery set off a major response from the scientific and medical professions to control or even eliminate them as major human pathogens.  Despite these efforts, however, MRSA have spread throughout the world and a half century after they burst upon the scene they continue to pose major challenges to research scientists and clinicians alike.  In a very real sense, this year marks the  birthday' of a remarkably successful pathogen.  The major reasons for the ability of MRSA to prosper and cause disease in settings inimical to its survival form the basis of this article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgGQfcz3v34rVg90H21EOLACvtfcHk0lhEroh7dEcmOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1CqtL3O&md5=08db62d42364ab35e83504ca27ba8482</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr437%26sid%3Dliteratum%253Aachs%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26atitle%3DMRSA%253A%2520the%2520first%2520half%2520century%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D4%26epage%3D11%26doi%3D10.1093%2Fjac%2Fdkr437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tapsall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmody, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limnios, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloots, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiley, D.</span><span> </span><span class="NLM_article-title">Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods</span> <span class="citation_source-journal">J. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span><span class="refDoi"> DOI: 10.1099/jmm.0.007641-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1099%2Fjmm.0.007641-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=19369534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1Wksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=683-687&author=J.+Tapsallauthor=P.+Readauthor=C.+Carmodyauthor=C.+Bourneauthor=S.+Rayauthor=A.+Limniosauthor=T.+Slootsauthor=D.+Whiley&title=Two+cases+of+failed+ceftriaxone+treatment+in+pharyngeal+gonorrhoea+verified+by+molecular+microbiological+methods&doi=10.1099%2Fjmm.0.007641-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods</span></div><div class="casAuthors">Tapsall, John; Read, Phillip; Carmody, Christopher; Bourne, Christopher; Ray, Sanghamitra; Limnios, Athena; Sloots, Theo; Whiley, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">683-687</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Diagnostic, genotypic and antibiotic-resistance determinants of Neisseria gonorrhoeae were analyzed by mol. methods to verify the failure of ceftriaxone treatment in two cases of pharyngeal gonorrhea.  Monoplex assays were needed to define competitive inhibition of a pos. Chalmydia PCR in a duplex assay.  Different penA changes were detected in the N. gonorrhoeae isolated from the two cases.  These were assocd. with raised ceftriaxone MICs of 0.03 and 0.016 mg l-1, which may have contributed to the treatment failures in these cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9P7ZuzU5CQ7Vg90H21EOLACvtfcHk0lg9r2IPM1-BMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1Wksb4%253D&md5=04cd13894de16cbd4238b8aee2afe61d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1099%2Fjmm.0.007641-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fjmm.0.007641-0%26sid%3Dliteratum%253Aachs%26aulast%3DTapsall%26aufirst%3DJ.%26aulast%3DRead%26aufirst%3DP.%26aulast%3DCarmody%26aufirst%3DC.%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DLimnios%26aufirst%3DA.%26aulast%3DSloots%26aufirst%3DT.%26aulast%3DWhiley%26aufirst%3DD.%26atitle%3DTwo%2520cases%2520of%2520failed%2520ceftriaxone%2520treatment%2520in%2520pharyngeal%2520gonorrhoea%2520verified%2520by%2520molecular%2520microbiological%2520methods%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2009%26volume%3D58%26spage%3D683%26epage%3D687%26doi%3D10.1099%2Fjmm.0.007641-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lewis, D. A.</span><span> </span><span class="NLM_article-title">The gonococcus fights back: is this time a knock out?</span> <span class="citation_source-journal">Sex. Transm. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1136/sti.2010.042648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1136%2Fsti.2010.042648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=20656721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVWisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=415-421&author=D.+A.+Lewis&title=The+gonococcus+fights+back%3A+is+this+time+a+knock+out%3F&doi=10.1136%2Fsti.2010.042648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Gonococcus fights back: is this time a knock out?</span></div><div class="casAuthors">Lewis David A</div><div class="citationInfo"><span class="NLM_cas:title">Sexually transmitted infections</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">415-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the introduction of antibiotics in the 1930s, Neisseria gonorrhoeae has exhibited a remarkable ability to acquire novel genetic resistance determinants.  Initially, sulphonamides were replaced by penicillin, while tetracyclines were prescribed for penicillin-allergic patients.  With the advent of penicillinase-producing gonococci, spectinomycin was only briefly useful as alternative treatment and plasmid-mediated tetracycline resistance spread rapidly from the mid-1980s onwards.  The fluoroquinolones followed but chromosomally mediated resistance appeared after only a decade of use.  Seventy years on, we now face a global public health challenge of immense significance--the emergence of resistance to cephalosporins.  With lack of investment in the search for new anti-gonococcal antimicrobial agents or vaccine research, the global spread of multiresistant gonococci can be seen.  The impact of untreatable gonorrhoea on HIV transmission could be enormous in high-prevalence countries.  This threat comes at a time when many national STI control programmes are weak.  To delay the emergence of extensively drug-resistant gonorrhoea, public health systems require strengthening and novel strategies need implementing to enhance the therapeutic lifespan of the few antimicrobial agents that we have left.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-iELkSGzG3Ug6wdEZmT2rfW6udTcc2eYUVUJd08pcPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVWisA%253D%253D&md5=fad625f773332a2a82201803bcd33b55</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1136%2Fsti.2010.042648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fsti.2010.042648%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BA.%26atitle%3DThe%2520gonococcus%2520fights%2520back%253A%2520is%2520this%2520time%2520a%2520knock%2520out%253F%26jtitle%3DSex.%2520Transm.%2520Infect.%26date%3D2010%26volume%3D86%26spage%3D415%26epage%3D421%26doi%3D10.1136%2Fsti.2010.042648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span>Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/" class="extLink">http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Action+Plan+to+Control+the+Spread+and+Impact+of+Antimicrobial+Resistance+in+Neisseria+gonorrhoeae%3B+World+Health+Organization%3A+Geneva%2C+2012%3B+http%3A%2F%2Fwww.who.int%2Freproductivehealth%2Fpublications%2Frtis%2F9789241503501%2Fen%2F+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Action%2520Plan%2520to%2520Control%2520the%2520Spread%2520and%2520Impact%2520of%2520Antimicrobial%2520Resistance%2520in%2520Neisseria%2520gonorrhoeae%26pub%3DWorld%2520Health%2520Organization%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>Gonorrhea Treatment Guidelines: Revised Guidelines to Preserve Last Effective Treatment Option. <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/nchhstp/newsroom/docs/Gonorrhea-Treatment-Guidelines-FactSheet.pdf" class="extLink">http://www.cdc.gov/nchhstp/newsroom/docs/Gonorrhea-Treatment-Guidelines-FactSheet.pdf</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gonorrhea+Treatment+Guidelines%3A+Revised+Guidelines+to+Preserve+Last+Effective+Treatment+Option.+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013%3B+http%3A%2F%2Fwww.cdc.gov%2Fnchhstp%2Fnewsroom%2Fdocs%2FGonorrhea-Treatment-Guidelines-FactSheet.pdf+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DGonorrhea%2520Treatment%2520Guidelines%253A%2520Revised%2520Guidelines%2520to%2520Preserve%2520Last%2520Effective%2520Treatment%2520Option%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Response Plan to Control and Manage the Threat of Multidrug-Resistant Gonorrhoea in Europe; <span class="NLM_publisher-name">European Centre for Disease Prevention and Control</span>: <span class="NLM_publisher-loc">Stockholm</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.ecdc.europa.eu/en/publications/publications/1206-ecdc-mdr-gonorrhoea-response-plan.pdf" class="extLink">http://www.ecdc.europa.eu/en/publications/publications/1206-ecdc-mdr-gonorrhoea-response-plan.pdf</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Response+Plan+to+Control+and+Manage+the+Threat+of+Multidrug-Resistant+Gonorrhoea+in+Europe%3B+European+Centre+for+Disease+Prevention+and+Control%3A+Stockholm%2C+2012%3B+http%3A%2F%2Fwww.ecdc.europa.eu%2Fen%2Fpublications%2Fpublications%2F1206-ecdc-mdr-gonorrhoea-response-plan.pdf+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DResponse%2520Plan%2520to%2520Control%2520and%2520Manage%2520the%2520Threat%2520of%2520Multidrug-Resistant%2520Gonorrhoea%2520in%2520Europe%26pub%3DEuropean%2520Centre%2520for%2520Disease%2520Prevention%2520and%2520Control%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwanathan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galullo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowravaram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimzey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morningstar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, V. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkup, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J. V.</span><span> </span><span class="NLM_article-title">Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">11827</span><span class="refDoi"> DOI: 10.1038/srep11827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fsrep11827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=26168713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FivVGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=11827&author=G.+S.+Basarabauthor=G.+H.+Kernauthor=J.+McNultyauthor=J.+P.+Muellerauthor=K.+Lawrenceauthor=K.+Vishwanathanauthor=R.+A.+Almauthor=K.+Barvianauthor=P.+Doigauthor=V.+Galulloauthor=H.+Gardnerauthor=M.+Gowravaramauthor=M.+Hubandauthor=A.+Kimzeyauthor=M.+Morningstarauthor=A.+Kutschkeauthor=S.+D.+Lahiriauthor=M.+Perrosauthor=R.+Singhauthor=V.+J.+A.+Schuckauthor=R.+Tommasiauthor=G.+Walkupauthor=J.+V.+Newman&title=Responding+to+the+challenge+of+untreatable+gonorrhea%3A+ETX0914%2C+a+first-in-class+agent+with+a+distinct+mechanism-of-action+against+bacterial+Type+II+topoisomerases.&doi=10.1038%2Fsrep11827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases</span></div><div class="casAuthors">Basarab Gregory S; Singh Renu; Kern Gunther H; Vishwanathan Karthick; Alm Richard A; Doig Peter; Galullo Vincent; Gardner Humphrey; Kimzey Amy; Kutschke Amy; Lahiri Sushmita D; Walkup Grant; Newman Joseph V; McNulty John; Perros Manos; Tommasi Ruben; Mueller John P; Lawrence Kenneth; Barvian Kevin; Gowravaram Madhusudhan; Huband Michael; Morningstar Marshall; Schuck Virna J A</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11827</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">With the diminishing effectiveness of current antibacterial therapies, it is critically important to discover agents that operate by a mechanism that circumvents existing resistance.  ETX0914, the first of a new class of antibacterial agent targeted for the treatment of gonorrhea, operates by a novel mode-of-inhibition against bacterial type II topoisomerases.  Incorporating an oxazolidinone on the scaffold mitigated toxicological issues often seen with topoisomerase inhibitors.  Organisms resistant to other topoisomerase inhibitors were not cross-resistant with ETX0914 nor were spontaneous resistant mutants to ETX0914 cross-resistant with other topoisomerase inhibitor classes, including the widely used fluoroquinolone class.  Preclinical evaluation of ETX0914 pharmacokinetics and pharmacodynamics showed distribution into vascular tissues and efficacy in a murine Staphylococcus aureus infection model that served as a surrogate for predicting efficacious exposures for the treatment of Neisseria gonorrhoeae infections.  A wide safety margin to the efficacious exposure in toxicological evaluations supported progression to Phase 1.  Dosing ETX0914 in human volunteers showed sufficient exposure and minimal adverse effects to expect a highly efficacious anti-gonorrhea therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx_MR4JXY8wBdUSIfHIn4FfW6udTcc2ebd_iQnhpLBT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FivVGqtA%253D%253D&md5=77968264a6789578bf075c12abcc5dc7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsrep11827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep11827%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DKern%26aufirst%3DG.%2BH.%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DMueller%26aufirst%3DJ.%2BP.%26aulast%3DLawrence%26aufirst%3DK.%26aulast%3DVishwanathan%26aufirst%3DK.%26aulast%3DAlm%26aufirst%3DR.%2BA.%26aulast%3DBarvian%26aufirst%3DK.%26aulast%3DDoig%26aufirst%3DP.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DGowravaram%26aufirst%3DM.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DKimzey%26aufirst%3DA.%26aulast%3DMorningstar%26aufirst%3DM.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DLahiri%26aufirst%3DS.%2BD.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DSchuck%26aufirst%3DV.%2BJ.%2BA.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DWalkup%26aufirst%3DG.%26aulast%3DNewman%26aufirst%3DJ.%2BV.%26atitle%3DResponding%2520to%2520the%2520challenge%2520of%2520untreatable%2520gonorrhea%253A%2520ETX0914%252C%2520a%2520first-in-class%2520agent%2520with%2520a%2520distinct%2520mechanism-of-action%2520against%2520bacterial%2520Type%2520II%2520topoisomerases.%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D11827%26doi%3D10.1038%2Fsrep11827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galullo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haimes, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, V. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowravaram, M.</span><span> </span><span class="NLM_article-title">Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9078</span><span class="NLM_x">–</span> <span class="NLM_lpage">9095</span><span class="refDoi"> DOI: 10.1021/jm501174m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501174m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yju7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9078-9095&author=G.+S.+Basarabauthor=P.+Brassilauthor=P.+Doigauthor=V.+Galulloauthor=H.+B.+Haimesauthor=G.+Kernauthor=A.+Kutschkeauthor=J.+McNultyauthor=V.+A.+J.+Schuckauthor=G.+Stoneauthor=M.+Gowravaram&title=Novel+DNA+gyrase+inhibiting+spiropyrimidinetriones+with+a+benzisoxazole+scaffold%3A+SAR+and+in+vivo+characterization&doi=10.1021%2Fjm501174m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization</span></div><div class="casAuthors">Basarab, Gregory S.; Brassil, Patrick; Doig, Peter; Galullo, Vincent; Haimes, Howard B.; Kern, Gunther; Kutschke, Amy; McNulty, John; Schuck, Virna J. A.; Stone, Gregory; Gowravaram, Madhusudhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9078-9095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The compds. described herein with a spirocyclic architecture fused to a benzisoxazole ring represent a new class of antibacterial agents that operate by inhibition of DNA gyrase as corroborated in an enzyme assay and by the inhibition of precursor thymidine into DNA during cell growth.  Activity resided in the configurationally lowest energy (2S,4R,4aR) diastereomer.  Highly active compds. against Staphylococcus aureus had sufficiently high soly., high plasma protein free fraction, and favorable pharmacokinetics to suggest that in vivo efficacy could be demonstrated, which was realized with compd. I in S. aureus mouse infection models.  A high drug exposure NOEL on oral dosing in the rat suggested that a high therapeutic margin could be achieved.  Importantly, I was not cross-resistant with other DNA gyrase inhibitors such as fluoroquinolone and aminocoumarin antibacterials.  Hence, this class shows considerable promise for the treatment of infections caused by multidrug resistant bacteria, including S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpvqD0DFpAALVg90H21EOLACvtfcHk0lhSokNZx7lcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yju7bE&md5=7eccef41b07e14842d79665591364050</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501174m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501174m%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DDoig%26aufirst%3DP.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DHaimes%26aufirst%3DH.%2BB.%26aulast%3DKern%26aufirst%3DG.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DSchuck%26aufirst%3DV.%2BA.%2BJ.%26aulast%3DStone%26aufirst%3DG.%26aulast%3DGowravaram%26aufirst%3DM.%26atitle%3DNovel%2520DNA%2520gyrase%2520inhibiting%2520spiropyrimidinetriones%2520with%2520a%2520benzisoxazole%2520scaffold%253A%2520SAR%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9078%26epage%3D9095%26doi%3D10.1021%2Fjm501174m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippke, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span> </span><span class="NLM_article-title">Crystal structures of <i>Escherichia coli</i> topoisomerase IV ParE subunit (24 and 43 kDas): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span><span class="refDoi"> DOI: 10.1128/AAC.48.5.1856-1864.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.48.5.1856-1864.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1856-1864&author=S.+Bellonauthor=J.+D.+Parsonsauthor=Y.+Weiauthor=K.+Hayakawaauthor=L.+L.+Swensonauthor=P.+S.+Charifsonauthor=J.+A.+Lippkeauthor=R.+Aldapeauthor=C.+H.+Gross&title=Crystal+structures+of+Escherichia+coli+topoisomerase+IV+ParE+subunit+%2824+and+43+kDas%29%3A+a+single+residue+dictates+differences+in+novobiocin+potency+against+topoisomerase+IV+and+DNA+gyrase&doi=10.1128%2FAAC.48.5.1856-1864.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1856-1864.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1856-1864.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DLippke%26aufirst%3DJ.%2BA.%26aulast%3DAldape%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DC.%2BH.%26atitle%3DCrystal%2520structures%2520of%2520Escherichia%2520coli%2520topoisomerase%2520IV%2520ParE%2520subunit%2520%252824%2520and%252043%2520kDas%2529%253A%2520a%2520single%2520residue%2520dictates%2520differences%2520in%2520novobiocin%2520potency%2520against%2520topoisomerase%2520IV%2520and%2520DNA%2520gyrase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1856%26epage%3D1864%26doi%3D10.1128%2FAAC.48.5.1856-1864.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markland, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botfield, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybuck, S. A.</span><span> </span><span class="NLM_article-title">Active-site residues of <i>Escherichia coli</i> DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1128/AAC.47.3.1037-1046.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.47.3.1037-1046.2003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2003&pages=1037-1046&author=C.+H.+Grossauthor=J.+D.+Parsonsauthor=T.+H.+Grossmanauthor=P.+S.+Charifsonauthor=S.+Bellonauthor=J.+Jerneeauthor=M.+Dwyerauthor=S.+P.+Chambersauthor=W.+Marklandauthor=M.+Botfieldauthor=S.+A.+Raybuck&title=Active-site+residues+of+Escherichia+coli+DNA+gyrase+required+in+coupling+ATP+hydrolysis+to+DNA+supercoiling+and+amino+acid+substitutions+leading+to+novobiocin+resistance&doi=10.1128%2FAAC.47.3.1037-1046.2003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.47.3.1037-1046.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.47.3.1037-1046.2003%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DJernee%26aufirst%3DJ.%26aulast%3DDwyer%26aufirst%3DM.%26aulast%3DChambers%26aufirst%3DS.%2BP.%26aulast%3DMarkland%26aufirst%3DW.%26aulast%3DBotfield%26aufirst%3DM.%26aulast%3DRaybuck%26aufirst%3DS.%2BA.%26atitle%3DActive-site%2520residues%2520of%2520Escherichia%2520coli%2520DNA%2520gyrase%2520required%2520in%2520coupling%2520ATP%2520hydrolysis%2520to%2520DNA%2520supercoiling%2520and%2520amino%2520acid%2520substitutions%2520leading%2520to%2520novobiocin%2520resistance%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2003%26volume%3D47%26spage%3D1037%26epage%3D1046%26doi%3D10.1128%2FAAC.47.3.1037-1046.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Barvian, K.; Basarab, G. S.; Gowravaram, M. R.; Hauck, S. I.; Zhou, F.</span><span> </span><span class="NLM_article-title">Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections</span>. U.S. Patent USP 8658641,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Barvian&author=G.+S.+Basarab&author=M.+R.+Gowravaram&author=S.+I.+Hauck&author=F.+Zhou&title=Fused%2C+spirocyclic+heteroaromatic+compounds+for+the+treatment+of+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarvian%26aufirst%3DK.%26atitle%3DFused%252C%2520spirocyclic%2520heteroaromatic%2520compounds%2520for%2520the%2520treatment%2520of%2520bacterial%2520infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljbzXElf0UqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">D’yachenko, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glukhareva, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyudya, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eltsov, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morzherin, Y. Y.</span><span> </span><span class="NLM_article-title">The <i>tert</i>-amino effect in heterocyclic chemistry. Synthesis of spiro heterocycles</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.3390/10091101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.3390%2F10091101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18007375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WmsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1101-1108&author=E.+V.+D%E2%80%99yachenkoauthor=T.+V.+Glukharevaauthor=L.+V.+Dyudyaauthor=O.+V.+Eltsovauthor=Y.+Y.+Morzherin&title=The+tert-amino+effect+in+heterocyclic+chemistry.+Synthesis+of+spiro+heterocycles&doi=10.3390%2F10091101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The tert-amino effect in heterocyclic chemistry. Synthesis of spiro heterocycles</span></div><div class="casAuthors">D'yachenko, Elisaveta V.; Glukhareva, Tatiana V.; Dyudya, Lyudmila V.; Eltsov, Oleg V.; Morzherin, Yury Yu.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1101-1108</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  The tert-amino reaction effect was examd.  A new method to synthesize spiro heterocycles is presented.  The tert-amino effect could be applied to the formation of spiro-fused heterocycles.  The formation of spiro compds. proceeds in most cases in good yields in a 1-pot reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4waXqp_8qa7Vg90H21EOLACvtfcHk0ljbzXElf0UqSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WmsrfN&md5=45dace56623d8dee541849f93f5a5b2f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2F10091101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252F10091101%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599yachenko%26aufirst%3DE.%2BV.%26aulast%3DGlukhareva%26aufirst%3DT.%2BV.%26aulast%3DDyudya%26aufirst%3DL.%2BV.%26aulast%3DEltsov%26aufirst%3DO.%2BV.%26aulast%3DMorzherin%26aufirst%3DY.%2BY.%26atitle%3DThe%2520tert-amino%2520effect%2520in%2520heterocyclic%2520chemistry.%2520Synthesis%2520of%2520spiro%2520heterocycles%26jtitle%3DMolecules%26date%3D2005%26volume%3D10%26spage%3D1101%26epage%3D1108%26doi%3D10.3390%2F10091101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Meth-Cohn, O.; Suschitzky, H.</span><span> </span><span class="NLM_article-title">Heterocycles by ring closure of ortho-substituted <i>t</i>-anilines (the <i>t</i>-amino effect)</span>. In  <span class="citation_source-book">Advances in Heterocyclic Chemistry</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1972</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">14</span>, pp  <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0065-2725%2808%2960954-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1972&pages=211-278&author=O.+Meth-Cohn&author=H.+Suschitzky&title=Advances+in+Heterocyclic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0065-2725%2808%2960954-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0065-2725%252808%252960954-X%26sid%3Dliteratum%253Aachs%26aulast%3DMeth-Cohn%26aufirst%3DO.%26atitle%3DHeterocycles%2520by%2520ring%2520closure%2520of%2520ortho-substituted%2520t-anilines%2520%2528the%2520t-amino%2520effect%2529%26btitle%3DAdvances%2520in%2520Heterocyclic%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D1972%26volume%3D14%26spage%3D211%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Matyus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapolcsanyi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonka-Balint, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halasz-Dajka, B.</span><span> </span><span class="NLM_article-title">Ring-closure reactions of ortho-vinyl-<i>tert</i>-anilines and (Di)aza-heterocyclic analogues via the <i>tert</i>-amino effect: recent developments</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">2625</span><span class="refDoi"> DOI: 10.1055/s-2006-942490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1055%2Fs-2006-942490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=2625&author=P.+Matyusauthor=O.+Eliasauthor=P.+Tapolcsanyiauthor=A.+Polonka-Balintauthor=B.+Halasz-Dajka&title=Ring-closure+reactions+of+ortho-vinyl-tert-anilines+and+%28Di%29aza-heterocyclic+analogues+via+the+tert-amino+effect%3A+recent+developments&doi=10.1055%2Fs-2006-942490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-942490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-942490%26sid%3Dliteratum%253Aachs%26aulast%3DMatyus%26aufirst%3DP.%26aulast%3DElias%26aufirst%3DO.%26aulast%3DTapolcsanyi%26aufirst%3DP.%26aulast%3DPolonka-Balint%26aufirst%3DA.%26aulast%3DHalasz-Dajka%26aufirst%3DB.%26atitle%3DRing-closure%2520reactions%2520of%2520ortho-vinyl-tert-anilines%2520and%2520%2528Di%2529aza-heterocyclic%2520analogues%2520via%2520the%2520tert-amino%2520effect%253A%2520recent%2520developments%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D2625%26doi%3D10.1055%2Fs-2006-942490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Visser, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verboom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benders, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhoudt, D. N.</span><span> </span><span class="NLM_article-title">1-Pyrrolidin-1-ylbuta-1,3-dienes as potential 1,5-dipoles; synthesis of pyrrolizines</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1039/c39820000669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1039%2Fc39820000669" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&pages=669-671&author=G.+W.+Visserauthor=W.+Verboomauthor=P.+H.+Bendersauthor=D.+N.+Reinhoudt&title=1-Pyrrolidin-1-ylbuta-1%2C3-dienes+as+potential+1%2C5-dipoles%3B+synthesis+of+pyrrolizines&doi=10.1039%2Fc39820000669"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc39820000669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39820000669%26sid%3Dliteratum%253Aachs%26aulast%3DVisser%26aufirst%3DG.%2BW.%26aulast%3DVerboom%26aufirst%3DW.%26aulast%3DBenders%26aufirst%3DP.%2BH.%26aulast%3DReinhoudt%26aufirst%3DD.%2BN.%26atitle%3D1-Pyrrolidin-1-ylbuta-1%252C3-dienes%2520as%2520potential%25201%252C5-dipoles%253B%2520synthesis%2520of%2520pyrrolizines%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1982%26spage%3D669%26epage%3D671%26doi%3D10.1039%2Fc39820000669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Verboom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhoudt, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkema, S.</span><span> </span><span class="NLM_article-title">″Tert-amino effect″ in heterocyclic synthesis. Formation of N heterocycles by ring-closure reactions of substituted 2-vinyl-N,N-dialkylanilines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1021/jo00176a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00176a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=269-276&author=W.+Verboomauthor=D.+N.+Reinhoudtauthor=R.+Visserauthor=S.+Harkema&title=%E2%80%B3Tert-amino+effect%E2%80%B3+in+heterocyclic+synthesis.+Formation+of+N+heterocycles+by+ring-closure+reactions+of+substituted+2-vinyl-N%2CN-dialkylanilines&doi=10.1021%2Fjo00176a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00176a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00176a011%26sid%3Dliteratum%253Aachs%26aulast%3DVerboom%26aufirst%3DW.%26aulast%3DReinhoudt%26aufirst%3DD.%2BN.%26aulast%3DVisser%26aufirst%3DR.%26aulast%3DHarkema%26aufirst%3DS.%26atitle%3D%25E2%2580%25B3Tert-amino%2520effect%25E2%2580%25B3%2520in%2520heterocyclic%2520synthesis.%2520Formation%2520of%2520N%2520heterocycles%2520by%2520ring-closure%2520reactions%2520of%2520substituted%25202-vinyl-N%252CN-dialkylanilines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D269%26epage%3D276%26doi%3D10.1021%2Fjo00176a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galullo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGrace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, S. S.</span><span> </span><span class="NLM_article-title">Synthesis of a tetrahydronaphthyridine spiropyrimidinetrione DNA gyrase inhibiting antibacterial agent - differential substitution at all five carbon atoms of pyridine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6456</span><span class="NLM_x">–</span> <span class="NLM_lpage">6459</span><span class="refDoi"> DOI: 10.1021/ol503256h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol503256h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=6456-6459&author=G.+S.+Basarabauthor=V.+Galulloauthor=N.+DeGraceauthor=S.+Hauckauthor=C.+Joubranauthor=S.+S.+Wesolowski&title=Synthesis+of+a+tetrahydronaphthyridine+spiropyrimidinetrione+DNA+gyrase+inhibiting+antibacterial+agent+-+differential+substitution+at+all+five+carbon+atoms+of+pyridine&doi=10.1021%2Fol503256h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Tetrahydronaphthyridine Spiropyrimidinetrione DNA Gyrase Inhibiting Antibacterial Agent - Differential Substitution at all Five Carbon Atoms of Pyridine.</span></div><div class="casAuthors">Basarab, Gregory S.; Galullo, Vincent; DeGrace, Nancy; Hauck, Sheila; Joubran, Camil; Wesolowski, Steven S.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6456-6459</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of I, a potent antibacterial agent, was achieved stereoselectively in nine steps from readily available starting materials.  Directed metalations were developed to assemble a pentasubstituted pyridine with appropriately positioned aldehyde and dimethylmorpholine substituents for a key tertiary amino effect reaction (T-reaction) that led to the spirocyclic architecture.  Ultimately, I was isolated as the thermodynamically most favored stereoisomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWsTrK9RkPp7Vg90H21EOLACvtfcHk0li_zTQIb2qK8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamsrzN&md5=d593296ffc77a54b3157e5641001d1a8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol503256h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol503256h%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DDeGrace%26aufirst%3DN.%26aulast%3DHauck%26aufirst%3DS.%26aulast%3DJoubran%26aufirst%3DC.%26aulast%3DWesolowski%26aufirst%3DS.%2BS.%26atitle%3DSynthesis%2520of%2520a%2520tetrahydronaphthyridine%2520spiropyrimidinetrione%2520DNA%2520gyrase%2520inhibiting%2520antibacterial%2520agent%2520-%2520differential%2520substitution%2520at%2520all%2520five%2520carbon%2520atoms%2520of%2520pyridine%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D6456%26epage%3D6459%26doi%3D10.1021%2Fol503256h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ruble, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurd, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundy, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graber, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamilar, G. M.</span><span> </span><span class="NLM_article-title">Synthesis of (−)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">3997</span><span class="refDoi"> DOI: 10.1021/ja808014h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja808014h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVeisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=3991-3997&author=J.+C.+Rubleauthor=A.+R.+Hurdauthor=T.+A.+Johnsonauthor=D.+A.+Sherryauthor=M.+R.+Barbachynauthor=P.+L.+Toogoodauthor=G.+L.+Bundyauthor=D.+R.+Graberauthor=G.+M.+Kamilar&title=Synthesis+of+%28%E2%88%92%29-PNU-286607+by+asymmetric+cyclization+of+alkylidene+barbiturates&doi=10.1021%2Fja808014h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (-)-PNU-286607 by Asymmetric Cyclization of Alkylidene Barbiturates</span></div><div class="casAuthors">Ruble, J. Craig; Hurd, Alexander R.; Johnson, Timothy A.; Sherry, Debra A.; Barbachyn, Michael R.; Toogood, Peter L.; Bundy, Gordon L.; Graber, David R.; Kamilar, Gregg M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3991-3997</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PNU 286607 I, a oxazinoquinolinespiropyrimidinetrione inhibitor of bacterial DNA gyrase for potential use as an antibacterial agent against antibiotic-resistant bacterial strains, is prepd. in two steps from 2-fluoro-5-nitrobenzaldehyde and (R,R)-2,6-dimethylmorpholine by nucleophilic arom. substitution followed by condensation with barbituric acid and a concomitant stereoselective cyclization of the benzylidenepyrimidinetrione.  The stereoselectivities and mechanism of the condensation and cyclization reactions (based on the rearrangements of vinyl anilines, known in the literature as the "tert-amino effect") are investigated using the NMR spectroscopic anal. of the reactions of racemic substrates and the reactions of racemic and nonracemic deuterated substrates; based on the data obtained, the asym. synthesis of I is developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwZZhoPHBHrVg90H21EOLACvtfcHk0liqImvnsfgRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVeisL4%253D&md5=f837986da667a40ce19753baa9d58125</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja808014h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja808014h%26sid%3Dliteratum%253Aachs%26aulast%3DRuble%26aufirst%3DJ.%2BC.%26aulast%3DHurd%26aufirst%3DA.%2BR.%26aulast%3DJohnson%26aufirst%3DT.%2BA.%26aulast%3DSherry%26aufirst%3DD.%2BA.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DBundy%26aufirst%3DG.%2BL.%26aulast%3DGraber%26aufirst%3DD.%2BR.%26aulast%3DKamilar%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%2520%2528%25E2%2588%2592%2529-PNU-286607%2520by%2520asymmetric%2520cyclization%2520of%2520alkylidene%2520barbiturates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D3991%26epage%3D3997%26doi%3D10.1021%2Fja808014h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maduakor, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, C. E.</span><span> </span><span class="NLM_article-title">Fluorine as an ortho-directing group in aromatic metalation: generality of the reaction and the high position of fluorine in the Dir-Met potency scale</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">7495</span><span class="NLM_x">–</span> <span class="NLM_lpage">7498</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)60805-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0040-4039%2800%2960805-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADyaK3sXht1Cmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1992&pages=7495-7498&author=A.+J.+Bridgesauthor=A.+Leeauthor=E.+C.+Maduakorauthor=C.+E.+Schwartz&title=Fluorine+as+an+ortho-directing+group+in+aromatic+metalation%3A+generality+of+the+reaction+and+the+high+position+of+fluorine+in+the+Dir-Met+potency+scale&doi=10.1016%2FS0040-4039%2800%2960805-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine as an ortho-directing group in aromatic metalation:  generality of the reaction and the high position of fluorine in the Dir-Met potency scale</span></div><div class="casAuthors">Bridges, Alexander J.; Lee, Arthur; Maduakor, Emmanuel C.; Schwartz, C. Eric</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">7495-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Many para-substituted fluorobenzenes can be lithiated ortho to fluorine in moderate to good yields, often with one of the dialkylamide bases, such as lithium diisopropylamide or lithium 2,2,6,6-tetramethylpiperidide.  Intramol. competition expts. reveal that fluorine is one of the most potent Dir-Met (directed-metalation) activating groups under these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN8Ys9Jbfn4bVg90H21EOLACvtfcHk0liqImvnsfgRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXht1Cmu7o%253D&md5=34687531295381104e2f30141f2f5431</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2960805-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252960805-5%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DMaduakor%26aufirst%3DE.%2BC.%26aulast%3DSchwartz%26aufirst%3DC.%2BE.%26atitle%3DFluorine%2520as%2520an%2520ortho-directing%2520group%2520in%2520aromatic%2520metalation%253A%2520generality%2520of%2520the%2520reaction%2520and%2520the%2520high%2520position%2520of%2520fluorine%2520in%2520the%2520Dir-Met%2520potency%2520scale%26jtitle%3DTetrahedron%2520Lett.%26date%3D1992%26volume%3D33%26spage%3D7495%26epage%3D7498%26doi%3D10.1016%2FS0040-4039%2800%2960805-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Moyroud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guesnet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennetau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, J.</span><span> </span><span class="NLM_article-title">Lithiations ortho-directed by carboxylic acid, fluorine, and chlorine functions. II. Regioselective synthesis of polysubstituted benzoic acids and acetophenones</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1996&pages=133-141&author=J.+Moyroudauthor=J.+Guesnetauthor=B.+Bennetauauthor=J.+Mortier&title=Lithiations+ortho-directed+by+carboxylic+acid%2C+fluorine%2C+and+chlorine+functions.+II.+Regioselective+synthesis+of+polysubstituted+benzoic+acids+and+acetophenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyroud%26aufirst%3DJ.%26aulast%3DGuesnet%26aufirst%3DJ.%26aulast%3DBennetau%26aufirst%3DB.%26aulast%3DMortier%26aufirst%3DJ.%26atitle%3DLithiations%2520ortho-directed%2520by%2520carboxylic%2520acid%252C%2520fluorine%252C%2520and%2520chlorine%2520functions.%2520II.%2520Regioselective%2520synthesis%2520of%2520polysubstituted%2520benzoic%2520acids%2520and%2520acetophenones%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1996%26volume%3D133%26spage%3D133%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Shapiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thresher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajec, L.</span><span> </span><span class="NLM_article-title">A homogeneous, high-throughput fluorescence anisotropy-based DNA supercoiling assay</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span><span class="refDoi"> DOI: 10.1177/1087057110378624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1177%2F1087057110378624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=20930214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVajsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=1088-1098&author=A.+Shapiroauthor=H.+Jahicauthor=S.+Prasadauthor=D.+Ehmannauthor=J.+Thresherauthor=N.+Gaoauthor=L.+Hajec&title=A+homogeneous%2C+high-throughput+fluorescence+anisotropy-based+DNA+supercoiling+assay&doi=10.1177%2F1087057110378624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A homogeneous, high-throughput fluorescence anisotropy-based DNA supercoiling assay</span></div><div class="casAuthors">Shapiro, Adam; Jahic, Haris; Prasad, Swati; Ehmann, David; Thresher, Jason; Gao, Ning; Hajec, Laurel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1088-1098</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The degree of supercoiling of DNA is vital for cellular processes, such as replication and transcription.  DNA topol. is controlled by the action of DNA topoisomerase enzymes.  Topoisomerases, because of their importance in cellular replication, are the targets of several anticancer and antibacterial drugs.  In the search for new drugs targeting topoisomerases, a biochem. assay compatible with automated high-throughput screening (HTS) would be valuable.  Gel electrophoresis is the std. method for measuring changes in the extent of supercoiling of plasmid DNA when acted upon by topoisomerases, but this is a low-throughput and laborious method.  A medium-throughput method was described previously that quant. distinguishes relaxed and supercoiled plasmids by the difference in their abilities to form triplex structures with an immobilized oligonucleotide.  In this article, the authors describe a homogeneous supercoiling assay based on triplex formation in which the oligonucleotide strand is labeled with a fluorescent dye and the readout is fluorescence anisotropy.  The new assay requires no immobilization, filtration, or plate washing steps and is therefore well suited to HTS for inhibitors of topoisomerases.  The utility of this assay is demonstrated with relaxation of supercoiled plasmid by Escherichia coli topoisomerase I, supercoiling of relaxed plasmid by E. coli DNA gyrase, and inhibition of gyrase by fluoroquinolones and nalidixic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLPydgbbQi2bVg90H21EOLACvtfcHk0liqImvnsfgRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVajsLrN&md5=51191c534eaf19b3e198866d0c68e14a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1087057110378624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057110378624%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DA.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DEhmann%26aufirst%3DD.%26aulast%3DThresher%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DHajec%26aufirst%3DL.%26atitle%3DA%2520homogeneous%252C%2520high-throughput%2520fluorescence%2520anisotropy-based%2520DNA%2520supercoiling%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2010%26volume%3D15%26spage%3D1088%26epage%3D1098%26doi%3D10.1177%2F1087057110378624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeTiran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span> </span><span class="NLM_article-title">Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.bmcl.2014.03.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2177-2181&author=E.+Perolaauthor=D.+Stamosauthor=A.+Grillotauthor=S.+Ronkinauthor=T.+Wangauthor=A.+LeTiranauthor=Q.+Tangauthor=D.+D.+Deiningerauthor=Y.+Liaoauthor=S.+Tianauthor=J.+E.+Drummauthor=D.+P.+Nicolauauthor=P.+R.+Tessierauthor=N.+Maniauthor=T.+H.+Grossmanauthor=P.+S.+Charifson&title=Successful+application+of+serum+shift+prediction+models+to+the+design+of+dual+targeting+inhibitors+of+bacterial+gyrase+B+and+topoisomerase+IV+with+improved+in+vivo+efficacy&doi=10.1016%2Fj.bmcl.2014.03.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DGrillot%26aufirst%3DA.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSuccessful%2520application%2520of%2520serum%2520shift%2520prediction%2520models%2520to%2520the%2520design%2520of%2520dual%2520targeting%2520inhibitors%2520of%2520bacterial%2520gyrase%2520B%2520and%2520topoisomerase%2520IV%2520with%2520improved%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2177%26epage%3D2181%26doi%3D10.1016%2Fj.bmcl.2014.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span><span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0ljTWG0uaSmjeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Heuberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span> </span><span class="NLM_article-title">When is protein binding important?</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3458</span><span class="NLM_x">–</span> <span class="NLM_lpage">3467</span><span class="refDoi"> DOI: 10.1002/jps.23559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2Fjps.23559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=23650013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=3458-3467&author=J.+Heubergerauthor=S.+Schmidtauthor=H.+Derendorf&title=When+is+protein+binding+important%3F&doi=10.1002%2Fjps.23559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">When is protein binding important?</span></div><div class="casAuthors">Heuberger, Jules; Schmidt, Stephan; Derendorf, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3458-3467</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The present paper is an ode to a classic citation by Benet and Hoener (2002. Clin Pharm Ther 71(3):115-121).  The now classic paper had a huge impact on drug development and the way the issue of protein binding is perceived and interpreted.  Although the authors very clearly pointed out the limitations and underlying assumptions for their delineations, these are too often overlooked and the classic paper's message is misinterpreted by broadening to cases that were not intended.  Some members of the scientific community concluded from the paper that protein binding is not important.  This was clearly not intended by the authors, as they finished their paper with a paragraph entitled: "When is protein binding important" Misinterpretation of the underlying assumptions in the classic work can result in major pitfalls in drug development.  Therefore, we revisit the topic of protein binding with the intention of clarifying when clin. relevant changes should be considered during drug development. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfgdnFH528PrVg90H21EOLACvtfcHk0ljTWG0uaSmjeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeitrs%253D&md5=c1de70fd6e594e3788371604f26dd768</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fjps.23559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23559%26sid%3Dliteratum%253Aachs%26aulast%3DHeuberger%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DDerendorf%26aufirst%3DH.%26atitle%3DWhen%2520is%2520protein%2520binding%2520important%253F%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D3458%26epage%3D3467%26doi%3D10.1002%2Fjps.23559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Berezhkovskiy, L. M.</span><span> </span><span class="NLM_article-title">On the influence of protein binding on pharmacological activity of drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2165</span><span class="refDoi"> DOI: 10.1002/jps.21958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2Fjps.21958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=2153-2165&author=L.+M.+Berezhkovskiy&title=On+the+influence+of+protein+binding+on+pharmacological+activity+of+drugs&doi=10.1002%2Fjps.21958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.21958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21958%26sid%3Dliteratum%253Aachs%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26atitle%3DOn%2520the%2520influence%2520of%2520protein%2520binding%2520on%2520pharmacological%2520activity%2520of%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D2153%26epage%3D2165%26doi%3D10.1002%2Fjps.21958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosberry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennessy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzfaden, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shillings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlkonig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwynn, M. N.</span><span> </span><span class="NLM_article-title">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span><span class="refDoi"> DOI: 10.1038/nature09197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fnature09197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=20686482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=935-942&author=B.+D.+Baxauthor=P.+F.+Chanauthor=D.+S.+Egglestonauthor=A.+Fosberryauthor=D.+R.+Gentryauthor=F.+Gorrecauthor=I.+Giordanoauthor=M.+M.+Hannauthor=A.+Hennessyauthor=M.+Hibbsauthor=J.+Huangauthor=E.+Jonesauthor=J.+Jonesauthor=K.+K.+Brownauthor=C.+J.+Lewisauthor=E.+W.+Mayauthor=M.+R.+Saundersauthor=O.+Singhauthor=C.+E.+Spitzfadenauthor=C.+Shenauthor=A.+Shillingsauthor=A.+J.+Theobaldauthor=A.+Wohlkonigauthor=N.+D.+Pearsonauthor=M.+N.+Gwynn&title=Type+IIA+topoisomerase+inhibition+by+a+new+class+of+antibacterial+agents&doi=10.1038%2Fnature09197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span></div><div class="casAuthors">Bax Benjamin D; Chan Pan F; Eggleston Drake S; Fosberry Andrew; Gentry Daniel R; Gorrec Fabrice; Giordano Ilaria; Hann Michael M; Hennessy Alan; Hibbs Martin; Huang Jianzhong; Jones Emma; Jones Jo; Brown Kristin Koretke; Lewis Ceri J; May Earl W; Saunders Martin R; Singh Onkar; Spitzfaden Claus E; Shen Carol; Shillings Anthony; Theobald Andrew J; Wohlkonig Alexandre; Pearson Neil D; Gwynn Michael N</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7309</span>),
    <span class="NLM_cas:pages">935-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance.  Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action.  Here we report the 2.1 A crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target.  The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites.  In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate.  This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzBPk2FYUX-kBuFdjgVNKSfW6udTcc2eaw77HGbn3uz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D&md5=006fef200c7a44f0671829b2a5fbddef</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnature09197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09197%26sid%3Dliteratum%253Aachs%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DChan%26aufirst%3DP.%2BF.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DFosberry%26aufirst%3DA.%26aulast%3DGentry%26aufirst%3DD.%2BR.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DHennessy%26aufirst%3DA.%26aulast%3DHibbs%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DMay%26aufirst%3DE.%2BW.%26aulast%3DSaunders%26aufirst%3DM.%2BR.%26aulast%3DSingh%26aufirst%3DO.%26aulast%3DSpitzfaden%26aufirst%3DC.%2BE.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DShillings%26aufirst%3DA.%26aulast%3DTheobald%26aufirst%3DA.%2BJ.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DN.%2BD.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26atitle%3DType%2520IIA%2520topoisomerase%2520inhibition%2520by%2520a%2520new%2520class%2520of%2520antibacterial%2520agents%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D935%26epage%3D942%26doi%3D10.1038%2Fnature09197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Laponogov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohi, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselkov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawhney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAuley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, M. R.</span><span> </span><span class="NLM_article-title">Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1038/nsmb.1604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fnsmb.1604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=19448616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=667-669&author=I.+Laponogovauthor=M.+K.+Sohiauthor=D.+A.+Veselkovauthor=X.+Panauthor=R.+Sawhneyauthor=A.+W.+Thompsonauthor=K.+E.+McAuleyauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structural+insight+into+the+quinolone%E2%80%93DNA+cleavage+complex+of+type+IIA+topoisomerases&doi=10.1038%2Fnsmb.1604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases</span></div><div class="casAuthors">Laponogov, Ivan; Sohi, Maninder K.; Veselkov, Dennis A.; Pan, Xiao-Su; Sawhney, Ritica; Thompson, Andrew W.; McAuley, Katherine E.; Fisher, L. Mark; Sanderson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-669</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type II topoisomerases alter DNA topol. by forming a covalent DNA-cleavage complex that allows DNA transport through a double-stranded DNA break.  We present the structures of cleavage complexes formed by the Streptococcus pneumoniae ParC breakage-reunion and ParE TOPRIM domains of topoisomerase IV stabilized by moxifloxacin and clinafloxacin, two antipneumococcal fluoroquinolones.  These structures reveal two drug mols. intercalated at the highly bent DNA gate and help explain antibacterial quinolone action and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDXhjTPq1GlrVg90H21EOLACvtfcHk0lgieaBPF2yveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D&md5=cd4c757dbb5d50c8113e658837d44a34</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1604%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DSohi%26aufirst%3DM.%2BK.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DSawhney%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DMcAuley%26aufirst%3DK.%2BE.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructural%2520insight%2520into%2520the%2520quinolone%25E2%2580%2593DNA%2520cleavage%2520complex%2520of%2520type%2520IIA%2520topoisomerases%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D667%26epage%3D669%26doi%3D10.1038%2Fnsmb.1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Laponogov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselkov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crevel, I. M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, M. R.</span><span> </span><span class="NLM_article-title">Structure of an ‘open’ clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9911</span><span class="NLM_x">–</span> <span class="NLM_lpage">9923</span><span class="refDoi"> DOI: 10.1093/nar/gkt749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fnar%2Fgkt749" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=9911-9923&author=I.+Laponogovauthor=D.+A.+Veselkovauthor=I.+M.-T.+Crevelauthor=X.+Panauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structure+of+an+%E2%80%98open%E2%80%99+clamp+type+II+topoisomerase-DNA+complex+provides+a+mechanism+for+DNA+capture+and+transport&doi=10.1093%2Fnar%2Fgkt749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt749%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DCrevel%26aufirst%3DI.%2BM.-T.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520an%2520%25E2%2580%2598open%25E2%2580%2599%2520clamp%2520type%2520II%2520topoisomerase-DNA%2520complex%2520provides%2520a%2520mechanism%2520for%2520DNA%2520capture%2520and%2520transport%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D9911%26epage%3D9923%26doi%3D10.1093%2Fnar%2Fgkt749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tsai, F. T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, O. M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarzynski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonacott, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weston, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeze, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyser, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigley, D. B.</span><span> </span><span class="NLM_article-title">The high-resolution crystal structure of a 24-kDa gyrase B fragment from <i>E. coli</i> complexed with one of the most potent coumarin inhibitors, clorobiocin</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0134(199705)28:1<41::AID-PROT4>3.3.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1997&pages=41-52&author=F.+T.+F.+Tsaiauthor=O.+M.+P.+Singhauthor=T.+Skarzynskiauthor=A.+J.+Wonacottauthor=S.+Westonauthor=A.+Tuckerauthor=R.+A.+Pauptitauthor=A.+L.+Breezeauthor=J.+P.+Poyserauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=D.+B.+Wigley&title=The+high-resolution+crystal+structure+of+a+24-kDa+gyrase+B+fragment+from+E.+coli+complexed+with+one+of+the+most+potent+coumarin+inhibitors%2C+clorobiocin&doi=10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0134%2528199705%252928%253A1%253C41%253A%253AAID-PROT4%253E3.3.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DF.%2BT.%2BF.%26aulast%3DSingh%26aufirst%3DO.%2BM.%2BP.%26aulast%3DSkarzynski%26aufirst%3DT.%26aulast%3DWonacott%26aufirst%3DA.%2BJ.%26aulast%3DWeston%26aufirst%3DS.%26aulast%3DTucker%26aufirst%3DA.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DPoyser%26aufirst%3DJ.%2BP.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DWigley%26aufirst%3DD.%2BB.%26atitle%3DThe%2520high-resolution%2520crystal%2520structure%2520of%2520a%252024-kDa%2520gyrase%2520B%2520fragment%2520from%2520E.%2520coli%2520complexed%2520with%2520one%2520of%2520the%2520most%2520potent%2520coumarin%2520inhibitors%252C%2520clorobiocin%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D1997%26volume%3D28%26spage%3D41%26epage%3D52%26doi%3D10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mayer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2313</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span><span class="refDoi"> DOI: 10.1021/cr4003984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4003984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2313-2342&author=C.+Mayerauthor=Y.+L.+Janin&title=Non-quinolone+inhibitors+of+bacterial+type+IIA+topoisomerases%3A+a+feat+of+bioisosterism&doi=10.1021%2Fcr4003984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism</span></div><div class="casAuthors">Mayer, Claudine; Janin, Yves L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2313-2342</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  DNA gyrase and topoisomerase IV are the bacterial type IIA topoisomerases.  These are ubiquitous nucleic acid-dependent nanomachines, essential to cell life, that solve DNA topol. problems resulting from the replication, transcription, and recombination of DNA.  From the discovery that novobiocin and fluoroquinolone antibiotics were selectively acting on bacterial type IIA topoisomerases, a remarkable no. of series of inhibitors of these enzymes has been reported.  The design of biochem. or cellular assays, amenable to high-throughput screenings, along with X-ray-derived structures of the early inhibitors bound to DNA gyrase, were instrumental in this.  From these structures, an array of strategies, which are today called fragment-based approaches, provided quite a no. of addnl. starting points for medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-y7YT9Lg6rVg90H21EOLACvtfcHk0ljYVkY40lgsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO&md5=8559c27866d96e85cc08763e0cae1c01</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcr4003984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4003984%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DNon-quinolone%2520inhibitors%2520of%2520bacterial%2520type%2520IIA%2520topoisomerases%253A%2520a%2520feat%2520of%2520bioisosterism%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2313%26epage%3D2342%26doi%3D10.1021%2Fcr4003984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Boos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopper, H.</span><span> </span><span class="NLM_article-title">Genotoxicity of several clinically used topoisomerase II inhibitors</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/S0378-4274(00)00192-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0378-4274%2800%2900192-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10906417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvVyqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2000&pages=7-16&author=G.+Boosauthor=H.+Stopper&title=Genotoxicity+of+several+clinically+used+topoisomerase+II+inhibitors&doi=10.1016%2FS0378-4274%2800%2900192-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity of several clinically used topoisomerase II inhibitors</span></div><div class="casAuthors">Boos, G.; Stopper, H.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">7-16</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">DNA topoisomerase II is an essential nuclear enzyme that modulates DNA topol. during multiple cellular processes such as DNA replication and chromosome segregation.  Several important clin. antitumor drugs and antibiotics act through inhibition of topoisomerase II.  There are a no. of different steps in the action of topoisomerase II, all of which are potential targets for inhibition through drugs and also for cellular and genetic toxicity as well as for mutagenesis.  We have investigated and compared the genotoxicity and mutagenicity of the mechanistically different topoisomerase II inhibitors m-amsacrine, mitoxantrone, etoposide, genistein, ICRF 193, and berenil using the in vitro micronucleus test, single cell elelectrophoresis (comet assay) and the mutation assay (tk-locus) in L5178Y mouse lymphoma cells.  All six compds. induced micronuclei and all except berenil were mutagenic.  M-amsacrine, mitoxantrone, etoposide and genistein induced DNA migration in the comet assay, whereas ICRF 193 was only weakly pos. and berenil was neg. in this test.  Our results are in good agreement with the compds.' proposed mechanisms of interaction with topoisomerase II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0kiIlE6JkNbVg90H21EOLACvtfcHk0ljYVkY40lgsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvVyqtrw%253D&md5=2d4d2ab9d9deb23b535c9312c67b5611</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0378-4274%2800%2900192-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4274%252800%252900192-2%26sid%3Dliteratum%253Aachs%26aulast%3DBoos%26aufirst%3DG.%26aulast%3DStopper%26aufirst%3DH.%26atitle%3DGenotoxicity%2520of%2520several%2520clinically%2520used%2520topoisomerase%2520II%2520inhibitors%26jtitle%3DToxicol.%2520Lett.%26date%3D2000%26volume%3D116%26spage%3D7%26epage%3D16%26doi%3D10.1016%2FS0378-4274%2800%2900192-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span>Withdrawal Assessment Report for Factive: International Nonproprietary Name Gemifloxacin; <span class="NLM_series">Procedure No. EMEA/H/C/995</span>; <span class="NLM_publisher-name">European Medicines Agency</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500060988.pdf" class="extLink">http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500060988.pdf</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Withdrawal+Assessment+Report+for+Factive%3A+International+Nonproprietary+Name+Gemifloxacin%3B+Procedure+No.+EMEA%2FH%2FC%2F995%3B+European+Medicines+Agency%3A+London%2C+2009%3B+http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FApplication_withdrawal_assessment_report%2F2010%2F01%2FWC500060988.pdf+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DWithdrawal%2520Assessment%2520Report%2520for%2520Factive%253A%2520International%2520Nonproprietary%2520Name%2520Gemifloxacin%26pub%3DEuropean%2520Medicines%2520Agency%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Shapiro, A. B.</span><span> </span><span class="NLM_article-title">A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.bcp.2013.02.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1269-1277&author=A.+B.+Shapiro&title=A+high-throughput-compatible%2C+fluorescence+anisotropy-based+assay+for+ATP-dependent+supercoiled+DNA+relaxation+by+human+topoisomerase+II%CE%B1&doi=10.1016%2Fj.bcp.2013.02.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26atitle%3DA%2520high-throughput-compatible%252C%2520fluorescence%2520anisotropy-based%2520assay%2520for%2520ATP-dependent%2520supercoiled%2520DNA%2520relaxation%2520by%2520human%2520topoisomerase%2520II%25CE%25B1%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1269%26epage%3D1277%26doi%3D10.1016%2Fj.bcp.2013.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Shapiro, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. A.</span><span> </span><span class="NLM_article-title">A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.ab.2013.11.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.ab.2013.11.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=24309019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlektLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2014&pages=23-29&author=A.+B.+Shapiroauthor=C.+A.+Austin&title=A+high-throughput+fluorescence+anisotropy-based+assay+for+human+topoisomerase+II+%CE%B2-catalyzed+ATP-dependent+supercoiled+DNA+relaxation&doi=10.1016%2Fj.ab.2013.11.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation</span></div><div class="casAuthors">Shapiro, Adam B.; Austin, Caroline A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Because of their essentiality for DNA replication, transcription, and repair, type II topoisomerases are targets for antibacterial and anticancer drugs.  There are two type II topoisomerases in humans, topoisomerase IIα (TOP2A) and topoisomerase IIβ (TOP2B), and two in bacteria, gyrase and topoisomerase IV.  Inhibition of one or both of the human type II topoisomerases by antibacterial compds. targeting their bacterial counterparts could result in toxicity.  In addn., side effects of anticancer drugs targeting TOP2A could result from inhibition of TOP2B.  A simple and rapid biochem. assay for the activity of TOP2A and TOP2B would be advantageous for screening for novel inhibitors, testing them for selectivity for one enzyme over the other, and testing for potential toxicity of antibacterial type II topoisomerases mediated by human topoisomerase II inhibition.  In this paper, we show that a previously reported high-throughput, fluorescence anisotropy-based assay for ATP-dependent relaxation of supercoiled DNA by human TOP2A can also be used under identical conditions for human TOP2B.  We used this assay to compare the potencies vs. both enzymes of 19 compds. reported in the literature to inhibit human and/or bacterial type II topoisomerases.  We also used the assay to investigate the effect of ATP concn. on inhibitor potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8YZAo9eRn8bVg90H21EOLACvtfcHk0ljYVkY40lgsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlektLw%253D&md5=2f4c35b785071d62252c04b6bd0c446f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.11.029%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26atitle%3DA%2520high-throughput%2520fluorescence%2520anisotropy-based%2520assay%2520for%2520human%2520topoisomerase%2520II%2520%25CE%25B2-catalyzed%2520ATP-dependent%2520supercoiled%2520DNA%2520relaxation%26jtitle%3DAnal.%2520Biochem.%26date%3D2014%26volume%3D448%26spage%3D23%26epage%3D29%26doi%3D10.1016%2Fj.ab.2013.11.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Thompson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidolf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenna, J. G.</span><span> </span><span class="NLM_article-title">In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span><span class="refDoi"> DOI: 10.1021/tx300091x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300091x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1616-1632&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=L.+Weidolfauthor=K.+Pageauthor=I.+Wilsonauthor=S.+Swallowauthor=B.+Middletonauthor=S.+Stahlauthor=A.+J.+Fosterauthor=H.+Dolgosauthor=R.+Weaverauthor=J.+G.+Kenna&title=In+vitro+approach+to+assess+the+potential+for+risk+of+idiosyncratic+adverse+reactions+caused+by+candidate+drugs&doi=10.1021%2Ftx300091x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1616-1632</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clin. significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling.  IADRs arise from both drug and patient related mechanisms and risk factors.  Drug related risk factors, resulting from parent compd. or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compd. disposition, and/or immune activation.  In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans.  The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P 450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance assocd. protein 2, Mrp2.  In addn., the CVB Burden was estd. by detg. the CVB of radiolabeled compd. to human hepatocytes and factoring in both the max. prescribed daily dose and the fraction of metab. leading to CVB.  Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG8lfWXT4vLVg90H21EOLACvtfcHk0lic50sxq01RAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D&md5=e657aaf23d4efc5466bca68dee95bded</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Ftx300091x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300091x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BJ.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520vitro%2520approach%2520to%2520assess%2520the%2520potential%2520for%2520risk%2520of%2520idiosyncratic%2520adverse%2520reactions%2520caused%2520by%2520candidate%2520drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26spage%3D1616%26epage%3D1632%26doi%3D10.1021%2Ftx300091x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Antoine, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.1517/17425255.4.11.1415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1517%2F17425255.4.11.1415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18950283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12jtbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1415-1427&author=D.+J.+Antoineauthor=D.+P.+Williamsauthor=B.+K.+Park&title=Understanding+the+role+of+reactive+metabolites+in+drug-induced+hepatotoxicity%3A+state+of+the+science&doi=10.1517%2F17425255.4.11.1415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science</span></div><div class="casAuthors">Antoine, Daniel J.; Williams, Dominic P.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1415-1427</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Drug-induced liver injury (DILI) represents a major impediment to the development of new drugs and is a leading cause of drug withdrawal.  The occurrence of hepatotoxicity has been closely assocd. with the formation of chem. reactive metabolites.  Huge investment has focused on the screening of chem. reactive metabolites to offer a pragmatic approach to produce safer drugs and also reduce drug attrition and prevent market place withdrawal.  However, questions surrounding the importance of chem. reactive metabolites still remain.  Increasing evidence now exists for the multi-factorial nature of DILI, in particular the role played by the host immune system or disease state in the pathogenesis of DILI.  This review aims to evaluate the current measures for the prediction and diagnosis of DILI and to highlight investigations being made to understand the multidimensional nature.  Some of the steps being made to generate improved physiol. systems to identify more sensitive, reflective mechanism-based biomarkers to aid the earlier identification of DILI and develop safer medicines are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGt3l_RkKOaLVg90H21EOLACvtfcHk0lic50sxq01RAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12jtbrO&md5=93c1c61013859c12017c2b3c2d9155d4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.11.1415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.11.1415%26sid%3Dliteratum%253Aachs%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DUnderstanding%2520the%2520role%2520of%2520reactive%2520metabolites%2520in%2520drug-induced%2520hepatotoxicity%253A%2520state%2520of%2520the%2520science%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D1415%26epage%3D1427%26doi%3D10.1517%2F17425255.4.11.1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">McMillian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. D.</span><span> </span><span class="NLM_article-title">An improved resazurin-based cytotoxicity assay for hepatic cells</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1023/A:1015559603643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1023%2FA%3A1015559603643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=12083422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVWqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=157-173&author=M.+K.+McMillianauthor=L.+Liauthor=J.+B.+Parkerauthor=L.+Patelauthor=Z.+Zhongauthor=J.+W.+Gunnettauthor=W.+J.+Powersauthor=M.+D.+Johnson&title=An+improved+resazurin-based+cytotoxicity+assay+for+hepatic+cells&doi=10.1023%2FA%3A1015559603643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An improved resazurin-based cytotoxicity assay for hepatic cells</span></div><div class="casAuthors">McMillian, M. K.; Li, L.; Parker, J. B.; Patel, L.; Zhong, Z.; Gunnett, J. W.; Powers, W. J.; Johnson, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-173</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A simple resazurin-based cytotoxicity assay is presented for screening of cytotoxicity in hepatocytes and liver cell lines.  Human hepatoma (HepG2) cells in 96-well culture plates were exposed to known toxic (cisplatin, 5-fluorouracil, ethionine, flufenamic acid, and diflunisal) and control (transplatin, 5-chlorouracil, methionine, and acetylsalicylic acid) compds. for 1-3 days, and resazurin (5 μmol/L) was added.  A conventional short-term (1 h) assay was first performed, where cytotoxicity is indicated by decreased redn. of resazurin to its fluorescent product resorufin.  Our improved assay consists of addnl. measuring fluorescence 2-4 days later, when cytotoxicity is indicated by a striking increase in the concn. of resorufin, resulting from two distinct processes.  First, viable liver-derived cells slowly convert resorufin to nonfluorescent metabolites.  Fluorescence of control cell wells decreased to background during a 2- to 4-day exposure to resazurin.  This metab. of resorufin was largely blocked by dicumarol and to lesser extents by disulfiram and SKF525a.  Second, dead or dying cells slowly convert resazurin to resorufin but do not further metabolize resorufin; thus this fluorescent metabolite accumulates to high levels in wells with dead cells by 2 to 4 days.  A similar increase in fluorescence assocd. with cytotoxicity was obsd. in primary cultures of rat hepatocytes using the long-term resazurin-based assay.  In addn. to an improved signal relative to the short-term assay, the inversion of the fluorescent signal from high = alive short-term to high = dead long-term allows detn. of two independent cytotoxicity endpoints after addn. of one innocuous vital dye.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcib981V1DhrVg90H21EOLACvtfcHk0lic50sxq01RAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVWqsbc%253D&md5=3efbbe079eeffee704146b774cdae556</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015559603643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015559603643%26sid%3Dliteratum%253Aachs%26aulast%3DMcMillian%26aufirst%3DM.%2BK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DJ.%2BB.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DGunnett%26aufirst%3DJ.%2BW.%26aulast%3DPowers%26aufirst%3DW.%2BJ.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26atitle%3DAn%2520improved%2520resazurin-based%2520cytotoxicity%2520assay%2520for%2520hepatic%2520cells%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2002%26volume%3D18%26spage%3D157%26epage%3D173%26doi%3D10.1023%2FA%3A1015559603643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Falagas, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manta, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziora, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardakas, K. Z.</span><span> </span><span class="NLM_article-title">Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1093/jac/dkl219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkl219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=16735427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD28Xotl2lsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=273-280&author=M.+E.+Falagasauthor=K.+G.+Mantaauthor=F.+Ntzioraauthor=K.+Z.+Vardakas&title=Linezolid+for+the+treatment+of+patients+with+endocarditis%3A+a+systematic+review+of+the+published+evidence&doi=10.1093%2Fjac%2Fdkl219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence</span></div><div class="casAuthors">Falagas, Matthew E.; Manta, Katerina G.; Ntziora, Fotinie; Vardakas, Konstantinos Z.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-280</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Linezolid is a bacteriostatic oxazolidinone antibiotic that was proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and possibly bacteremia, due to Gram-pos. cocci.  However, the drug is sometimes used for the treatment of patients with endocarditis due to Gram-pos. cocci resistant to other antibiotics.  The authors carried out a review of the available literature to evaluate whether linezolid is also effective for the treatment of patients with infective endocarditis.  The authors identified 23 case reports and 3 case series reporting the experience with 56 patients with endocarditis treated with linezolid.  Evaluable data for 33 patients who received linezolid and for whom individual patient data were reported were further analyzed.  Prosthetic valve infective endocarditis accounted for 25% of the reviewed cases.  Methicillin-resistant Staphylococcus aureus and vancomycin-intermediate S. aureus were the most commonly isolated cocci (24.2% and 30.3% of cases, resp.).  Linezolid alone was administered to 66.7% of patients while the rest received the antibiotic in combination with rifampicin, gentamicin, fusidic acid or amikacin.  A total of 63.6% (21/33) of patients with endocarditis were cured after linezolid administration.  The overall and endocarditis-related mortality was 33.3% (11/33) and 12.1% (4/33), resp.  Thrombocytopenia developed in 30.8% (8/26) of patients for whom relevant data were available.  The limited available evidence suggests that linezolid may be considered as a therapeutic option for the treatment of patients with endocarditis due to multidrug-resistant Gram-pos. cocci.  However, further published experience is needed to answer the question of whether a bacteriostatic antibiotic could be proven beneficial for patients with an infection for which bactericidal antibiotics were traditionally used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYf2_20F6GBbVg90H21EOLACvtfcHk0liPQZHjX8mcdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xotl2lsLo%253D&md5=3c55aaa141a0f6c23d5ac7ec06971f6a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkl219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkl219%26sid%3Dliteratum%253Aachs%26aulast%3DFalagas%26aufirst%3DM.%2BE.%26aulast%3DManta%26aufirst%3DK.%2BG.%26aulast%3DNtziora%26aufirst%3DF.%26aulast%3DVardakas%26aufirst%3DK.%2BZ.%26atitle%3DLinezolid%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520endocarditis%253A%2520a%2520systematic%2520review%2520of%2520the%2520published%2520evidence%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2006%26volume%3D58%26spage%3D273%26epage%3D280%26doi%3D10.1093%2Fjac%2Fdkl219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Attassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, M. J.</span><span> </span><span class="NLM_article-title">Thrombocytopenia associated with linezolid therapy</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1086/338403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1086%2F338403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=11803505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=695-698&author=K.+Attassiauthor=E.+Hershbergerauthor=R.+Alamauthor=M.+J.+Zervos&title=Thrombocytopenia+associated+with+linezolid+therapy&doi=10.1086%2F338403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombocytopenia associated with linezolid therapy</span></div><div class="casAuthors">Attassi Kinan; Hershberger Ellie; Alam Rabiul; Zervos Marcus J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We evaluated the incidence and clinical characteristics of linezolid-induced thrombocytopenia in 19 patients who were treated with linezolid.  Overall, thrombocytopenia (platelet count, <100,000 platelets/mm(3)) was observed in 32% of patients who received linezolid for >10 days; gastrointestinal bleeding was observed in 1 patient and 4 patients required platelet transfusions.  These data suggest that even patients who are not considered to be at risk for development of thrombocytopenia should be monitored closely if linezolid therapy is continued for >10 days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIIyZakd2UiZggzHGM8X5CfW6udTcc2eZm_azvxcnIZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D&md5=be07b767a34bffcea4e16105cf1993fa</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1086%2F338403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F338403%26sid%3Dliteratum%253Aachs%26aulast%3DAttassi%26aufirst%3DK.%26aulast%3DHershberger%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26atitle%3DThrombocytopenia%2520associated%2520with%2520linezolid%2520therapy%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2002%26volume%3D34%26spage%3D695%26epage%3D698%26doi%3D10.1086%2F338403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Volpe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, M. K.</span><span> </span><span class="NLM_article-title">Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents</span> <span class="citation_source-journal">Toxicol. In Vitro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/S0887-2333(03)00012-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0887-2333%2803%2900012-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=271-277&author=D.+A.+Volpeauthor=M.+K.+Warren&title=Myeloid+clonogenic+assays+for+comparison+of+the+in+vitro+toxicity+of+alkylating+agents&doi=10.1016%2FS0887-2333%2803%2900012-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0887-2333%2803%2900012-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0887-2333%252803%252900012-2%26sid%3Dliteratum%253Aachs%26aulast%3DVolpe%26aufirst%3DD.%2BA.%26aulast%3DWarren%26aufirst%3DM.%2BK.%26atitle%3DMyeloid%2520clonogenic%2520assays%2520for%2520comparison%2520of%2520the%2520in%2520vitro%2520toxicity%2520of%2520alkylating%2520agents%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2003%26volume%3D17%26spage%3D271%26epage%3D277%26doi%3D10.1016%2FS0887-2333%2803%2900012-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Boehm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A.</span><span> </span><span class="NLM_article-title">Simply red: A novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies</span> <span class="citation_source-journal">Biotechnol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.btre.2014.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.btre.2014.07.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=34-41&author=D.+Boehmauthor=A.+Bell&title=Simply+red%3A+A+novel+spectrophotometric+erythroid+proliferation+assay+as+a+tool+for+erythropoiesis+and+erythrotoxicity+studies&doi=10.1016%2Fj.btre.2014.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.btre.2014.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.btre.2014.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DA.%26atitle%3DSimply%2520red%253A%2520A%2520novel%2520spectrophotometric%2520erythroid%2520proliferation%2520assay%2520as%2520a%2520tool%2520for%2520erythropoiesis%2520and%2520erythrotoxicity%2520studies%26jtitle%3DBiotechnol.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D34%26epage%3D41%26doi%3D10.1016%2Fj.btre.2014.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Andes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, W. A.</span><span> </span><span class="NLM_article-title">In vivo activities of amoxicillin and amoxicillin-clavulanate against <i>Streptococcus pneumoniae</i>: application to breakpoint determinations</span> <span class="citation_source-journal">Chemotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=2375-2379&author=D.+Andesauthor=W.+A.+Craig&title=In+vivo+activities+of+amoxicillin+and+amoxicillin-clavulanate+against+Streptococcus+pneumoniae%3A+application+to+breakpoint+determinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndes%26aufirst%3DD.%26aulast%3DCraig%26aufirst%3DW.%2BA.%26atitle%3DIn%2520vivo%2520activities%2520of%2520amoxicillin%2520and%2520amoxicillin-clavulanate%2520against%2520Streptococcus%2520pneumoniae%253A%2520application%2520to%2520breakpoint%2520determinations%26jtitle%3DChemotherapy%26date%3D1998%26volume%3D42%26spage%3D2375%26epage%3D2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. W.</span><span> </span><span class="NLM_article-title">Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in Guinea pigs and mice using serial sampling</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1124/dmd.104.000349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1124%2Fdmd.104.000349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1092-1095&author=S.+K.+Balaniauthor=P.+Liauthor=J.+Nguyenauthor=K.+Cardozaauthor=H.+Zengauthor=D.+Muauthor=J.+Wuauthor=L.+Ganauthor=F.+W.+Lee&title=Effective+dosing+regimen+of+1-aminobenzotriazole+for+inhibition+of+antipyrine+clearance+in+Guinea+pigs+and+mice+using+serial+sampling&doi=10.1124%2Fdmd.104.000349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000349%26sid%3Dliteratum%253Aachs%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DCardoza%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DF.%2BW.%26atitle%3DEffective%2520dosing%2520regimen%2520of%25201-aminobenzotriazole%2520for%2520inhibition%2520of%2520antipyrine%2520clearance%2520in%2520Guinea%2520pigs%2520and%2520mice%2520using%2520serial%2520sampling%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1092%26epage%3D1095%26doi%3D10.1124%2Fdmd.104.000349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Miller, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundy, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mott, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skepner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hromockyj, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotti, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurenko, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzner, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammert, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graber, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruble, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamilar, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banitt, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurd, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span> </span><span class="NLM_article-title">Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2806</span><span class="NLM_x">–</span> <span class="NLM_lpage">2812</span><span class="refDoi"> DOI: 10.1128/AAC.00247-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.00247-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18519725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ogt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2806-2812&author=A.+A.+Millerauthor=G.+L.+Bundyauthor=J.+E.+Mottauthor=J.+E.+Skepnerauthor=T.+P.+Boyleauthor=D.+W.+Harrisauthor=A.+E.+Hromockyjauthor=K.+R.+Marottiauthor=G.+E.+Zurenkoauthor=J.+B.+Munznerauthor=M.+T.+Sweeneyauthor=G.+F.+Bammertauthor=J.+C.+Hamelauthor=C.+W.+Fordauthor=W.+Zhongauthor=D.+R.+Graberauthor=G.+E.+Martinauthor=F.+Hanauthor=L.+A.+Dolakauthor=E.+P.+Seestauthor=J.+C.+Rubleauthor=G.+M.+Kamilarauthor=J.+R.+Palmerauthor=L.+S.+Banittauthor=A.+R.+Hurdauthor=M.+R.+Barbachyn&title=Discovery+and+characterization+of+QPT-1%2C+the+progenitor+of+a+new+class+of+bacterial+topoisomerase+inhibitors&doi=10.1128%2FAAC.00247-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors</span></div><div class="casAuthors">Miller, Alita A.; Bundy, Gordon L.; Mott, John E.; Skepner, Jill E.; Boyle, Timothy P.; Harris, Douglas W.; Hromockyj, Alexander E.; Marotti, Keith R.; Zurenko, Gary E.; Munzner, Jennifer B.; Sweeney, Michael T.; Bammert, Gary F.; Hamel, Judith C.; Ford, Charles W.; Zhong, Wei-Zhu; Graber, David R.; Martin, Gary E.; Han, Fusen; Dolak, Lester A.; Seest, Eric P.; Ruble, J. Craig; Kamilar, Gregg M.; Palmer, John R.; Banitt, Lee S.; Hurd, Alexander R.; Barbachyn, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2806-2812</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">QPT-1 was discovered in a compd. library by high-throughput screening and triage for substances with whole-cell antibacterial activity.  This totally synthetic compd. is an unusual barbituric acid deriv. whose activity resides in the (-)-enantiomer.  QPT-1 had activity against a broad spectrum of pathogenic, antibiotic-resistant bacteria, was nontoxic to eukaryotic cells, and showed oral efficacy in a murine infection model, all before any medicinal chem. optimization.  Biochem. and genetic characterization showed that the QPT-1 targets the β subunit of bacterial type II topoisomerases via a mechanism of inhibition distinct from the mechanisms of fluoroquinolones and novobiocin.  Given these attributes, this compd. represents a promising new class of antibacterial agents.  The success of this reverse genomics effort demonstrates the utility of exploring strategies that are alternatives to target-based screens in antibacterial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoPSHAUxaaj7Vg90H21EOLACvtfcHk0lj_zUQuY6cuHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ogt7c%253D&md5=c459d15b895768ec27648222ad03d20d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.00247-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00247-08%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DA.%2BA.%26aulast%3DBundy%26aufirst%3DG.%2BL.%26aulast%3DMott%26aufirst%3DJ.%2BE.%26aulast%3DSkepner%26aufirst%3DJ.%2BE.%26aulast%3DBoyle%26aufirst%3DT.%2BP.%26aulast%3DHarris%26aufirst%3DD.%2BW.%26aulast%3DHromockyj%26aufirst%3DA.%2BE.%26aulast%3DMarotti%26aufirst%3DK.%2BR.%26aulast%3DZurenko%26aufirst%3DG.%2BE.%26aulast%3DMunzner%26aufirst%3DJ.%2BB.%26aulast%3DSweeney%26aufirst%3DM.%2BT.%26aulast%3DBammert%26aufirst%3DG.%2BF.%26aulast%3DHamel%26aufirst%3DJ.%2BC.%26aulast%3DFord%26aufirst%3DC.%2BW.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DGraber%26aufirst%3DD.%2BR.%26aulast%3DMartin%26aufirst%3DG.%2BE.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DRuble%26aufirst%3DJ.%2BC.%26aulast%3DKamilar%26aufirst%3DG.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BR.%26aulast%3DBanitt%26aufirst%3DL.%2BS.%26aulast%3DHurd%26aufirst%3DA.%2BR.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520QPT-1%252C%2520the%2520progenitor%2520of%2520a%2520new%2520class%2520of%2520bacterial%2520topoisomerase%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2806%26epage%3D2812%26doi%3D10.1128%2FAAC.00247-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Black, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachyra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruneau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miossec, C.</span><span> </span><span class="NLM_article-title">Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span><span class="refDoi"> DOI: 10.1128/AAC.00496-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.00496-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18625781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3339-3349&author=M.+T.+Blackauthor=T.+Stachyraauthor=D.+Platelauthor=A.+Girardauthor=M.+Claudonauthor=J.+Bruneauauthor=C.+Miossec&title=Mechanism+of+action+of+the+antibiotic+NXL101%2C+a+novel+nonfluoroquinolone+inhibitor+of+bacterial+type+II+topoisomerases&doi=10.1128%2FAAC.00496-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases</span></div><div class="casAuthors">Black, Michael T.; Stachyra, Therese; Platel, Denis; Girard, Anne-Marie; Claudon, Monique; Bruneau, Jean-Michel; Miossec, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3339-3349</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">NXL101 is one of a new class of quinoline antibacterial DNA gyrase and topoisomerase IV inhibitors showing potent activity against gram-pos. bacteria, including methicillin- and fluoroquinolone-resistant strains.  NXL101 inhibited topoisomerase IV more effectively than gyrase from Escherichia coli, whereas the converse is true of enzymes from Staphylococcus aureus.  This apparent target preference is opposite to that which is assocd. with most fluoroquinolone antibiotics.  In vitro isolation of S. aureus mutants resistant to NXL101 followed by cloning and sequencing of the genes encoding gyrase and topoisomerase IV led to the identification of several different point mutations within, or close to, the quinolone resistance-detg. region (QRDR) of GyrA.  However, the mutations were not those that are most frequently assocd. with decreased sensitivity to quinolones.  A fluoroquinolone-resistant mutant variant of gyrase generated in vitro was highly resistant to inhibition by the fluoroquinolones ciprofloxacin and moxifloxacin but remained fully susceptible to inhibition by NXL101.  Two mutant gyrases constructed in vitro, with mutations in gyrA engineered according to those most frequently found in S. aureus strains resistant to NXL101, were insensitive to inhibition by NXL101 and had a diminished sensitivity to ciprofloxacin and moxifloxacin.  Certain combinations of mutations giving rise to NXL101 resistance and those giving rise to fluoroquinolone resistance may be mutually exclusive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRmIzSCazIbVg90H21EOLACvtfcHk0lj_zUQuY6cuHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt77L&md5=a39fe88e84c958369d86f4614c9f3e06</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FAAC.00496-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00496-08%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DM.%2BT.%26aulast%3DStachyra%26aufirst%3DT.%26aulast%3DPlatel%26aufirst%3DD.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DClaudon%26aufirst%3DM.%26aulast%3DBruneau%26aufirst%3DJ.%26aulast%3DMiossec%26aufirst%3DC.%26atitle%3DMechanism%2520of%2520action%2520of%2520the%2520antibiotic%2520NXL101%252C%2520a%2520novel%2520nonfluoroquinolone%2520inhibitor%2520of%2520bacterial%2520type%2520II%2520topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3339%26epage%3D3349%26doi%3D10.1128%2FAAC.00496-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Robinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osheroff, N.</span><span> </span><span class="NLM_article-title">Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3638</span><span class="NLM_x">–</span> <span class="NLM_lpage">3643</span><span class="refDoi"> DOI: 10.1021/bi00065a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00065a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=3638-3643&author=M.+J.+Robinsonauthor=A.+H.+Corbettauthor=N.+Osheroff&title=Effects+of+topoisomerase+II-targeted+drugs+on+enzyme-mediated+DNA+cleavage+and+ATP+hydrolysis%3A+evidence+for+distinct+drug+interaction+domains+on+topoisomerase+II&doi=10.1021%2Fbi00065a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi00065a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00065a016%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BJ.%26aulast%3DCorbett%26aufirst%3DA.%2BH.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DEffects%2520of%2520topoisomerase%2520II-targeted%2520drugs%2520on%2520enzyme-mediated%2520DNA%2520cleavage%2520and%2520ATP%2520hydrolysis%253A%2520evidence%2520for%2520distinct%2520drug%2520interaction%2520domains%2520on%2520topoisomerase%2520II%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D3638%26epage%3D3643%26doi%3D10.1021%2Fbi00065a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Huband, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacobbe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patey, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. P.</span><span> </span><span class="NLM_article-title">In vitro antibacterial activity of AZD0914: a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fasitidious Gram-negative, and atypcial bacteria</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1128/AAC.04124-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.04124-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=467-474&author=M.+D.+Hubandauthor=P.+A.+Bradfordauthor=L.+A.+Ottersonauthor=G.+S.+Basarabauthor=A.+Kutschkeauthor=R.+A.+Giacobbeauthor=S.+A.+Pateyauthor=R.+A.+Almauthor=M.+R.+Johnstoneauthor=M.+E.+Potterauthor=P.+F.+Millerauthor=J.+P.+Mueller&title=In+vitro+antibacterial+activity+of+AZD0914%3A+a+new+spiropyrimidinetrione+DNA+gyrase%2Ftopoisomerase+inhibitor+with+potent+activity+against+Gram-positive%2C+fasitidious+Gram-negative%2C+and+atypcial+bacteria&doi=10.1128%2FAAC.04124-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FAAC.04124-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04124-14%26sid%3Dliteratum%253Aachs%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DBradford%26aufirst%3DP.%2BA.%26aulast%3DOtterson%26aufirst%3DL.%2BA.%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DGiacobbe%26aufirst%3DR.%2BA.%26aulast%3DPatey%26aufirst%3DS.%2BA.%26aulast%3DAlm%26aufirst%3DR.%2BA.%26aulast%3DJohnstone%26aufirst%3DM.%2BR.%26aulast%3DPotter%26aufirst%3DM.%2BE.%26aulast%3DMiller%26aufirst%3DP.%2BF.%26aulast%3DMueller%26aufirst%3DJ.%2BP.%26atitle%3DIn%2520vitro%2520antibacterial%2520activity%2520of%2520AZD0914%253A%2520a%2520new%2520spiropyrimidinetrione%2520DNA%2520gyrase%252Ftopoisomerase%2520inhibitor%2520with%2520potent%2520activity%2520against%2520Gram-positive%252C%2520fasitidious%2520Gram-negative%252C%2520and%2520atypcial%2520bacteria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D467%26epage%3D474%26doi%3D10.1128%2FAAC.04124-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Alm, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteaker, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. P.</span><span> </span><span class="NLM_article-title">Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in <i>Neisseria gonorrhoeae</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1486</span><span class="refDoi"> DOI: 10.1128/AAC.04456-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.04456-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1478-1486&author=R.+A.+Almauthor=S.+D.+Lahiriauthor=A.+Kutschkeauthor=L.+G.+Ottersonauthor=R.+E.+McLaughlinauthor=J.+D.+Whiteakerauthor=L.+A.+Lewisauthor=X.+Suauthor=M.+D.+Hubandauthor=H.+Gardnerauthor=J.+P.+Mueller&title=Characterization+of+the+novel+DNA+gyrase+inhibitor+AZD0914%3A+low+resistance+potential+and+lack+of+cross-resistance+in+Neisseria+gonorrhoeae&doi=10.1128%2FAAC.04456-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.04456-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04456-14%26sid%3Dliteratum%253Aachs%26aulast%3DAlm%26aufirst%3DR.%2BA.%26aulast%3DLahiri%26aufirst%3DS.%2BD.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DOtterson%26aufirst%3DL.%2BG.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DWhiteaker%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DL.%2BA.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMueller%26aufirst%3DJ.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520novel%2520DNA%2520gyrase%2520inhibitor%2520AZD0914%253A%2520low%2520resistance%2520potential%2520and%2520lack%2520of%2520cross-resistance%2520in%2520Neisseria%2520gonorrhoeae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D1478%26epage%3D1486%26doi%3D10.1128%2FAAC.04456-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Basarab, G. S.; Gowravaram, M. R.; Hauck, S. I.; Zhou, F.</span><span> </span><span class="NLM_article-title">Preparation of spiro[oxazino[4,3-<i>a</i>]isoxazolo[4,5-<i>g</i>]quinoline-pyrimidine]trione compounds and methods for treating bacterial infections</span>. U.S. Patent US 20140206677,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+S.+Basarab&author=M.+R.+Gowravaram&author=S.+I.+Hauck&author=F.+Zhou&title=Preparation+of+spiro%5Boxazino%5B4%2C3-a%5Disoxazolo%5B4%2C5-g%5Dquinoline-pyrimidine%5Dtrione+compounds+and+methods+for+treating+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26atitle%3DPreparation%2520of%2520spiro%255Boxazino%255B4%252C3-a%255Disoxazolo%255B4%252C5-g%255Dquinoline-pyrimidine%255Dtrione%2520compounds%2520and%2520methods%2520for%2520treating%2520bacterial%2520infections%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Unemo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golparian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, W. M.</span><span> </span><span class="NLM_article-title">Challenges with gonorrhea in the era of multi-drug and extensively drug resistance – are we on the right track?</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span><span class="refDoi"> DOI: 10.1586/14787210.2014.906902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1586%2F14787210.2014.906902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=24702589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVelsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=653-656&author=M.+Unemoauthor=D.+Golparianauthor=W.+M.+Shafer&title=Challenges+with+gonorrhea+in+the+era+of+multi-drug+and+extensively+drug+resistance+%E2%80%93+are+we+on+the+right+track%3F&doi=10.1586%2F14787210.2014.906902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track?</span></div><div class="casAuthors">Unemo, Magnus; Golparian, Daniel; Shafer, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-656</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Neisseria gonorrhoeae has retained antimicrobial resistance to drugs previously recommended for first-line empiric treatment of gonorrhea, and resistance to ceftriaxone, the last option for monotherapy, is evolving.  Crucial actions to combat this developing situation include implementing response plans; considering use of dual antimicrobial regimens; enhancing surveillance of gonorrhea, gonococcal antimicrobial resistance, treatment failures and antimicrobial use/misuse and improving prevention, early diagnosis, contact tracing and treatment.  The ways forward also include an intensified research to identify novel antimicrobial resistance determinants and develop and evaluate appropriate use of mol. antimicrobial resistance testing, ideally point-of-care and with simultaneous detection of gonococci, to supplement culture-based methods and ideally guide tailored treatment.  It is crucial with an enhanced understanding of the dynamics of the national and international emergence, transmission and evolution of antimicrobial-resistant gonococcal strains.  Genome sequencing combined with epidemiol. metadata will detail these issues and might also revolutionize the mol. antimicrobial resistance testing.  Ultimately, novel antimicrobials are essential and some antimicrobials in development have shown potent in vitro activity against gonococci.  Several of these antimicrobials deserve further attention for potential future treatment of gonorrhea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVg4fD4qxD7Vg90H21EOLACvtfcHk0lh4lxuy5jAzpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVelsbw%253D&md5=4bb17602fb4cd971ebf09d9f5f9a3049</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1586%2F14787210.2014.906902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.2014.906902%26sid%3Dliteratum%253Aachs%26aulast%3DUnemo%26aufirst%3DM.%26aulast%3DGolparian%26aufirst%3DD.%26aulast%3DShafer%26aufirst%3DW.%2BM.%26atitle%3DChallenges%2520with%2520gonorrhea%2520in%2520the%2520era%2520of%2520multi-drug%2520and%2520extensively%2520drug%2520resistance%2520%25E2%2580%2593%2520are%2520we%2520on%2520the%2520right%2520track%253F%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2014%26volume%3D12%26spage%3D653%26epage%3D656%26doi%3D10.1586%2F14787210.2014.906902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Rein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goicoechea-Pappas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anklekar, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawley, R. E.</span><span> </span><span class="NLM_article-title">Chiral dipole-stabilized anions: experiment and theory in benzylic and allylic systems. Stereoselective deprotonations, pyramidal inversions, and stereoselective alkylations of lithiated (tetrahydroisoquinolyl)oxazolines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2211</span><span class="NLM_x">–</span> <span class="NLM_lpage">2217</span><span class="refDoi"> DOI: 10.1021/ja00188a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00188a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1989&pages=2211-2217&author=K.+Reinauthor=M.+Goicoechea-Pappasauthor=T.+V.+Anklekarauthor=G.+C.+Hartauthor=G.+A.+Smithauthor=R.+E.+Gawley&title=Chiral+dipole-stabilized+anions%3A+experiment+and+theory+in+benzylic+and+allylic+systems.+Stereoselective+deprotonations%2C+pyramidal+inversions%2C+and+stereoselective+alkylations+of+lithiated+%28tetrahydroisoquinolyl%29oxazolines&doi=10.1021%2Fja00188a040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja00188a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00188a040%26sid%3Dliteratum%253Aachs%26aulast%3DRein%26aufirst%3DK.%26aulast%3DGoicoechea-Pappas%26aufirst%3DM.%26aulast%3DAnklekar%26aufirst%3DT.%2BV.%26aulast%3DHart%26aufirst%3DG.%2BC.%26aulast%3DSmith%26aufirst%3DG.%2BA.%26aulast%3DGawley%26aufirst%3DR.%2BE.%26atitle%3DChiral%2520dipole-stabilized%2520anions%253A%2520experiment%2520and%2520theory%2520in%2520benzylic%2520and%2520allylic%2520systems.%2520Stereoselective%2520deprotonations%252C%2520pyramidal%2520inversions%252C%2520and%2520stereoselective%2520alkylations%2520of%2520lithiated%2520%2528tetrahydroisoquinolyl%2529oxazolines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1989%26volume%3D111%26spage%3D2211%26epage%3D2217%26doi%3D10.1021%2Fja00188a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Chouhan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alper, H.</span><span> </span><span class="NLM_article-title">Synthesis of ring-fused oxazolo- and pyrazoloisoquinolinones by a one-pot Pd-catalyzed carboxamidation and aldol-aype condensation cascade process</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">6181</span><span class="NLM_x">–</span> <span class="NLM_lpage">6189</span><span class="refDoi"> DOI: 10.1021/jo9010574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9010574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=6181-6189&author=G.+Chouhanauthor=H.+Alper&title=Synthesis+of+ring-fused+oxazolo-+and+pyrazoloisoquinolinones+by+a+one-pot+Pd-catalyzed+carboxamidation+and+aldol-aype+condensation+cascade+process&doi=10.1021%2Fjo9010574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjo9010574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9010574%26sid%3Dliteratum%253Aachs%26aulast%3DChouhan%26aufirst%3DG.%26aulast%3DAlper%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520ring-fused%2520oxazolo-%2520and%2520pyrazoloisoquinolinones%2520by%2520a%2520one-pot%2520Pd-catalyzed%2520carboxamidation%2520and%2520aldol-aype%2520condensation%2520cascade%2520process%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D6181%26epage%3D6189%26doi%3D10.1021%2Fjo9010574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Nishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, F.</span><span> </span><span class="NLM_article-title">Synthesis and spectral behavior of 5-methyl-3-phenyl-1,3-oxazolidin-2-ones using NMR</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span><span class="refDoi"> DOI: 10.1002/jhet.5570230535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2Fjhet.5570230535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1986&pages=1427-1429&author=T.+Nishiyamaauthor=S.+Matsuiauthor=F.+Yamada&title=Synthesis+and+spectral+behavior+of+5-methyl-3-phenyl-1%2C3-oxazolidin-2-ones+using+NMR&doi=10.1002%2Fjhet.5570230535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570230535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570230535%26sid%3Dliteratum%253Aachs%26aulast%3DNishiyama%26aufirst%3DT.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520spectral%2520behavior%2520of%25205-methyl-3-phenyl-1%252C3-oxazolidin-2-ones%2520using%2520NMR%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1986%26volume%3D23%26spage%3D1427%26epage%3D1429%26doi%3D10.1002%2Fjhet.5570230535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Berkowitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloss, D. G.</span><span> </span><span class="NLM_article-title">Diallyl (lithiodifluoromethyl)phosphonate: a new reagent for the introduction of the (difluoromethylene)phosphonate functionality</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7047</span><span class="NLM_x">–</span> <span class="NLM_lpage">7050</span><span class="refDoi"> DOI: 10.1021/jo00126a073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00126a073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7047-7050&author=D.+B.+Berkowitzauthor=D.+G.+Sloss&title=Diallyl+%28lithiodifluoromethyl%29phosphonate%3A+a+new+reagent+for+the+introduction+of+the+%28difluoromethylene%29phosphonate+functionality&doi=10.1021%2Fjo00126a073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjo00126a073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00126a073%26sid%3Dliteratum%253Aachs%26aulast%3DBerkowitz%26aufirst%3DD.%2BB.%26aulast%3DSloss%26aufirst%3DD.%2BG.%26atitle%3DDiallyl%2520%2528lithiodifluoromethyl%2529phosphonate%253A%2520a%2520new%2520reagent%2520for%2520the%2520introduction%2520of%2520the%2520%2528difluoromethylene%2529phosphonate%2520functionality%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7047%26epage%3D7050%26doi%3D10.1021%2Fjo00126a073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. V.</span><span> </span><span class="NLM_article-title">Bromocyclization of unsaturated thiocarbamidates. Synthesis of (+-)-sporamine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6985</span><span class="NLM_x">–</span> <span class="NLM_lpage">6986</span><span class="refDoi"> DOI: 10.1021/ja00361a053</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00361a053" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1983&pages=6985-6986&author=S.+Knappauthor=D.+V.+Patel&title=Bromocyclization+of+unsaturated+thiocarbamidates.+Synthesis+of+%28%2B-%29-sporamine&doi=10.1021%2Fja00361a053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja00361a053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00361a053%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26atitle%3DBromocyclization%2520of%2520unsaturated%2520thiocarbamidates.%2520Synthesis%2520of%2520%2528%252B-%2529-sporamine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1983%26volume%3D105%26spage%3D6985%26epage%3D6986%26doi%3D10.1021%2Fja00361a053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Enders, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallfass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, B.</span><span> </span><span class="NLM_article-title">A short diastereo- and enantioselective synthesis of cis-4,5-disubstituted oxazolidin-2-ones</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">0033</span><span class="NLM_x">–</span> <span class="NLM_lpage">0036</span><span class="refDoi"> DOI: 10.1055/s-2002-19341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1055%2Fs-2002-19341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2002&publication_year=2002&pages=0033-0036&author=D.+Endersauthor=U.+Kallfassauthor=B.+Nolte&title=A+short+diastereo-+and+enantioselective+synthesis+of+cis-4%2C5-disubstituted+oxazolidin-2-ones&doi=10.1055%2Fs-2002-19341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1055%2Fs-2002-19341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2002-19341%26sid%3Dliteratum%253Aachs%26aulast%3DEnders%26aufirst%3DD.%26aulast%3DKallfass%26aufirst%3DU.%26aulast%3DNolte%26aufirst%3DB.%26atitle%3DA%2520short%2520diastereo-%2520and%2520enantioselective%2520synthesis%2520of%2520cis-4%252C5-disubstituted%2520oxazolidin-2-ones%26jtitle%3DSynlett%26date%3D2002%26volume%3D2002%26spage%3D0033%26epage%3D0036%26doi%3D10.1055%2Fs-2002-19341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span>M07-A9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">42</span>, pp  <span class="NLM_fpage">88</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=M07-A9.+Methods+for+Dilution+Antimicrobial+Susceptibility+Tests+for+Bacteria+That+Grow+Aerobically%3B+Approved+Standard.+Clinical+and+Laboratory+Standards+Institute%3A+Wayne%2C+PA%2C+2012%3B+Vol.+42%2C+pp+88."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DM07-A9.%2520Methods%2520for%2520Dilution%2520Antimicrobial%2520Susceptibility%2520Tests%2520for%2520Bacteria%2520That%2520Grow%2520Aerobically%253B%2520Approved%2520Standard%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2012%26volume%3D42%26spage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span>M100-S24. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement; <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">34</span>, pp  <span class="NLM_fpage">10</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=M100-S24.+Performance+Standards+for+Antimicrobial+Susceptibility+Testing%3B+Twenty-Fourth+Informational+Supplement%3B+Clinical+and+Laboratory+Standards+Institute%3A+Wayne%2C+PA%2C+2014%3B+Vol.+34%2C+pp+10."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DM100-S24.%2520Performance%2520Standards%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%253B%2520Twenty-Fourth%2520Informational%2520Supplement%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2014%26volume%3D34%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Cory, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barltrop, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, J. G.</span><span> </span><span class="NLM_article-title">Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture</span> <span class="citation_source-journal">Cancer Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.3727%2F095535491820873191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1867954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADyaK38Xhsl2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=207-212&author=A.+H.+Coryauthor=T.+C.+Owenauthor=J.+A.+Barltropauthor=J.+G.+Cory&title=Use+of+an+aqueous+soluble+tetrazolium%2Fformazan+assay+for+cell+growth+assays+in+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture</span></div><div class="casAuthors">Cory, Ann H.; Owen, Terence C.; Barltrop, John A.; Cory, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">207-12</span>CODEN:
                <span class="NLM_cas:coden">CNCMET</span>;
        ISSN:<span class="NLM_cas:issn">0955-3541</span>.
    </div><div class="casAbstract">A new tetrazolium analog of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was evaluated as a substitute for MTT in the microculture screening assay for in vitro cell growth.  This new tetrazolium compd., 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS), in the presence of phenazine methosulfate (PMS), gave a water-sol. formazan product that had an absorbance max. at 490-500 nm in phosphate-buffered saline.  The amt. of colored product formed was proportional to the no. of cells and the time of incubation of the cells with MTS/PMS.  MTS/PMS was reactive in all the cell lines tested which included mouse leukemia L1210 cells, mouse Ehrlich tumor cells, mouse 3T3 fibroblasts, and human colon tumor cells (HT-29).  HT-29 and 3T3 fibroblasts reduced MTS/PMS more efficiently than they reduced MTT.  Comparable to the amt. of product formed from MTT, MTS/PMS gave excellent product formation.  The IC50 value for pyrazoloimidazole obtained using MTS/PMS was 200 μM; for 5-fluoro-2'-deoxyuridine, the IC50 value was 0.9 nM.  These values compared very favorably with the IC50 values obtained by direct cell counts.  Further, the same IC50 values were obtained when the absorbances of the formazan product in the 96-well plates were detd. after different times of incubation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9L9qsNf3ks7Vg90H21EOLACvtfcHk0ljWvicnZqRAZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xhsl2qsQ%253D%253D&md5=9648145be5846e739645e64db964403d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.3727%2F095535491820873191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F095535491820873191%26sid%3Dliteratum%253Aachs%26aulast%3DCory%26aufirst%3DA.%2BH.%26aulast%3DOwen%26aufirst%3DT.%2BC.%26aulast%3DBarltrop%26aufirst%3DJ.%2BA.%26aulast%3DCory%26aufirst%3DJ.%2BG.%26atitle%3DUse%2520of%2520an%2520aqueous%2520soluble%2520tetrazolium%252Fformazan%2520assay%2520for%2520cell%2520growth%2520assays%2520in%2520culture%26jtitle%3DCancer%2520Commun.%26date%3D1991%26volume%3D3%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Doherty, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M.</span><span> </span><span class="NLM_article-title">A rapid, semi-automated method for scoring micronuclei in mononucleated mouse lymphoma cells</span> <span class="citation_source-journal">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">726</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.mrgentox.2011.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.mrgentox.2011.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12rurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=726&publication_year=2011&pages=36-41&author=A.+T.+Dohertyauthor=J.+Hayesauthor=M.+Fellowsauthor=S.+Kirkauthor=M.+O%E2%80%99Donovan&title=A+rapid%2C+semi-automated+method+for+scoring+micronuclei+in+mononucleated+mouse+lymphoma+cells&doi=10.1016%2Fj.mrgentox.2011.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid, semi-automated method for scoring micronuclei in mononucleated mouse lymphoma cells</span></div><div class="casAuthors">Doherty, Ann T.; Hayes, Julie; Fellows, Mick; Kirk, Sarah; O'Donovan, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">726</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A semi-automated scoring system has been developed to provide rapid, accurate assessment of micronuclei in prepns. of mononuclear mouse lymphoma L5178Y cells.  Following exposure to a range of test agents, flat, single-cell prepns. were produced from exponentially growing cultures by cytocentrifugation.  Following staining with 4'-6-diamidino-2-phenylindole (DAPI), cells were scanned by use of the MicroNuc module of Metafer 4 v 3.4.102, after modifying the classifier developed for selecting micronuclei in binucleate cells to increase its sensitivity.  The image gallery of all cells was then sorted to bring aberrant cells to the top of the gallery to assess visually the nos. of cells with micronuclei, as distinct from other debris.  Slide quality was shown to be paramount in obtaining accurate results from an automated scan and the data obtained compared very well with the incidence of micronuclei scored conventionally by microscopy.  Compared with manual scoring the time saving is considerable, as more than 2000 images are captured in approx. 2 min, with subsequent visual assessment of aberrant cells in the image gallery taking about 1-2 min/slide.  By scanning all aberrant cells, the system also captures addnl. information on necrotic, apoptotic and fragmented cells.  Although optimized for mouse lymphoma cells, it should be simple to adapt the method for any cell type growing in suspension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVN4Bt_LDuxbVg90H21EOLACvtfcHk0ljbOzZwUJ6C5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12rurvI&md5=0e85329ca1060c131ed364bdcfa00d2d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.mrgentox.2011.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrgentox.2011.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DDoherty%26aufirst%3DA.%2BT.%26aulast%3DHayes%26aufirst%3DJ.%26aulast%3DFellows%26aufirst%3DM.%26aulast%3DKirk%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26atitle%3DA%2520rapid%252C%2520semi-automated%2520method%2520for%2520scoring%2520micronuclei%2520in%2520mononucleated%2520mouse%2520lymphoma%2520cells%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2011%26volume%3D726%26spage%3D36%26epage%3D41%26doi%3D10.1016%2Fj.mrgentox.2011.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Lloyd, M.; Kidd, D.</span><span> </span><span class="NLM_article-title">The mouse lymphoma assay</span>. In <span class="NLM_contrib-group">Parry, J. M.; Parry, E. M.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">817</span>, pp  <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1007%2F978-1-61779-421-6_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lloyd%2C+M.%3B+Kidd%2C+D.+The+mouse+lymphoma+assay.+In+Parry%2C+J.+M.%3B+Parry%2C+E.+M.%2C+Eds.%3B+Springer%3A+New+York%2C+2012%3B+Vol.+817%2C+pp+35%E2%80%9354."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-421-6_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-61779-421-6_3%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DM.%26atitle%3DThe%2520mouse%2520lymphoma%2520assay%26aulast%3DParry%26aufirst%3DJ.%2BM.%26pub%3DSpringer%26date%3D2012%26volume%3D817%26spage%3D35%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Mortelmans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeiger, E.</span><span> </span><span class="NLM_article-title">The Ames Salmonella/microsome mutagenicity assay</span> <span class="citation_source-journal">Mutat. Res., Fundam. Mol. Mech. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/S0027-5107(00)00064-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0027-5107%2800%2900064-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=11113466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2000&pages=29-60&author=K.+Mortelmansauthor=E.+Zeiger&title=The+Ames+Salmonella%2Fmicrosome+mutagenicity+assay&doi=10.1016%2FS0027-5107%2800%2900064-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The Ames Salmonella/microsome mutagenicity assay</span></div><div class="casAuthors">Mortelmans, K.; Zeiger, E.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">29-60</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review and discussion with 95 refs.  The Ames Salmonella/microsome mutagenicity assay (Salmonella test; Ames test) is a short-term bacterial reverse mutation assay specifically designed to detect a wide range of chem. substances that can produce genetic damage that leads to gene mutations.  The test employs several histidine dependent Salmonella strains each carrying different mutations in various genes in the histidine operon.  These mutations act as hot spots for mutagens that cause DNA damage via different mechanisms.  When the Salmonella tester strains are grown on a minimal media agar plate contg. a trace of histidine, only those bacteria that revert to histidine independence (his+) are able to form colonies.  The no. of spontaneously induced revertant colonies per plate is relatively const.  However, when a mutagen is added to the plate, the no. of revertant colonies per plate is increased, usually in a dose-related manner. The Ames test is used world-wide as an initial screen to det. the mutagenic potential of new chems. and drugs.  The test is also used for submission of data to regulatory agencies for registration or acceptance of many chems., including drugs and biocides.  International guidelines have been developed for use by corporations and testing labs. to ensure uniformity of testing procedures. This review provides historical aspects of how the Ames was developed and detailed procedures for performing the test, including the design and interpretation of results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOx1kKxVF6LVg90H21EOLACvtfcHk0ljbOzZwUJ6C5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGhtr0%253D&md5=8c4804f0b78e09c6c6609859428a39bf</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0027-5107%2800%2900064-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0027-5107%252800%252900064-6%26sid%3Dliteratum%253Aachs%26aulast%3DMortelmans%26aufirst%3DK.%26aulast%3DZeiger%26aufirst%3DE.%26atitle%3DThe%2520Ames%2520Salmonella%252Fmicrosome%2520mutagenicity%2520assay%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2000%26volume%3D455%26spage%3D29%26epage%3D60%26doi%3D10.1016%2FS0027-5107%2800%2900064-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Pallavi Sharma, M. R. Ranga Prabhath, Derek Wong, Maame Adjoa Ampem-Lassen, Shreesha V. Bhat, Luke Williams, <span class="NLM_string-name hlFld-ContribAuthor">Teresa G. Carvalho</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Biologically Active Heterospirocycles through Iterative 1,3-Dipolar Cycloaddition Pathways. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (1)
                                     , 1223-1230. <a href="https://doi.org/10.1021/acs.joc.0c02424" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02424%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBiologically%252BActive%252BHeterospirocycles%252Bthrough%252BIterative%252B1%25252C3-Dipolar%252BCycloaddition%252BPathways%26aulast%3DSharma%26aufirst%3DPallavi%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D13102020%26date%3D14122020%26volume%3D86%26issue%3D1%26spage%3D1223%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kaifeng Wang, Qiao Wu, Yuxia Liu, Lingjun Liu, Guang Chen, Yulin Li, <span class="NLM_string-name hlFld-ContribAuthor">Siwei Bi</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical Insights into Ester-Directed Reactions between Propiolates with 1,2-Benzisoxazoles by Au(I) Catalyst: [4 + 2]-Annulation versus Michael-Type Products. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (22)
                                     , 4061-4068. <a href="https://doi.org/10.1021/acs.organomet.0c00624" title="DOI URL">https://doi.org/10.1021/acs.organomet.0c00624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.0c00624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.0c00624%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DTheoretical%252BInsights%252Binto%252BEster-Directed%252BReactions%252Bbetween%252BPropiolates%252Bwith%252B1%25252C2-Benzisoxazoles%252Bby%252BAu%252528I%252529%252BCatalyst%25253A%252B%25255B4%252B%25252B%252B2%25255D-Annulation%252Bversus%252BMichael-Type%252BProducts%26aulast%3DWang%26aufirst%3DKaifeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21092020%26date%3D12112020%26volume%3D39%26issue%3D22%26spage%3D4061%26epage%3D4068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gregory S. Basarab, Peter Doig, Charles J. Eyermann, Vincent Galullo, Gunther Kern, Amy Kimzey, Amy Kutschke, Marshall Morningstar, Virna Schuck, Karthick Vishwanathan, Fei Zhou, Madhusudhan Gowravaram, <span class="NLM_string-name hlFld-ContribAuthor">Sheila Hauck</span>. </span><span class="cited-content_cbyCitation_article-title">Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11882-11901. <a href="https://doi.org/10.1021/acs.jmedchem.0c01100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibacterial%252BSpiropyrimidinetriones%252Bwith%252BN-Linked%252BAzole%252BSubstituents%252Bon%252Ba%252BBenzisoxazole%252BScaffold%252BTargeting%252BDNA%252BGyrase%26aulast%3DBasarab%26aufirst%3DGregory%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02072020%26date%3D02102020%26date%3D11092020%26volume%3D63%26issue%3D20%26spage%3D11882%26epage%3D11901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patricia A. Bradford, Alita A. Miller, John O’Donnell, <span class="NLM_string-name hlFld-ContribAuthor">John P. Mueller</span>. </span><span class="cited-content_cbyCitation_article-title">Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (6)
                                     , 1332-1345. <a href="https://doi.org/10.1021/acsinfecdis.0c00021" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00021%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DZoliflodacin%25253A%252BAn%252BOral%252BSpiropyrimidinetrione%252BAntibiotic%252Bfor%252Bthe%252BTreatment%252Bof%252BNeisseria%252Bgonorrheae%25252C%252BIncluding%252BMulti-Drug-Resistant%252BIsolates%26aulast%3DBradford%26aufirst%3DPatricia%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15012020%26date%3D12052020%26date%3D24042020%26volume%3D6%26issue%3D6%26spage%3D1332%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuemeng Chen, Xue Xiao, Haotian Sun, Yue Li, Haolin Cao, Xuemei Zhang, Shengyong Yang, <span class="NLM_string-name hlFld-ContribAuthor">Zhong Lian</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Catalyzed Transformation of Sulfonates via S–O Bond Cleavage: Synthesis of Alkyl Aryl Ether and Diaryl Ether. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (22)
                                     , 8879-8883. <a href="https://doi.org/10.1021/acs.orglett.9b02858" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02858%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransition-Metal-Catalyzed%252BTransformation%252Bof%252BSulfonates%252Bvia%252BS%2525E2%252580%252593O%252BBond%252BCleavage%25253A%252BSynthesis%252Bof%252BAlkyl%252BAryl%252BEther%252Band%252BDiaryl%252BEther%26aulast%3DChen%26aufirst%3DXuemeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15082019%26date%3D01112019%26volume%3D21%26issue%3D22%26spage%3D8879%26epage%3D8883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chenghui Shi, Yinyong Zhang, Ting Wang, Wenchao Lu, Shuhua Zhang, Bin Guo, Qian Chen, Cheng Luo, Xianli Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Yushe Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2950-2973. <a href="https://doi.org/10.1021/acs.jmedchem.8b01750" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01750%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BDNA%252BGyrase-Inhibiting%252BSpiropyrimidinetriones%252Bas%252BPotent%252BAntibiotics%252Bfor%252BTreatment%252Bof%252BInfections%252BCaused%252Bby%252BMultidrug-Resistant%252BGram-Positive%252BBacteria%26aulast%3DShi%26aufirst%3DChenghui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D11112018%26date%3D06032019%26date%3D30012019%26volume%3D62%26issue%3D6%26spage%3D2950%26epage%3D2973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yueqin Xie, Chengrong Lu, Bei Zhao, Qianyu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yingming Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Cycloaddition of Aziridine with CO2/CS2 Catalyzed by Amidato Divalent Lanthanide Complexes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (4)
                                     , 1951-1958. <a href="https://doi.org/10.1021/acs.joc.8b02924" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02924%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCycloaddition%252Bof%252BAziridine%252Bwith%252BCO2%25252FCS2%252BCatalyzed%252Bby%252BAmidato%252BDivalent%252BLanthanide%252BComplexes%26aulast%3DXie%26aufirst%3DYueqin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D16112018%26date%3D31012019%26date%3D16012019%26volume%3D84%26issue%3D4%26spage%3D1951%26epage%3D1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yashwant
Bhaskar Pandit, Rajkumar Lalji Sahani, <span class="NLM_string-name hlFld-ContribAuthor">Rai-Shung Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Gold-Catalyzed Michael-Type Reactions and [4 + 2]-Annulations between Propiolates and 1,2-Benzisoxazoles with Ester-Directed Chemoselectivity. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (21)
                                     , 6655-6658. <a href="https://doi.org/10.1021/acs.orglett.8b02663" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02663%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DGold-Catalyzed%252BMichael-Type%252BReactions%252Band%252B%25255B4%252B%25252B%252B2%25255D-Annulations%252Bbetween%252BPropiolates%252Band%252B1%25252C2-Benzisoxazoles%252Bwith%252BEster-Directed%252BChemoselectivity%26aulast%3DPandit%26aufirst%3DYashwant%2BBhaskar%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21082018%26date%3D25102018%26volume%3D20%26issue%3D21%26spage%3D6655%26epage%3D6658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hong-Wu Zhao, Ning-Ning Feng, Jia-Ming Guo, Juan Du, Wan-Qiu Ding, Li-Ru Wang, <span class="NLM_string-name hlFld-ContribAuthor">Xiu-Qing Song</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective and Enantioselective Synthesis of Barbiturate-Fused Spirotetrahydroquinolines via Chiral Palladium(0)/Ligand Complex Catalyzed [4 + 2] Cycloaddition of Vinyl Benzoxazinanones with Barbiturate-Based Olefins. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9291-9299. <a href="https://doi.org/10.1021/acs.joc.8b01268" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01268%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiastereoselective%252Band%252BEnantioselective%252BSynthesis%252Bof%252BBarbiturate-Fused%252BSpirotetrahydroquinolines%252Bvia%252BChiral%252BPalladium%2525280%252529%25252FLigand%252BComplex%252BCatalyzed%252B%25255B4%252B%25252B%252B2%25255D%252BCycloaddition%252Bof%252BVinyl%252BBenzoxazinanones%252Bwith%252BBarbiturate-Based%252BOlefins%26aulast%3DZhao%26aufirst%3DHong-Wu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17052018%26date%3D25072018%26date%3D18072018%26volume%3D83%26issue%3D16%26spage%3D9291%26epage%3D9299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aleksey
I. Gerasyuto, Michael A. Arnold, Jiashi Wang, Guangming Chen, Xiaoyan Zhang, Sean Smith, Matthew G. Woll, John Baird, Nanjing Zhang, Neil G. Almstead, Jana Narasimhan, Srinivasa Peddi, Melissa Dumble, Josephine Sheedy, Marla Weetall, Arthur A. Branstrom, J. V. N. Prasad, <span class="NLM_string-name hlFld-ContribAuthor">Gary M. Karp</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4456-4475. <a href="https://doi.org/10.1021/acs.jmedchem.8b00114" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BIndolyl-Containing%252B4-Hydroxy-2-Pyridone%252BType%252BII%252BDNA%252BTopoisomerase%252BInhibitors%252BActive%252Bagainst%252BMultidrug%252BResistant%252BGram-negative%252BBacteria%26aulast%3DGerasyuto%26aufirst%3DAleksey%2BI.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22012018%26date%3D14052018%26date%3D04052018%26volume%3D61%26issue%3D10%26spage%3D4456%26epage%3D4475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Remani Vasudevan  Sumesh</span>, <span class="hlFld-ContribAuthor ">Muthumani  Muthu</span>, <span class="hlFld-ContribAuthor ">Abdulrahman I.  Almansour</span>, <span class="hlFld-ContribAuthor ">Raju  Suresh Kumar</span>, <span class="hlFld-ContribAuthor ">Natarajan  Arumugam</span>, <span class="hlFld-ContribAuthor ">S.  Athimoolam</span>, <span class="hlFld-ContribAuthor ">E. Arockia  Jeya Yasmi Prabha</span>, and <span class="hlFld-ContribAuthor ">Raju Ranjith  Kumar</span>  . </span><span class="cited-content_cbyCitation_article-title">Multicomponent Dipolar Cycloaddition Strategy: Combinatorial Synthesis of Novel Spiro-Tethered Pyrazolo[3,4-b]quinoline Hybrid Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2016,</strong> <em>18 </em>
                                    (5)
                                     , 262-270. <a href="https://doi.org/10.1021/acscombsci.6b00003" title="DOI URL">https://doi.org/10.1021/acscombsci.6b00003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.6b00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.6b00003%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DMulticomponent%252BDipolar%252BCycloaddition%252BStrategy%25253A%252BCombinatorial%252BSynthesis%252Bof%252BNovel%252BSpiro-Tethered%252BPyrazolo%25255B3%25252C4-b%25255Dquinoline%252BHybrid%252BHeterocycles%26aulast%3DSumesh%26aufirst%3DRemani%2BVasudevan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13012016%26date%3D20032016%26date%3D08042016%26date%3D09052016%26date%3D30032016%26volume%3D18%26issue%3D5%26spage%3D262%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songtao  Liu</span>, <span class="hlFld-ContribAuthor ">Pei  Shao</span>, <span class="hlFld-ContribAuthor ">Yanli  Li</span>, <span class="hlFld-ContribAuthor ">Donghao  Wang</span>, <span class="hlFld-ContribAuthor ">Deshan  Hou</span>, <span class="hlFld-ContribAuthor ">Chaofan  Qu</span>, <span class="hlFld-ContribAuthor ">Xixi  Song</span>, <span class="hlFld-ContribAuthor ">Xuebin  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of spirobarbiturate-dihydrofurans and dihydrofuro[2,3-d]pyrimidines via one-pot cascade reaction of barbiturate-based olefins and ethyl acetoacetate. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>79 </em>, 131859. <a href="https://doi.org/10.1016/j.tet.2020.131859" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131859%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bspirobarbiturate-dihydrofurans%252Band%252Bdihydrofuro%25255B2%25252C3-d%25255Dpyrimidines%252Bvia%252Bone-pot%252Bcascade%252Breaction%252Bof%252Bbarbiturate-based%252Bolefins%252Band%252Bethyl%252Bacetoacetate%26aulast%3DLiu%26aufirst%3DSongtao%26date%3D2021%26volume%3D79%26spage%3D131859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satish N.  Dighe</span>, <span class="hlFld-ContribAuthor ">Trudi A.  Collet</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in DNA gyrase-targeted antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112326. <a href="https://doi.org/10.1016/j.ejmech.2020.112326" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112326%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252BDNA%252Bgyrase-targeted%252Bantimicrobial%252Bagents%26aulast%3DDighe%26aufirst%3DSatish%2BN.%26date%3D2020%26volume%3D199%26spage%3D112326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikhailo V.  Slivka</span>, <span class="hlFld-ContribAuthor ">Maksym M.  Fizer</span>, <span class="hlFld-ContribAuthor ">Nataliya I.  Korol</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 6-6 Systems With One Bridgehead Nitrogen Atom: One Extra Heteroatom 1:0. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14917-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14917-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14917-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14917-0%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B6-6%252BSystems%252BWith%252BOne%252BBridgehead%252BNitrogen%252BAtom%25253A%252BOne%252BExtra%252BHeteroatom%252B1%25253A0%26aulast%3DSlivka%26aufirst%3DMikhailo%2BV.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minglei  Yuan</span>, <span class="hlFld-ContribAuthor ">Ifenna I.  Mbaezue</span>, <span class="hlFld-ContribAuthor ">Zhi  Zhou</span>, <span class="hlFld-ContribAuthor ">Filip  Topic</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>. </span><span class="cited-content_cbyCitation_article-title">P
              -Chiral,
              N
              -phosphoryl sulfonamide Brønsted acids with an intramolecular hydrogen bond interaction that modulates organocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (38)
                                     , 8690-8694. <a href="https://doi.org/10.1039/C9OB01774G" title="DOI URL">https://doi.org/10.1039/C9OB01774G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01774G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01774G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DP%252B-Chiral%25252C%252BN%252B-phosphoryl%252Bsulfonamide%252BBr%2525C3%2525B8nsted%252Bacids%252Bwith%252Ban%252Bintramolecular%252Bhydrogen%252Bbond%252Binteraction%252Bthat%252Bmodulates%252Borganocatalysis%26aulast%3DYuan%26aufirst%3DMinglei%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D38%26spage%3D8690%26epage%3D8694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jere K.  Mannisto</span>, <span class="hlFld-ContribAuthor ">Aleksi  Sahari</span>, <span class="hlFld-ContribAuthor ">Kalle  Lagerblom</span>, <span class="hlFld-ContribAuthor ">Teemu  Niemi</span>, <span class="hlFld-ContribAuthor ">Martin  Nieger</span>, <span class="hlFld-ContribAuthor ">Gábor  Sztanó</span>, <span class="hlFld-ContribAuthor ">Timo  Repo</span>. </span><span class="cited-content_cbyCitation_article-title">One‐Step Synthesis of 3,4‐Disubstituted 2‐Oxazolidinones by Base‐Catalyzed CO
              2
              Fixation and Aza‐Michael Addition. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (44)
                                     , 10284-10289. <a href="https://doi.org/10.1002/chem.201902451" title="DOI URL">https://doi.org/10.1002/chem.201902451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201902451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201902451%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DOne%2525E2%252580%252590Step%252BSynthesis%252Bof%252B3%25252C4%2525E2%252580%252590Disubstituted%252B2%2525E2%252580%252590Oxazolidinones%252Bby%252BBase%2525E2%252580%252590Catalyzed%252BCO%252B2%252BFixation%252Band%252BAza%2525E2%252580%252590Michael%252BAddition%26aulast%3DMannisto%26aufirst%3DJere%2BK.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D44%26spage%3D10284%26epage%3D10289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  O’Donnell</span>, <span class="hlFld-ContribAuthor ">Ken  Lawrence</span>, <span class="hlFld-ContribAuthor ">Karthick  Vishwanathan</span>, <span class="hlFld-ContribAuthor ">Vinayak  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">John P.  Mueller</span>. </span><span class="cited-content_cbyCitation_article-title">Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/AAC.01808-18" title="DOI URL">https://doi.org/10.1128/AAC.01808-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01808-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01808-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DSingle-Dose%252BPharmacokinetics%25252C%252BExcretion%25252C%252Band%252BMetabolism%252Bof%252BZoliflodacin%25252C%252Ba%252BNovel%252BSpiropyrimidinetrione%252BAntibiotic%25252C%252Bin%252BHealthy%252BVolunteers%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJohn%26date%3D2019%26volume%3D63%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunqi  Chen</span>, <span class="hlFld-ContribAuthor ">Lubin  Xu</span>, <span class="hlFld-ContribAuthor ">Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai-Shuai  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient construction of tetrahydroquinolines
              via
              fluorinated alcohol mediated cascade [1,5]-hydride transfer/cyclization. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (39)
                                     , 7109-7114. <a href="https://doi.org/10.1039/C8OB02012D" title="DOI URL">https://doi.org/10.1039/C8OB02012D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02012D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02012D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEfficient%252Bconstruction%252Bof%252Btetrahydroquinolines%252Bvia%252Bfluorinated%252Balcohol%252Bmediated%252Bcascade%252B%25255B1%25252C5%25255D-hydride%252Btransfer%25252Fcyclization%26aulast%3DChen%26aufirst%3DChunqi%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D39%26spage%3D7109%26epage%3D7114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tabassum  Khan</span>, <span class="hlFld-ContribAuthor ">Kaksha  Sankhe</span>, <span class="hlFld-ContribAuthor ">Vasanti  Suvarna</span>, <span class="hlFld-ContribAuthor ">Atul  Sherje</span>, <span class="hlFld-ContribAuthor ">Kavitkumar  Patel</span>, <span class="hlFld-ContribAuthor ">Bhushan  Dravyakar</span>. </span><span class="cited-content_cbyCitation_article-title">DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>103 </em>, 923-938. <a href="https://doi.org/10.1016/j.biopha.2018.04.021" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.04.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.04.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DDNA%252Bgyrase%252Binhibitors%25253A%252BProgress%252Band%252Bsynthesis%252Bof%252Bpotent%252Bcompounds%252Bas%252Bantibacterial%252Bagents%26aulast%3DKhan%26aufirst%3DTabassum%26date%3D2018%26volume%3D103%26spage%3D923%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Lal  Badshah</span>, <span class="hlFld-ContribAuthor ">Asad  Ullah</span>. </span><span class="cited-content_cbyCitation_article-title">New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 393-400. <a href="https://doi.org/10.1016/j.ejmech.2018.04.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bdevelopments%252Bin%252Bnon-quinolone-based%252Bantibiotics%252Bfor%252Bthe%252Binhibiton%252Bof%252Bbacterial%252Bgyrase%252Band%252Btopoisomerase%252BIV%26aulast%3DBadshah%26aufirst%3DSyed%2BLal%26date%3D2018%26volume%3D152%26spage%3D393%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju Suresh  Kumar</span>, <span class="hlFld-ContribAuthor ">Paulrayer  Antonisamy</span>, <span class="hlFld-ContribAuthor ">Abdulrahman I.  Almansour</span>, <span class="hlFld-ContribAuthor ">Natarajan  Arumugam</span>, <span class="hlFld-ContribAuthor ">Govindasami  Periyasami</span>, <span class="hlFld-ContribAuthor ">Mohammad  Altaf</span>, <span class="hlFld-ContribAuthor ">Ha-Rim  Kim</span>, <span class="hlFld-ContribAuthor ">Kang-Beom  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized spirooxindole-indolizine hybrids: Stereoselective green synthesis and evaluation of anti-inflammatory effect involving TNF-α and nitrite inhibition. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 417-423. <a href="https://doi.org/10.1016/j.ejmech.2018.04.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFunctionalized%252Bspirooxindole-indolizine%252Bhybrids%25253A%252BStereoselective%252Bgreen%252Bsynthesis%252Band%252Bevaluation%252Bof%252Banti-inflammatory%252Beffect%252Binvolving%252BTNF-%2525CE%2525B1%252Band%252Bnitrite%252Binhibition%26aulast%3DKumar%26aufirst%3DRaju%2BSuresh%26date%3D2018%26volume%3D152%26spage%3D417%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asher M.  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Jitendra A.  Sattigeri</span>, <span class="hlFld-ContribAuthor ">Kalim  Javed</span>, <span class="hlFld-ContribAuthor ">Syed  Shafi</span>, <span class="hlFld-ContribAuthor ">M.  Shamim</span>, <span class="hlFld-ContribAuthor ">Smita  Singhal</span>, <span class="hlFld-ContribAuthor ">Zubbair M.  Malik</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (7)
                                     , 1198-1206. <a href="https://doi.org/10.1016/j.bmcl.2018.02.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.02.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.02.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bspiropyrimidinetriones%252Boxazolidinone%252Bderivatives%252Bas%252Bantibacterial%252Bagents%26aulast%3DSiddiqui%26aufirst%3DAsher%2BM.%26date%3D2018%26volume%3D28%26issue%3D7%26spage%3D1198%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fateh V  Singh</span>, <span class="hlFld-ContribAuthor ">Priyanka B  Kole</span>, <span class="hlFld-ContribAuthor ">Saeesh R  Mangaonkar</span>, <span class="hlFld-ContribAuthor ">Samata E  Shetgaonkar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of spirocyclic scaffolds using hypervalent iodine reagents. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 1778-1805. <a href="https://doi.org/10.3762/bjoc.14.152" title="DOI URL">https://doi.org/10.3762/bjoc.14.152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.152%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bspirocyclic%252Bscaffolds%252Busing%252Bhypervalent%252Biodine%252Breagents%26aulast%3DSingh%26aufirst%3DFateh%2BV%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D1778%26epage%3D1805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Reiche</span>, <span class="hlFld-ContribAuthor ">Digby F.  Warner</span>, <span class="hlFld-ContribAuthor ">Valerie  Mizrahi</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2017,</strong> <em>4 </em><a href="https://doi.org/10.3389/fmolb.2017.00075" title="DOI URL">https://doi.org/10.3389/fmolb.2017.00075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2017.00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2017.00075%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DTargeting%252BDNA%252BReplication%252Band%252BRepair%252Bfor%252Bthe%252BDevelopment%252Bof%252BNovel%252BTherapeutics%252Bagainst%252BTuberculosis%26aulast%3DReiche%26aufirst%3DMichael%2BA.%26date%3D2017%26date%3D2017%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karen  Bush</span>, <span class="hlFld-ContribAuthor ">Malcolm G. P.  Page</span>. </span><span class="cited-content_cbyCitation_article-title">What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacokinetics and Pharmacodynamics</span><span> <strong>2017,</strong> <em>44 </em>
                                    (2)
                                     , 113-132. <a href="https://doi.org/10.1007/s10928-017-9506-4" title="DOI URL">https://doi.org/10.1007/s10928-017-9506-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10928-017-9506-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10928-017-9506-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacokinetics%2520and%2520Pharmacodynamics%26atitle%3DWhat%252Bwe%252Bmay%252Bexpect%252Bfrom%252Bnovel%252Bantibacterial%252Bagents%252Bin%252Bthe%252Bpipeline%252Bwith%252Brespect%252Bto%252Bresistance%252Band%252Bpharmacodynamic%252Bprinciples%26aulast%3DBush%26aufirst%3DKaren%26date%3D2017%26date%3D2017%26volume%3D44%26issue%3D2%26spage%3D113%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan J.  Weyand</span>. </span><span class="cited-content_cbyCitation_article-title">Neisseria models of infection and persistence in the upper respiratory tract. </span><span class="cited-content_cbyCitation_journal-name">Pathogens and Disease</span><span> <strong>2017,</strong> <em>75 </em>
                                    (3)
                                     <a href="https://doi.org/10.1093/femspd/ftx031" title="DOI URL">https://doi.org/10.1093/femspd/ftx031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/femspd/ftx031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ffemspd%2Fftx031%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%2520and%2520Disease%26atitle%3DNeisseria%252Bmodels%252Bof%252Binfection%252Band%252Bpersistence%252Bin%252Bthe%252Bupper%252Brespiratory%252Btract%26aulast%3DWeyand%26aufirst%3DNathan%2BJ.%26date%3D2017%26date%3D2017%26volume%3D75%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Modesto  de Candia</span>, <span class="hlFld-ContribAuthor ">Claudia  Altamura</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Manuel  Nuzzolese</span>, <span class="hlFld-ContribAuthor ">Danila  De Vito</span>, <span class="hlFld-ContribAuthor ">Leonid G.  Voskressensky</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Varlamov</span>, <span class="hlFld-ContribAuthor ">Cosimo D.  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Physicochemical properties and antimicrobial activity of new spirocyclic thieno[2,3-d]pyrimidin-4(3H)-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (3)
                                     , 357-363. <a href="https://doi.org/10.1007/s10593-017-2057-1" title="DOI URL">https://doi.org/10.1007/s10593-017-2057-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-2057-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-2057-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DPhysicochemical%252Bproperties%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bnew%252Bspirocyclic%252Bthieno%25255B2%25252C3-d%25255Dpyrimidin-4%2525283H%252529-one%252Bderivatives%26aulast%3Dde%2BCandia%26aufirst%3DModesto%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D3%26spage%3D357%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Guo</span>, <span class="hlFld-ContribAuthor ">Camil  Joubran</span>, <span class="hlFld-ContribAuthor ">Ricardo A.  Luzietti</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Basarab</span>, <span class="hlFld-ContribAuthor ">Scott W.  Grimm</span>, <span class="hlFld-ContribAuthor ">Karthick  Vishwanathan</span>. </span><span class="cited-content_cbyCitation_article-title">Absorption, distribution, metabolism and elimination of 14C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2017,</strong> <em>47 </em>
                                    (1)
                                     , 31-49. <a href="https://doi.org/10.3109/00498254.2016.1156186" title="DOI URL">https://doi.org/10.3109/00498254.2016.1156186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00498254.2016.1156186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00498254.2016.1156186%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DAbsorption%25252C%252Bdistribution%25252C%252Bmetabolism%252Band%252Belimination%252Bof%252B14C-ETX0914%25252C%252Ba%252Bnovel%252Binhibitor%252Bof%252Bbacterial%252Btype-II%252Btopoisomerases%252Bin%252Brodents%26aulast%3DGuo%26aufirst%3DJian%26date%3D2017%26date%3D2016%26volume%3D47%26issue%3D1%26spage%3D31%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory S.  Basarab</span>. </span><span class="cited-content_cbyCitation_article-title">Four Ways to Skin a Cat: Inhibition of Bacterial Topoisomerases Leading to the Clinic. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 165-188. <a href="https://doi.org/10.1007/7355_2017_7" title="DOI URL">https://doi.org/10.1007/7355_2017_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_7%26sid%3Dliteratum%253Aachs%26atitle%3DFour%252BWays%252Bto%252BSkin%252Ba%252BCat%25253A%252BInhibition%252Bof%252BBacterial%252BTopoisomerases%252BLeading%252Bto%252Bthe%252BClinic%26aulast%3DBasarab%26aufirst%3DGregory%2BS.%26date%3D2017%26date%3D2017%26spage%3D165%26epage%3D188%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAntibacterials%26aulast%3DFisher%26aufirst%3DJed%2BF.%26date%3D2018%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.G.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">New Drugs and Emerging Leads in Antibacterial Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 682-702. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12409-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12409-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12409-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12409-6%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BDrugs%252Band%252BEmerging%252BLeads%252Bin%252BAntibacterial%252BDrug%252BDiscovery%26aulast%3DBrown%26aufirst%3DD.G.%26date%3D2017%26spage%3D682%26epage%3D702%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Zhu</span>, <span class="hlFld-ContribAuthor ">Chunqi  Chen</span>, <span class="hlFld-ContribAuthor ">Mingyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Liping  Yu</span>, <span class="hlFld-ContribAuthor ">Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of the tetrahydroquinoline spiro skeleton
              via
              cascade [1,5]-hydride transfer-involved C(sp
              3
              )–H functionalization “on water”. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2017,</strong> <em>19 </em>
                                    (23)
                                     , 5653-5658. <a href="https://doi.org/10.1039/C7GC02353G" title="DOI URL">https://doi.org/10.1039/C7GC02353G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7GC02353G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7GC02353G%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DConstruction%252Bof%252Bthe%252Btetrahydroquinoline%252Bspiro%252Bskeleton%252Bvia%252Bcascade%252B%25255B1%25252C5%25255D-hydride%252Btransfer-involved%252BC%252528sp%252B3%252B%252529%2525E2%252580%252593H%252Bfunctionalization%252B%2525E2%252580%25259Con%252Bwater%2525E2%252580%25259D%26aulast%3DZhu%26aufirst%3DShuai%26date%3D2017%26date%3D2017%26volume%3D19%26issue%3D23%26spage%3D5653%26epage%3D5658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">C. S.  Shantharam</span>, <span class="hlFld-ContribAuthor ">M. B.  Sridhara</span>, <span class="hlFld-ContribAuthor ">H. M.  Manukumar</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Benzisoxazole: a privileged scaffold for medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2023-2039. <a href="https://doi.org/10.1039/C7MD00449D" title="DOI URL">https://doi.org/10.1039/C7MD00449D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00449D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00449D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DBenzisoxazole%25253A%252Ba%252Bprivileged%252Bscaffold%252Bfor%252Bmedicinal%252Bchemistry%26aulast%3DRakesh%26aufirst%3DK.%2BP.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D11%26spage%3D2023%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Jun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>. </span><span class="cited-content_cbyCitation_article-title">The utilization of spirocyclic scaffolds in novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (9)
                                     , 831-834. <a href="https://doi.org/10.1080/17460441.2016.1195367" title="DOI URL">https://doi.org/10.1080/17460441.2016.1195367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1195367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1195367%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Butilization%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYa-Jun%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D9%26spage%3D831%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan  Laponogov</span>, <span class="hlFld-ContribAuthor ">Xiao-Su  Pan</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Veselkov</span>, <span class="hlFld-ContribAuthor ">Ryan T.  Cirz</span>, <span class="hlFld-ContribAuthor ">Allan  Wagman</span>, <span class="hlFld-ContribAuthor ">Heinz E.  Moser</span>, <span class="hlFld-ContribAuthor ">L. Mark  Fisher</span>, <span class="hlFld-ContribAuthor ">Mark R.  Sanderson</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the active site of the
              Streptococcus pneumoniae
              topoisomerase IV–DNA cleavage complex with novel 7,8-bridged fluoroquinolones. </span><span class="cited-content_cbyCitation_journal-name">Open Biology</span><span> <strong>2016,</strong> <em>6 </em>
                                    (9)
                                     , 160157. <a href="https://doi.org/10.1098/rsob.160157" title="DOI URL">https://doi.org/10.1098/rsob.160157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsob.160157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsob.160157%26sid%3Dliteratum%253Aachs%26jtitle%3DOpen%2520Biology%26atitle%3DExploring%252Bthe%252Bactive%252Bsite%252Bof%252Bthe%252BStreptococcus%252Bpneumoniae%252Btopoisomerase%252BIV%2525E2%252580%252593DNA%252Bcleavage%252Bcomplex%252Bwith%252Bnovel%252B7%25252C8-bridged%252Bfluoroquinolones%26aulast%3DLaponogov%26aufirst%3DIvan%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D9%26spage%3D160157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teemu  Niemi</span>, <span class="hlFld-ContribAuthor ">Jesus E.  Perea-Buceta</span>, <span class="hlFld-ContribAuthor ">Israel  Fernández</span>, <span class="hlFld-ContribAuthor ">Otto-Matti  Hiltunen</span>, <span class="hlFld-ContribAuthor ">Vili  Salo</span>, <span class="hlFld-ContribAuthor ">Sari  Rautiainen</span>, <span class="hlFld-ContribAuthor ">Minna T.  Räisänen</span>, <span class="hlFld-ContribAuthor ">Timo  Repo</span>. </span><span class="cited-content_cbyCitation_article-title">A One-Pot Synthesis of
              N
              -Aryl-2-Oxazolidinones and Cyclic Urethanes by the Lewis Base Catalyzed Fixation of Carbon Dioxide into Anilines and Bromoalkanes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (30)
                                     , 10355-10359. <a href="https://doi.org/10.1002/chem.201602338" title="DOI URL">https://doi.org/10.1002/chem.201602338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201602338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201602338%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BOne-Pot%252BSynthesis%252Bof%252BN%252B-Aryl-2-Oxazolidinones%252Band%252BCyclic%252BUrethanes%252Bby%252Bthe%252BLewis%252BBase%252BCatalyzed%252BFixation%252Bof%252BCarbon%252BDioxide%252Binto%252BAnilines%252Band%252BBromoalkanes%26aulast%3DNiemi%26aufirst%3DTeemu%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D30%26spage%3D10355%26epage%3D10359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Tian</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Basarab</span>, <span class="hlFld-ContribAuthor ">Nidhal  Selmi</span>, <span class="hlFld-ContribAuthor ">Thierry  Kogej</span>, <span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Matthew  Clark</span>, <span class="hlFld-ContribAuthor ">Robert A.  Goodnow Jr.</span>. </span><span class="cited-content_cbyCitation_article-title">Development and design of the tertiary amino effect reaction for DNA-encoded library synthesis. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (7)
                                     , 1316-1322. <a href="https://doi.org/10.1039/C6MD00088F" title="DOI URL">https://doi.org/10.1039/C6MD00088F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00088F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00088F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Band%252Bdesign%252Bof%252Bthe%252Btertiary%252Bamino%252Beffect%252Breaction%252Bfor%252BDNA-encoded%252Blibrary%252Bsynthesis%26aulast%3DTian%26aufirst%3DXia%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D7%26spage%3D1316%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jed F.  Fisher</span>, <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Endless resistance. Endless antibiotics?. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 37-49. <a href="https://doi.org/10.1039/C5MD00394F" title="DOI URL">https://doi.org/10.1039/C5MD00394F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00394F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00394F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DEndless%252Bresistance.%252BEndless%252Bantibiotics%25253F%26aulast%3DFisher%26aufirst%3DJed%2BF.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D37%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franca M.  Cordero</span>, <span class="hlFld-ContribAuthor ">Donatella  Giomi</span>, <span class="hlFld-ContribAuthor ">Luisa  Lascialfari</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems With O and N Atoms. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 361-390. <a href="https://doi.org/10.1016/B978-0-08-100755-6.00011-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-100755-6.00011-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100755-6.00011-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100755-6.00011-9%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%252BWith%252BO%252Band%252BN%252BAtoms%26aulast%3DCordero%26aufirst%3DFranca%2BM.%26date%3D2016%26spage%3D361%26epage%3D390%26pub%3DElsevier%26date%3D2016%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pan F.  Chan</span>, <span class="hlFld-ContribAuthor ">Velupillai  Srikannathasan</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Huang</span>, <span class="hlFld-ContribAuthor ">Haifeng  Cui</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Fosberry</span>, <span class="hlFld-ContribAuthor ">Minghua  Gu</span>, <span class="hlFld-ContribAuthor ">Michael M.  Hann</span>, <span class="hlFld-ContribAuthor ">Martin  Hibbs</span>, <span class="hlFld-ContribAuthor ">Paul  Homes</span>, <span class="hlFld-ContribAuthor ">Karen  Ingraham</span>, <span class="hlFld-ContribAuthor ">Jason  Pizzollo</span>, <span class="hlFld-ContribAuthor ">Carol  Shen</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Shillings</span>, <span class="hlFld-ContribAuthor ">Claus E.  Spitzfaden</span>, <span class="hlFld-ContribAuthor ">Robert  Tanner</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Theobald</span>, <span class="hlFld-ContribAuthor ">Robert A.  Stavenger</span>, <span class="hlFld-ContribAuthor ">Benjamin D.  Bax</span>, <span class="hlFld-ContribAuthor ">Michael N.  Gwynn</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms10048" title="DOI URL">https://doi.org/10.1038/ncomms10048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms10048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms10048%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructural%252Bbasis%252Bof%252BDNA%252Bgyrase%252Binhibition%252Bby%252Bantibacterial%252BQPT-1%25252C%252Banticancer%252Bdrug%252Betoposide%252Band%252Bmoxifloxacin%26aulast%3DChan%26aufirst%3DPan%2BF.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antibacterial agents <b>1</b>–<b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of N-Linked Oxazolidinones and Imidazolidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, 80 °C, 2–16 h, 12–47%; (b) AcOH, H<sub>2</sub>O or EtOH, 6 N HCl, 120 °C, 1 h, 15–72%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Alternative Synthetic Scheme to N-Linked Oxazolidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethylene glycol, <i>p</i>-TsOH, refluxing toluene, 78% yield; (b) <i>n</i>-BuLi, −70 °C, THF, DMF quench, 93% yield; (c) NH<sub>2</sub>OH, EtOH, rt, 24 h, 80% yield; (d) NCS, DMF, rt, 4 h, 76% yield; (e) excess amine, DMF, rt, 1–3 h; (f) NaO<i>t</i>-Bu or Cs<sub>2</sub>CO<sub>3</sub>, rt, 2 steps, 59–93%; (g) CDI, DIEA, DMF, 70 °C, 2–3 h; (h) HCl, dioxane or THF, water, 70 °C, 2 steps: 75–99%; (i) K<sub>2</sub>CO<sub>3</sub> or DIEA, CH<sub>3</sub>CN, water, 80 °C, 4–5 h, 73–98%; (j) AcOH, water 120 °C, 1h, 26–81%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>1u</b> (data in the Cambridge Crystallographic Data Centre: CCDC 1025296). Left: Ortep representation with MeOH solvate removed. Right: side view (with hydrogen atoms also removed) showing morpholine chair conformation and perpendicular orientation of oxazolidinone methyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Correlation between <i>E. coli</i> DNA gyrase inhibitory potency and antibacterial activity: (A) compounds within <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>; (B) select compounds with a narrow log <i>D</i> range (1.5–1.9).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/medium/jm-2015-00863k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response of <b>1t</b> (left) and <b>1u</b> (right) in a mouse neutropenic <i>S. aureus</i> thigh infection model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00863/20150807/images/large/jm-2015-00863k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00863&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Livermore, D. M.</span><span> </span><span class="NLM_article-title">Discovery research: the scientific challenge of finding new antibiotics</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1941</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span><span class="refDoi"> DOI: 10.1093/jac/dkr262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkr262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=21700626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1941-1944&author=D.+M.+Livermore&title=Discovery+research%3A+the+scientific+challenge+of+finding+new+antibiotics&doi=10.1093%2Fjac%2Fdkr262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery research: the scientific challenge of finding new antibiotics</span></div><div class="casAuthors">Livermore, David M.; Blaser, Martin; Carrs, Otto; Cassell, Gail; Fishman, Neil; Guidos, Robert; Levy, Stuart; Powers, John; Norrby, Ragnar; Tillotson, Glenn; Davies, Rick; Projan, Steven; Dawson, Mike; Monnet, Dominique; Keogh-Brown, Marcus; Hand, Kieran; Garner, Sarah; Findlay, David; Morel, Chantal; Wise, Richard; Bax, Richard; Burke, Frances; Chopra, Ian; Czaplewski, Lloyd; Finch, Roger; Livermore, David; Piddock, Laura J. V.; White, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1941-1944</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The dwindling supply of new antibiotics largely reflects regulatory and com. challenges, but also a failure of discovery.  In the 1990s the pharmaceutical industry abandoned its classical ways of seeking antibiotics and instead adopted a strategy that combined genomics with high-throughput screening of existing compd. libraries.  Too much emphasis was placed on identifying targets and mols. that bound to them, and too little emphasis was placed on the ability of these mols. to permeate bacteria, evade efflux and avoid mutational resistance; moreover, the compd. libraries were systematically biased against antibiotics.  The sorry result is that no antibiotic found by this strategy has yet entered clin. use and many major pharmaceutical companies have abandoned antibiotic discovery.  Although a raft of start-up companies-variously financed by venture capital, charity or public money-are now finding new antibiotic compds. (some of them very promising in vitro or in early trials), their development through Phase III depends on financial commitments from large pharmaceutical companies, where the discouraging regulatory environment and the poor likely return on investment remain paramount issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwO4njZRli1rVg90H21EOLACvtfcHk0lirIVZKlCc8Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLjL&md5=cf9e5b409fdb2d7a98f3e3b4c976ef05</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr262%26sid%3Dliteratum%253Aachs%26aulast%3DLivermore%26aufirst%3DD.%2BM.%26atitle%3DDiscovery%2520research%253A%2520the%2520scientific%2520challenge%2520of%2520finding%2520new%2520antibiotics%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1941%26epage%3D1944%26doi%3D10.1093%2Fjac%2Fdkr262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrs, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norrby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillotson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Projan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keogh-Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piddock, L. J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T.</span><span> </span><span class="NLM_article-title">The urgent need for new antibacterial agents</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1939</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span><span class="refDoi"> DOI: 10.1093/jac/dkr261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkr261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=21700627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1939-1940&author=R.+Wiseauthor=M.+Blaserauthor=O.+Carrsauthor=G.+Cassellauthor=N.+Fishmanauthor=R.+Guidosauthor=S.+Levyauthor=J.+Powersauthor=R.+Norrbyauthor=G.+Tillotsonauthor=R.+Daviesauthor=S.+Projanauthor=M.+Dawsonauthor=D.+Monnetauthor=M.+Keogh-Brownauthor=K.+Handauthor=S.+Garnerauthor=D.+Findlayauthor=C.+Morelauthor=R.+Wiseauthor=R.+Baxauthor=F.+Burkeauthor=I.+Chopraauthor=L.+Czaplewskiauthor=R.+Finchauthor=D.+Livermoreauthor=L.+J.+V.+Piddockauthor=T.+White&title=The+urgent+need+for+new+antibacterial+agents&doi=10.1093%2Fjac%2Fdkr261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The urgent need for new antibacterial agents</span></div><div class="casAuthors">Wise, Richard; Blaser, Martin; Carrs, Otto; Cassell, Gail; Fishman, Neil; Guidos, Robert; Levy, Stuart; Powers, John; Norrby, Ragnar; Tillotson, Glenn; Davies, Rick; Projan, Steven; Dawson, Mike; Monnet, Dominique; Keogh-Brown, Marcus; Hand, Kieran; Garner, Sarah; Findlay, David; Morel, Chantal; Wise, Richard; Bax, Richard; Burke, Frances; Chopra, Ian; Czaplewski, Lloyd; Finch, Roger; Livermore, David; Piddock, Laura J. V.; White, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1939-1940</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfUVMX8PqCsrVg90H21EOLACvtfcHk0lggrDY851aUUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVeitLfM&md5=22fd52867f58bbeb905b807f36084d24</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr261%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DR.%26aulast%3DBlaser%26aufirst%3DM.%26aulast%3DCarrs%26aufirst%3DO.%26aulast%3DCassell%26aufirst%3DG.%26aulast%3DFishman%26aufirst%3DN.%26aulast%3DGuidos%26aufirst%3DR.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DNorrby%26aufirst%3DR.%26aulast%3DTillotson%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DProjan%26aufirst%3DS.%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DMonnet%26aufirst%3DD.%26aulast%3DKeogh-Brown%26aufirst%3DM.%26aulast%3DHand%26aufirst%3DK.%26aulast%3DGarner%26aufirst%3DS.%26aulast%3DFindlay%26aufirst%3DD.%26aulast%3DMorel%26aufirst%3DC.%26aulast%3DWise%26aufirst%3DR.%26aulast%3DBax%26aufirst%3DR.%26aulast%3DBurke%26aufirst%3DF.%26aulast%3DChopra%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%26aulast%3DFinch%26aufirst%3DR.%26aulast%3DLivermore%26aufirst%3DD.%26aulast%3DPiddock%26aufirst%3DL.%2BJ.%2BV.%26aulast%3DWhite%26aufirst%3DT.%26atitle%3DThe%2520urgent%2520need%2520for%2520new%2520antibacterial%2520agents%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1939%26epage%3D1940%26doi%3D10.1093%2Fjac%2Fdkr261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Walsh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wencewicz, T. A.</span><span> </span><span class="NLM_article-title">Prospects for new antibiotics: a molecule-centered perspective</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1038/ja.2013.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fja.2013.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=23756684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1yitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=7-22&author=C.+T.+Walshauthor=T.+A.+Wencewicz&title=Prospects+for+new+antibiotics%3A+a+molecule-centered+perspective&doi=10.1038%2Fja.2013.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for new antibiotics: a molecule-centered perspective</span></div><div class="casAuthors">Walsh, Christopher T.; Wencewicz, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-22</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a continuous need for iterative cycles of antibiotic discovery and development to deal with the selection of resistant pathogens that emerge as therapeutic application of an antibiotic becomes widespread.  A short golden age of antibiotic discovery from nature followed by a subsequent golden half century of medicinal chem. optimization of existing mol. scaffolds emphasizes the need for new antibiotic mol. frameworks.  The authors bring a mol.-centered perspective to the questions of where will new scaffolds come from, when will chemogenetic approaches yield useful new antibiotics and what existing bacterial targets merit contemporary re-examn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8hr8BTzzMG7Vg90H21EOLACvtfcHk0lggrDY851aUUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1yitrc%253D&md5=fb100c0954679a78210c497daa4fab1d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fja.2013.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2013.49%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DWencewicz%26aufirst%3DT.%2BA.%26atitle%3DProspects%2520for%2520new%2520antibiotics%253A%2520a%2520molecule-centered%2520perspective%26jtitle%3DJ.%2520Antibiot.%26date%3D2014%26volume%3D67%26spage%3D7%26epage%3D22%26doi%3D10.1038%2Fja.2013.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Georgopapadakou, N. H.</span><span> </span><span class="NLM_article-title">Prospects for new antibacterials: can we do better?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1517/13543784.2014.847087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1517%2F13543784.2014.847087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=145-148&author=N.+H.+Georgopapadakou&title=Prospects+for+new+antibacterials%3A+can+we+do+better%3F&doi=10.1517%2F13543784.2014.847087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.847087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.847087%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgopapadakou%26aufirst%3DN.%2BH.%26atitle%3DProspects%2520for%2520new%2520antibacterials%253A%2520can%2520we%2520do%2520better%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D145%26epage%3D148%26doi%3D10.1517%2F13543784.2014.847087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Rice, L. B.</span><span> </span><span class="NLM_article-title">Progress and challenges in implementing the research on ESKAPE pathogens</span> <span class="citation_source-journal">Infect. Cont. Hosp. Ep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">S7</span><span class="NLM_x">–</span> <span class="NLM_lpage">S10</span><span class="refDoi"> DOI: 10.1086/655995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1086%2F655995" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=S7-S10&author=L.+B.+Rice&title=Progress+and+challenges+in+implementing+the+research+on+ESKAPE+pathogens&doi=10.1086%2F655995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1086%2F655995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F655995%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DL.%2BB.%26atitle%3DProgress%2520and%2520challenges%2520in%2520implementing%2520the%2520research%2520on%2520ESKAPE%2520pathogens%26jtitle%3DInfect.%2520Cont.%2520Hosp.%2520Ep.%26date%3D2010%26volume%3D31%26spage%3DS7%26epage%3DS10%26doi%3D10.1086%2F655995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Boucher, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, J.</span><span> </span><span class="NLM_article-title">Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1086/595011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1086%2F595011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=19035777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Krsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1-12&author=H.+W.+Boucherauthor=G.+H.+Talbotauthor=J.+S.+Bradleyauthor=J.+E.+Edwardsauthor=D.+Gilbertauthor=L.+B.+Riceauthor=M.+Scheldauthor=B.+Spellbergauthor=J.+Bartlett&title=Bad+bugs%2C+no+drugs%3A+no+ESKAPE%21+An+update+from+the+Infectious+Diseases+Society+of+America&doi=10.1086%2F595011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America</span></div><div class="casAuthors">Boucher Helen W; Talbot George H; Bradley John S; Edwards John E; Gilbert David; Rice Louis B; Scheld Michael; Spellberg Brad; Bartlett John</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Infectious Diseases Society of America (IDSA) continues to view with concern the lean pipeline for novel therapeutics to treat drug-resistant infections, especially those caused by gram-negative pathogens.  Infections now occur that are resistant to all current antibacterial options.  Although the IDSA is encouraged by the prospect of success for some agents currently in preclinical development, there is an urgent, immediate need for new agents with activity against these panresistant organisms.  There is no evidence that this need will be met in the foreseeable future.  Furthermore, we remain concerned that the infrastructure for discovering and developing new antibacterials continues to stagnate, thereby risking the future pipeline of antibacterial drugs.  The IDSA proposed solutions in its 2004 policy report, "Bad Bugs, No Drugs: As Antibiotic R&D Stagnates, a Public Health Crisis Brews," and recently issued a "Call to Action" to provide an update on the scope of the problem and the proposed solutions.  A primary objective of these periodic reports is to encourage a community and legislative response to establish greater financial parity between the antimicrobial development and the development of other drugs.  Although recent actions of the Food and Drug Administration and the 110th US Congress present a glimmer of hope, significant uncertainly remains.  Now, more than ever, it is essential to create a robust and sustainable antibacterial research and development infrastructure--one that can respond to current antibacterial resistance now and anticipate evolving resistance.  This challenge requires that industry, academia, the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control and Prevention, the US Department of Defense, and the new Biomedical Advanced Research and Development Authority at the Department of Health and Human Services work productively together.  This report provides an update on potentially effective antibacterial drugs in the late-stage development pipeline, in the hope of encouraging such collaborative action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKtuWEUmAWleWhZTslLrfffW6udTcc2eYJA9om0taEY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fit1Krsg%253D%253D&md5=a3f71406b891f90f4f0f77b5f1ebc4f8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1086%2F595011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F595011%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DH.%2BW.%26aulast%3DTalbot%26aufirst%3DG.%2BH.%26aulast%3DBradley%26aufirst%3DJ.%2BS.%26aulast%3DEdwards%26aufirst%3DJ.%2BE.%26aulast%3DGilbert%26aufirst%3DD.%26aulast%3DRice%26aufirst%3DL.%2BB.%26aulast%3DScheld%26aufirst%3DM.%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DBartlett%26aufirst%3DJ.%26atitle%3DBad%2520bugs%252C%2520no%2520drugs%253A%2520no%2520ESKAPE%2521%2520An%2520update%2520from%2520the%2520Infectious%2520Diseases%2520Society%2520of%2520America%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D48%26spage%3D1%26epage%3D12%26doi%3D10.1086%2F595011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Stryjewski, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, G. R.</span><span> </span><span class="NLM_article-title">Methicillin-resistant <i>Staphylococcus aureus</i>: an evolving pathogen</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">S10</span><span class="NLM_x">–</span> <span class="NLM_lpage">S19</span><span class="refDoi"> DOI: 10.1093/cid/cit613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fcid%2Fcit613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=24343827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCjs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=S10-S19&author=M.+E.+Stryjewskiauthor=G.+R.+Corey&title=Methicillin-resistant+Staphylococcus+aureus%3A+an+evolving+pathogen&doi=10.1093%2Fcid%2Fcit613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen</span></div><div class="casAuthors">Stryjewski, Martin E.; Corey, G. Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">suppl. 1</span>),
    <span class="NLM_cas:pages">S10-S19</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The horizontal transmission of methicillin resistance to Staphylococcus aureus (MRSA) in hospital and community settings, and growing prevalence of these strains, presents a significant clin. challenge to the management of serious infections worldwide.  While infection control initiatives have stemmed the rising prevalence, MRSA remains a significant pathogen.  More recently, evidence that MRSA is becoming resistant to glycopeptides and newer therapies raises concern about the use of these therapies in clin. practice.  Vancomycin resistance has become evident in select clin. settings through rising MICs, growing awareness of heteroresistance, and emergence of intermediate-resistant and fully resistant strains.  While resistance to linezolid and daptomycin remains low overall, point mutations leading to resistance have been described for linezolid, and horizontal transmission of cfr-mediated resistance to linezolid has been reported in clin. isolates.  These resistance trends for newer therapies highlight the ongoing need for new and more potent antimicrobial therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Ok0jZWhNbLVg90H21EOLACvtfcHk0li9aTQt6WaJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCjs73K&md5=fcf0e4157684d88420eee2d4eed09501</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcit613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcit613%26sid%3Dliteratum%253Aachs%26aulast%3DStryjewski%26aufirst%3DM.%2BE.%26aulast%3DCorey%26aufirst%3DG.%2BR.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%253A%2520an%2520evolving%2520pathogen%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D58%26spage%3DS10%26epage%3DS19%26doi%3D10.1093%2Fcid%2Fcit613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Rodvold, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConeghy, K. W.</span><span> </span><span class="NLM_article-title">Methicillin-resistant <i>Staphylococcus aureus</i> therapy: past, present and future</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S20</span><span class="NLM_x">–</span> <span class="NLM_lpage">S27</span><span class="refDoi"> DOI: 10.1093/cid/cit614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fcid%2Fcit614" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=S20-S27&issue=S1&author=K.+A.+Rodvoldauthor=K.+W.+McConeghy&title=Methicillin-resistant+Staphylococcus+aureus+therapy%3A+past%2C+present+and+future&doi=10.1093%2Fcid%2Fcit614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcit614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcit614%26sid%3Dliteratum%253Aachs%26aulast%3DRodvold%26aufirst%3DK.%2BA.%26aulast%3DMcConeghy%26aufirst%3DK.%2BW.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%2520therapy%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D58%26issue%3DS1%26spage%3DS20%26epage%3DS27%26doi%3D10.1093%2Fcid%2Fcit614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Moellering, R. C.</span><span> </span><span class="NLM_article-title">MRSA: the first half century</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1093/jac/dkr437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkr437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=22010206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1CqtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=4-11&author=R.+C.+Moellering&title=MRSA%3A+the+first+half+century&doi=10.1093%2Fjac%2Fdkr437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MRSA: the first half century</span></div><div class="casAuthors">Moellering, Robert C., Jr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-11</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Fifty years ago methicillin-resistant Staphylococcus aureus (MRSA) first revealed themselves to the medical community, having been described in a landmark article published in the British Medical Journal.  Among other things, their discovery set off a major response from the scientific and medical professions to control or even eliminate them as major human pathogens.  Despite these efforts, however, MRSA have spread throughout the world and a half century after they burst upon the scene they continue to pose major challenges to research scientists and clinicians alike.  In a very real sense, this year marks the  birthday' of a remarkably successful pathogen.  The major reasons for the ability of MRSA to prosper and cause disease in settings inimical to its survival form the basis of this article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgGQfcz3v34rVg90H21EOLACvtfcHk0li9aTQt6WaJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1CqtL3O&md5=08db62d42364ab35e83504ca27ba8482</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr437%26sid%3Dliteratum%253Aachs%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26atitle%3DMRSA%253A%2520the%2520first%2520half%2520century%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D4%26epage%3D11%26doi%3D10.1093%2Fjac%2Fdkr437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tapsall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmody, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limnios, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloots, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiley, D.</span><span> </span><span class="NLM_article-title">Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods</span> <span class="citation_source-journal">J. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span><span class="refDoi"> DOI: 10.1099/jmm.0.007641-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1099%2Fjmm.0.007641-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=19369534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1Wksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=683-687&author=J.+Tapsallauthor=P.+Readauthor=C.+Carmodyauthor=C.+Bourneauthor=S.+Rayauthor=A.+Limniosauthor=T.+Slootsauthor=D.+Whiley&title=Two+cases+of+failed+ceftriaxone+treatment+in+pharyngeal+gonorrhoea+verified+by+molecular+microbiological+methods&doi=10.1099%2Fjmm.0.007641-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods</span></div><div class="casAuthors">Tapsall, John; Read, Phillip; Carmody, Christopher; Bourne, Christopher; Ray, Sanghamitra; Limnios, Athena; Sloots, Theo; Whiley, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">683-687</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Diagnostic, genotypic and antibiotic-resistance determinants of Neisseria gonorrhoeae were analyzed by mol. methods to verify the failure of ceftriaxone treatment in two cases of pharyngeal gonorrhea.  Monoplex assays were needed to define competitive inhibition of a pos. Chalmydia PCR in a duplex assay.  Different penA changes were detected in the N. gonorrhoeae isolated from the two cases.  These were assocd. with raised ceftriaxone MICs of 0.03 and 0.016 mg l-1, which may have contributed to the treatment failures in these cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9P7ZuzU5CQ7Vg90H21EOLACvtfcHk0lgvYc8V-qHgeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1Wksb4%253D&md5=04cd13894de16cbd4238b8aee2afe61d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1099%2Fjmm.0.007641-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fjmm.0.007641-0%26sid%3Dliteratum%253Aachs%26aulast%3DTapsall%26aufirst%3DJ.%26aulast%3DRead%26aufirst%3DP.%26aulast%3DCarmody%26aufirst%3DC.%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DLimnios%26aufirst%3DA.%26aulast%3DSloots%26aufirst%3DT.%26aulast%3DWhiley%26aufirst%3DD.%26atitle%3DTwo%2520cases%2520of%2520failed%2520ceftriaxone%2520treatment%2520in%2520pharyngeal%2520gonorrhoea%2520verified%2520by%2520molecular%2520microbiological%2520methods%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2009%26volume%3D58%26spage%3D683%26epage%3D687%26doi%3D10.1099%2Fjmm.0.007641-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lewis, D. A.</span><span> </span><span class="NLM_article-title">The gonococcus fights back: is this time a knock out?</span> <span class="citation_source-journal">Sex. Transm. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1136/sti.2010.042648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1136%2Fsti.2010.042648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=20656721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVWisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=415-421&author=D.+A.+Lewis&title=The+gonococcus+fights+back%3A+is+this+time+a+knock+out%3F&doi=10.1136%2Fsti.2010.042648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Gonococcus fights back: is this time a knock out?</span></div><div class="casAuthors">Lewis David A</div><div class="citationInfo"><span class="NLM_cas:title">Sexually transmitted infections</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">415-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the introduction of antibiotics in the 1930s, Neisseria gonorrhoeae has exhibited a remarkable ability to acquire novel genetic resistance determinants.  Initially, sulphonamides were replaced by penicillin, while tetracyclines were prescribed for penicillin-allergic patients.  With the advent of penicillinase-producing gonococci, spectinomycin was only briefly useful as alternative treatment and plasmid-mediated tetracycline resistance spread rapidly from the mid-1980s onwards.  The fluoroquinolones followed but chromosomally mediated resistance appeared after only a decade of use.  Seventy years on, we now face a global public health challenge of immense significance--the emergence of resistance to cephalosporins.  With lack of investment in the search for new anti-gonococcal antimicrobial agents or vaccine research, the global spread of multiresistant gonococci can be seen.  The impact of untreatable gonorrhoea on HIV transmission could be enormous in high-prevalence countries.  This threat comes at a time when many national STI control programmes are weak.  To delay the emergence of extensively drug-resistant gonorrhoea, public health systems require strengthening and novel strategies need implementing to enhance the therapeutic lifespan of the few antimicrobial agents that we have left.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-iELkSGzG3Ug6wdEZmT2rfW6udTcc2eZZpACyHWq-OLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVWisA%253D%253D&md5=fad625f773332a2a82201803bcd33b55</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1136%2Fsti.2010.042648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fsti.2010.042648%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BA.%26atitle%3DThe%2520gonococcus%2520fights%2520back%253A%2520is%2520this%2520time%2520a%2520knock%2520out%253F%26jtitle%3DSex.%2520Transm.%2520Infect.%26date%3D2010%26volume%3D86%26spage%3D415%26epage%3D421%26doi%3D10.1136%2Fsti.2010.042648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span>Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/" class="extLink">http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Global+Action+Plan+to+Control+the+Spread+and+Impact+of+Antimicrobial+Resistance+in+Neisseria+gonorrhoeae%3B+World+Health+Organization%3A+Geneva%2C+2012%3B+http%3A%2F%2Fwww.who.int%2Freproductivehealth%2Fpublications%2Frtis%2F9789241503501%2Fen%2F+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Action%2520Plan%2520to%2520Control%2520the%2520Spread%2520and%2520Impact%2520of%2520Antimicrobial%2520Resistance%2520in%2520Neisseria%2520gonorrhoeae%26pub%3DWorld%2520Health%2520Organization%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>Gonorrhea Treatment Guidelines: Revised Guidelines to Preserve Last Effective Treatment Option. <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/nchhstp/newsroom/docs/Gonorrhea-Treatment-Guidelines-FactSheet.pdf" class="extLink">http://www.cdc.gov/nchhstp/newsroom/docs/Gonorrhea-Treatment-Guidelines-FactSheet.pdf</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gonorrhea+Treatment+Guidelines%3A+Revised+Guidelines+to+Preserve+Last+Effective+Treatment+Option.+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013%3B+http%3A%2F%2Fwww.cdc.gov%2Fnchhstp%2Fnewsroom%2Fdocs%2FGonorrhea-Treatment-Guidelines-FactSheet.pdf+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DGonorrhea%2520Treatment%2520Guidelines%253A%2520Revised%2520Guidelines%2520to%2520Preserve%2520Last%2520Effective%2520Treatment%2520Option%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Response Plan to Control and Manage the Threat of Multidrug-Resistant Gonorrhoea in Europe; <span class="NLM_publisher-name">European Centre for Disease Prevention and Control</span>: <span class="NLM_publisher-loc">Stockholm</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.ecdc.europa.eu/en/publications/publications/1206-ecdc-mdr-gonorrhoea-response-plan.pdf" class="extLink">http://www.ecdc.europa.eu/en/publications/publications/1206-ecdc-mdr-gonorrhoea-response-plan.pdf</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Response+Plan+to+Control+and+Manage+the+Threat+of+Multidrug-Resistant+Gonorrhoea+in+Europe%3B+European+Centre+for+Disease+Prevention+and+Control%3A+Stockholm%2C+2012%3B+http%3A%2F%2Fwww.ecdc.europa.eu%2Fen%2Fpublications%2Fpublications%2F1206-ecdc-mdr-gonorrhoea-response-plan.pdf+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DResponse%2520Plan%2520to%2520Control%2520and%2520Manage%2520the%2520Threat%2520of%2520Multidrug-Resistant%2520Gonorrhoea%2520in%2520Europe%26pub%3DEuropean%2520Centre%2520for%2520Disease%2520Prevention%2520and%2520Control%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwanathan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galullo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowravaram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimzey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morningstar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, V. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkup, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J. V.</span><span> </span><span class="NLM_article-title">Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">11827</span><span class="refDoi"> DOI: 10.1038/srep11827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fsrep11827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=26168713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FivVGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=11827&author=G.+S.+Basarabauthor=G.+H.+Kernauthor=J.+McNultyauthor=J.+P.+Muellerauthor=K.+Lawrenceauthor=K.+Vishwanathanauthor=R.+A.+Almauthor=K.+Barvianauthor=P.+Doigauthor=V.+Galulloauthor=H.+Gardnerauthor=M.+Gowravaramauthor=M.+Hubandauthor=A.+Kimzeyauthor=M.+Morningstarauthor=A.+Kutschkeauthor=S.+D.+Lahiriauthor=M.+Perrosauthor=R.+Singhauthor=V.+J.+A.+Schuckauthor=R.+Tommasiauthor=G.+Walkupauthor=J.+V.+Newman&title=Responding+to+the+challenge+of+untreatable+gonorrhea%3A+ETX0914%2C+a+first-in-class+agent+with+a+distinct+mechanism-of-action+against+bacterial+Type+II+topoisomerases.&doi=10.1038%2Fsrep11827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases</span></div><div class="casAuthors">Basarab Gregory S; Singh Renu; Kern Gunther H; Vishwanathan Karthick; Alm Richard A; Doig Peter; Galullo Vincent; Gardner Humphrey; Kimzey Amy; Kutschke Amy; Lahiri Sushmita D; Walkup Grant; Newman Joseph V; McNulty John; Perros Manos; Tommasi Ruben; Mueller John P; Lawrence Kenneth; Barvian Kevin; Gowravaram Madhusudhan; Huband Michael; Morningstar Marshall; Schuck Virna J A</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11827</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">With the diminishing effectiveness of current antibacterial therapies, it is critically important to discover agents that operate by a mechanism that circumvents existing resistance.  ETX0914, the first of a new class of antibacterial agent targeted for the treatment of gonorrhea, operates by a novel mode-of-inhibition against bacterial type II topoisomerases.  Incorporating an oxazolidinone on the scaffold mitigated toxicological issues often seen with topoisomerase inhibitors.  Organisms resistant to other topoisomerase inhibitors were not cross-resistant with ETX0914 nor were spontaneous resistant mutants to ETX0914 cross-resistant with other topoisomerase inhibitor classes, including the widely used fluoroquinolone class.  Preclinical evaluation of ETX0914 pharmacokinetics and pharmacodynamics showed distribution into vascular tissues and efficacy in a murine Staphylococcus aureus infection model that served as a surrogate for predicting efficacious exposures for the treatment of Neisseria gonorrhoeae infections.  A wide safety margin to the efficacious exposure in toxicological evaluations supported progression to Phase 1.  Dosing ETX0914 in human volunteers showed sufficient exposure and minimal adverse effects to expect a highly efficacious anti-gonorrhea therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx_MR4JXY8wBdUSIfHIn4FfW6udTcc2eZDuNvio2FPLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FivVGqtA%253D%253D&md5=77968264a6789578bf075c12abcc5dc7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsrep11827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep11827%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DKern%26aufirst%3DG.%2BH.%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DMueller%26aufirst%3DJ.%2BP.%26aulast%3DLawrence%26aufirst%3DK.%26aulast%3DVishwanathan%26aufirst%3DK.%26aulast%3DAlm%26aufirst%3DR.%2BA.%26aulast%3DBarvian%26aufirst%3DK.%26aulast%3DDoig%26aufirst%3DP.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DGowravaram%26aufirst%3DM.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DKimzey%26aufirst%3DA.%26aulast%3DMorningstar%26aufirst%3DM.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DLahiri%26aufirst%3DS.%2BD.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DSchuck%26aufirst%3DV.%2BJ.%2BA.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DWalkup%26aufirst%3DG.%26aulast%3DNewman%26aufirst%3DJ.%2BV.%26atitle%3DResponding%2520to%2520the%2520challenge%2520of%2520untreatable%2520gonorrhea%253A%2520ETX0914%252C%2520a%2520first-in-class%2520agent%2520with%2520a%2520distinct%2520mechanism-of-action%2520against%2520bacterial%2520Type%2520II%2520topoisomerases.%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D11827%26doi%3D10.1038%2Fsrep11827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galullo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haimes, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, V. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowravaram, M.</span><span> </span><span class="NLM_article-title">Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9078</span><span class="NLM_x">–</span> <span class="NLM_lpage">9095</span><span class="refDoi"> DOI: 10.1021/jm501174m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501174m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yju7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9078-9095&author=G.+S.+Basarabauthor=P.+Brassilauthor=P.+Doigauthor=V.+Galulloauthor=H.+B.+Haimesauthor=G.+Kernauthor=A.+Kutschkeauthor=J.+McNultyauthor=V.+A.+J.+Schuckauthor=G.+Stoneauthor=M.+Gowravaram&title=Novel+DNA+gyrase+inhibiting+spiropyrimidinetriones+with+a+benzisoxazole+scaffold%3A+SAR+and+in+vivo+characterization&doi=10.1021%2Fjm501174m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization</span></div><div class="casAuthors">Basarab, Gregory S.; Brassil, Patrick; Doig, Peter; Galullo, Vincent; Haimes, Howard B.; Kern, Gunther; Kutschke, Amy; McNulty, John; Schuck, Virna J. A.; Stone, Gregory; Gowravaram, Madhusudhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9078-9095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The compds. described herein with a spirocyclic architecture fused to a benzisoxazole ring represent a new class of antibacterial agents that operate by inhibition of DNA gyrase as corroborated in an enzyme assay and by the inhibition of precursor thymidine into DNA during cell growth.  Activity resided in the configurationally lowest energy (2S,4R,4aR) diastereomer.  Highly active compds. against Staphylococcus aureus had sufficiently high soly., high plasma protein free fraction, and favorable pharmacokinetics to suggest that in vivo efficacy could be demonstrated, which was realized with compd. I in S. aureus mouse infection models.  A high drug exposure NOEL on oral dosing in the rat suggested that a high therapeutic margin could be achieved.  Importantly, I was not cross-resistant with other DNA gyrase inhibitors such as fluoroquinolone and aminocoumarin antibacterials.  Hence, this class shows considerable promise for the treatment of infections caused by multidrug resistant bacteria, including S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpvqD0DFpAALVg90H21EOLACvtfcHk0libTEwOmunmSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yju7bE&md5=7eccef41b07e14842d79665591364050</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501174m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501174m%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DDoig%26aufirst%3DP.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DHaimes%26aufirst%3DH.%2BB.%26aulast%3DKern%26aufirst%3DG.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DSchuck%26aufirst%3DV.%2BA.%2BJ.%26aulast%3DStone%26aufirst%3DG.%26aulast%3DGowravaram%26aufirst%3DM.%26atitle%3DNovel%2520DNA%2520gyrase%2520inhibiting%2520spiropyrimidinetriones%2520with%2520a%2520benzisoxazole%2520scaffold%253A%2520SAR%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9078%26epage%3D9095%26doi%3D10.1021%2Fjm501174m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippke, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span> </span><span class="NLM_article-title">Crystal structures of <i>Escherichia coli</i> topoisomerase IV ParE subunit (24 and 43 kDas): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span><span class="refDoi"> DOI: 10.1128/AAC.48.5.1856-1864.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.48.5.1856-1864.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1856-1864&author=S.+Bellonauthor=J.+D.+Parsonsauthor=Y.+Weiauthor=K.+Hayakawaauthor=L.+L.+Swensonauthor=P.+S.+Charifsonauthor=J.+A.+Lippkeauthor=R.+Aldapeauthor=C.+H.+Gross&title=Crystal+structures+of+Escherichia+coli+topoisomerase+IV+ParE+subunit+%2824+and+43+kDas%29%3A+a+single+residue+dictates+differences+in+novobiocin+potency+against+topoisomerase+IV+and+DNA+gyrase&doi=10.1128%2FAAC.48.5.1856-1864.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1856-1864.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1856-1864.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DLippke%26aufirst%3DJ.%2BA.%26aulast%3DAldape%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DC.%2BH.%26atitle%3DCrystal%2520structures%2520of%2520Escherichia%2520coli%2520topoisomerase%2520IV%2520ParE%2520subunit%2520%252824%2520and%252043%2520kDas%2529%253A%2520a%2520single%2520residue%2520dictates%2520differences%2520in%2520novobiocin%2520potency%2520against%2520topoisomerase%2520IV%2520and%2520DNA%2520gyrase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1856%26epage%3D1864%26doi%3D10.1128%2FAAC.48.5.1856-1864.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markland, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botfield, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybuck, S. A.</span><span> </span><span class="NLM_article-title">Active-site residues of <i>Escherichia coli</i> DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1128/AAC.47.3.1037-1046.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.47.3.1037-1046.2003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2003&pages=1037-1046&author=C.+H.+Grossauthor=J.+D.+Parsonsauthor=T.+H.+Grossmanauthor=P.+S.+Charifsonauthor=S.+Bellonauthor=J.+Jerneeauthor=M.+Dwyerauthor=S.+P.+Chambersauthor=W.+Marklandauthor=M.+Botfieldauthor=S.+A.+Raybuck&title=Active-site+residues+of+Escherichia+coli+DNA+gyrase+required+in+coupling+ATP+hydrolysis+to+DNA+supercoiling+and+amino+acid+substitutions+leading+to+novobiocin+resistance&doi=10.1128%2FAAC.47.3.1037-1046.2003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.47.3.1037-1046.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.47.3.1037-1046.2003%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DJernee%26aufirst%3DJ.%26aulast%3DDwyer%26aufirst%3DM.%26aulast%3DChambers%26aufirst%3DS.%2BP.%26aulast%3DMarkland%26aufirst%3DW.%26aulast%3DBotfield%26aufirst%3DM.%26aulast%3DRaybuck%26aufirst%3DS.%2BA.%26atitle%3DActive-site%2520residues%2520of%2520Escherichia%2520coli%2520DNA%2520gyrase%2520required%2520in%2520coupling%2520ATP%2520hydrolysis%2520to%2520DNA%2520supercoiling%2520and%2520amino%2520acid%2520substitutions%2520leading%2520to%2520novobiocin%2520resistance%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2003%26volume%3D47%26spage%3D1037%26epage%3D1046%26doi%3D10.1128%2FAAC.47.3.1037-1046.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Barvian, K.; Basarab, G. S.; Gowravaram, M. R.; Hauck, S. I.; Zhou, F.</span><span> </span><span class="NLM_article-title">Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections</span>. U.S. Patent USP 8658641,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Barvian&author=G.+S.+Basarab&author=M.+R.+Gowravaram&author=S.+I.+Hauck&author=F.+Zhou&title=Fused%2C+spirocyclic+heteroaromatic+compounds+for+the+treatment+of+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarvian%26aufirst%3DK.%26atitle%3DFused%252C%2520spirocyclic%2520heteroaromatic%2520compounds%2520for%2520the%2520treatment%2520of%2520bacterial%2520infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lj1lzIQutX-NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">D’yachenko, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glukhareva, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyudya, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eltsov, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morzherin, Y. Y.</span><span> </span><span class="NLM_article-title">The <i>tert</i>-amino effect in heterocyclic chemistry. Synthesis of spiro heterocycles</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.3390/10091101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.3390%2F10091101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18007375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WmsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1101-1108&author=E.+V.+D%E2%80%99yachenkoauthor=T.+V.+Glukharevaauthor=L.+V.+Dyudyaauthor=O.+V.+Eltsovauthor=Y.+Y.+Morzherin&title=The+tert-amino+effect+in+heterocyclic+chemistry.+Synthesis+of+spiro+heterocycles&doi=10.3390%2F10091101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The tert-amino effect in heterocyclic chemistry. Synthesis of spiro heterocycles</span></div><div class="casAuthors">D'yachenko, Elisaveta V.; Glukhareva, Tatiana V.; Dyudya, Lyudmila V.; Eltsov, Oleg V.; Morzherin, Yury Yu.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1101-1108</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  The tert-amino reaction effect was examd.  A new method to synthesize spiro heterocycles is presented.  The tert-amino effect could be applied to the formation of spiro-fused heterocycles.  The formation of spiro compds. proceeds in most cases in good yields in a 1-pot reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4waXqp_8qa7Vg90H21EOLACvtfcHk0lj1lzIQutX-NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WmsrfN&md5=45dace56623d8dee541849f93f5a5b2f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2F10091101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252F10091101%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599yachenko%26aufirst%3DE.%2BV.%26aulast%3DGlukhareva%26aufirst%3DT.%2BV.%26aulast%3DDyudya%26aufirst%3DL.%2BV.%26aulast%3DEltsov%26aufirst%3DO.%2BV.%26aulast%3DMorzherin%26aufirst%3DY.%2BY.%26atitle%3DThe%2520tert-amino%2520effect%2520in%2520heterocyclic%2520chemistry.%2520Synthesis%2520of%2520spiro%2520heterocycles%26jtitle%3DMolecules%26date%3D2005%26volume%3D10%26spage%3D1101%26epage%3D1108%26doi%3D10.3390%2F10091101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Meth-Cohn, O.; Suschitzky, H.</span><span> </span><span class="NLM_article-title">Heterocycles by ring closure of ortho-substituted <i>t</i>-anilines (the <i>t</i>-amino effect)</span>. In  <span class="citation_source-book">Advances in Heterocyclic Chemistry</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1972</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">14</span>, pp  <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0065-2725%2808%2960954-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1972&pages=211-278&author=O.+Meth-Cohn&author=H.+Suschitzky&title=Advances+in+Heterocyclic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0065-2725%2808%2960954-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0065-2725%252808%252960954-X%26sid%3Dliteratum%253Aachs%26aulast%3DMeth-Cohn%26aufirst%3DO.%26atitle%3DHeterocycles%2520by%2520ring%2520closure%2520of%2520ortho-substituted%2520t-anilines%2520%2528the%2520t-amino%2520effect%2529%26btitle%3DAdvances%2520in%2520Heterocyclic%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D1972%26volume%3D14%26spage%3D211%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Matyus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapolcsanyi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonka-Balint, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halasz-Dajka, B.</span><span> </span><span class="NLM_article-title">Ring-closure reactions of ortho-vinyl-<i>tert</i>-anilines and (Di)aza-heterocyclic analogues via the <i>tert</i>-amino effect: recent developments</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">2625</span><span class="refDoi"> DOI: 10.1055/s-2006-942490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1055%2Fs-2006-942490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=2625&author=P.+Matyusauthor=O.+Eliasauthor=P.+Tapolcsanyiauthor=A.+Polonka-Balintauthor=B.+Halasz-Dajka&title=Ring-closure+reactions+of+ortho-vinyl-tert-anilines+and+%28Di%29aza-heterocyclic+analogues+via+the+tert-amino+effect%3A+recent+developments&doi=10.1055%2Fs-2006-942490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-942490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-942490%26sid%3Dliteratum%253Aachs%26aulast%3DMatyus%26aufirst%3DP.%26aulast%3DElias%26aufirst%3DO.%26aulast%3DTapolcsanyi%26aufirst%3DP.%26aulast%3DPolonka-Balint%26aufirst%3DA.%26aulast%3DHalasz-Dajka%26aufirst%3DB.%26atitle%3DRing-closure%2520reactions%2520of%2520ortho-vinyl-tert-anilines%2520and%2520%2528Di%2529aza-heterocyclic%2520analogues%2520via%2520the%2520tert-amino%2520effect%253A%2520recent%2520developments%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D2625%26doi%3D10.1055%2Fs-2006-942490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Visser, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verboom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benders, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhoudt, D. N.</span><span> </span><span class="NLM_article-title">1-Pyrrolidin-1-ylbuta-1,3-dienes as potential 1,5-dipoles; synthesis of pyrrolizines</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1039/c39820000669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1039%2Fc39820000669" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&pages=669-671&author=G.+W.+Visserauthor=W.+Verboomauthor=P.+H.+Bendersauthor=D.+N.+Reinhoudt&title=1-Pyrrolidin-1-ylbuta-1%2C3-dienes+as+potential+1%2C5-dipoles%3B+synthesis+of+pyrrolizines&doi=10.1039%2Fc39820000669"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc39820000669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39820000669%26sid%3Dliteratum%253Aachs%26aulast%3DVisser%26aufirst%3DG.%2BW.%26aulast%3DVerboom%26aufirst%3DW.%26aulast%3DBenders%26aufirst%3DP.%2BH.%26aulast%3DReinhoudt%26aufirst%3DD.%2BN.%26atitle%3D1-Pyrrolidin-1-ylbuta-1%252C3-dienes%2520as%2520potential%25201%252C5-dipoles%253B%2520synthesis%2520of%2520pyrrolizines%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1982%26spage%3D669%26epage%3D671%26doi%3D10.1039%2Fc39820000669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Verboom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhoudt, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkema, S.</span><span> </span><span class="NLM_article-title">″Tert-amino effect″ in heterocyclic synthesis. Formation of N heterocycles by ring-closure reactions of substituted 2-vinyl-N,N-dialkylanilines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1021/jo00176a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00176a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=269-276&author=W.+Verboomauthor=D.+N.+Reinhoudtauthor=R.+Visserauthor=S.+Harkema&title=%E2%80%B3Tert-amino+effect%E2%80%B3+in+heterocyclic+synthesis.+Formation+of+N+heterocycles+by+ring-closure+reactions+of+substituted+2-vinyl-N%2CN-dialkylanilines&doi=10.1021%2Fjo00176a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00176a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00176a011%26sid%3Dliteratum%253Aachs%26aulast%3DVerboom%26aufirst%3DW.%26aulast%3DReinhoudt%26aufirst%3DD.%2BN.%26aulast%3DVisser%26aufirst%3DR.%26aulast%3DHarkema%26aufirst%3DS.%26atitle%3D%25E2%2580%25B3Tert-amino%2520effect%25E2%2580%25B3%2520in%2520heterocyclic%2520synthesis.%2520Formation%2520of%2520N%2520heterocycles%2520by%2520ring-closure%2520reactions%2520of%2520substituted%25202-vinyl-N%252CN-dialkylanilines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D269%26epage%3D276%26doi%3D10.1021%2Fjo00176a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galullo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGrace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, S. S.</span><span> </span><span class="NLM_article-title">Synthesis of a tetrahydronaphthyridine spiropyrimidinetrione DNA gyrase inhibiting antibacterial agent - differential substitution at all five carbon atoms of pyridine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6456</span><span class="NLM_x">–</span> <span class="NLM_lpage">6459</span><span class="refDoi"> DOI: 10.1021/ol503256h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol503256h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=6456-6459&author=G.+S.+Basarabauthor=V.+Galulloauthor=N.+DeGraceauthor=S.+Hauckauthor=C.+Joubranauthor=S.+S.+Wesolowski&title=Synthesis+of+a+tetrahydronaphthyridine+spiropyrimidinetrione+DNA+gyrase+inhibiting+antibacterial+agent+-+differential+substitution+at+all+five+carbon+atoms+of+pyridine&doi=10.1021%2Fol503256h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Tetrahydronaphthyridine Spiropyrimidinetrione DNA Gyrase Inhibiting Antibacterial Agent - Differential Substitution at all Five Carbon Atoms of Pyridine.</span></div><div class="casAuthors">Basarab, Gregory S.; Galullo, Vincent; DeGrace, Nancy; Hauck, Sheila; Joubran, Camil; Wesolowski, Steven S.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6456-6459</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of I, a potent antibacterial agent, was achieved stereoselectively in nine steps from readily available starting materials.  Directed metalations were developed to assemble a pentasubstituted pyridine with appropriately positioned aldehyde and dimethylmorpholine substituents for a key tertiary amino effect reaction (T-reaction) that led to the spirocyclic architecture.  Ultimately, I was isolated as the thermodynamically most favored stereoisomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWsTrK9RkPp7Vg90H21EOLACvtfcHk0lgoDV8-SuekZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamsrzN&md5=d593296ffc77a54b3157e5641001d1a8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol503256h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol503256h%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DDeGrace%26aufirst%3DN.%26aulast%3DHauck%26aufirst%3DS.%26aulast%3DJoubran%26aufirst%3DC.%26aulast%3DWesolowski%26aufirst%3DS.%2BS.%26atitle%3DSynthesis%2520of%2520a%2520tetrahydronaphthyridine%2520spiropyrimidinetrione%2520DNA%2520gyrase%2520inhibiting%2520antibacterial%2520agent%2520-%2520differential%2520substitution%2520at%2520all%2520five%2520carbon%2520atoms%2520of%2520pyridine%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D6456%26epage%3D6459%26doi%3D10.1021%2Fol503256h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ruble, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurd, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundy, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graber, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamilar, G. M.</span><span> </span><span class="NLM_article-title">Synthesis of (−)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3991</span><span class="NLM_x">–</span> <span class="NLM_lpage">3997</span><span class="refDoi"> DOI: 10.1021/ja808014h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja808014h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVeisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=3991-3997&author=J.+C.+Rubleauthor=A.+R.+Hurdauthor=T.+A.+Johnsonauthor=D.+A.+Sherryauthor=M.+R.+Barbachynauthor=P.+L.+Toogoodauthor=G.+L.+Bundyauthor=D.+R.+Graberauthor=G.+M.+Kamilar&title=Synthesis+of+%28%E2%88%92%29-PNU-286607+by+asymmetric+cyclization+of+alkylidene+barbiturates&doi=10.1021%2Fja808014h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (-)-PNU-286607 by Asymmetric Cyclization of Alkylidene Barbiturates</span></div><div class="casAuthors">Ruble, J. Craig; Hurd, Alexander R.; Johnson, Timothy A.; Sherry, Debra A.; Barbachyn, Michael R.; Toogood, Peter L.; Bundy, Gordon L.; Graber, David R.; Kamilar, Gregg M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3991-3997</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PNU 286607 I, a oxazinoquinolinespiropyrimidinetrione inhibitor of bacterial DNA gyrase for potential use as an antibacterial agent against antibiotic-resistant bacterial strains, is prepd. in two steps from 2-fluoro-5-nitrobenzaldehyde and (R,R)-2,6-dimethylmorpholine by nucleophilic arom. substitution followed by condensation with barbituric acid and a concomitant stereoselective cyclization of the benzylidenepyrimidinetrione.  The stereoselectivities and mechanism of the condensation and cyclization reactions (based on the rearrangements of vinyl anilines, known in the literature as the "tert-amino effect") are investigated using the NMR spectroscopic anal. of the reactions of racemic substrates and the reactions of racemic and nonracemic deuterated substrates; based on the data obtained, the asym. synthesis of I is developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwZZhoPHBHrVg90H21EOLACvtfcHk0lhYI4XNXJqcZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVeisL4%253D&md5=f837986da667a40ce19753baa9d58125</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja808014h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja808014h%26sid%3Dliteratum%253Aachs%26aulast%3DRuble%26aufirst%3DJ.%2BC.%26aulast%3DHurd%26aufirst%3DA.%2BR.%26aulast%3DJohnson%26aufirst%3DT.%2BA.%26aulast%3DSherry%26aufirst%3DD.%2BA.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DBundy%26aufirst%3DG.%2BL.%26aulast%3DGraber%26aufirst%3DD.%2BR.%26aulast%3DKamilar%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%2520%2528%25E2%2588%2592%2529-PNU-286607%2520by%2520asymmetric%2520cyclization%2520of%2520alkylidene%2520barbiturates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D3991%26epage%3D3997%26doi%3D10.1021%2Fja808014h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maduakor, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, C. E.</span><span> </span><span class="NLM_article-title">Fluorine as an ortho-directing group in aromatic metalation: generality of the reaction and the high position of fluorine in the Dir-Met potency scale</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">7495</span><span class="NLM_x">–</span> <span class="NLM_lpage">7498</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)60805-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0040-4039%2800%2960805-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADyaK3sXht1Cmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1992&pages=7495-7498&author=A.+J.+Bridgesauthor=A.+Leeauthor=E.+C.+Maduakorauthor=C.+E.+Schwartz&title=Fluorine+as+an+ortho-directing+group+in+aromatic+metalation%3A+generality+of+the+reaction+and+the+high+position+of+fluorine+in+the+Dir-Met+potency+scale&doi=10.1016%2FS0040-4039%2800%2960805-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine as an ortho-directing group in aromatic metalation:  generality of the reaction and the high position of fluorine in the Dir-Met potency scale</span></div><div class="casAuthors">Bridges, Alexander J.; Lee, Arthur; Maduakor, Emmanuel C.; Schwartz, C. Eric</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">7495-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Many para-substituted fluorobenzenes can be lithiated ortho to fluorine in moderate to good yields, often with one of the dialkylamide bases, such as lithium diisopropylamide or lithium 2,2,6,6-tetramethylpiperidide.  Intramol. competition expts. reveal that fluorine is one of the most potent Dir-Met (directed-metalation) activating groups under these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN8Ys9Jbfn4bVg90H21EOLACvtfcHk0lhYI4XNXJqcZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXht1Cmu7o%253D&md5=34687531295381104e2f30141f2f5431</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2960805-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252960805-5%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DMaduakor%26aufirst%3DE.%2BC.%26aulast%3DSchwartz%26aufirst%3DC.%2BE.%26atitle%3DFluorine%2520as%2520an%2520ortho-directing%2520group%2520in%2520aromatic%2520metalation%253A%2520generality%2520of%2520the%2520reaction%2520and%2520the%2520high%2520position%2520of%2520fluorine%2520in%2520the%2520Dir-Met%2520potency%2520scale%26jtitle%3DTetrahedron%2520Lett.%26date%3D1992%26volume%3D33%26spage%3D7495%26epage%3D7498%26doi%3D10.1016%2FS0040-4039%2800%2960805-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Moyroud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guesnet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennetau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, J.</span><span> </span><span class="NLM_article-title">Lithiations ortho-directed by carboxylic acid, fluorine, and chlorine functions. II. Regioselective synthesis of polysubstituted benzoic acids and acetophenones</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1996&pages=133-141&author=J.+Moyroudauthor=J.+Guesnetauthor=B.+Bennetauauthor=J.+Mortier&title=Lithiations+ortho-directed+by+carboxylic+acid%2C+fluorine%2C+and+chlorine+functions.+II.+Regioselective+synthesis+of+polysubstituted+benzoic+acids+and+acetophenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyroud%26aufirst%3DJ.%26aulast%3DGuesnet%26aufirst%3DJ.%26aulast%3DBennetau%26aufirst%3DB.%26aulast%3DMortier%26aufirst%3DJ.%26atitle%3DLithiations%2520ortho-directed%2520by%2520carboxylic%2520acid%252C%2520fluorine%252C%2520and%2520chlorine%2520functions.%2520II.%2520Regioselective%2520synthesis%2520of%2520polysubstituted%2520benzoic%2520acids%2520and%2520acetophenones%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1996%26volume%3D133%26spage%3D133%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Shapiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thresher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajec, L.</span><span> </span><span class="NLM_article-title">A homogeneous, high-throughput fluorescence anisotropy-based DNA supercoiling assay</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span><span class="refDoi"> DOI: 10.1177/1087057110378624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1177%2F1087057110378624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=20930214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVajsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=1088-1098&author=A.+Shapiroauthor=H.+Jahicauthor=S.+Prasadauthor=D.+Ehmannauthor=J.+Thresherauthor=N.+Gaoauthor=L.+Hajec&title=A+homogeneous%2C+high-throughput+fluorescence+anisotropy-based+DNA+supercoiling+assay&doi=10.1177%2F1087057110378624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A homogeneous, high-throughput fluorescence anisotropy-based DNA supercoiling assay</span></div><div class="casAuthors">Shapiro, Adam; Jahic, Haris; Prasad, Swati; Ehmann, David; Thresher, Jason; Gao, Ning; Hajec, Laurel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1088-1098</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The degree of supercoiling of DNA is vital for cellular processes, such as replication and transcription.  DNA topol. is controlled by the action of DNA topoisomerase enzymes.  Topoisomerases, because of their importance in cellular replication, are the targets of several anticancer and antibacterial drugs.  In the search for new drugs targeting topoisomerases, a biochem. assay compatible with automated high-throughput screening (HTS) would be valuable.  Gel electrophoresis is the std. method for measuring changes in the extent of supercoiling of plasmid DNA when acted upon by topoisomerases, but this is a low-throughput and laborious method.  A medium-throughput method was described previously that quant. distinguishes relaxed and supercoiled plasmids by the difference in their abilities to form triplex structures with an immobilized oligonucleotide.  In this article, the authors describe a homogeneous supercoiling assay based on triplex formation in which the oligonucleotide strand is labeled with a fluorescent dye and the readout is fluorescence anisotropy.  The new assay requires no immobilization, filtration, or plate washing steps and is therefore well suited to HTS for inhibitors of topoisomerases.  The utility of this assay is demonstrated with relaxation of supercoiled plasmid by Escherichia coli topoisomerase I, supercoiling of relaxed plasmid by E. coli DNA gyrase, and inhibition of gyrase by fluoroquinolones and nalidixic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLPydgbbQi2bVg90H21EOLACvtfcHk0ljsCIsOGHINSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVajsLrN&md5=51191c534eaf19b3e198866d0c68e14a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1087057110378624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057110378624%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DA.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DEhmann%26aufirst%3DD.%26aulast%3DThresher%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DHajec%26aufirst%3DL.%26atitle%3DA%2520homogeneous%252C%2520high-throughput%2520fluorescence%2520anisotropy-based%2520DNA%2520supercoiling%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2010%26volume%3D15%26spage%3D1088%26epage%3D1098%26doi%3D10.1177%2F1087057110378624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeTiran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span> </span><span class="NLM_article-title">Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.bmcl.2014.03.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2177-2181&author=E.+Perolaauthor=D.+Stamosauthor=A.+Grillotauthor=S.+Ronkinauthor=T.+Wangauthor=A.+LeTiranauthor=Q.+Tangauthor=D.+D.+Deiningerauthor=Y.+Liaoauthor=S.+Tianauthor=J.+E.+Drummauthor=D.+P.+Nicolauauthor=P.+R.+Tessierauthor=N.+Maniauthor=T.+H.+Grossmanauthor=P.+S.+Charifson&title=Successful+application+of+serum+shift+prediction+models+to+the+design+of+dual+targeting+inhibitors+of+bacterial+gyrase+B+and+topoisomerase+IV+with+improved+in+vivo+efficacy&doi=10.1016%2Fj.bmcl.2014.03.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DGrillot%26aufirst%3DA.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSuccessful%2520application%2520of%2520serum%2520shift%2520prediction%2520models%2520to%2520the%2520design%2520of%2520dual%2520targeting%2520inhibitors%2520of%2520bacterial%2520gyrase%2520B%2520and%2520topoisomerase%2520IV%2520with%2520improved%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2177%26epage%3D2181%26doi%3D10.1016%2Fj.bmcl.2014.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span><span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0ljsCIsOGHINSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Heuberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span> </span><span class="NLM_article-title">When is protein binding important?</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3458</span><span class="NLM_x">–</span> <span class="NLM_lpage">3467</span><span class="refDoi"> DOI: 10.1002/jps.23559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2Fjps.23559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=23650013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=3458-3467&author=J.+Heubergerauthor=S.+Schmidtauthor=H.+Derendorf&title=When+is+protein+binding+important%3F&doi=10.1002%2Fjps.23559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">When is protein binding important?</span></div><div class="casAuthors">Heuberger, Jules; Schmidt, Stephan; Derendorf, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3458-3467</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The present paper is an ode to a classic citation by Benet and Hoener (2002. Clin Pharm Ther 71(3):115-121).  The now classic paper had a huge impact on drug development and the way the issue of protein binding is perceived and interpreted.  Although the authors very clearly pointed out the limitations and underlying assumptions for their delineations, these are too often overlooked and the classic paper's message is misinterpreted by broadening to cases that were not intended.  Some members of the scientific community concluded from the paper that protein binding is not important.  This was clearly not intended by the authors, as they finished their paper with a paragraph entitled: "When is protein binding important" Misinterpretation of the underlying assumptions in the classic work can result in major pitfalls in drug development.  Therefore, we revisit the topic of protein binding with the intention of clarifying when clin. relevant changes should be considered during drug development. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfgdnFH528PrVg90H21EOLACvtfcHk0ljsCIsOGHINSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeitrs%253D&md5=c1de70fd6e594e3788371604f26dd768</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fjps.23559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23559%26sid%3Dliteratum%253Aachs%26aulast%3DHeuberger%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DDerendorf%26aufirst%3DH.%26atitle%3DWhen%2520is%2520protein%2520binding%2520important%253F%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D3458%26epage%3D3467%26doi%3D10.1002%2Fjps.23559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Berezhkovskiy, L. M.</span><span> </span><span class="NLM_article-title">On the influence of protein binding on pharmacological activity of drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2165</span><span class="refDoi"> DOI: 10.1002/jps.21958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2Fjps.21958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=2153-2165&author=L.+M.+Berezhkovskiy&title=On+the+influence+of+protein+binding+on+pharmacological+activity+of+drugs&doi=10.1002%2Fjps.21958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.21958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21958%26sid%3Dliteratum%253Aachs%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26atitle%3DOn%2520the%2520influence%2520of%2520protein%2520binding%2520on%2520pharmacological%2520activity%2520of%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D2153%26epage%3D2165%26doi%3D10.1002%2Fjps.21958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosberry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennessy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzfaden, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shillings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlkonig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwynn, M. N.</span><span> </span><span class="NLM_article-title">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span><span class="refDoi"> DOI: 10.1038/nature09197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fnature09197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=20686482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=935-942&author=B.+D.+Baxauthor=P.+F.+Chanauthor=D.+S.+Egglestonauthor=A.+Fosberryauthor=D.+R.+Gentryauthor=F.+Gorrecauthor=I.+Giordanoauthor=M.+M.+Hannauthor=A.+Hennessyauthor=M.+Hibbsauthor=J.+Huangauthor=E.+Jonesauthor=J.+Jonesauthor=K.+K.+Brownauthor=C.+J.+Lewisauthor=E.+W.+Mayauthor=M.+R.+Saundersauthor=O.+Singhauthor=C.+E.+Spitzfadenauthor=C.+Shenauthor=A.+Shillingsauthor=A.+J.+Theobaldauthor=A.+Wohlkonigauthor=N.+D.+Pearsonauthor=M.+N.+Gwynn&title=Type+IIA+topoisomerase+inhibition+by+a+new+class+of+antibacterial+agents&doi=10.1038%2Fnature09197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span></div><div class="casAuthors">Bax Benjamin D; Chan Pan F; Eggleston Drake S; Fosberry Andrew; Gentry Daniel R; Gorrec Fabrice; Giordano Ilaria; Hann Michael M; Hennessy Alan; Hibbs Martin; Huang Jianzhong; Jones Emma; Jones Jo; Brown Kristin Koretke; Lewis Ceri J; May Earl W; Saunders Martin R; Singh Onkar; Spitzfaden Claus E; Shen Carol; Shillings Anthony; Theobald Andrew J; Wohlkonig Alexandre; Pearson Neil D; Gwynn Michael N</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7309</span>),
    <span class="NLM_cas:pages">935-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance.  Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action.  Here we report the 2.1 A crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target.  The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites.  In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate.  This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzBPk2FYUX-kBuFdjgVNKSfW6udTcc2eYpVEdSDMd0Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D&md5=006fef200c7a44f0671829b2a5fbddef</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnature09197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09197%26sid%3Dliteratum%253Aachs%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DChan%26aufirst%3DP.%2BF.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DFosberry%26aufirst%3DA.%26aulast%3DGentry%26aufirst%3DD.%2BR.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DHennessy%26aufirst%3DA.%26aulast%3DHibbs%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DMay%26aufirst%3DE.%2BW.%26aulast%3DSaunders%26aufirst%3DM.%2BR.%26aulast%3DSingh%26aufirst%3DO.%26aulast%3DSpitzfaden%26aufirst%3DC.%2BE.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DShillings%26aufirst%3DA.%26aulast%3DTheobald%26aufirst%3DA.%2BJ.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DN.%2BD.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26atitle%3DType%2520IIA%2520topoisomerase%2520inhibition%2520by%2520a%2520new%2520class%2520of%2520antibacterial%2520agents%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D935%26epage%3D942%26doi%3D10.1038%2Fnature09197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Laponogov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohi, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselkov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawhney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAuley, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, M. R.</span><span> </span><span class="NLM_article-title">Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1038/nsmb.1604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1038%2Fnsmb.1604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=19448616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=667-669&author=I.+Laponogovauthor=M.+K.+Sohiauthor=D.+A.+Veselkovauthor=X.+Panauthor=R.+Sawhneyauthor=A.+W.+Thompsonauthor=K.+E.+McAuleyauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structural+insight+into+the+quinolone%E2%80%93DNA+cleavage+complex+of+type+IIA+topoisomerases&doi=10.1038%2Fnsmb.1604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases</span></div><div class="casAuthors">Laponogov, Ivan; Sohi, Maninder K.; Veselkov, Dennis A.; Pan, Xiao-Su; Sawhney, Ritica; Thompson, Andrew W.; McAuley, Katherine E.; Fisher, L. Mark; Sanderson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-669</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type II topoisomerases alter DNA topol. by forming a covalent DNA-cleavage complex that allows DNA transport through a double-stranded DNA break.  We present the structures of cleavage complexes formed by the Streptococcus pneumoniae ParC breakage-reunion and ParE TOPRIM domains of topoisomerase IV stabilized by moxifloxacin and clinafloxacin, two antipneumococcal fluoroquinolones.  These structures reveal two drug mols. intercalated at the highly bent DNA gate and help explain antibacterial quinolone action and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDXhjTPq1GlrVg90H21EOLACvtfcHk0liGb606W8ZFtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D&md5=cd4c757dbb5d50c8113e658837d44a34</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1604%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DSohi%26aufirst%3DM.%2BK.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DSawhney%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DMcAuley%26aufirst%3DK.%2BE.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructural%2520insight%2520into%2520the%2520quinolone%25E2%2580%2593DNA%2520cleavage%2520complex%2520of%2520type%2520IIA%2520topoisomerases%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D667%26epage%3D669%26doi%3D10.1038%2Fnsmb.1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Laponogov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselkov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crevel, I. M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, M. R.</span><span> </span><span class="NLM_article-title">Structure of an ‘open’ clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9911</span><span class="NLM_x">–</span> <span class="NLM_lpage">9923</span><span class="refDoi"> DOI: 10.1093/nar/gkt749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fnar%2Fgkt749" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=9911-9923&author=I.+Laponogovauthor=D.+A.+Veselkovauthor=I.+M.-T.+Crevelauthor=X.+Panauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structure+of+an+%E2%80%98open%E2%80%99+clamp+type+II+topoisomerase-DNA+complex+provides+a+mechanism+for+DNA+capture+and+transport&doi=10.1093%2Fnar%2Fgkt749"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt749%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DCrevel%26aufirst%3DI.%2BM.-T.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520an%2520%25E2%2580%2598open%25E2%2580%2599%2520clamp%2520type%2520II%2520topoisomerase-DNA%2520complex%2520provides%2520a%2520mechanism%2520for%2520DNA%2520capture%2520and%2520transport%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D9911%26epage%3D9923%26doi%3D10.1093%2Fnar%2Fgkt749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tsai, F. T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, O. M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarzynski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonacott, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weston, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeze, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyser, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigley, D. B.</span><span> </span><span class="NLM_article-title">The high-resolution crystal structure of a 24-kDa gyrase B fragment from <i>E. coli</i> complexed with one of the most potent coumarin inhibitors, clorobiocin</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0134(199705)28:1<41::AID-PROT4>3.3.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1997&pages=41-52&author=F.+T.+F.+Tsaiauthor=O.+M.+P.+Singhauthor=T.+Skarzynskiauthor=A.+J.+Wonacottauthor=S.+Westonauthor=A.+Tuckerauthor=R.+A.+Pauptitauthor=A.+L.+Breezeauthor=J.+P.+Poyserauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=D.+B.+Wigley&title=The+high-resolution+crystal+structure+of+a+24-kDa+gyrase+B+fragment+from+E.+coli+complexed+with+one+of+the+most+potent+coumarin+inhibitors%2C+clorobiocin&doi=10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0134%2528199705%252928%253A1%253C41%253A%253AAID-PROT4%253E3.3.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DF.%2BT.%2BF.%26aulast%3DSingh%26aufirst%3DO.%2BM.%2BP.%26aulast%3DSkarzynski%26aufirst%3DT.%26aulast%3DWonacott%26aufirst%3DA.%2BJ.%26aulast%3DWeston%26aufirst%3DS.%26aulast%3DTucker%26aufirst%3DA.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DPoyser%26aufirst%3DJ.%2BP.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DWigley%26aufirst%3DD.%2BB.%26atitle%3DThe%2520high-resolution%2520crystal%2520structure%2520of%2520a%252024-kDa%2520gyrase%2520B%2520fragment%2520from%2520E.%2520coli%2520complexed%2520with%2520one%2520of%2520the%2520most%2520potent%2520coumarin%2520inhibitors%252C%2520clorobiocin%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D1997%26volume%3D28%26spage%3D41%26epage%3D52%26doi%3D10.1002%2F%28SICI%291097-0134%28199705%2928%3A1%3C41%3A%3AAID-PROT4%3E3.3.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mayer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2313</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span><span class="refDoi"> DOI: 10.1021/cr4003984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4003984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2313-2342&author=C.+Mayerauthor=Y.+L.+Janin&title=Non-quinolone+inhibitors+of+bacterial+type+IIA+topoisomerases%3A+a+feat+of+bioisosterism&doi=10.1021%2Fcr4003984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism</span></div><div class="casAuthors">Mayer, Claudine; Janin, Yves L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2313-2342</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  DNA gyrase and topoisomerase IV are the bacterial type IIA topoisomerases.  These are ubiquitous nucleic acid-dependent nanomachines, essential to cell life, that solve DNA topol. problems resulting from the replication, transcription, and recombination of DNA.  From the discovery that novobiocin and fluoroquinolone antibiotics were selectively acting on bacterial type IIA topoisomerases, a remarkable no. of series of inhibitors of these enzymes has been reported.  The design of biochem. or cellular assays, amenable to high-throughput screenings, along with X-ray-derived structures of the early inhibitors bound to DNA gyrase, were instrumental in this.  From these structures, an array of strategies, which are today called fragment-based approaches, provided quite a no. of addnl. starting points for medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-y7YT9Lg6rVg90H21EOLACvtfcHk0ljU_sWDsTWM6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO&md5=8559c27866d96e85cc08763e0cae1c01</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcr4003984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4003984%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DNon-quinolone%2520inhibitors%2520of%2520bacterial%2520type%2520IIA%2520topoisomerases%253A%2520a%2520feat%2520of%2520bioisosterism%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2313%26epage%3D2342%26doi%3D10.1021%2Fcr4003984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Boos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopper, H.</span><span> </span><span class="NLM_article-title">Genotoxicity of several clinically used topoisomerase II inhibitors</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/S0378-4274(00)00192-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0378-4274%2800%2900192-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10906417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvVyqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2000&pages=7-16&author=G.+Boosauthor=H.+Stopper&title=Genotoxicity+of+several+clinically+used+topoisomerase+II+inhibitors&doi=10.1016%2FS0378-4274%2800%2900192-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity of several clinically used topoisomerase II inhibitors</span></div><div class="casAuthors">Boos, G.; Stopper, H.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">7-16</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">DNA topoisomerase II is an essential nuclear enzyme that modulates DNA topol. during multiple cellular processes such as DNA replication and chromosome segregation.  Several important clin. antitumor drugs and antibiotics act through inhibition of topoisomerase II.  There are a no. of different steps in the action of topoisomerase II, all of which are potential targets for inhibition through drugs and also for cellular and genetic toxicity as well as for mutagenesis.  We have investigated and compared the genotoxicity and mutagenicity of the mechanistically different topoisomerase II inhibitors m-amsacrine, mitoxantrone, etoposide, genistein, ICRF 193, and berenil using the in vitro micronucleus test, single cell elelectrophoresis (comet assay) and the mutation assay (tk-locus) in L5178Y mouse lymphoma cells.  All six compds. induced micronuclei and all except berenil were mutagenic.  M-amsacrine, mitoxantrone, etoposide and genistein induced DNA migration in the comet assay, whereas ICRF 193 was only weakly pos. and berenil was neg. in this test.  Our results are in good agreement with the compds.' proposed mechanisms of interaction with topoisomerase II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0kiIlE6JkNbVg90H21EOLACvtfcHk0ljU_sWDsTWM6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvVyqtrw%253D&md5=2d4d2ab9d9deb23b535c9312c67b5611</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0378-4274%2800%2900192-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4274%252800%252900192-2%26sid%3Dliteratum%253Aachs%26aulast%3DBoos%26aufirst%3DG.%26aulast%3DStopper%26aufirst%3DH.%26atitle%3DGenotoxicity%2520of%2520several%2520clinically%2520used%2520topoisomerase%2520II%2520inhibitors%26jtitle%3DToxicol.%2520Lett.%26date%3D2000%26volume%3D116%26spage%3D7%26epage%3D16%26doi%3D10.1016%2FS0378-4274%2800%2900192-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span>Withdrawal Assessment Report for Factive: International Nonproprietary Name Gemifloxacin; <span class="NLM_series">Procedure No. EMEA/H/C/995</span>; <span class="NLM_publisher-name">European Medicines Agency</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500060988.pdf" class="extLink">http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500060988.pdf</a> (accessed July 8, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Withdrawal+Assessment+Report+for+Factive%3A+International+Nonproprietary+Name+Gemifloxacin%3B+Procedure+No.+EMEA%2FH%2FC%2F995%3B+European+Medicines+Agency%3A+London%2C+2009%3B+http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FApplication_withdrawal_assessment_report%2F2010%2F01%2FWC500060988.pdf+%28accessed+July+8%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DWithdrawal%2520Assessment%2520Report%2520for%2520Factive%253A%2520International%2520Nonproprietary%2520Name%2520Gemifloxacin%26pub%3DEuropean%2520Medicines%2520Agency%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Shapiro, A. B.</span><span> </span><span class="NLM_article-title">A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.bcp.2013.02.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1269-1277&author=A.+B.+Shapiro&title=A+high-throughput-compatible%2C+fluorescence+anisotropy-based+assay+for+ATP-dependent+supercoiled+DNA+relaxation+by+human+topoisomerase+II%CE%B1&doi=10.1016%2Fj.bcp.2013.02.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26atitle%3DA%2520high-throughput-compatible%252C%2520fluorescence%2520anisotropy-based%2520assay%2520for%2520ATP-dependent%2520supercoiled%2520DNA%2520relaxation%2520by%2520human%2520topoisomerase%2520II%25CE%25B1%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D1269%26epage%3D1277%26doi%3D10.1016%2Fj.bcp.2013.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Shapiro, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. A.</span><span> </span><span class="NLM_article-title">A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.ab.2013.11.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.ab.2013.11.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=24309019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlektLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2014&pages=23-29&author=A.+B.+Shapiroauthor=C.+A.+Austin&title=A+high-throughput+fluorescence+anisotropy-based+assay+for+human+topoisomerase+II+%CE%B2-catalyzed+ATP-dependent+supercoiled+DNA+relaxation&doi=10.1016%2Fj.ab.2013.11.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation</span></div><div class="casAuthors">Shapiro, Adam B.; Austin, Caroline A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Because of their essentiality for DNA replication, transcription, and repair, type II topoisomerases are targets for antibacterial and anticancer drugs.  There are two type II topoisomerases in humans, topoisomerase IIα (TOP2A) and topoisomerase IIβ (TOP2B), and two in bacteria, gyrase and topoisomerase IV.  Inhibition of one or both of the human type II topoisomerases by antibacterial compds. targeting their bacterial counterparts could result in toxicity.  In addn., side effects of anticancer drugs targeting TOP2A could result from inhibition of TOP2B.  A simple and rapid biochem. assay for the activity of TOP2A and TOP2B would be advantageous for screening for novel inhibitors, testing them for selectivity for one enzyme over the other, and testing for potential toxicity of antibacterial type II topoisomerases mediated by human topoisomerase II inhibition.  In this paper, we show that a previously reported high-throughput, fluorescence anisotropy-based assay for ATP-dependent relaxation of supercoiled DNA by human TOP2A can also be used under identical conditions for human TOP2B.  We used this assay to compare the potencies vs. both enzymes of 19 compds. reported in the literature to inhibit human and/or bacterial type II topoisomerases.  We also used the assay to investigate the effect of ATP concn. on inhibitor potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8YZAo9eRn8bVg90H21EOLACvtfcHk0liShO15pxWs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlektLw%253D&md5=2f4c35b785071d62252c04b6bd0c446f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.11.029%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26atitle%3DA%2520high-throughput%2520fluorescence%2520anisotropy-based%2520assay%2520for%2520human%2520topoisomerase%2520II%2520%25CE%25B2-catalyzed%2520ATP-dependent%2520supercoiled%2520DNA%2520relaxation%26jtitle%3DAnal.%2520Biochem.%26date%3D2014%26volume%3D448%26spage%3D23%26epage%3D29%26doi%3D10.1016%2Fj.ab.2013.11.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Thompson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidolf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenna, J. G.</span><span> </span><span class="NLM_article-title">In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span><span class="refDoi"> DOI: 10.1021/tx300091x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300091x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1616-1632&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=L.+Weidolfauthor=K.+Pageauthor=I.+Wilsonauthor=S.+Swallowauthor=B.+Middletonauthor=S.+Stahlauthor=A.+J.+Fosterauthor=H.+Dolgosauthor=R.+Weaverauthor=J.+G.+Kenna&title=In+vitro+approach+to+assess+the+potential+for+risk+of+idiosyncratic+adverse+reactions+caused+by+candidate+drugs&doi=10.1021%2Ftx300091x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1616-1632</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clin. significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling.  IADRs arise from both drug and patient related mechanisms and risk factors.  Drug related risk factors, resulting from parent compd. or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compd. disposition, and/or immune activation.  In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans.  The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P 450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance assocd. protein 2, Mrp2.  In addn., the CVB Burden was estd. by detg. the CVB of radiolabeled compd. to human hepatocytes and factoring in both the max. prescribed daily dose and the fraction of metab. leading to CVB.  Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG8lfWXT4vLVg90H21EOLACvtfcHk0liShO15pxWs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D&md5=e657aaf23d4efc5466bca68dee95bded</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Ftx300091x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300091x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BJ.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520vitro%2520approach%2520to%2520assess%2520the%2520potential%2520for%2520risk%2520of%2520idiosyncratic%2520adverse%2520reactions%2520caused%2520by%2520candidate%2520drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26spage%3D1616%26epage%3D1632%26doi%3D10.1021%2Ftx300091x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Antoine, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.1517/17425255.4.11.1415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1517%2F17425255.4.11.1415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18950283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12jtbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1415-1427&author=D.+J.+Antoineauthor=D.+P.+Williamsauthor=B.+K.+Park&title=Understanding+the+role+of+reactive+metabolites+in+drug-induced+hepatotoxicity%3A+state+of+the+science&doi=10.1517%2F17425255.4.11.1415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science</span></div><div class="casAuthors">Antoine, Daniel J.; Williams, Dominic P.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1415-1427</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Drug-induced liver injury (DILI) represents a major impediment to the development of new drugs and is a leading cause of drug withdrawal.  The occurrence of hepatotoxicity has been closely assocd. with the formation of chem. reactive metabolites.  Huge investment has focused on the screening of chem. reactive metabolites to offer a pragmatic approach to produce safer drugs and also reduce drug attrition and prevent market place withdrawal.  However, questions surrounding the importance of chem. reactive metabolites still remain.  Increasing evidence now exists for the multi-factorial nature of DILI, in particular the role played by the host immune system or disease state in the pathogenesis of DILI.  This review aims to evaluate the current measures for the prediction and diagnosis of DILI and to highlight investigations being made to understand the multidimensional nature.  Some of the steps being made to generate improved physiol. systems to identify more sensitive, reflective mechanism-based biomarkers to aid the earlier identification of DILI and develop safer medicines are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGt3l_RkKOaLVg90H21EOLACvtfcHk0liShO15pxWs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12jtbrO&md5=93c1c61013859c12017c2b3c2d9155d4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.11.1415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.11.1415%26sid%3Dliteratum%253Aachs%26aulast%3DAntoine%26aufirst%3DD.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DUnderstanding%2520the%2520role%2520of%2520reactive%2520metabolites%2520in%2520drug-induced%2520hepatotoxicity%253A%2520state%2520of%2520the%2520science%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D1415%26epage%3D1427%26doi%3D10.1517%2F17425255.4.11.1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">McMillian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. D.</span><span> </span><span class="NLM_article-title">An improved resazurin-based cytotoxicity assay for hepatic cells</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1023/A:1015559603643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1023%2FA%3A1015559603643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=12083422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVWqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=157-173&author=M.+K.+McMillianauthor=L.+Liauthor=J.+B.+Parkerauthor=L.+Patelauthor=Z.+Zhongauthor=J.+W.+Gunnettauthor=W.+J.+Powersauthor=M.+D.+Johnson&title=An+improved+resazurin-based+cytotoxicity+assay+for+hepatic+cells&doi=10.1023%2FA%3A1015559603643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An improved resazurin-based cytotoxicity assay for hepatic cells</span></div><div class="casAuthors">McMillian, M. K.; Li, L.; Parker, J. B.; Patel, L.; Zhong, Z.; Gunnett, J. W.; Powers, W. J.; Johnson, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-173</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A simple resazurin-based cytotoxicity assay is presented for screening of cytotoxicity in hepatocytes and liver cell lines.  Human hepatoma (HepG2) cells in 96-well culture plates were exposed to known toxic (cisplatin, 5-fluorouracil, ethionine, flufenamic acid, and diflunisal) and control (transplatin, 5-chlorouracil, methionine, and acetylsalicylic acid) compds. for 1-3 days, and resazurin (5 μmol/L) was added.  A conventional short-term (1 h) assay was first performed, where cytotoxicity is indicated by decreased redn. of resazurin to its fluorescent product resorufin.  Our improved assay consists of addnl. measuring fluorescence 2-4 days later, when cytotoxicity is indicated by a striking increase in the concn. of resorufin, resulting from two distinct processes.  First, viable liver-derived cells slowly convert resorufin to nonfluorescent metabolites.  Fluorescence of control cell wells decreased to background during a 2- to 4-day exposure to resazurin.  This metab. of resorufin was largely blocked by dicumarol and to lesser extents by disulfiram and SKF525a.  Second, dead or dying cells slowly convert resazurin to resorufin but do not further metabolize resorufin; thus this fluorescent metabolite accumulates to high levels in wells with dead cells by 2 to 4 days.  A similar increase in fluorescence assocd. with cytotoxicity was obsd. in primary cultures of rat hepatocytes using the long-term resazurin-based assay.  In addn. to an improved signal relative to the short-term assay, the inversion of the fluorescent signal from high = alive short-term to high = dead long-term allows detn. of two independent cytotoxicity endpoints after addn. of one innocuous vital dye.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcib981V1DhrVg90H21EOLACvtfcHk0liANKAxBrwN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVWqsbc%253D&md5=3efbbe079eeffee704146b774cdae556</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015559603643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015559603643%26sid%3Dliteratum%253Aachs%26aulast%3DMcMillian%26aufirst%3DM.%2BK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DJ.%2BB.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DGunnett%26aufirst%3DJ.%2BW.%26aulast%3DPowers%26aufirst%3DW.%2BJ.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26atitle%3DAn%2520improved%2520resazurin-based%2520cytotoxicity%2520assay%2520for%2520hepatic%2520cells%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2002%26volume%3D18%26spage%3D157%26epage%3D173%26doi%3D10.1023%2FA%3A1015559603643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Falagas, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manta, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziora, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardakas, K. Z.</span><span> </span><span class="NLM_article-title">Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1093/jac/dkl219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1093%2Fjac%2Fdkl219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=16735427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD28Xotl2lsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=273-280&author=M.+E.+Falagasauthor=K.+G.+Mantaauthor=F.+Ntzioraauthor=K.+Z.+Vardakas&title=Linezolid+for+the+treatment+of+patients+with+endocarditis%3A+a+systematic+review+of+the+published+evidence&doi=10.1093%2Fjac%2Fdkl219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence</span></div><div class="casAuthors">Falagas, Matthew E.; Manta, Katerina G.; Ntziora, Fotinie; Vardakas, Konstantinos Z.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-280</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Linezolid is a bacteriostatic oxazolidinone antibiotic that was proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and possibly bacteremia, due to Gram-pos. cocci.  However, the drug is sometimes used for the treatment of patients with endocarditis due to Gram-pos. cocci resistant to other antibiotics.  The authors carried out a review of the available literature to evaluate whether linezolid is also effective for the treatment of patients with infective endocarditis.  The authors identified 23 case reports and 3 case series reporting the experience with 56 patients with endocarditis treated with linezolid.  Evaluable data for 33 patients who received linezolid and for whom individual patient data were reported were further analyzed.  Prosthetic valve infective endocarditis accounted for 25% of the reviewed cases.  Methicillin-resistant Staphylococcus aureus and vancomycin-intermediate S. aureus were the most commonly isolated cocci (24.2% and 30.3% of cases, resp.).  Linezolid alone was administered to 66.7% of patients while the rest received the antibiotic in combination with rifampicin, gentamicin, fusidic acid or amikacin.  A total of 63.6% (21/33) of patients with endocarditis were cured after linezolid administration.  The overall and endocarditis-related mortality was 33.3% (11/33) and 12.1% (4/33), resp.  Thrombocytopenia developed in 30.8% (8/26) of patients for whom relevant data were available.  The limited available evidence suggests that linezolid may be considered as a therapeutic option for the treatment of patients with endocarditis due to multidrug-resistant Gram-pos. cocci.  However, further published experience is needed to answer the question of whether a bacteriostatic antibiotic could be proven beneficial for patients with an infection for which bactericidal antibiotics were traditionally used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYf2_20F6GBbVg90H21EOLACvtfcHk0liANKAxBrwN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xotl2lsLo%253D&md5=3c55aaa141a0f6c23d5ac7ec06971f6a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkl219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkl219%26sid%3Dliteratum%253Aachs%26aulast%3DFalagas%26aufirst%3DM.%2BE.%26aulast%3DManta%26aufirst%3DK.%2BG.%26aulast%3DNtziora%26aufirst%3DF.%26aulast%3DVardakas%26aufirst%3DK.%2BZ.%26atitle%3DLinezolid%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520endocarditis%253A%2520a%2520systematic%2520review%2520of%2520the%2520published%2520evidence%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2006%26volume%3D58%26spage%3D273%26epage%3D280%26doi%3D10.1093%2Fjac%2Fdkl219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Attassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, M. J.</span><span> </span><span class="NLM_article-title">Thrombocytopenia associated with linezolid therapy</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1086/338403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1086%2F338403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=11803505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=695-698&author=K.+Attassiauthor=E.+Hershbergerauthor=R.+Alamauthor=M.+J.+Zervos&title=Thrombocytopenia+associated+with+linezolid+therapy&doi=10.1086%2F338403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombocytopenia associated with linezolid therapy</span></div><div class="casAuthors">Attassi Kinan; Hershberger Ellie; Alam Rabiul; Zervos Marcus J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We evaluated the incidence and clinical characteristics of linezolid-induced thrombocytopenia in 19 patients who were treated with linezolid.  Overall, thrombocytopenia (platelet count, <100,000 platelets/mm(3)) was observed in 32% of patients who received linezolid for >10 days; gastrointestinal bleeding was observed in 1 patient and 4 patients required platelet transfusions.  These data suggest that even patients who are not considered to be at risk for development of thrombocytopenia should be monitored closely if linezolid therapy is continued for >10 days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIIyZakd2UiZggzHGM8X5CfW6udTcc2eYSrkIM1lv7arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D&md5=be07b767a34bffcea4e16105cf1993fa</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1086%2F338403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F338403%26sid%3Dliteratum%253Aachs%26aulast%3DAttassi%26aufirst%3DK.%26aulast%3DHershberger%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26atitle%3DThrombocytopenia%2520associated%2520with%2520linezolid%2520therapy%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2002%26volume%3D34%26spage%3D695%26epage%3D698%26doi%3D10.1086%2F338403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Volpe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, M. K.</span><span> </span><span class="NLM_article-title">Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents</span> <span class="citation_source-journal">Toxicol. In Vitro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/S0887-2333(03)00012-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0887-2333%2803%2900012-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=271-277&author=D.+A.+Volpeauthor=M.+K.+Warren&title=Myeloid+clonogenic+assays+for+comparison+of+the+in+vitro+toxicity+of+alkylating+agents&doi=10.1016%2FS0887-2333%2803%2900012-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0887-2333%2803%2900012-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0887-2333%252803%252900012-2%26sid%3Dliteratum%253Aachs%26aulast%3DVolpe%26aufirst%3DD.%2BA.%26aulast%3DWarren%26aufirst%3DM.%2BK.%26atitle%3DMyeloid%2520clonogenic%2520assays%2520for%2520comparison%2520of%2520the%2520in%2520vitro%2520toxicity%2520of%2520alkylating%2520agents%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2003%26volume%3D17%26spage%3D271%26epage%3D277%26doi%3D10.1016%2FS0887-2333%2803%2900012-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Boehm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A.</span><span> </span><span class="NLM_article-title">Simply red: A novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies</span> <span class="citation_source-journal">Biotechnol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.btre.2014.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.btre.2014.07.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=34-41&author=D.+Boehmauthor=A.+Bell&title=Simply+red%3A+A+novel+spectrophotometric+erythroid+proliferation+assay+as+a+tool+for+erythropoiesis+and+erythrotoxicity+studies&doi=10.1016%2Fj.btre.2014.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.btre.2014.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.btre.2014.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DA.%26atitle%3DSimply%2520red%253A%2520A%2520novel%2520spectrophotometric%2520erythroid%2520proliferation%2520assay%2520as%2520a%2520tool%2520for%2520erythropoiesis%2520and%2520erythrotoxicity%2520studies%26jtitle%3DBiotechnol.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D34%26epage%3D41%26doi%3D10.1016%2Fj.btre.2014.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Andes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, W. A.</span><span> </span><span class="NLM_article-title">In vivo activities of amoxicillin and amoxicillin-clavulanate against <i>Streptococcus pneumoniae</i>: application to breakpoint determinations</span> <span class="citation_source-journal">Chemotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=2375-2379&author=D.+Andesauthor=W.+A.+Craig&title=In+vivo+activities+of+amoxicillin+and+amoxicillin-clavulanate+against+Streptococcus+pneumoniae%3A+application+to+breakpoint+determinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndes%26aufirst%3DD.%26aulast%3DCraig%26aufirst%3DW.%2BA.%26atitle%3DIn%2520vivo%2520activities%2520of%2520amoxicillin%2520and%2520amoxicillin-clavulanate%2520against%2520Streptococcus%2520pneumoniae%253A%2520application%2520to%2520breakpoint%2520determinations%26jtitle%3DChemotherapy%26date%3D1998%26volume%3D42%26spage%3D2375%26epage%3D2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. W.</span><span> </span><span class="NLM_article-title">Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in Guinea pigs and mice using serial sampling</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1124/dmd.104.000349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1124%2Fdmd.104.000349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1092-1095&author=S.+K.+Balaniauthor=P.+Liauthor=J.+Nguyenauthor=K.+Cardozaauthor=H.+Zengauthor=D.+Muauthor=J.+Wuauthor=L.+Ganauthor=F.+W.+Lee&title=Effective+dosing+regimen+of+1-aminobenzotriazole+for+inhibition+of+antipyrine+clearance+in+Guinea+pigs+and+mice+using+serial+sampling&doi=10.1124%2Fdmd.104.000349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000349%26sid%3Dliteratum%253Aachs%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DCardoza%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DF.%2BW.%26atitle%3DEffective%2520dosing%2520regimen%2520of%25201-aminobenzotriazole%2520for%2520inhibition%2520of%2520antipyrine%2520clearance%2520in%2520Guinea%2520pigs%2520and%2520mice%2520using%2520serial%2520sampling%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1092%26epage%3D1095%26doi%3D10.1124%2Fdmd.104.000349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Miller, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundy, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mott, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skepner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hromockyj, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotti, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurenko, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzner, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammert, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graber, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruble, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamilar, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banitt, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurd, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span> </span><span class="NLM_article-title">Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2806</span><span class="NLM_x">–</span> <span class="NLM_lpage">2812</span><span class="refDoi"> DOI: 10.1128/AAC.00247-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.00247-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18519725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ogt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2806-2812&author=A.+A.+Millerauthor=G.+L.+Bundyauthor=J.+E.+Mottauthor=J.+E.+Skepnerauthor=T.+P.+Boyleauthor=D.+W.+Harrisauthor=A.+E.+Hromockyjauthor=K.+R.+Marottiauthor=G.+E.+Zurenkoauthor=J.+B.+Munznerauthor=M.+T.+Sweeneyauthor=G.+F.+Bammertauthor=J.+C.+Hamelauthor=C.+W.+Fordauthor=W.+Zhongauthor=D.+R.+Graberauthor=G.+E.+Martinauthor=F.+Hanauthor=L.+A.+Dolakauthor=E.+P.+Seestauthor=J.+C.+Rubleauthor=G.+M.+Kamilarauthor=J.+R.+Palmerauthor=L.+S.+Banittauthor=A.+R.+Hurdauthor=M.+R.+Barbachyn&title=Discovery+and+characterization+of+QPT-1%2C+the+progenitor+of+a+new+class+of+bacterial+topoisomerase+inhibitors&doi=10.1128%2FAAC.00247-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors</span></div><div class="casAuthors">Miller, Alita A.; Bundy, Gordon L.; Mott, John E.; Skepner, Jill E.; Boyle, Timothy P.; Harris, Douglas W.; Hromockyj, Alexander E.; Marotti, Keith R.; Zurenko, Gary E.; Munzner, Jennifer B.; Sweeney, Michael T.; Bammert, Gary F.; Hamel, Judith C.; Ford, Charles W.; Zhong, Wei-Zhu; Graber, David R.; Martin, Gary E.; Han, Fusen; Dolak, Lester A.; Seest, Eric P.; Ruble, J. Craig; Kamilar, Gregg M.; Palmer, John R.; Banitt, Lee S.; Hurd, Alexander R.; Barbachyn, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2806-2812</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">QPT-1 was discovered in a compd. library by high-throughput screening and triage for substances with whole-cell antibacterial activity.  This totally synthetic compd. is an unusual barbituric acid deriv. whose activity resides in the (-)-enantiomer.  QPT-1 had activity against a broad spectrum of pathogenic, antibiotic-resistant bacteria, was nontoxic to eukaryotic cells, and showed oral efficacy in a murine infection model, all before any medicinal chem. optimization.  Biochem. and genetic characterization showed that the QPT-1 targets the β subunit of bacterial type II topoisomerases via a mechanism of inhibition distinct from the mechanisms of fluoroquinolones and novobiocin.  Given these attributes, this compd. represents a promising new class of antibacterial agents.  The success of this reverse genomics effort demonstrates the utility of exploring strategies that are alternatives to target-based screens in antibacterial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoPSHAUxaaj7Vg90H21EOLACvtfcHk0lizXa9_nS4gxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ogt7c%253D&md5=c459d15b895768ec27648222ad03d20d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.00247-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00247-08%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DA.%2BA.%26aulast%3DBundy%26aufirst%3DG.%2BL.%26aulast%3DMott%26aufirst%3DJ.%2BE.%26aulast%3DSkepner%26aufirst%3DJ.%2BE.%26aulast%3DBoyle%26aufirst%3DT.%2BP.%26aulast%3DHarris%26aufirst%3DD.%2BW.%26aulast%3DHromockyj%26aufirst%3DA.%2BE.%26aulast%3DMarotti%26aufirst%3DK.%2BR.%26aulast%3DZurenko%26aufirst%3DG.%2BE.%26aulast%3DMunzner%26aufirst%3DJ.%2BB.%26aulast%3DSweeney%26aufirst%3DM.%2BT.%26aulast%3DBammert%26aufirst%3DG.%2BF.%26aulast%3DHamel%26aufirst%3DJ.%2BC.%26aulast%3DFord%26aufirst%3DC.%2BW.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DGraber%26aufirst%3DD.%2BR.%26aulast%3DMartin%26aufirst%3DG.%2BE.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DRuble%26aufirst%3DJ.%2BC.%26aulast%3DKamilar%26aufirst%3DG.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BR.%26aulast%3DBanitt%26aufirst%3DL.%2BS.%26aulast%3DHurd%26aufirst%3DA.%2BR.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520QPT-1%252C%2520the%2520progenitor%2520of%2520a%2520new%2520class%2520of%2520bacterial%2520topoisomerase%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2806%26epage%3D2812%26doi%3D10.1128%2FAAC.00247-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Black, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachyra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruneau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miossec, C.</span><span> </span><span class="NLM_article-title">Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span><span class="refDoi"> DOI: 10.1128/AAC.00496-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.00496-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=18625781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3339-3349&author=M.+T.+Blackauthor=T.+Stachyraauthor=D.+Platelauthor=A.+Girardauthor=M.+Claudonauthor=J.+Bruneauauthor=C.+Miossec&title=Mechanism+of+action+of+the+antibiotic+NXL101%2C+a+novel+nonfluoroquinolone+inhibitor+of+bacterial+type+II+topoisomerases&doi=10.1128%2FAAC.00496-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases</span></div><div class="casAuthors">Black, Michael T.; Stachyra, Therese; Platel, Denis; Girard, Anne-Marie; Claudon, Monique; Bruneau, Jean-Michel; Miossec, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3339-3349</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">NXL101 is one of a new class of quinoline antibacterial DNA gyrase and topoisomerase IV inhibitors showing potent activity against gram-pos. bacteria, including methicillin- and fluoroquinolone-resistant strains.  NXL101 inhibited topoisomerase IV more effectively than gyrase from Escherichia coli, whereas the converse is true of enzymes from Staphylococcus aureus.  This apparent target preference is opposite to that which is assocd. with most fluoroquinolone antibiotics.  In vitro isolation of S. aureus mutants resistant to NXL101 followed by cloning and sequencing of the genes encoding gyrase and topoisomerase IV led to the identification of several different point mutations within, or close to, the quinolone resistance-detg. region (QRDR) of GyrA.  However, the mutations were not those that are most frequently assocd. with decreased sensitivity to quinolones.  A fluoroquinolone-resistant mutant variant of gyrase generated in vitro was highly resistant to inhibition by the fluoroquinolones ciprofloxacin and moxifloxacin but remained fully susceptible to inhibition by NXL101.  Two mutant gyrases constructed in vitro, with mutations in gyrA engineered according to those most frequently found in S. aureus strains resistant to NXL101, were insensitive to inhibition by NXL101 and had a diminished sensitivity to ciprofloxacin and moxifloxacin.  Certain combinations of mutations giving rise to NXL101 resistance and those giving rise to fluoroquinolone resistance may be mutually exclusive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRmIzSCazIbVg90H21EOLACvtfcHk0lizXa9_nS4gxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt77L&md5=a39fe88e84c958369d86f4614c9f3e06</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FAAC.00496-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00496-08%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DM.%2BT.%26aulast%3DStachyra%26aufirst%3DT.%26aulast%3DPlatel%26aufirst%3DD.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DClaudon%26aufirst%3DM.%26aulast%3DBruneau%26aufirst%3DJ.%26aulast%3DMiossec%26aufirst%3DC.%26atitle%3DMechanism%2520of%2520action%2520of%2520the%2520antibiotic%2520NXL101%252C%2520a%2520novel%2520nonfluoroquinolone%2520inhibitor%2520of%2520bacterial%2520type%2520II%2520topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3339%26epage%3D3349%26doi%3D10.1128%2FAAC.00496-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Robinson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osheroff, N.</span><span> </span><span class="NLM_article-title">Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3638</span><span class="NLM_x">–</span> <span class="NLM_lpage">3643</span><span class="refDoi"> DOI: 10.1021/bi00065a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00065a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=3638-3643&author=M.+J.+Robinsonauthor=A.+H.+Corbettauthor=N.+Osheroff&title=Effects+of+topoisomerase+II-targeted+drugs+on+enzyme-mediated+DNA+cleavage+and+ATP+hydrolysis%3A+evidence+for+distinct+drug+interaction+domains+on+topoisomerase+II&doi=10.1021%2Fbi00065a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi00065a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00065a016%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DM.%2BJ.%26aulast%3DCorbett%26aufirst%3DA.%2BH.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DEffects%2520of%2520topoisomerase%2520II-targeted%2520drugs%2520on%2520enzyme-mediated%2520DNA%2520cleavage%2520and%2520ATP%2520hydrolysis%253A%2520evidence%2520for%2520distinct%2520drug%2520interaction%2520domains%2520on%2520topoisomerase%2520II%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D3638%26epage%3D3643%26doi%3D10.1021%2Fbi00065a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Huband, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basarab, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacobbe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patey, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. P.</span><span> </span><span class="NLM_article-title">In vitro antibacterial activity of AZD0914: a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fasitidious Gram-negative, and atypcial bacteria</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1128/AAC.04124-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.04124-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=467-474&author=M.+D.+Hubandauthor=P.+A.+Bradfordauthor=L.+A.+Ottersonauthor=G.+S.+Basarabauthor=A.+Kutschkeauthor=R.+A.+Giacobbeauthor=S.+A.+Pateyauthor=R.+A.+Almauthor=M.+R.+Johnstoneauthor=M.+E.+Potterauthor=P.+F.+Millerauthor=J.+P.+Mueller&title=In+vitro+antibacterial+activity+of+AZD0914%3A+a+new+spiropyrimidinetrione+DNA+gyrase%2Ftopoisomerase+inhibitor+with+potent+activity+against+Gram-positive%2C+fasitidious+Gram-negative%2C+and+atypcial+bacteria&doi=10.1128%2FAAC.04124-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FAAC.04124-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04124-14%26sid%3Dliteratum%253Aachs%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DBradford%26aufirst%3DP.%2BA.%26aulast%3DOtterson%26aufirst%3DL.%2BA.%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DGiacobbe%26aufirst%3DR.%2BA.%26aulast%3DPatey%26aufirst%3DS.%2BA.%26aulast%3DAlm%26aufirst%3DR.%2BA.%26aulast%3DJohnstone%26aufirst%3DM.%2BR.%26aulast%3DPotter%26aufirst%3DM.%2BE.%26aulast%3DMiller%26aufirst%3DP.%2BF.%26aulast%3DMueller%26aufirst%3DJ.%2BP.%26atitle%3DIn%2520vitro%2520antibacterial%2520activity%2520of%2520AZD0914%253A%2520a%2520new%2520spiropyrimidinetrione%2520DNA%2520gyrase%252Ftopoisomerase%2520inhibitor%2520with%2520potent%2520activity%2520against%2520Gram-positive%252C%2520fasitidious%2520Gram-negative%252C%2520and%2520atypcial%2520bacteria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D467%26epage%3D474%26doi%3D10.1128%2FAAC.04124-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Alm, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteaker, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, J. P.</span><span> </span><span class="NLM_article-title">Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in <i>Neisseria gonorrhoeae</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1486</span><span class="refDoi"> DOI: 10.1128/AAC.04456-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1128%2FAAC.04456-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1478-1486&author=R.+A.+Almauthor=S.+D.+Lahiriauthor=A.+Kutschkeauthor=L.+G.+Ottersonauthor=R.+E.+McLaughlinauthor=J.+D.+Whiteakerauthor=L.+A.+Lewisauthor=X.+Suauthor=M.+D.+Hubandauthor=H.+Gardnerauthor=J.+P.+Mueller&title=Characterization+of+the+novel+DNA+gyrase+inhibitor+AZD0914%3A+low+resistance+potential+and+lack+of+cross-resistance+in+Neisseria+gonorrhoeae&doi=10.1128%2FAAC.04456-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.04456-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04456-14%26sid%3Dliteratum%253Aachs%26aulast%3DAlm%26aufirst%3DR.%2BA.%26aulast%3DLahiri%26aufirst%3DS.%2BD.%26aulast%3DKutschke%26aufirst%3DA.%26aulast%3DOtterson%26aufirst%3DL.%2BG.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DWhiteaker%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DL.%2BA.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMueller%26aufirst%3DJ.%2BP.%26atitle%3DCharacterization%2520of%2520the%2520novel%2520DNA%2520gyrase%2520inhibitor%2520AZD0914%253A%2520low%2520resistance%2520potential%2520and%2520lack%2520of%2520cross-resistance%2520in%2520Neisseria%2520gonorrhoeae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D1478%26epage%3D1486%26doi%3D10.1128%2FAAC.04456-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Basarab, G. S.; Gowravaram, M. R.; Hauck, S. I.; Zhou, F.</span><span> </span><span class="NLM_article-title">Preparation of spiro[oxazino[4,3-<i>a</i>]isoxazolo[4,5-<i>g</i>]quinoline-pyrimidine]trione compounds and methods for treating bacterial infections</span>. U.S. Patent US 20140206677,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+S.+Basarab&author=M.+R.+Gowravaram&author=S.+I.+Hauck&author=F.+Zhou&title=Preparation+of+spiro%5Boxazino%5B4%2C3-a%5Disoxazolo%5B4%2C5-g%5Dquinoline-pyrimidine%5Dtrione+compounds+and+methods+for+treating+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26atitle%3DPreparation%2520of%2520spiro%255Boxazino%255B4%252C3-a%255Disoxazolo%255B4%252C5-g%255Dquinoline-pyrimidine%255Dtrione%2520compounds%2520and%2520methods%2520for%2520treating%2520bacterial%2520infections%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Unemo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golparian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, W. M.</span><span> </span><span class="NLM_article-title">Challenges with gonorrhea in the era of multi-drug and extensively drug resistance – are we on the right track?</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span><span class="refDoi"> DOI: 10.1586/14787210.2014.906902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1586%2F14787210.2014.906902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=24702589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVelsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=653-656&author=M.+Unemoauthor=D.+Golparianauthor=W.+M.+Shafer&title=Challenges+with+gonorrhea+in+the+era+of+multi-drug+and+extensively+drug+resistance+%E2%80%93+are+we+on+the+right+track%3F&doi=10.1586%2F14787210.2014.906902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track?</span></div><div class="casAuthors">Unemo, Magnus; Golparian, Daniel; Shafer, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-656</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Neisseria gonorrhoeae has retained antimicrobial resistance to drugs previously recommended for first-line empiric treatment of gonorrhea, and resistance to ceftriaxone, the last option for monotherapy, is evolving.  Crucial actions to combat this developing situation include implementing response plans; considering use of dual antimicrobial regimens; enhancing surveillance of gonorrhea, gonococcal antimicrobial resistance, treatment failures and antimicrobial use/misuse and improving prevention, early diagnosis, contact tracing and treatment.  The ways forward also include an intensified research to identify novel antimicrobial resistance determinants and develop and evaluate appropriate use of mol. antimicrobial resistance testing, ideally point-of-care and with simultaneous detection of gonococci, to supplement culture-based methods and ideally guide tailored treatment.  It is crucial with an enhanced understanding of the dynamics of the national and international emergence, transmission and evolution of antimicrobial-resistant gonococcal strains.  Genome sequencing combined with epidemiol. metadata will detail these issues and might also revolutionize the mol. antimicrobial resistance testing.  Ultimately, novel antimicrobials are essential and some antimicrobials in development have shown potent in vitro activity against gonococci.  Several of these antimicrobials deserve further attention for potential future treatment of gonorrhea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVg4fD4qxD7Vg90H21EOLACvtfcHk0lj3Gh3UTLhONA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVelsbw%253D&md5=4bb17602fb4cd971ebf09d9f5f9a3049</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1586%2F14787210.2014.906902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.2014.906902%26sid%3Dliteratum%253Aachs%26aulast%3DUnemo%26aufirst%3DM.%26aulast%3DGolparian%26aufirst%3DD.%26aulast%3DShafer%26aufirst%3DW.%2BM.%26atitle%3DChallenges%2520with%2520gonorrhea%2520in%2520the%2520era%2520of%2520multi-drug%2520and%2520extensively%2520drug%2520resistance%2520%25E2%2580%2593%2520are%2520we%2520on%2520the%2520right%2520track%253F%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2014%26volume%3D12%26spage%3D653%26epage%3D656%26doi%3D10.1586%2F14787210.2014.906902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Rein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goicoechea-Pappas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anklekar, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawley, R. E.</span><span> </span><span class="NLM_article-title">Chiral dipole-stabilized anions: experiment and theory in benzylic and allylic systems. Stereoselective deprotonations, pyramidal inversions, and stereoselective alkylations of lithiated (tetrahydroisoquinolyl)oxazolines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2211</span><span class="NLM_x">–</span> <span class="NLM_lpage">2217</span><span class="refDoi"> DOI: 10.1021/ja00188a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00188a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1989&pages=2211-2217&author=K.+Reinauthor=M.+Goicoechea-Pappasauthor=T.+V.+Anklekarauthor=G.+C.+Hartauthor=G.+A.+Smithauthor=R.+E.+Gawley&title=Chiral+dipole-stabilized+anions%3A+experiment+and+theory+in+benzylic+and+allylic+systems.+Stereoselective+deprotonations%2C+pyramidal+inversions%2C+and+stereoselective+alkylations+of+lithiated+%28tetrahydroisoquinolyl%29oxazolines&doi=10.1021%2Fja00188a040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja00188a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00188a040%26sid%3Dliteratum%253Aachs%26aulast%3DRein%26aufirst%3DK.%26aulast%3DGoicoechea-Pappas%26aufirst%3DM.%26aulast%3DAnklekar%26aufirst%3DT.%2BV.%26aulast%3DHart%26aufirst%3DG.%2BC.%26aulast%3DSmith%26aufirst%3DG.%2BA.%26aulast%3DGawley%26aufirst%3DR.%2BE.%26atitle%3DChiral%2520dipole-stabilized%2520anions%253A%2520experiment%2520and%2520theory%2520in%2520benzylic%2520and%2520allylic%2520systems.%2520Stereoselective%2520deprotonations%252C%2520pyramidal%2520inversions%252C%2520and%2520stereoselective%2520alkylations%2520of%2520lithiated%2520%2528tetrahydroisoquinolyl%2529oxazolines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1989%26volume%3D111%26spage%3D2211%26epage%3D2217%26doi%3D10.1021%2Fja00188a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Chouhan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alper, H.</span><span> </span><span class="NLM_article-title">Synthesis of ring-fused oxazolo- and pyrazoloisoquinolinones by a one-pot Pd-catalyzed carboxamidation and aldol-aype condensation cascade process</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">6181</span><span class="NLM_x">–</span> <span class="NLM_lpage">6189</span><span class="refDoi"> DOI: 10.1021/jo9010574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9010574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=6181-6189&author=G.+Chouhanauthor=H.+Alper&title=Synthesis+of+ring-fused+oxazolo-+and+pyrazoloisoquinolinones+by+a+one-pot+Pd-catalyzed+carboxamidation+and+aldol-aype+condensation+cascade+process&doi=10.1021%2Fjo9010574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjo9010574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9010574%26sid%3Dliteratum%253Aachs%26aulast%3DChouhan%26aufirst%3DG.%26aulast%3DAlper%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520ring-fused%2520oxazolo-%2520and%2520pyrazoloisoquinolinones%2520by%2520a%2520one-pot%2520Pd-catalyzed%2520carboxamidation%2520and%2520aldol-aype%2520condensation%2520cascade%2520process%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D6181%26epage%3D6189%26doi%3D10.1021%2Fjo9010574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Nishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, F.</span><span> </span><span class="NLM_article-title">Synthesis and spectral behavior of 5-methyl-3-phenyl-1,3-oxazolidin-2-ones using NMR</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span><span class="refDoi"> DOI: 10.1002/jhet.5570230535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1002%2Fjhet.5570230535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1986&pages=1427-1429&author=T.+Nishiyamaauthor=S.+Matsuiauthor=F.+Yamada&title=Synthesis+and+spectral+behavior+of+5-methyl-3-phenyl-1%2C3-oxazolidin-2-ones+using+NMR&doi=10.1002%2Fjhet.5570230535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570230535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570230535%26sid%3Dliteratum%253Aachs%26aulast%3DNishiyama%26aufirst%3DT.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520spectral%2520behavior%2520of%25205-methyl-3-phenyl-1%252C3-oxazolidin-2-ones%2520using%2520NMR%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1986%26volume%3D23%26spage%3D1427%26epage%3D1429%26doi%3D10.1002%2Fjhet.5570230535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Berkowitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloss, D. G.</span><span> </span><span class="NLM_article-title">Diallyl (lithiodifluoromethyl)phosphonate: a new reagent for the introduction of the (difluoromethylene)phosphonate functionality</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7047</span><span class="NLM_x">–</span> <span class="NLM_lpage">7050</span><span class="refDoi"> DOI: 10.1021/jo00126a073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00126a073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7047-7050&author=D.+B.+Berkowitzauthor=D.+G.+Sloss&title=Diallyl+%28lithiodifluoromethyl%29phosphonate%3A+a+new+reagent+for+the+introduction+of+the+%28difluoromethylene%29phosphonate+functionality&doi=10.1021%2Fjo00126a073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjo00126a073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00126a073%26sid%3Dliteratum%253Aachs%26aulast%3DBerkowitz%26aufirst%3DD.%2BB.%26aulast%3DSloss%26aufirst%3DD.%2BG.%26atitle%3DDiallyl%2520%2528lithiodifluoromethyl%2529phosphonate%253A%2520a%2520new%2520reagent%2520for%2520the%2520introduction%2520of%2520the%2520%2528difluoromethylene%2529phosphonate%2520functionality%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7047%26epage%3D7050%26doi%3D10.1021%2Fjo00126a073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. V.</span><span> </span><span class="NLM_article-title">Bromocyclization of unsaturated thiocarbamidates. Synthesis of (+-)-sporamine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6985</span><span class="NLM_x">–</span> <span class="NLM_lpage">6986</span><span class="refDoi"> DOI: 10.1021/ja00361a053</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00361a053" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1983&pages=6985-6986&author=S.+Knappauthor=D.+V.+Patel&title=Bromocyclization+of+unsaturated+thiocarbamidates.+Synthesis+of+%28%2B-%29-sporamine&doi=10.1021%2Fja00361a053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja00361a053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00361a053%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26atitle%3DBromocyclization%2520of%2520unsaturated%2520thiocarbamidates.%2520Synthesis%2520of%2520%2528%252B-%2529-sporamine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1983%26volume%3D105%26spage%3D6985%26epage%3D6986%26doi%3D10.1021%2Fja00361a053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Enders, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallfass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, B.</span><span> </span><span class="NLM_article-title">A short diastereo- and enantioselective synthesis of cis-4,5-disubstituted oxazolidin-2-ones</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">0033</span><span class="NLM_x">–</span> <span class="NLM_lpage">0036</span><span class="refDoi"> DOI: 10.1055/s-2002-19341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1055%2Fs-2002-19341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2002&publication_year=2002&pages=0033-0036&author=D.+Endersauthor=U.+Kallfassauthor=B.+Nolte&title=A+short+diastereo-+and+enantioselective+synthesis+of+cis-4%2C5-disubstituted+oxazolidin-2-ones&doi=10.1055%2Fs-2002-19341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1055%2Fs-2002-19341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2002-19341%26sid%3Dliteratum%253Aachs%26aulast%3DEnders%26aufirst%3DD.%26aulast%3DKallfass%26aufirst%3DU.%26aulast%3DNolte%26aufirst%3DB.%26atitle%3DA%2520short%2520diastereo-%2520and%2520enantioselective%2520synthesis%2520of%2520cis-4%252C5-disubstituted%2520oxazolidin-2-ones%26jtitle%3DSynlett%26date%3D2002%26volume%3D2002%26spage%3D0033%26epage%3D0036%26doi%3D10.1055%2Fs-2002-19341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span>M07-A9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">42</span>, pp  <span class="NLM_fpage">88</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=M07-A9.+Methods+for+Dilution+Antimicrobial+Susceptibility+Tests+for+Bacteria+That+Grow+Aerobically%3B+Approved+Standard.+Clinical+and+Laboratory+Standards+Institute%3A+Wayne%2C+PA%2C+2012%3B+Vol.+42%2C+pp+88."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DM07-A9.%2520Methods%2520for%2520Dilution%2520Antimicrobial%2520Susceptibility%2520Tests%2520for%2520Bacteria%2520That%2520Grow%2520Aerobically%253B%2520Approved%2520Standard%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2012%26volume%3D42%26spage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span>M100-S24. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement; <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">34</span>, pp  <span class="NLM_fpage">10</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=M100-S24.+Performance+Standards+for+Antimicrobial+Susceptibility+Testing%3B+Twenty-Fourth+Informational+Supplement%3B+Clinical+and+Laboratory+Standards+Institute%3A+Wayne%2C+PA%2C+2014%3B+Vol.+34%2C+pp+10."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DM100-S24.%2520Performance%2520Standards%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%253B%2520Twenty-Fourth%2520Informational%2520Supplement%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2014%26volume%3D34%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Cory, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barltrop, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, J. G.</span><span> </span><span class="NLM_article-title">Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture</span> <span class="citation_source-journal">Cancer Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.3727%2F095535491820873191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1867954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADyaK38Xhsl2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=207-212&author=A.+H.+Coryauthor=T.+C.+Owenauthor=J.+A.+Barltropauthor=J.+G.+Cory&title=Use+of+an+aqueous+soluble+tetrazolium%2Fformazan+assay+for+cell+growth+assays+in+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture</span></div><div class="casAuthors">Cory, Ann H.; Owen, Terence C.; Barltrop, John A.; Cory, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">207-12</span>CODEN:
                <span class="NLM_cas:coden">CNCMET</span>;
        ISSN:<span class="NLM_cas:issn">0955-3541</span>.
    </div><div class="casAbstract">A new tetrazolium analog of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was evaluated as a substitute for MTT in the microculture screening assay for in vitro cell growth.  This new tetrazolium compd., 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS), in the presence of phenazine methosulfate (PMS), gave a water-sol. formazan product that had an absorbance max. at 490-500 nm in phosphate-buffered saline.  The amt. of colored product formed was proportional to the no. of cells and the time of incubation of the cells with MTS/PMS.  MTS/PMS was reactive in all the cell lines tested which included mouse leukemia L1210 cells, mouse Ehrlich tumor cells, mouse 3T3 fibroblasts, and human colon tumor cells (HT-29).  HT-29 and 3T3 fibroblasts reduced MTS/PMS more efficiently than they reduced MTT.  Comparable to the amt. of product formed from MTT, MTS/PMS gave excellent product formation.  The IC50 value for pyrazoloimidazole obtained using MTS/PMS was 200 μM; for 5-fluoro-2'-deoxyuridine, the IC50 value was 0.9 nM.  These values compared very favorably with the IC50 values obtained by direct cell counts.  Further, the same IC50 values were obtained when the absorbances of the formazan product in the 96-well plates were detd. after different times of incubation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9L9qsNf3ks7Vg90H21EOLACvtfcHk0lhO_GDtcl4CRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xhsl2qsQ%253D%253D&md5=9648145be5846e739645e64db964403d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.3727%2F095535491820873191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F095535491820873191%26sid%3Dliteratum%253Aachs%26aulast%3DCory%26aufirst%3DA.%2BH.%26aulast%3DOwen%26aufirst%3DT.%2BC.%26aulast%3DBarltrop%26aufirst%3DJ.%2BA.%26aulast%3DCory%26aufirst%3DJ.%2BG.%26atitle%3DUse%2520of%2520an%2520aqueous%2520soluble%2520tetrazolium%252Fformazan%2520assay%2520for%2520cell%2520growth%2520assays%2520in%2520culture%26jtitle%3DCancer%2520Commun.%26date%3D1991%26volume%3D3%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Doherty, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M.</span><span> </span><span class="NLM_article-title">A rapid, semi-automated method for scoring micronuclei in mononucleated mouse lymphoma cells</span> <span class="citation_source-journal">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">726</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.mrgentox.2011.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2Fj.mrgentox.2011.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12rurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=726&publication_year=2011&pages=36-41&author=A.+T.+Dohertyauthor=J.+Hayesauthor=M.+Fellowsauthor=S.+Kirkauthor=M.+O%E2%80%99Donovan&title=A+rapid%2C+semi-automated+method+for+scoring+micronuclei+in+mononucleated+mouse+lymphoma+cells&doi=10.1016%2Fj.mrgentox.2011.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid, semi-automated method for scoring micronuclei in mononucleated mouse lymphoma cells</span></div><div class="casAuthors">Doherty, Ann T.; Hayes, Julie; Fellows, Mick; Kirk, Sarah; O'Donovan, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology and Environmental Mutagenesis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">726</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">MRGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1383-5718</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A semi-automated scoring system has been developed to provide rapid, accurate assessment of micronuclei in prepns. of mononuclear mouse lymphoma L5178Y cells.  Following exposure to a range of test agents, flat, single-cell prepns. were produced from exponentially growing cultures by cytocentrifugation.  Following staining with 4'-6-diamidino-2-phenylindole (DAPI), cells were scanned by use of the MicroNuc module of Metafer 4 v 3.4.102, after modifying the classifier developed for selecting micronuclei in binucleate cells to increase its sensitivity.  The image gallery of all cells was then sorted to bring aberrant cells to the top of the gallery to assess visually the nos. of cells with micronuclei, as distinct from other debris.  Slide quality was shown to be paramount in obtaining accurate results from an automated scan and the data obtained compared very well with the incidence of micronuclei scored conventionally by microscopy.  Compared with manual scoring the time saving is considerable, as more than 2000 images are captured in approx. 2 min, with subsequent visual assessment of aberrant cells in the image gallery taking about 1-2 min/slide.  By scanning all aberrant cells, the system also captures addnl. information on necrotic, apoptotic and fragmented cells.  Although optimized for mouse lymphoma cells, it should be simple to adapt the method for any cell type growing in suspension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVN4Bt_LDuxbVg90H21EOLACvtfcHk0lhO_GDtcl4CRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12rurvI&md5=0e85329ca1060c131ed364bdcfa00d2d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.mrgentox.2011.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrgentox.2011.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DDoherty%26aufirst%3DA.%2BT.%26aulast%3DHayes%26aufirst%3DJ.%26aulast%3DFellows%26aufirst%3DM.%26aulast%3DKirk%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26atitle%3DA%2520rapid%252C%2520semi-automated%2520method%2520for%2520scoring%2520micronuclei%2520in%2520mononucleated%2520mouse%2520lymphoma%2520cells%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2011%26volume%3D726%26spage%3D36%26epage%3D41%26doi%3D10.1016%2Fj.mrgentox.2011.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Lloyd, M.; Kidd, D.</span><span> </span><span class="NLM_article-title">The mouse lymphoma assay</span>. In <span class="NLM_contrib-group">Parry, J. M.; Parry, E. M.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">817</span>, pp  <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1007%2F978-1-61779-421-6_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lloyd%2C+M.%3B+Kidd%2C+D.+The+mouse+lymphoma+assay.+In+Parry%2C+J.+M.%3B+Parry%2C+E.+M.%2C+Eds.%3B+Springer%3A+New+York%2C+2012%3B+Vol.+817%2C+pp+35%E2%80%9354."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-421-6_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-61779-421-6_3%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DM.%26atitle%3DThe%2520mouse%2520lymphoma%2520assay%26aulast%3DParry%26aufirst%3DJ.%2BM.%26pub%3DSpringer%26date%3D2012%26volume%3D817%26spage%3D35%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Mortelmans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeiger, E.</span><span> </span><span class="NLM_article-title">The Ames Salmonella/microsome mutagenicity assay</span> <span class="citation_source-journal">Mutat. Res., Fundam. Mol. Mech. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/S0027-5107(00)00064-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=10.1016%2FS0027-5107%2800%2900064-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=11113466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2000&pages=29-60&author=K.+Mortelmansauthor=E.+Zeiger&title=The+Ames+Salmonella%2Fmicrosome+mutagenicity+assay&doi=10.1016%2FS0027-5107%2800%2900064-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The Ames Salmonella/microsome mutagenicity assay</span></div><div class="casAuthors">Mortelmans, K.; Zeiger, E.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">29-60</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review and discussion with 95 refs.  The Ames Salmonella/microsome mutagenicity assay (Salmonella test; Ames test) is a short-term bacterial reverse mutation assay specifically designed to detect a wide range of chem. substances that can produce genetic damage that leads to gene mutations.  The test employs several histidine dependent Salmonella strains each carrying different mutations in various genes in the histidine operon.  These mutations act as hot spots for mutagens that cause DNA damage via different mechanisms.  When the Salmonella tester strains are grown on a minimal media agar plate contg. a trace of histidine, only those bacteria that revert to histidine independence (his+) are able to form colonies.  The no. of spontaneously induced revertant colonies per plate is relatively const.  However, when a mutagen is added to the plate, the no. of revertant colonies per plate is increased, usually in a dose-related manner. The Ames test is used world-wide as an initial screen to det. the mutagenic potential of new chems. and drugs.  The test is also used for submission of data to regulatory agencies for registration or acceptance of many chems., including drugs and biocides.  International guidelines have been developed for use by corporations and testing labs. to ensure uniformity of testing procedures. This review provides historical aspects of how the Ames was developed and detailed procedures for performing the test, including the design and interpretation of results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOx1kKxVF6LVg90H21EOLACvtfcHk0lhO_GDtcl4CRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGhtr0%253D&md5=8c4804f0b78e09c6c6609859428a39bf</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0027-5107%2800%2900064-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0027-5107%252800%252900064-6%26sid%3Dliteratum%253Aachs%26aulast%3DMortelmans%26aufirst%3DK.%26aulast%3DZeiger%26aufirst%3DE.%26atitle%3DThe%2520Ames%2520Salmonella%252Fmicrosome%2520mutagenicity%2520assay%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2000%26volume%3D455%26spage%3D29%26epage%3D60%26doi%3D10.1016%2FS0027-5107%2800%2900064-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i89"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00863">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01444"></div></div></div></div></div><hr /></hr><p class="last">Syntheses of intermediates <b>2b</b>, <b>2c</b>, and <b>8</b> and of <i>ent</i>-<b>7t</b> and <i>ent</i>-<b>7u</b> (PDF). The SMILES formula, DNA gyrase inhibitory potency and select MIC values for compounds are provided (CSV). The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00863">10.1021/acs.jmedchem.5b00863</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00863/suppl_file/jm5b00863_si_001.pdf">jm5b00863_si_001.pdf (481.15 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00863/suppl_file/jm5b00863_si_002.csv">jm5b00863_si_002.csv (2.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00863&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00863%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-15" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00863" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997917af3a3ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
